Emerging Medical Technologies (EMT) Database

The premier online business intelligence tool tracking the start-up companies driving the future of medical device innovation.


Select A License:
$5,000 - 1-Year (Single License)





Quarterly online events which showcase 20-40 new early-stage medtech companies that LSI has identified as particularly innovative. Spotlight companies are often raising capital and seeking strategic partners. These events are ideal for investors looking for deal-flow and business development executives from major medtech and pharmaceutical companies looking for M&A and licensing opportunities.

Sample Spotlight Presentation and Company Profile

Presenter: Boaz Assaf, CEO
Financing Status: Seeking Funding
Round: Series C
Amount: $6-$8M
Development Status: CE Marked, Pilot clinical trial completed ready to launch FDA pivotal trial
Sales Projection: $7,725,000 in 2021
Seeking Partners: Financing, M&A, Licensing



Q4 2018 EMT Spotlight


AMB Surgical II - AMB Surgical's groundbreaking, patented technology is intended to reduce the necessity for invasive and repetitive surgery in children and teens with orthopedic deformities such as scoliosis and limb abnormalities. FLYTE™ smart automated growing rod technology is a sophisticated electro-mechanical, software activated device to provide real-time biomechanical feedback to guide treatment, as well as, allow surgeons to perform accurate, non-surgical skeletal adjustments.
C. Light Technologies, Inc. - C. Light Technologies is a neurotech and machine learning company that uses novel eye motion technology to revolutionize the detection, monitoring, and treatment of neurodegenerative diseases (starting with multiple sclerosis). We apply advanced machine learning algorithms to the patterns of eye motion to provide objective and clinically actionable metrics in order to monitor disease progression and drug efficacy. With eye-tracking technology 120-150x better than commercially available pupil trackers, the TSLO generates 10+ data points that have never previously existed, which can be commoditized and advance medical science. Future Applications include: Alzheimer's, Parkinson's, and concussions.
CorFigo - We are an early stage medical device company developing a product called the HeArTPAD™ intended to treat persistent atrial fibrillation. It is a novel, minimally invasive, video-guided surgical approach (sub-xiphoid or laparoscopic/trans-diaphragmatic) to ablate the posterior wall of the left atrium that can be used concomitantly with an EP catheter ablation. The HeArTPAD Cryo-Ablation System will employ a continuous, high flow rate of very cold gas through a maze like pattern within a broad, flat pad to ablate atrial tissue and overcome the heat sink of blood flowing within the left atrium.
DermaSensor Inc - DermaSensor, Inc. is a connected device company that enables healthcare professionals to efficiently check for skin cancer by leveraging cutting edge technologies. The DermaSensor device is an affordable handheld tool that uses artificial intelligence and spectroscopy to evaluate skin lesions for potential skin cancer in a matter of seconds.
Empirical Spine - LimiFlex is a lumbar spinal implant for sciatica patients suffering from degenerative spondylolisthesis (DS), the most common diagnosis leading to lumbar spinal fusion. Current treatments for DS include standalone decompression, with a high risk of recurrence, or decompression plus fusion, a highly invasive surgery with higher morbidity and increased risk of adjacent segment degeneration. LimiFlex offers the benefits of segmental stability, like fusion, while preserving motion, reducing long-term risk, procedure invasiveness, and recovery time. In addition, LimiFlex is usually performed as an outpatient procedure, matching the current clinical trends and saving cost while increasing patient satisfaction. LimiFlex is completely reversible and thus preserves future surgical options.
Epic Neuro - An early stage medical device company built around a patented minimally invasive brain stimulation technology used in stroke rehabilitation. The miniature-sized EPIC device is inserted into a burr hole in the skull and is externally powered, providing stimulation to either cortical or deep structures. EPIC is far less invasive than existing technology with a much shorter procedure, lower cost, fewer complications, and faster recovery time. It involves no tunneled leads or battery changes, and is easily removable.
Forest Devices - Pre-hospital stroke identification--an ECG for the brain.
Green Sun Medical - Green Sun Medical was founded to develop innovative treatments to address Adolescent Idiopathic Scoliosis and Kyphosis. We are developing a dynamic orthotic that will aid in correcting these spinal deformities. The Green Sun Medical device is the first orthotic to address directly the complex biomechanics of Adolescent Idiopathic Scoliosis (AIS). Additionally Bluetooth connected sensors will allow patients and physicians to ensure proper treatment is being provided.
HIL Applied Medical - HIL Applied Medical is developing ultra-compact, high-performance systems for cancer Proton Therapy.
Healthup Sp. z o.o. - AioCare device is a personal, connected and ultra-portable spirometer with a dedicated mobile application for a smartphone. The device is capable of measuring all important and widely used spirometry parameters including: FVC, FEV1, FEV1/FVC, PEF, FEF 25-75, etc. Additionally, the device measures heart rate and ambient environmental conditions (temperature, humidity, and pressure). AioCare works with iOS and Android operating systems. It is designed for self-monitoring by patients suffering from asthma, COPD and cystic fibrosis. AioCare is also available for physicians to examine their patient's spirometry parameters in-hospital/outpatient settings, with examination results available in the application and the AioCare Health Cloud.
Histologics - Histologics manufactures and markets Internationally multi-patented evidence-based (proven) and burgeoning commercialized technology to acquire a-traumatic mucosal biopsies and perform less traumatic wound care debridement. This replaces traumatic sharp instruments with a patient friendly brush-biopsy approach. The devices employ a proprietary medical fabric "Kylon®", attached to several applicator devices to allow for minimally invasive trans-epithelial and dermal tissue sampling/biopsy and the automatic trapping of specimens for easy transport for laboratory analysis.
LifeHealth - LifeHealth is one of only three companies in the world that manufactures bedside point of care blood gas analysis systems. LifeHealth has recently released a new, best in class analyzer and is early in development on a new, best in class single use disposable cartridge. This new solution will lead to significant penetration of the point of care critical care blood diagnostics market segment.
LivOnyx Inc. - LivOnyx Inc. is developing a rapid hand disinfection system to reduce healthcare associated infections (HAIs) using its proprietary, patented thinSpray technology and antiseptic LVNX-001. There is an unmet need for a hand hygiene solution that takes no more than 3-5 seconds, leaves hands dry, facilitates hand health, is portable to optimize workflow around the patient, and is effective against the pathogen Clostridium difficile, a leading cause of HAIs in hospitals.
MobileODT - We create smart, connected visual assessment solutions for women's health clinicians to screen for cervical cancer and replace expensive and time-consuming laboratory tests with point-of-care AI-based decision support.
NanoVault Medical - Cellular & Biotherapeutics Delivery: utilizing nanotechnology-derived materials to address chronic and costly diseases, These include diabetes related insulin- dependency, a near 100 year old, $43 Billion industry.
Paragate Medical Ltd. - Paragate Medical is an innovative device company, aiming to revolutionize heart failure management by introducing the first ever fully implantable device to actively and continuously prevent fluid overload in congestive heart failure patients.
Serenno Medical - Serenno Medical is developing a robust, hands free, automatic and low cost Urine Output monitoring device for the ICU, assisting in AKI detection and prevention.
Vascular Genesis - Vascular Genesis is building a vascular regeneration platform with its line of cell-free, synthetic scaffold products, eliminating the need for tissue donation, immune suppressants, and the ever-present risk of transplant rejection. Our first product offering is a resorbable arteriovenous (AV) graft for dialysis access. The graft will degrade over a scheduled period of time and allow the body to create a new native tissue fistula for continual dialysis access. The graft is designed to match the compliance of the native artery/vein to which it attaches. Its self-healing capabilities will allow it to achieve stasis (stop bleeding) faster than competing products.
VerteCore Technologies - VerteCore Technologies is a medical device development company which creates products addressing orthopedic niche markets. Thru creating innovative medical devices for ambulatory, non-surgical treatment of spinal disorders, we offer a novel approach to back and neck pain treatment, enabling rapid recovery while helping eliminate the need for hospitalization, drugs, and surgery. Three versions of the company's lead device have already been designed with the participation of leading physicians in the orthopedic field. Multiple Patent Pending statuses have been obtained and patent assignment provided into the company.
Voxello - Voxello develops pioneering technology providing severely impaired patients the ability to communicate with caregivers and family effectively. Voxello developed the noddle® and noddle-chat to reduce adverse events, achieve better outcomes, and improve patient satisfaction while returning a sizable ROI to the hospital. Using any voluntary gesture such as a tongue click or minimal movement such as a head nod, a patient can access the nurse call and the noddle-chat, which is a speech generation device to communicate.


Q3 2018 EMT Spotlight


AIT Therapeutics - AIT has a nitirc oxide (NO) generator and delivery system. The device generates NO from ambient air and can deliver it to a patient's lungs via a breathing circuit and mask or through a ventilator. The device is powered through any standard electrical outlet and should, upon certain regulatory approvals, be used anywhere in the hospital or at home.
Alpha Tau Medical - Alpha Tau Medical focuses on research, development, and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid tumors.
Auctus Surgical - Auctus is developing a system to treat pediatric scoliosis with non-fusion surgical system - an internal brace or sorts. Our growth modulation system includes a tether affixed to the anterior/lateral portion of the vertebral bodies. As the child grows the spine straightens over time. Our system includes a non-surgical adjustable component that allows for further increasing or reduction in tension over time.
BeamLine Diagnostics - BeamLine develops real-time, point-of-care clinical screening systems that streamline diagnostic pathways enabling the expansion of life-saving screening programmes
Biosig Technologies - BioSig is developing a proprietary advanced signal processing technology, PURE EP, designed to provide enhanced real-time, precise and uninterrupted information for real-time clinical decision-making during electrophysiology studies and ablation procedures.
Cam Med - Cam Med is developing the Evopump, the first truly bandage-like, actively controllable patch pump for delivering one or multiple injectable medications.
Cellgen Diagnostics - Cellgen is developing the industry's first precision medicine platform for immuno-oncology therapeutics. Cellgen's technology measures the genetic expression of a patient's immune system to determine if that patient is likely to respond to the given immunotherapy...all in just 2 hours.
Consensus Orthopedics - TracPatch Wearable medical device for pre and post-op patient monitoring, patient engagement, data analytics and post op cost reduction. Consensus also designs, markets and sells knee and hip replacement implants.
CorInnova - CorInnova is developing a non-blood contacting biventricular cardiac assist device to treat end stage heart failure (HF).
Elbe Valley Medical - We are developing a therapy for treating large and aggressive cancer tumours which are beyond treatment with conventional therapies.
Embody - Embody is a medical device company developing collagen-based implants for the treatment of tendon and ligament injuries.
Fertility Focus - Direct to Consumer ovulation monitoring device operating on a Software as a Service model
Opus KSD - Opus KSD has successfully developed the SubQ It! Bioabsorbable Skin Closure System, for closing surgical incisions. The SubQ It! stapler inserts a patented bioabsorbable fastener subcutaneously, never piercing the external skin, offering the surgeon the speed and ease of use of a metal stapler and the patient lowered risk of infection and no need to return for staple removal.
PhotoniCare - PhotoniCare is a medical device company that has developed a low-cost, handheld imaging platform that uses light to see through tissue. Our first product on this platform is a device that can see through the eardrum to visualize the middle ear without cutting the eardrum open. We have subsequent products in ophthalmic, dental, and consumer applications.
Prima-Temp - Prima-temp has developed Priya, a novel device designed to measure core body temperature in women trying to conceive. 'Why guess when you can know' your fertile window.
Promaxo - Promaxo is a medical technology company that develops and commercializes office-based modular MRI and MRI based technologies. The Company is currently focused on advancing the solutions for prostate disease management and other urology and pelvic conditions.
Smart Medical Devices - Smart Medical Devices, Inc., a company founded by surgeons for surgeons, developed the revolutionary dual-motor SMARTdrill® to improve patient outcomes in orthopedic surgery. Only the SMARTdrill® measures depth, prevents plunge, measures bone density, reduces waste, provides real-time performance data, and uploads the data to a global bone database.
Sparo - Sparo has developed Lift Pulmonary Rehab a digital, home-based rehab program designed for seniors, helping increase energy and endurance, reduce shortness of breath, and improve quality of life.
Steadiwear - Steadiwear Inc has developed the Steadi-One. A lightweight, compact and responsive exoskeleton that resists tremors in Essential Tremor and Parkinson's disease. It uses our novel & battery free technology to stabilize tremors (>2Hz) while allowing voluntary motion(<2Hz).
TAS Medical - TAS Medical will revolutionize abdominal surgery. We are dedicated to saving healthcare millions of dollars while improving the outcomes of ventral hernia repair. Our mission is to provide an alternative to mesh for ventral hernia repairs. Convert ventral hernia procedures from a costly open repair to a minimally invasive laparoscopic repair. Develop first to market tension measurement device for abdominal surgery. Our Trans Abdominal Strap has the strong potential to eliminate the need for mesh in many ventral hernia repairs and to convert procedures from a highly morbid open surgery to a minimally invasive laparoscopic surgery.


Q2 2018 EMT Spotlight


3R Cardio - TAVR SmartGuidewire™ allows cardiologists to monitor valve function continuously throughout transcatheter aortic heart valve replacements (TAVR) procedure providing actionable data to cardiologists during valve positioning. The TAVR SmartGuidewire™ simplifies workflow offering direct savings to hospitals and the additional data collected may be used to improve patients outcomes.
AVACEN Medical - The AVACEN 100 is a non-invasive device that infuses heat into the circulatory system to: (i) increase microcirculation systemically; (ii) reduce blood viscosity and; (iii) enhance organ tissue nutrition and overall health. The patents also cover multiple therapeutic uses to alleviate symptoms associated with a circulatory, neurological, lymphatic, endocrinal dysfunction, or any combination thereof.
All Clear Diagnostics - ACDx uses novel, patented algorithms, AI and advanced functions to reduce MRI-impacting artifacts to improve image quality & patient safety monitoring, reduce exam times and deliver enhanced decision-support data.
Avra Medical Robotics - Precision guided surgical robotics. Integrating image-guidance with navigation and organ-targeting to bring a diverse and multidimensional system.
Biosig Technologies - A proprietary technology platform to improve the quality of cardiac recordings during electrophysiology studies and ablation procedures.
BresoTec - Simplifying sleep apnea diagnostics with acoustics.
Cam Med - Cam Med is developing the Evopump, the first truly bandage-like, actively controllable patch pump for delivering one or multiple injectable medications.
CardioThrive - Producing the world's first lightweight, ultra-portable, fully automatic, single use AED that requires no assembly prior to use. Our goal is to make Sudden Cardiac Arrest a routinely survivable event by making AEDs easier to afford, carry, and operate.
Consensus Orthopedics - TracPatch Wearable medical device for pre and post-op patient monitoring, patient engagement, data analytics and post op cost reduction. Consensus also designs, markets and sells knee and hip replacement implants.
CorInnova - CorInnova is developing a non-blood contacting biventricular cardiac assist device to treat end stage heart failure (HF).
Deep 6 AI - We build applications that understand massive amounts of unstructured data at a very high speed and learn from users to single out the information that is most important to them. We apply artificial intelligence and natural language processing to all clinical data to find eligible patients for clinical trials faster, accelerating recruitment exponentially and getting cures to the people quicker.
Fertility Focus - Direct to Consumer ovulation monitoring device operating on a Software as a Service model
Mimetis Biomaterials - Bone regenerative solutions. 4th gen synthetic bone regenerative solution. Biomimetic technology.
Opus KSD - Opus KSD has successfully developed the SubQ It! Bioabsorbable Skin Closure System, for closing surgical incisions. The SubQ It! stapler inserts a patented bioabsorbable fastener subcutaneously, never piercing the external skin, offering the surgeon the speed and ease of use of a metal stapler and the patient lowered risk of infection and no need to return for staple removal.
PhotoniCare - PhotoniCare is a medical device company that has developed a low-cost, handheld imaging platform that uses light to see through tissue. Our first product on this platform is a device that can see through the eardrum to visualize the middle ear without cutting the eardrum open. We have subsequent products in ophthalmic, dental, and consumer applications.
Physcient - Physcient develops new surgical instruments that speed surgery, expand surgeons abilities, and improve outcomes by combining proprietary insights into the mechanics of tissues with advanced technologies from other industries. Our lead technology, the Differential Dissector replaces centuries old technology and allows a surgeon to safely dissect tissues more rapidly, displacing instruments that contribute to hundreds of thousands of severe surgical complications each year in the US.
SELFA - SELFA is a medical device company based on a semiconductor biosensor with extraordinary sensitivity, scalable multiplexing, simultaneous protein and nucleic acid quantitation.
Smart Medical Devices - Smart Medical Devices, Inc., a company founded by surgeons for surgeons, developed the revolutionary dual-motor SMARTdrill® to improve patient outcomes in orthopedic surgery. Only the SMARTdrill® measures depth, prevents plunge, measures bone density, reduces waste, provides real-time performance data, and uploads the data to a global bone database.
SweetBio - SweetBio is revolutionizing the healing of dental and chronic wounds through our Manuka honey-incorporated, biodegradable medical devices.
Zelegent - Zelegent is developing a Single-Use Kit used by Otolaryngologists to perform a minimally-invasive office procedure, Elevoplasty™ to shorten and stiffen the soft palate to treat snoring.
gel-e - Products engineered to stop bleeding quickly and conveniently. Using safe, naturally occurring biomaterials, gel-e designs wound treatments for a variety of applications and patients, spanning from surgical gels to bandages for patients on blood-thinners experiencing routine nuisance bleeds.


Q1 2018 EMT Spotlight


Avancen MOD - Patient controlled analgesia device for pain management
Betalin Therapeutics - Tissue engineering alternative for insulin therapy in diabetes
CSD Labs - Clinically verified medical software for the objective, automated detection of heart defects
ClearCut Medical - Magnetic resonance imaging system intended for the assessment of the margins of excised breast lumps taken from breast cancer patients undergoing breast-conserving surgery or lumpectomy procedures
ContinUse Biometrics - Sensor platform that can continuously monitor physiological state, including heart and respiratory rate, blood flow dynamics, and muscle activity, from a distance of up to several hundred meters
Dermala - Advanced acne treatment systems.
DxNOW - Combining novel portable bio-imaging systems with microfluidic-based consumables, their products address applications in male fertility, forensics, renal dialysis, cancer, hematology, infectious disease, and life science research.
EarlySense - Non-intrusive patient monitoring systems that facilitate timely intervention for cardiac/respiratory deterioration
Efferent Labs - Implantable biosensor technology designed to serve as a real-time monitoring system, using living cells to assess cellular function in vivo
ElastiMed - Compression stocking made from smart materials that mimics rhythmic calf muscle contractions and stimulates blood flow
Engage Therapeutics - Easy-to-use, hand-held drug-device combination product for use in the cessation of active and acute epileptic seizures
Flowonix - Implantable, programmable pump designed to deliver therapeutic drugs into the spine, for the treatment of chronic intractable pain and the management of severe spasticity
Genomic Expression - Genomic Expression have made RNA sequencing actionable in oncology: we are finding the best drug for the patient and the best patient for the drug
ID-NEST Medical - Easy-to-use and compliant 'click-connect' stenting system to treat venous and arterial diseases
IonMed - Advanced tissue welding enabled by cold plasma
LifeWave Biomedical - Developing a digital health, non-invasive RF sensor and AI analytics system that improves care management of patients living with: 1) respiratory distress and lung diseases and 2) congestive heart failure (CHF) in hospital, ambulatory, and home settings.
NEOFECT - Game-based rehabilitation devices and exercises for patients with neurological, central nervous system, and musculoskeletal injuries such as stroke
NimbleHeart - FDA approved, wearable, dry electrode based real time ambulatory ECG for long term monitoring of at risk population
NuCryo Vascular - A cryoplasty balloon dilatation system
OB Smart - A home use device to accurately measure dilation and effacement of the cervix
OcuSciences - Non-invasive, rapid, quantitative measurement of metabolic health of the retina using a novel spectroscopic biomarker
Peerwell - Pre- and post-surgical patient care app, to help improve outcomes and lower complications and costs after joint replacement surgery
PhotoniCare - Technology that enables quick, easy, and accurate diagnostic assessment of middle ear health during routine examinations
RFPi - Real-time, non-invasive medical imaging to provide immediate visualization and quantification of blood flow and perfusion without injections/dyes, radiation or the need for direct patient contact
Robin Medical - New core biopsy technology that has been optimized to minimize the duration of image-guided biopsy procedures while addressing the specific needs of targeted medicine - to better preserve biomarker, to maximize the ratio between biopsy sample size and needle size, to streamline and automate the processing of the biopsy samples in the pathology lab.
Stepscan Technologies - Movement tracking and gait profiling technology company with solutions for medical gait analysis, security, and virtual training platforms
SurePulse Medical - Innovative heart rate monitor for newborns providing a continuous, reliable and hands-free heart rate within minutes after birth. Reduces time spent in intensive care. Technology includes a single-use Cap which integrates a sensor and a reusable Display with wireless Modules.
Velico Medical - A spray-dried plasma product to improve the survival rate of patients suffering from blood loss
Vigor Medical Technologies - Life-saving innovative devices for treatment of chest trauma and for thoracic/abdominal drainage


Q4 2017 EMT Spotlight


3R Cardio - TAVR SmartGuidewire™ allows cardiologists to monitor valve function continuously throughout transcatheter aortic heart valve replacements (TAVR) procedure providing actionable data to cardiologists during valve positioning. The TAVR SmartGuidewire™ simplifies workflow offering direct savings to hospitals and the additional data collected may be used to improve patients outcomes.
Abreos Biosciences - Personalized dosing of biologic therapeutics as well as aiding in the discovery and development of novel precision treatments
AcuMEMS - Wireless ocular implants and smartphone for continuous direct measurement of intraocular pressure (IOP), the only modifiable risk factor for glaucoma
AcuityBio - AcuityBio's mission is to prevent post-surgical cancer recurrence in early stage cancer patients using localized drug delivery.
Advanced Maternity Innovations - Advanced womens health technologies aimed at reducing the occurrence and associated cost of premature births.
Advanced Silicon Group - Silicon nanotechnology including photovoltaics, Li-ion batteries, microfluidics, MEMS, and more.
Anagenesis Biotechnologies - Stem cell-based technologies for genetic and age-related muscle degenerative diseases.
Arc Devices - Harnessing the power of sensor technology to revolutionize connected health solutions
Arkis Biosciences - Advanced medical technologies used in treating hydrocephalus, pain management, plastic surgeries, and other treatment areas.
Avisa Pharma - Avisa is a venture-backed healthcare company commercializing a rapid, point-of-care breath test for the diagnosis of pulmonary infections
Avra Medical Robotics - Precision guided surgical robotics. Integrating image-guidance with navigation and organ-targeting to bring a diverse and multidimensional system.
Avro Life Science - Developing a transdermal patch for the delivery of medications with emphasis in the pediatric patient populations.
Axolotl Biologix - Biological-related products that foster regeneration and healing for many conditions including applications in orthopedics, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
BAROnova - A clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.
BedLab - Advanced mechanical beds and technologies aimed to prevent and treat immobility-induced complications such as pressure ulcers (bedsores) and pulmonary complications.
Betalin Therapeutics - Innovative therapy for diabetes treatment to replace insulin therapy using an Engineered Micro Pancreas (EMP).
BioDirection - Rapid point-of-care (POC) technologies for the objective diagnosis and management of concussion and other traumatic brain injury (TBI).
BioSculpture - Advanced power assisted dual-cannula tissue aspiration systems which allow controlled and efficient tissue removal. Advanced technology which can be safely adapted for other specialties and uses for which manual and other powered systems would pose a hazard.
BioVigil Systems - Electronic hand hygiene compliance system for use in healthcare facilities
Biobeat - Wearable monitor for remote non-invasive accurate medical-grade monitoring of vital signs and other medically relevant parameters.
Biospecimen Technologies - Proprietary devices for the collection, handling and processing of blood samples for testing and for therapeutic products.
BrainCool - Patented medical cooling technologies with an initial focus on brain cooling and prevention of oral mucositis.
BriteSeed - An innovative surgical device system that makes operations safer by alerting the surgeon before an unsafe cut is made.
CardioThrive - Producing the world's first lightweight, ultra-portable, fully automatic, single use AED that requires no assembly prior to use. Our goal is to make Sudden Cardiac Arrest a routinely survivable event by making AEDs easier to afford, carry, and operate.
CareWave - Leveraging over a century of combined experience in pain management, technology development and business, Carewave Medical is dedicated to delivering drug-free, non-invasive products to alleviate suffering of those with moderate to severe pain.
Carena Healthcare - Personalized patient care by mapping disease distribution to device design and selection. 3D visualization and analysis of diseased arteries. Image fusion of intravascular ultrasound and X-Ray angiography. Design of bespoke replacement aortic heart valves for the treatment of aortic stenosis
Carmell Therapeutics - Carmell Therapeutics has created a unique, highly innovative, patented technology based on biologically-active adaptive materials manufactured from human blood plasma. These plasma-based materials contain a concentration of natural regenerative factors that promote healing, reduce complications, and lead to healthcare savings.
CellMax Life - Non-invasive, accurate blood tests for early detection of cancer.
Cibiem - Ablation of carotid body chemoreceptors via directed ultrasound energy with a catheter deployed in the jugular vein using intravascular ultrasound imaging for positioning and targeting
Cologuard Ltd - A clinical stage medical device company developing novel and proprietary technology for colorectal surgery aiming to prevent the profound clinical and economic pains associated with anastomotic leaks and diverting colonic stomas.
ConcentRx - ConcentRx is a preclinical stage company with a patented Immunotherapy developed for Ovarian, Breast and Lymphoma. Outside of the body we activate a patient's or a donor's white cells with a proprietary and specific activation protocol to induce enrichment and selection of NK-T cells home to and target selectively tumor cells. Prior to infusion into the patient the NK-T cells are allowed to take up a tumor lysis agent for selective killing of the tumor cells. In preclinical animal models of disease our therapy is active against chemo therapy resistant cells of multiple tumor types and reduces the recurrence of disease.
D&P Bioinnovations - We are developing an implantable, bioresorbable medical device to functionally regenerate a damaged esophagus within the body.
Daidalos Solutions - AnchorValve, a single procedure low-profile transcatheter mitral/tricuspid valve replacement (TMVR/TTVR) device with simple direct anchoring to mitral/tricuspid valve annulus only, proven feasibility, and IP protection.
DermaTec - DermaTec\'s alcohol detection patch is unique in the alcohol detection marketplace for its multi-day usage, non-invasive application and its ability to provide a visual indication that someone has been drinking.
DoseVue - Products for in-vivo dosimetry that are easy to use and with minimal impact on the overall treatment cost
EXOVITE - Technological innovation in tools and medical procedures in Tele-RHB, E-Health and M-Health
Edge Surgical - The first single-use technology enabling more accurate and safe orthopedic and spinal surgical screws placement. Improved accuracy when selecting screws to fuse bone fractures, and mitigating bioburden contamination risk, a leading cause of surgical site infections (SSIs).
Efferent Labs - In vivo biosensor that uses cells as the main sensor. Device allows for the live streaming of data including pathway activation.
ElastiMed - Advanced compression stocking made from smart materials that mimic rhythmic calf muscle contractions and stimulates blood flow to treat venous and lymphatic diseases on the lower limbs.
Evav Technologies - Advanced endovascular medical devices
Eyevensys - A novel approach in the treatment of major ophthalmic diseases using a bio therapeutics factory in the eye to allow safe local sustained production of therapeutic proteins, an approach that can address a wide range of ophthalmic diseases.
Feeligreen - Microelectronics, chemistry and nanotechnologies that improve protocols and treatments for multiple healthcare applications.
Fischer Imaging - Improved outcomes for cancer patients using advanced imaging technology that doubles the resolution and contrast of today\'s mammography using less than half the x-ray dose and removes the need for painful breast compression.
GRISAL - Advanced surgical technologies and innovations
Glucorecs - Glucorecs breakthrough Non-Invasive BGM (Blood- Glucose Measurement) technology will invoke a digital transformation in portable, personal and wearable devices for SMBG (Self-Monitoring of Blood Glucose).
Hemovent - Self-contained fully portable Extra Corporeal Membrane Oxygenation (ECMO) system that supports or replaces heart and lung function in the event of cardiac and respiratory failure.
HepaTx - Innovative therapies for serious liver disease.
Highland Innovation Centre - The handheld BREAST-i home use device with memory and advanced sensor technology for self breast examination.
ID-NEST Medical - Easy to assemble and compliant branched vascular endografts. Modules are inserted through various approaches and click-connected in-situ.
IGI Technologies - IGI Technologies has developed a medical image fusion technology that enables interventional radiologists to go 20% faster on procedures while improving care and hospital throughput.
IVDiagnostics - Diagnostic tools for addressing rare circulating tumor cells and blood borne diseases.
Implandata Ophthalmic Products GmbH - Implandata Ophthalmic Products, is a Hannover, Germany based clinical stage company developing transformative products for the improved care of intraocular pressure related eye diseases. This is accomplished by merging proprietary implantable micro-sensors for telemetric measurement of Intraocular Pressure (IOP) with digital health technology. With its family of products, Implandata addresses medical needs in cataract, glaucoma, corneal and vitreoretinal surgery.
Innoblative Designs - Innoblative is a medical device company whose mission is to develop products to innovate and improve the way surgeons and interventionalists treat surgical margins post excision. Our first product is a radiofrequency ablation (RFA) applicator that allows surgeons and interventionalists to effectively coagulate and ablate soft tissue beds intra-operatively. Innoblative is currently investigating the patient benefits of using radiofrequency ablation (RFA) to ablate an approximately one-centimeter margin or perimeter of soft tissue following standard lumpectomy removal of a breast tumor.
Intent Solutions - A technology-enabled services company focused on monitoring and managing medication adherence in clinical research and applied healthcare sectors. A connected portable device that only dispenses medication at the right dose, at the right time, and most importantly, to the right patient.
Intuity Medical - The first blood glucose meter and multi-test cartridge designed to automate testing into one easy step, without the need for separate test supplies.
Kejako - Kejako research and develop novel medical devices for the worldwide ophthalmic surgery market. Our technical and commercial goal is to launch premium, innovative solutions for common ophthalmic diseases which have high impact on peoples everyday life.
Lab Sensor Solutions - Temperature monitoring system that provides a real time 'mobile sensor as a service' solution for health and safety applications.
Laser Associated Sciences - Non-invasive technology to measure blood flow in the extremities. A compact device used during vascular surgery to dramatically improve outcomes by guiding more effective procedures.
Leviticus-Cardio - A wireless system capable of providing the day-to-day power needs of today\'s implanted Ventricular Assist Devices (VADs), whilst eliminating complications related to the driveline. The technology enables effective Transcutaneous Energy Transfer.
Lightpoint Medical - Advanced molecular imaging technology, based on Cerenkov Luminescence Imaging, to detect cancer in real-time during surgery, providing more accurate cancer treatment while sparing healthy tissue.
Linear Health Sciences - Linear Health Sciences is a pre-clinical medical device company in the infusion disposables space. Their flagship ORCHID SRV (safety release valve) reduces intravenous (IV) catheter dislodgment by way of a patent-pending, metal-free, breakaway valve. ORCHID valve addresses macro forces at the IV site. Preventing large sudden forces from being translated to the catheter assembly reduces not only total dislodgment, but also keeps away forces responsible for micro movements that lead to pistoning and its sequelae: phlebitis and bloodstream infections.
Lynx Biosciences - Predictive technologies to individualize blood cancer therapy.
Madorra - Changing the paradigm for treating vaginal dryness, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. Provides post-menopausal women and breast cancer survivors a non-hormonal treatment option.
Magentiq Eye - A medical device startup company, focused on the field of endoscopic medical procedures. Our software and devices are planned to help doctors to see beyond the visible. We apply cutting edge deep learning, computer vision and video analysis technologies to aid doctors in the difficult task of performing medical exams and procedures. Our first product is planned for the colonoscopy screening test.
Magnetic Insight - Magnetic Particle Imaging (MPI), a new imaging modality that directly detects magnetic nanoparticle tracers enabling deep tissue imaging of functional events and disease states.
Medical 21 - Developing artificial blood vessels using cellulose and an external support made of nitinol as an alternative to harvesting blood vessels for coronary artery bypass graft surgeries.
MedicalCue - A healthcare IT tool for assisting nurses and doctors in helping newborns, with significant big data opportunities.
Mespere LifeSciences - Non-invasive, disruptive solutions in hemodynamic patient monitoring. Replacing invasive procedures with non-invasive solutions.
MicroOptx - MicroOptx is an early stage medical device company that is building a platform technology to shunt aqueous humor from the anterior chamber to the surface of the eye.
Multisensor Diagnostics - Non-invasive portable handheld device designed to perform rapid health assessment of an individual by recording key vitals.
N8 Medical - Medical device company developing novel solutions for the prevention of hospital-acquired infections.
NERv - Nano-systems to improve health care delivery and remote real-time patient monitoring.
NangioTx - NangioTx has a unique approach to treating PAD that is based on molecular mimicry of the body's natural mechanism for blood vessel generation. The process is mediated by the engagement of the Vascular Endothelial Growth Factor (VEGF) to its cognate receptors (VEGFR). Towards this end, NangioTx has licensed "V-10", the lead self-assembling peptide mimic of VEGF for inducing angiogenesis and treating poor blood flow in PAD.
Neoscope2020 - Neoscope2020 has developed Family of Single Use, NeoscopeTm / NeoflexTm- Digital Video Endoscopic System for Digital Video Cystoscopy, Hysteroscopy, Ureteroscopy, Bronchoscopy, Arthroscopy, 3D Laparoscopy & other Minimally Invasive Diagnostic & Therapeutic Endoscopic procedures. The family of NeoscopeTm/ NeoflexTm Products have received marketing clearance from FDA approval and has CE Mark approval. The Neoscope Digital Video Endoscopy products can display "Real Time" Video images, using Laptop/PC Tablet computers and HD Video monitors.
NeuroRecovery Technologies - Innovative therapeutic systems designed to provide functional recovery for individuals suffering from paralysis.
Neurosteer - Continuous neurological bedside monitor and wellness wearable which provides real-time interpretation for assessment, intervention and neurofeedback in a wide spectrum of neurological disorders.
Nexeon MedSystems - Neurostimulation products that improve the quality of life of patients suffering from debilitating neurological disease
Nido Surgical - The CardioPort™, a novel platform designed to enable video-endoscopic trans-cardiac surgical repairs inside the beating heart based on technology developed at Boston Children\'s Hospital.
NuvOx Pharma - Developing an innovative platform of oxygen therapeutics to treat life-threatening diseases where hypoxia plays a role.
ODS Medical - Optical instrument which identifies cancerous tissue in real-time during surgery directly in the patient without contrast agents, uses Raman Spectroscopy signatures and machine learning for cancer detection at cellular resolution.
PARE Surgical - Has developed and is marketing an FDA approved, patented, hand held LED battery powered Electrosurgical light source pencil, the NOVA, to be used with or without smoke evacuation. It provides intense, bright and shadow free visualization in the growing minimally invasive surgical market. It eliminates the need for expensive and bulky headlamps and eliminates the constant strain on the surgeon's neck while providing increased accuracy & productivity for the surgeon.
Patrona Medical - Wireless device to detect and alert the early onset presence of a Catheter Assisted Urinary Tract Infection.
PerfAction Technologies - High-pressure jet technology to laterally introduce healing agents deep into the dermal layer of the skin for a wide range of aesthetic indications.
PhotoSonix Medical - Combination of ultrasound and light to treat chronic bacterial infections, especially those causing acne.
PhysioCue - PhysioCue is a consumer digital health and therapy device company approach for hypertension management that combines the latest bio-sensor (PPG & ECG) technology. PhysioCue's therapy is efficient, safe, easy to use, and has none of the side effects associated with anti-hypertensive drugs.
Portela Soni Medical - Advanced urinary catheter technologies significantly reducing the risk of CAUTIs in catheterized patients.
Prescient Surgical - CleanCision technology platform, a portfolio of products for the prevention of surgical site infection (SSI).
Pulmostics - Breath analysis diagnostic systems using advanced biomarker analytical technology and data analysis algorithms for next generation point of care diagnosis and management of disease.
RayVio - An advanced health and hygiene company that delivers clean water and environments. RayVio helps protect billions from germs and creates new markets and revenue streams by enabling a new class of products. Its powerful and efficient UV LED technology can be integrated into a variety of applications, powering versatile on-demand solutions that give consumers control over health without chemicals or costly consumables.
Reapplix - Platform technology for regenerative medicine with first lead indication to treat diabetic foot ulcers.
Rosivo - Biological implants with applications in facial reconstruction and various other areas including intervertebral disc repair and articular cartilage repair.
SafKan - The first automated and wearable impacted cerumen removal device for clinical use.
Sanovas - Sanovas is redefining intervention with access, imaging, and measurement technologies that enable physicians to perform MORE interventional procedures, in MORE places, MORE affordably. The company is dedicated to developing the full continuum of best-in-class minimally invasive diagnostic and therapeutic technologies and solutions that are affordable, accessible, and safe across multiple procedures and specialty areas.
Scinovia - Laser biophotonics devices to enable doctors to remotely visualize actual blood flow speeds across vessels & tissue with no injections, probes, or additional instruments.
Semler HealthPerks - Digital health technology to prevent heart disease.
Sonavex - Improving outcomes for surgical patients by using cutting-edge imaging technology to provide clinicians with visualization of critical data -- directly at the point of care.
SpineOvations - Next generation of minimally invasive treatments for back pain due to disc disease.
Stent Tek - A novel catheter based system that provides a better way for patients to receive haemodialysis (HD) for kidney failure.
Stimwave - Technologies for spinal cord stimulation, dorsal root ganglion stimulation, and peripheral nerve stimulation. The system utilizes a small, wireless, micro-size neurostimulator leveraging advancements in nanotechnology.
Stroma Medical - Late-stage research and development company developed and patented a non-invasive procedure to change eye color from brown to blue with only a topical anesthetic and will take less than 20 seconds to complete. The permanent eye color change will occur gradually over the following two to four weeks and our clinical studies are designed to confirm these results.
SurePulse Medical - Innovative heart rate monitor for newborns providing a continuous, reliable and hands-free heart rate within minutes after birth. Reduces time spent in intensive care. Technology includes a single-use Cap which integrates a sensor and a reusable Display with wireless Modules.
Synthasome - Orthobiologics to enhance soft tissue and cartilage regeneration.
Tasso - Painless blood collection system that will modernize diagnostics by enabling consumers to self-test from home.
Transverse Medical - Cerebral embolic protection device. Adapts and conforms to complex arch anatomy by maintaining contact with the aorta, enabling maximum great arch vessel coverage, and directing debris-laden blood through the filter. Initial procedure focus is Transcatheter Aortic Valve Replacement (TAVR).
UVision360 - An all-in one hysteroscopy system to fulfill unmet needs for diagnostic & therapeutic procedures for the office space.
V-Sense Medical Devices - Measures vital signs from a distance without physical contact using radar.
Vascor - Vascor is a pre-clinical company that has developed and patented a failsafe non-rotary implantable counter pulsation heart assist device that is powered by a transcutaneous energy transmission system. The Vascor Ventricular Assist Device (VAD) overcomes the shortcomings of existing devices, which will result in improved efficacy and safety for patients with advanced heart failure.
Virtu Surgical - Virtu Surgical has reinvented surgical robotics with the creation of a prototype for a compact and precise surgical robotic system. This system provides tactile feedback to the surgeon's hand as well as new previously unavailable surgical movements. It also will prove effective in new surgical fields beyond hysterectomy and prostatectomy. Because of its compact size and lower price point, this system is the perfect candidate to make robotic surgery both accessible and affordable for mid-size clinics and mid-income countries. We have started bench and tissues tests and expect to complete animal model in 2017.
Vybion - The leading developer of Intrabodies for neurodegenerative diseases, leveraging the safety and effectiveness of antibody technologies to address unmet medical needs.
Woven Orthopedic Technologies - Woven Orthopedic Technologies is a medical device company that designs and develops specialized orthopedic solutions for the aging population (Orthogeriatric patients). Our premiere product is a bio-textile device, for use in fracture repair surgery, to directly address the risk of losing implant fixation in patients with compromised bone. It is a simple-to-use, bio-textile device that applies a proven carpenters solution to the healthcare industry and works in conjunction with existing plate and screw systems.
XenoTherapeutics - Xeno-skin is a human tissue substitute derived from special, genetically modified pigs and has the potential to save countless lives and effectively treat burn victims.
ZenFlow - Office-based treatment to permanently relieve symptoms of BPH. The device is a small nitinol implant delivered in an atraumatic five-minute procedure under local anesthesia.
Ziptek - With ZipE® - Knotless tissue repair and attachment devices are a tissue repair system that utilizes a surgical button with increased surface area for improved healing. The surgical button moves forward across suture with protuberances in a forward direction and is prevented from moving in the opposite direction offering a Zip-Tie type engineering for repairing soft-tissue.
gel-e - Products engineered to stop bleeding quickly and conveniently. Using safe, naturally occurring biomaterials, gel-e designs wound treatments for a variety of applications and patients, spanning from surgical gels to bandages for patients on blood-thinners experiencing routine nuisance bleeds.
kelaHealth - A comprehensive platform for personalized surgical risk prediction and modification. Predict surgical complication risks using machine-learning at the point-of-care for individual patients. Recommend risk-targeted, best-practice interventions to prevent avoidable complications. Improve surgical outcomes and reduce cost.
nView Medical - Improved surgical accuracy for minimally invasive procedures without interfering with the surgical workflow through instant 3D imaging.


Q3 2017 EMT Spotlight


Arkis Biosciences - Advanced medical technologies used in treating hydrocephalus, pain management, plastic surgeries, and other treatment areas.
BedLab - Advanced mechanical beds and technologies aimed to prevent and treat immobility-induced complications such as pressure ulcers (bedsores) and pulmonary complications.
BioDirection - Rapid point-of-care (POC) technologies for the objective diagnosis and management of concussion and other traumatic brain injury (TBI).
Biobeat - Wearable monitor for remote non-invasive accurate medical-grade monitoring of vital signs and other medically relevant parameters.
BrainCool - Patented medical cooling technologies with an initial focus on brain cooling and prevention of oral mucositis.
CardioThrive - Producing the world's first lightweight, ultra-portable, fully automatic, single use AED that requires no assembly prior to use. Our goal is to make Sudden Cardiac Arrest a routinely survivable event by making AEDs easier to afford, carry, and operate.
Carmell Therapeutics - A unique, highly innovative, patented technology based on biologically-active adaptive materials manufactured from human blood plasma. These plasma-based materials contain a concentration of natural regenerative factors that promote healing, reduce complications, and lead to healthcare savings.
CellMax Life - Non-invasive, accurate blood tests for early detection of cancer.
DoseVue - Products for in-vivo dosimetry that are easy to use and with minimal impact on the overall treatment cost
Evav Technologies - Advanced endovascular medical devices
Eyevensys - A novel approach in the treatment of major ophthalmic diseases using a bio therapeutics factory in the eye to allow safe local sustained production of therapeutic proteins, an approach that can address a wide range of ophthalmic diseases.
Glucorecs - Glucorecs breakthrough Non-Invasive BGM (Blood- Glucose Measurement) technology will invoke a digital transformation in portable, personal and wearable devices for SMBG (Self-Monitoring of Blood Glucose).
ID-NEST Medical - Easy to assemble and compliant branched vascular endografts. Modules are inserted through various approaches and click-connected in-situ.
IGI Technologies - IGI Technologies has developed a medical image fusion technology that enables interventional radiologists to go 20% faster on procedures while improving care and hospital throughput.
IVDiagnostics - Diagnostic tools for addressing rare circulating tumor cells and blood borne diseases.
Intent Solutions - A technology-enabled services company focused on monitoring and managing medication adherence in clinical research and applied healthcare sectors. A connected portable device that only dispenses medication at the right dose, at the right time, and most importantly, to the right patient.
Leviticus-Cardio - A wireless system capable of providing the day-to-day power needs of today\'s implanted Ventricular Assist Devices (VADs), whilst eliminating complications related to the driveline. The technology enables effective Transcutaneous Energy Transfer.
Medical 21 - Developing artificial blood vessels using cellulose and an external support made of nitinol as an alternative to harvesting blood vessels for coronary artery bypass graft surgeries.
Mespere LifeSciences - Non-invasive, disruptive solutions in hemodynamic patient monitoring. Replacing invasive procedures with non-invasive solutions.
Multisensor Diagnostics - Non-invasive portable handheld device designed to perform rapid health assessment of an individual by recording key vitals.
N8 Medical - Medical device company developing novel solutions for the prevention of hospital-acquired infections.
Neurosteer - Continuous neurological bedside monitor and wellness wearable which provides real-time interpretation for assessment, intervention and neurofeedback in a wide spectrum of neurological disorders.
Nexeon MedSystems - Neurostimulation products that improve the quality of life of patients suffering from debilitating neurological disease
Nido Surgical - The CardioPort™, a novel platform designed to enable video-endoscopic trans-cardiac surgical repairs inside the beating heart based on technology developed at Boston Children\'s Hospital.
Patrona Medical - Wireless device to detect and alert the early onset presence of a Catheter Assisted Urinary Tract Infection.
PerfAction Technologies - High-pressure jet technology to laterally introduce healing agents deep into the dermal layer of the skin for a wide range of aesthetic indications.
Pulmostics - Breath analysis diagnostic systems using advanced biomarker analytical technology and data analysis algorithms for next generation point of care diagnosis and management of disease.
Semler HealthPerks - Digital health technology to prevent heart disease.
Sonavex - Improving outcomes for surgical patients by using cutting-edge imaging technology to provide clinicians with visualization of critical data -- directly at the point of care.
Stent Tek - A novel catheter based system that provides a better way for patients to receive haemodialysis (HD) for kidney failure.
Transverse Medical - Cerebral embolic protection device. Adapts and conforms to complex arch anatomy by maintaining contact with the aorta, enabling maximum great arch vessel coverage, and directing debris-laden blood through the filter. Initial procedure focus is Transcatheter Aortic Valve Replacement (TAVR).
Vybion - The leading developer of Intrabodies for neurodegenerative diseases, leveraging the safety and effectiveness of antibody technologies to address unmet medical needs.
XenoTherapeutics - Xeno-skin is a human tissue substitute derived from special, genetically modified pigs and has the potential to save countless lives and effectively treat burn victims.
gel-e - Products engineered to stop bleeding quickly and conveniently. Using safe, naturally occurring biomaterials, gel-e designs wound treatments for a variety of applications and patients, spanning from surgical gels to bandages for patients on blood-thinners experiencing routine nuisance bleeds.
kelaHealth - A comprehensive platform for personalized surgical risk prediction and modification. Predict surgical complication risks using machine-learning at the point-of-care for individual patients. Recommend risk-targeted, best-practice interventions to prevent avoidable complications. Improve surgical outcomes and reduce cost.


Q2 2017 EMT Spotlight


Abreos Biosciences - Personalized dosing of biologic therapeutics as well as aiding in the discovery and development of novel precision treatments
AcuMEMS - Wireless ocular implants and smartphone for continuous direct measurement of intraocular pressure (IOP), the only modifiable risk factor for glaucoma
Advanced Maternity Innovations - Advanced womens health technologies aimed at reducing the occurrence and associated cost of premature births.
Advanced Silicon Group - Silicon nanotechnology including photovoltaics, Li-ion batteries, microfluidics, MEMS, and more.
Anagenesis Biotechnologies - Stem cell-based technologies for genetic and age-related muscle degenerative diseases.
Avro Life Science - Developing a transdermal patch for the delivery of medications with emphasis in the pediatric patient populations.
Axolotl Biologix - Biological-related products that foster regeneration and healing for many conditions including applications in orthopedics, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Betalin Therapeutics - Innovative therapy for diabetes treatment to replace insulin therapy using an Engineered Micro Pancreas (EMP).
BioSculpture - Advanced power assisted dual-cannula tissue aspiration systems which allow controlled and efficient tissue removal. Advanced technology which can be safely adapted for other specialties and uses for which manual and other powered systems would pose a hazard.
Biospecimen Technologies - Proprietary devices for the collection, handling and processing of blood samples for testing and for therapeutic products.
CareWave - Leveraging over a century of combined experience in pain management, technology development and business, Carewave Medical is dedicated to delivering drug-free, non-invasive products to alleviate suffering of those with moderate to severe pain.
Carena Healthcare - Personalized patient care by mapping disease distribution to device design and selection. 3D visualization and analysis of diseased arteries. Image fusion of intravascular ultrasound and X-Ray angiography. Design of bespoke replacement aortic heart valves for the treatment of aortic stenosis
Cibiem - Ablation of carotid body chemoreceptors via directed ultrasound energy with a catheter deployed in the jugular vein using intravascular ultrasound imaging for positioning and targeting
Daidalos Solutions - AnchorValve, a single procedure low-profile transcatheter mitral/tricuspid valve replacement (TMVR/TTVR) device with simple direct anchoring to mitral/tricuspid valve annulus only, proven feasibility, and IP protection.
EXOVITE - Technological innovation in tools and medical procedures in Tele-RHB, E-Health and M-Health
Edge Surgical - The first single-use technology enabling more accurate and safe orthopedic and spinal surgical screws placement. Improved accuracy when selecting screws to fuse bone fractures, and mitigating bioburden contamination risk, a leading cause of surgical site infections (SSIs).
Efferent Labs - In vivo biosensor that uses cells as the main sensor. Device allows for the live streaming of data including pathway activation.
ElastiMed - Advanced compression stocking made from smart materials that mimic rhythmic calf muscle contractions and stimulates blood flow to treat venous and lymphatic diseases on the lower limbs.
Feeligreen - Microelectronics, chemistry and nanotechnologies that improve protocols and treatments for multiple healthcare applications.
GRISAL - Advanced surgical technologies and innovations
Hemovent - Self-contained fully portable Extra Corporeal Membrane Oxygenation (ECMO) system that supports or replaces heart and lung function in the event of cardiac and respiratory failure.
HepaTx - Innovative therapies for serious liver disease.
Highland Innovation Centre - The handheld BREAST-i home use device with memory and advanced sensor technology for self breast examination.
ID-NEST Medical - Easy to assemble and compliant branched vascular endografts. Modules are inserted through various approaches and click-connected in-situ.
Intuity Medical - The first blood glucose meter and multi-test cartridge designed to automate testing into one easy step, without the need for separate test supplies.
Lab Sensor Solutions - Temperature monitoring system that provides a real time 'mobile sensor as a service' solution for health and safety applications.
Laser Associated Sciences - Non-invasive technology to measure blood flow in the extremities. A compact device used during vascular surgery to dramatically improve outcomes by guiding more effective procedures.
Lightpoint Medical - Advanced molecular imaging technology, based on Cerenkov Luminescence Imaging, to detect cancer in real-time during surgery, providing more accurate cancer treatment while sparing healthy tissue.
Lynx Biosciences - Predictive technologies to individualize blood cancer therapy.
Madorra - Changing the paradigm for treating vaginal dryness, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. Provides post-menopausal women and breast cancer survivors a non-hormonal treatment option.
Magnetic Insight - Magnetic Particle Imaging (MPI), a new imaging modality that directly detects magnetic nanoparticle tracers enabling deep tissue imaging of functional events and disease states.
MedicalCue - A healthcare IT tool for assisting nurses and doctors in helping newborns, with significant big data opportunities.
NERv - Nano-systems to improve health care delivery and remote real-time patient monitoring.
NeuroRecovery Technologies - Innovative therapeutic systems designed to provide functional recovery for individuals suffering from paralysis.
ODS Medical - Optical instrument which identifies cancerous tissue in real-time during surgery directly in the patient without contrast agents, uses Raman Spectroscopy signatures and machine learning for cancer detection at cellular resolution.
PhotoSonix Medical - Combination of ultrasound and light to treat chronic bacterial infections, especially those causing acne.
Portela Soni Medical - Advanced urinary catheter technologies significantly reducing the risk of CAUTIs in catheterized patients.
Prescient Surgical - CleanCision technology platform, a portfolio of products for the prevention of surgical site infection (SSI).
Reapplix - Platform technology for regenerative medicine with first lead indication to treat diabetic foot ulcers.
Rosivo - Biological implants with applications in facial reconstruction and various other areas including intervertebral disc repair and articular cartilage repair.
SafKan - The first automated and wearable impacted cerumen removal device for clinical use.
Scinovia - Laser biophotonics devices to enable doctors to remotely visualize actual blood flow speeds across vessels & tissue with no injections, probes, or additional instruments.
Stimwave - Technologies for spinal cord stimulation, dorsal root ganglion stimulation, and peripheral nerve stimulation. The system utilizes a small, wireless, micro-size neurostimulator leveraging advancements in nanotechnology.
Synthasome - Orthobiologics to enhance soft tissue and cartilage regeneration.
Tasso - Painless blood collection system that will modernize diagnostics by enabling consumers to self-test from home.
Transverse Medical - Cerebral embolic protection device. Adapts and conforms to complex arch anatomy by maintaining contact with the aorta, enabling maximum great arch vessel coverage, and directing debris-laden blood through the filter. Initial procedure focus is Transcatheter Aortic Valve Replacement (TAVR).
UVision360 - An all-in one hysteroscopy system to fulfill unmet needs for diagnostic & therapeutic procedures for the office space.
V-Sense Medical Devices - Measures vital signs from a distance without physical contact using radar.
XenoTherapeutics - Xeno-skin is a human tissue substitute derived from special, genetically modified pigs and has the potential to save countless lives and effectively treat burn victims.
ZenFlow - Office-based treatment to permanently relieve symptoms of BPH. The device is a small nitinol implant delivered in an atraumatic five-minute procedure under local anesthesia.
nView Medical - Improved surgical accuracy for minimally invasive procedures without interfering with the surgical workflow through instant 3D imaging.


Q1 2017 EMT Spotlight


AcuityBio - AcuityBio's mission is to prevent post-surgical cancer recurrence in early stage cancer patients using localized drug delivery.
Arc Devices - Harnessing the power of sensor technology to revolutionize connected health solutions
Avisa Pharma - Avisa is a venture-backed healthcare company commercializing a rapid, point-of-care breath test for the diagnosis of pulmonary infections
BAROnova - A clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.
BioVigil Systems - Electronic hand hygiene compliance system for use in healthcare facilities
BriteSeed - An innovative surgical device system that makes operations safer by alerting the surgeon before an unsafe cut is made.
Carmell Therapeutics - Carmell Therapeutics has created a unique, highly innovative, patented technology based on biologically-active adaptive materials manufactured from human blood plasma. These plasma-based materials contain a concentration of natural regenerative factors that promote healing, reduce complications, and lead to healthcare savings.
Cologuard Ltd - A clinical stage medical device company developing novel and proprietary technology for colorectal surgery aiming to prevent the profound clinical and economic pains associated with anastomotic leaks and diverting colonic stomas.
ConcentRx - ConcentRx is a preclinical stage company with a patented Immunotherapy developed for Ovarian, Breast and Lymphoma. Outside of the body we activate a patient's or a donor's white cells with a proprietary and specific activation protocol to induce enrichment and selection of NK-T cells home to and target selectively tumor cells. Prior to infusion into the patient the NK-T cells are allowed to take up a tumor lysis agent for selective killing of the tumor cells. In preclinical animal models of disease our therapy is active against chemo therapy resistant cells of multiple tumor types and reduces the recurrence of disease.
D&P Bioinnovations - We are developing an implantable, bioresorbable medical device to functionally regenerate a damaged esophagus within the body.
Implandata Ophthalmic Products GmbH - Implandata Ophthalmic Products, is a Hannover, Germany based clinical stage company developing transformative products for the improved care of intraocular pressure related eye diseases. This is accomplished by merging proprietary implantable micro-sensors for telemetric measurement of Intraocular Pressure (IOP) with digital health technology. With its family of products, Implandata addresses medical needs in cataract, glaucoma, corneal and vitreoretinal surgery.
Innoblative Designs - Innoblative is a medical device company whose mission is to develop products to innovate and improve the way surgeons and interventionalists treat surgical margins post excision. Our first product is a radiofrequency ablation (RFA) applicator that allows surgeons and interventionalists to effectively coagulate and ablate soft tissue beds intra-operatively. Innoblative is currently investigating the patient benefits of using radiofrequency ablation (RFA) to ablate an approximately one-centimeter margin or perimeter of soft tissue following standard lumpectomy removal of a breast tumor.
Kejako - Kejako research and develop novel medical devices for the worldwide ophthalmic surgery market. Our technical and commercial goal is to launch premium, innovative solutions for common ophthalmic diseases which have high impact on peoples everyday life.
Linear Health Sciences - Linear Health Sciences is a pre-clinical medical device company in the infusion disposables space. Their flagship ORCHID SRV (safety release valve) reduces intravenous (IV) catheter dislodgment by way of a patent-pending, metal-free, breakaway valve. ORCHID valve addresses macro forces at the IV site. Preventing large sudden forces from being translated to the catheter assembly reduces not only total dislodgment, but also keeps away forces responsible for micro movements that lead to pistoning and its sequelae: phlebitis and bloodstream infections.
Magentiq Eye - A medical device startup company, focused on the field of endoscopic medical procedures. Our software and devices are planned to help doctors to see beyond the visible. We apply cutting edge deep learning, computer vision and video analysis technologies to aid doctors in the difficult task of performing medical exams and procedures. Our first product is planned for the colonoscopy screening test.
MicroOptx - MicroOptx is an early stage medical device company that is building a platform technology to shunt aqueous humor from the anterior chamber to the surface of the eye.
NangioTx - NangioTx has a unique approach to treating PAD that is based on molecular mimicry of the body's natural mechanism for blood vessel generation. The process is mediated by the engagement of the Vascular Endothelial Growth Factor (VEGF) to its cognate receptors (VEGFR). Towards this end, NangioTx has licensed "V-10", the lead self-assembling peptide mimic of VEGF for inducing angiogenesis and treating poor blood flow in PAD.
Neoscope2020 - Neoscope2020 has developed Family of Single Use, NeoscopeTm / NeoflexTm- Digital Video Endoscopic System for Digital Video Cystoscopy, Hysteroscopy, Ureteroscopy, Bronchoscopy, Arthroscopy, 3D Laparoscopy & other Minimally Invasive Diagnostic & Therapeutic Endoscopic procedures. The family of NeoscopeTm/ NeoflexTm Products have received marketing clearance from FDA approval and has CE Mark approval. The Neoscope Digital Video Endoscopy products can display "Real Time" Video images, using Laptop/PC Tablet computers and HD Video monitors.
PARE Surgical - Has developed and is marketing an FDA approved, patented, hand held LED battery powered Electrosurgical light source pencil, the NOVA, to be used with or without smoke evacuation. It provides intense, bright and shadow free visualization in the growing minimally invasive surgical market. It eliminates the need for expensive and bulky headlamps and eliminates the constant strain on the surgeon's neck while providing increased accuracy & productivity for the surgeon.
PhysioCue - PhysioCue is a consumer digital health and therapy device company approach for hypertension management that combines the latest bio-sensor (PPG & ECG) technology. PhysioCue's therapy is efficient, safe, easy to use, and has none of the side effects associated with anti-hypertensive drugs.
RayVio - An advanced health and hygiene company that delivers clean water and environments. RayVio helps protect billions from germs and creates new markets and revenue streams by enabling a new class of products. Its powerful and efficient UV LED technology can be integrated into a variety of applications, powering versatile on-demand solutions that give consumers control over health without chemicals or costly consumables.
Sanovas - Sanovas is redefining intervention with access, imaging, and measurement technologies that enable physicians to perform MORE interventional procedures, in MORE places, MORE affordably. The company is dedicated to developing the full continuum of best-in-class minimally invasive diagnostic and therapeutic technologies and solutions that are affordable, accessible, and safe across multiple procedures and specialty areas.
Stroma Medical - Late-stage research and development company developed and patented a non-invasive procedure to change eye color from brown to blue with only a topical anesthetic and will take less than 20 seconds to complete. The permanent eye color change will occur gradually over the following two to four weeks and our clinical studies are designed to confirm these results.
Transverse Medical - (TMI) is developing the POINT-GUARD™, the first and only cerebral embolic protection device with Dynamic Double-Edge Sealing. The Seal adapts and conforms to complex arch anatomy by maintaining contact with the aorta, enabling maximum great arch vessel coverage, and directing debris-laden blood through the filter. Thus, safeguarding the brain to provide complete embolic protection for addressing the unmet clinical need to keep debris out of the cerebral arteries and protect all territories of the brain during left heart procedures. Initial procedure focus is Transcatheter Aortic Valve Replacement (TAVR).
Vascor - Vascor is a pre-clinical company that has developed and patented a failsafe non-rotary implantable counter pulsation heart assist device that is powered by a transcutaneous energy transmission system. The Vascor Ventricular Assist Device (VAD) overcomes the shortcomings of existing devices, which will result in improved efficacy and safety for patients with advanced heart failure.
Virtu Surgical - Virtu Surgical has reinvented surgical robotics with the creation of a prototype for a compact and precise surgical robotic system. This system provides tactile feedback to the surgeon's hand as well as new previously unavailable surgical movements. It also will prove effective in new surgical fields beyond hysterectomy and prostatectomy. Because of its compact size and lower price point, this system is the perfect candidate to make robotic surgery both accessible and affordable for mid-size clinics and mid-income countries. We have started bench and tissues tests and expect to complete animal model in 2017.
Woven Orthopedic Technologies - Woven Orthopedic Technologies is a medical device company that designs and develops specialized orthopedic solutions for the aging population (Orthogeriatric patients). Our premiere product is a bio-textile device, for use in fracture repair surgery, to directly address the risk of losing implant fixation in patients with compromised bone. It is a simple-to-use, bio-textile device that applies a proven carpenters solution to the healthcare industry and works in conjunction with existing plate and screw systems.
Ziptek - With ZipE® - Knotless tissue repair and attachment devices are a tissue repair system that utilizes a surgical button with increased surface area for improved healing. The surgical button moves forward across suture with protuberances in a forward direction and is prevented from moving in the opposite direction offering a Zip-Tie type engineering for repairing soft-tissue.

Regularly updated company profiles of privately-held medical device companies. There are over 2000 companies currently covered in the database and 30 new companies are added each month. Company profiles include discreet and detailed information including:



Sample Company Profile
(click to preview)
Recently Added Companies:

  • Company #4348 - Anatomically accurate cleft palate and other surgical simulation training products
  • Company #4347 - Anti-biofouling ear tube implants with unique drug transport capabilities
  • Company #4346 - Flushable and eco-friendly pregnancy test
  • Company #4345 - Nerve-on-a-chip technology which uses micro engineering and biomaterials to create a 3D cell-based model that mimics living tissue
  • Company #4344 - Minimally invasive laparoscopic robot
  • Company #4343 - Bio-integrative bone fixation platform
  • Company #4342 - Magnesium alloy for use in multiple applications within orthopedics
  • Company #4341 - Soft tissue balancing instruments for knee replacement surgery
  • Company #4340 - Technologies intended to revolutionize bone fixation after orthopedic, surgical and trauma situations
  • Company #4339 - AI-driven computational pathology cancer diagnosis system
  • Company #4338 - Innovative solutions for the treatment of spinal and orthopaedic degeneration and deformities
  • Company #4337 - A nanoparticle-based method to identify and better assess dental caries in its early stages, monitor progression and to treat it non-invasively or non-surgically
  • Company #4336 - Surgical instruments for minimally invasive tissue harvesting
  • Company #4335 - Additive manufacturing to develop and deliver unique orthopedic implant solutions for better patient outcomes
  • Company #4334 - 3-D bioprinter technology
  • Company #4333 - Anti-inflammatory and anti-coagulant biotechnology solution for use in extra-corporeal treatments like dialysis and cardiopulmonary bypass
  • Company #4332 - Wearable cranial electrotherapy stimulator for the treatment of anxiety, depression and insomnia
  • Company #4331 - In-home, toilet seat-based monitor for heart failure patients
  • Company #4330 - Robotics system that integrates advanced computer vision and artificial intelligence to seamlessly fit within operating room workflow while providing advanced imaging and diagnostic accuracy during surgery
  • Company #4329 - Life-saving heart and lung therapies that generate nitric oxide from air and electricity on-demand and on-site, potentially eliminating the need for large compressed gas cylinders
  • Company #4328 - Simple, quantitative and automatable microsampling solutions for biological samples
  • Company #4327 - Automated breast imaging system producing high-resolution transmission ultrasound images
  • Company #4326 - Nephroureteral stent system for use in treating urological and biliary obstructions
  • Company #4325 - Remote monitoring platform for patients with connected pacemakers and defibrillators
  • Company #4324 - AI-based heart-auscultation solutions
  • Company #4323 - Venous stent portfolio to address the multiple anatomical challenges presented by the iliac and femoral veins
  • Company #4322 - Digital health-based solutions to track cognitive fitness and spot early signs of dementia
  • Company #4321 - World's first accurate breastfeeding monitor
  • Company #4320 - An ingestible capsule and external receiver that quickly detects bleeding in the gastrointestinal tract
  • Company #4319 - Medical products which enable surgeons and clinicians to repair serious tissue injuries
  • Company #4318 - Novel technologies for cardiovascular surgical procedures
  • Company #4317 - Advanced neurorehabilitation devices
  • Company #4316 - Patient-specific 3-D implants
  • Company #4315 - Medical monitoring and radiation safety systems for use in healthcare environments such as the cardiac cath lab
  • Company #4314 - Left atrial appendage (LAA) technology for the treatment of atrial fibrillation
  • Company #4313 - Advanced technology products for minimally invasive spine surgery
  • Company #4312 - AI platform for early detection of cognitive impairment, dementia and Alzheimer's
  • Company #4311 - Products for treating spinal instabilities and degenerative conditions via a minimally invasive approach
  • Company #4310 - Diagnostic tests to improve adherence to HIV medications
  • Company #4309 - Implants for minimally invasive and transcatheter surgery in the cardiovascular and urology fields
  • Company #4308 - Artificial heart valve technology
  • Company #4307 - Endoscopic products and procedures for use in orthopedic procedures such as carpal tunnel, plantar fasciitis and gastoc release
  • Company #4306 - Non-invasive electromyography technology designed to translate neural signals into digital input
  • Company #4305 - Robotic technology designed for Transcranial Magnetic Stimulation
  • Company #4304 - Non-invasive white blood cell assessment device
  • Company #4303 - Novel urinary catheter designed to reduce urethral trauma as a result of premature balloon inflation during placement
  • Company #4302 - Cryoablation technology for the treatment of chronic rhinitis
  • Company #4301 - Technologies for the surgical management of bunion deformities
  • Company #4300 - Advanced robotics for use in dental implant surgery
  • Company #4299 - Remote monitoring for implantable cardiac devices
  • Company #4298 - Technology for the treatment of acute decompensated heart failure (ADHF)
  • Company #4297 - Multifunctional microendoscope capable of high-quality, minimally invasive imaging within a super slim fiber
  • Company #4296 - Wearable medical device designed to deliver neuromodulation therapy directly to the nerves that regulate bladder function, without the need for surgical implant
  • Company #4295 - Medical technology products for venous access
  • Company #4294 - Cerebrovascular imaging analysis technology
  • Company #4293 - Imaging software to support clinical decision making for neurological and cerebrovascular diseases
  • Company #4292 - Bioelectronics technology, with an initial focus in dermatology
  • Company #4291 - Comprehensive solution for correcting motion artifacts in medical imaging
  • Company #4290 - ArtificiaI intelligence-based eye screening technology for autonomous disease detection, including diabetic retinopathy
  • Company #4289 - Disruptive technologies to address endovascular diseases
  • Company #4288 - Neurovascular therapeutic devices
  • Company #4287 - Endoscopy-related medical devices used in medical specialties such as urology and gynecology
  • Company #4286 - Non-invasive neuromodulation devices to address a broad range of medical conditions through the neuromodulation of the spinal cord
  • Company #4285 - Neuroprosthetics that can improve mental function and treat disorders
  • Company #4284 - Brain-computer interfaces that allow people to control software and devices using only their brain activity
  • Company #4283 - Neurological biosignal recognition system to help people affected by communication disabilities
  • Company #4282 - Products intended to reduce traumatic brain injury as a result of concussive forces to participants in athletic, battle or work environments
  • Company #4281 - Proprietary bone graft substitutes used for bone fusion procedures
  • Company #4280 - Devices for the treatment of aortic valve disease
  • Company #4279 - Long-term resorbable surgical mesh
  • Company #4278 - Non-invasive therapy devices for neurological and psychiatric disorders including depression and chronic pain
  • Company #4277 - Spine surgery devices and simulation technology
  • Company #4276 - Acute and chronic pain management solutions, and respiratory and IV therapy solutions, all designed to improve patient recovery following surgery
  • Company #4275 - Fluorescence imaging guided systems to assist surgeons
  • Company #4274 - Access catheters designed to deliver interventional treatments during minimally invasive neurovascular procedures for aneurysms, stroke and other brain blood vessel conditions
  • Company #4273 - Imaging and illumination technologies for use during many minimally invasive surgery (MIS) procedures
  • Company #4272 - Next-generation catheter-based technology to treat acute ischemic stroke
  • Company #4271 - Imaging technology for detecting small tumors and assessing soft-tissue musculoskeletal problems in the emergency room, in diagnosing trauma and underlying disease, and for real-time, intra-operative imaging
  • Company #4270 - Blood glucose meter that attaches to the back of a cell phone case, and syncs with the company's app via Bluetooth
  • Company #4269 - Home-based, non-invasive solution that allows consumers to collect and preserve live cells for future therapeutic uses
  • Company #4268 - Unique, injectable hydrogel platform technology for a wide range of medical applications
  • Company #4267 - Evidence-based digital health treatments for a range of disorders including back pain, Parkinson's disease, osteoarthritis and chronic obstructive pulmonary disease
  • Company #4266 - Microcurrent therapy solutions for chronic diseases and conditions, including sinus pain associated with allergic rhinitis
  • Company #4265 - Innovative spectacle lenses to reduce the progression of myopia in children
  • Company #4264 - Platform for regenerative medicine therapy
  • Company #4263 - Autologous fat grafting solutions for the regenerative aesthetics market
  • Company #4262 - Smart, wearable, non-invasive energy-based system for the treatment of uncontrolled hypertension and prehypertension
  • Company #4261 - Smart wearable-technology device that reduces hand and leg tremor, specifically Essential Tremor
  • Company #4260 - Next-generation treatment for cerebral aneurysms
  • Company #4259 - Intra-body imaging and tracking to guide a variety of minimally invasive catheter-based interventions
  • Company #4258 - Serenno Medical is developing a robust, hands free, automatic and low cost Urine Output monitoring device for the ICU, assisting in AKI detection and prevention.
  • Company #4257 - Paragate Medical is an innovative device company, aiming to revolutionize heart failure management by introducing the first ever fully implantable device to actively and continuously prevent fluid overload in congestive heart failure patients.
  • Company #4256 - Cellular & Biotherapeutics Delivery: utilizing nanotechnology-derived materials to address chronic and costly diseases, These include diabetes related insulin- dependency, a near 100 year old, $43 Billion industry.
  • Company #4255 - An early stage medical device company built around a patented minimally invasive brain stimulation technology used in stroke rehabilitation. The miniature-sized EPIC device is inserted into a burr hole in the skull and is externally powered, providing stimulation to either cortical or deep structures. EPIC is far less invasive than existing technology with a much shorter procedure, lower cost, fewer complications, and faster recovery time. It involves no tunneled leads or battery changes, and is easily removable.
  • Company #4254 - LifeHealth is one of only three companies in the world that manufactures bedside point of care blood gas analysis systems. LifeHealth has recently released a new, best in class analyzer and is early in development on a new, best in class single use disposable cartridge. This new solution will lead to significant penetration of the point of care critical care blood diagnostics market segment.
  • Company #4253 - LimiFlex is a lumbar spinal implant for sciatica patients suffering from degenerative spondylolisthesis (DS), the most common diagnosis leading to lumbar spinal fusion. Current treatments for DS include standalone decompression, with a high risk of recurrence, or decompression plus fusion, a highly invasive surgery with higher morbidity and increased risk of adjacent segment degeneration. LimiFlex offers the benefits of segmental stability, like fusion, while preserving motion, reducing long-term risk, procedure invasiveness, and recovery time. In addition, LimiFlex is usually performed as an outpatient procedure, matching the current clinical trends and saving cost while increasing patient satisfaction. LimiFlex is completely reversible and thus preserves future surgical options.
  • Company #4252 - We are an early stage medical device company developing a product called the HeArTPAD™ intended to treat persistent atrial fibrillation. It is a novel, minimally invasive, video-guided surgical approach (sub-xiphoid or laparoscopic/trans-diaphragmatic) to ablate the posterior wall of the left atrium that can be used concomitantly with an EP catheter ablation. The HeArTPAD Cryo-Ablation System will employ a continuous, high flow rate of very cold gas through a maze like pattern within a broad, flat pad to ablate atrial tissue and overcome the heat sink of blood flowing within the left atrium.
  • Company #4251 - AMB Surgical's groundbreaking, patented technology is intended to reduce the necessity for invasive and repetitive surgery in children and teens with orthopedic deformities such as scoliosis and limb abnormalities. FLYTE™ smart automated growing rod technology is a sophisticated electro-mechanical, software activated device to provide real-time biomechanical feedback to guide treatment, as well as, allow surgeons to perform accurate, non-surgical skeletal adjustments.
  • Company #4250 - TAS Medical will revolutionize abdominal surgery. We are dedicated to saving healthcare millions of dollars while improving the outcomes of ventral hernia repair. Our mission is to provide an alternative to mesh for ventral hernia repairs. Convert ventral hernia procedures from a costly open repair to a minimally invasive laparoscopic repair. Develop first to market tension measurement device for abdominal surgery. Our Trans Abdominal Strap has the strong potential to eliminate the need for mesh in many ventral hernia repairs and to convert procedures from a highly morbid open surgery to a minimally invasive laparoscopic surgery.
  • Company #4249 - Auctus is developing a system to treat pediatric scoliosis with non-fusion surgical system - an internal brace or sorts. Our growth modulation system includes a tether affixed to the anterior/lateral portion of the vertebral bodies. As the child grows the spine straightens over time. Our system includes a non-surgical adjustable component that allows for further increasing or reduction in tension over time.
  • Company #4248 - Molecular imaging diagnostics consisting of novel PET imaging agents to inform clinical management and guide care for cancer patients
  • Company #4247 - Advanced plasma electrosurgical and robotic devices
  • Company #4246 - A tool that improves both speed and comfort during the prosthesis fitting process, and helps monitor patient rehabilitation
  • Company #4245 - Augmented real-time fusion imaging, artificial intelligence and intra-body navigation for use in early lung cancer diagnostics and treatment
  • Company #4244 - Reduced pressure therapy for spine and orthopedic indications
  • Company #4243 - Monitoring system for measuring hand hygiene
  • Company #4242 - Stem cell-based treatments for cancer, vision loss, and skin care
  • Company #4241 - Implant and data management ecosystem technology used for remote patient monitoring
  • Company #4240 - Continuous noninvasive blood pressure and wireless vital signs monitoring
  • Company #4239 - Noninvasive devices for the prediction and diagnosis of gastrointestinal and other medical conditions
  • Company #4238 - Robotic platform for microsurgery
  • Company #4237 - Virtual reality (VR) pain management technologies
  • Company #4236 - Transcatheter mitral valve replacement (TMVR) platform
  • Company #4235 - Device-based therapies that continuously clear toxic proteins from cerebrospinal fluids
  • Company #4234 - Deep learning imaging technologies to improve medical imaging efficiency and patient experience
  • Company #4233 - Software solution for the care of preterm infants
  • Company #4232 - Medical and surgical simulators
  • Company #4231 - Vapor ablation therapy to treat a variety of endourology cancers
  • Company #4230 - Diabetes device software-as-a-service platform
  • Company #4229 - Surgical solutions for peripheral nerve injuries and damage
  • Company #4228 - Rapid, accurate cardiac magnetic resonance diagnostics for preventative care and treatment management
  • Company #4227 - Artificial intelligence-powered medical image diagnostics platform
  • Company #4226 - Devices to prevent stroke in patients with non-valvular atrial fibrillation
  • Company #4225 - Transcatheter mitral valve implant for treating valve prolapse
  • Company #4224 - The first transfemoral system for mitral valve chordal repair in the beating heart
  • Company #4223 - Connected medical devices used to track vital signs
  • Company #4222 - Technologies to help protect patients from healthcare-associated infections
  • Company #4221 - Next generation automated external defibrillator and software solutions designed to significantly increase survival rates from Sudden Cardiac Arrest
  • Company #4220 - Assay delivery platform that quickly provides actionable multi-parameter results using a small instrument and a room temperature stable cartridge
  • Company #4219 - 1) Ultrasonic endoscopic disk surgical instruments, and 2) enzyme-free ultrasound stem cell separators based on an ultrasonic technology platform
  • Company #4218 - Non-powered single patient, portable suction apparatus developed to save the life of a choking victim
  • Company #4217 - Solutions that will help doctors in low-income countries successfully treat patients suffering from debilitating wounds
  • Company #4216 - Temperature-controlled radiofrequency technology to help address common signs of aging and/or weight loss, which may include fine lines, post-baby body, cellulite, loose skin and intimate tissue/vaginal laxity
  • Company #4215 - Advanced electroceuticals for migraine and other idiopathic pain disorders
  • Company #4214 - Microvascular interventions designed to reduce the rate of amputations, improve clinical outcomes and patient quality of life in peripheral artery disease and critical limb ischemia
  • Company #4213 - Therapeutic bone products for use during surgical procedures
  • Company #4212 - Non-surgical, minimally invasive device that uses radiofrequency to modulate a nerve group to offer relief from nasal obstruction and rhinorrhea
  • Company #4211 - Surgical robot for laparoscopy
  • Company #4210 - Next-generation genetic tests
  • Company #4209 - Artificial intelligence-enabled clinical diagnostic solutions for the early detection of kidney disease and transplant management
  • Company #4208 - Regenerative medical products based on utilizing human mesenchymal stem cells
  • Company #4207 - Regenerative medical technologies, including a robust line of biologic and kyphoplasty products, with applications in orthopedics, plastic surgery, general surgery, podiatry and more
  • Company #4206 - Prostate cancer screening via direct-to-consumer membership
  • Company #4205 - Radial artery occlusion device that achieves and confirms patent hemostasis
  • Company #4204 - Hybrid mouthpiece for the elimination of snoring
  • Company #4203 - Advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology
  • Company #4202 - Advanced medical imaging and radiotherapy equipment
  • Company #4201 - Medical technologies and devices to improve operating room needle safety, workflow and efficiency
  • Company #4200 - Non-surgical, appliance-based treatment with the goal of offering a potentially permanent solution for sleep apnea
  • Company #4199 - Flowable dermal matrix for utilization for a variety of wound types
  • Company #4198 - System designed to treat rib fractures through a minimally invasive approach
  • Company #4197 - Zero-prep, easy to wear EEG (Electroencephalography) headset with dry electrodes backed by a digital platform that offers instant upload and tools for analysis
  • Company #4196 - Novel, discreet, non-invasive neurostimulation therapies for the under-treated overactive bladder market
  • Company #4195 - Ultraportable inflatable surgical environment that fits in a backpack
  • Company #4194 - Neurovascular stent with distal protection
  • Company #4193 - Stent retriever technology for use in the treatment of stroke
  • Company #4192 - Point-of-care diagnostic devices designed to simplify blood testing, making it extremely accessible anywhere and to anyone
  • Company #4191 - Diagnostic test for autism spectrum disorder (ASD)
  • Company #4190 - Transcatheter alternative to cardiac surgery for the placement of artificial chords for the mitral heart valve
  • Company #4189 - Large bore arterial closure technology
  • Company #4188 - Vaginal sidewall retraction device
  • Company #4187 - Cost-effective diagnostic testing technology for infectious disease and common genetic disorders
  • Company #4186 - Easy to use, laboratory quality, portable medical diagnostic testing platform
  • Company #4185 - Simple eye scan to detect a key biomarker of Alzheimer's disease
  • Company #4184 - Concussion impact monitoring technology that detects concussion-causing impacts in real time, delivering alerts to caregivers that identify athletes for assessment
  • Company #4183 - Diagnostics to enable noninvasive and predictive monitoring of multiple human diseases
  • Company #4182 - Drug delivery medical devices for use in various applications including cardiovascular and peripheral vascular disease
  • Company #4181 - Bonding device for expecting parents which helps them share the pregnancy experience and strengthen the emotional connection to their unborn baby
  • Company #4180 - Efficient medication delivery and integrated health diagnostics for people who suffer from asthma
  • Company #4179 - Novel therapies and external stimulation device for neurodegenerative retinal diseases and diseases of the central nervous system
  • Company #4178 - Device designed to improve the lives of patients living with the disease of pulmonary hypertension
  • Company #4177 - Musculoskeletal products focused on the upper extremities
  • Company #4176 - Shoulder replacement implant systems
  • Company #4175 - Mobile health technology allowing clinically required urine testing with a simple smartphone scan
  • Company #4174 - Spinal cord stimulation technology for the treatment of axial low-back pain, complex regional pain syndrome, lower-extremity, and upper extremity pain
  • Company #4173 - Sensitive test for objective, reliable, and quantified measurement of cognitive function
  • Company #4172 - Virtual reality-based eye-tracking technology for diagnosing disorientation, a major concussion symptom
  • Company #4171 - Personalized surgical implants for patients with debilitating spine deformities
  • Company #4170 - Washable, flexible circuits that can be embedded into fabrics to track elements of cardiovascular disease in women
  • Company #4169 - Elder-monitoring smart sensor using infrared to measure motion and evaluate health
  • Company #4168 - The world's first completely passive fetal monitor
  • Company #4167 - Augmented surgery tools for surgeons to secure hip arthroscopy surgery and reduce the risk of revision
  • Company #4166 - Specialized light treatments for treating neurodegenerative disorders through the eyes
  • Company #4165 - Surgical scissors for cutting and dissecting tissue and sutures during endoscopic procedures
  • Company #4164 - High impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions such as cardiovascular disease and hypertension
  • Company #4163 - Patches for local and transdermal delivery of drugs
  • Company #4162 - External counter-pulsation system designed to improve overall blood flow and VO2 MAX
  • Company #4161 - Highly accurate, low-cost, non-invasive tests for the early detection of lung cancer, colon cancer, and other high incidence cancers
  • Company #4160 - Intelligent medical tools that apply the emerging field of artificial intelligence with the extreme miniaturization of ultrasound to solve common everyday problems in healthcare
  • Company #4159 - Products designed to provide significantly improved outcomes for children born with rare congenital heart defects
  • Company #4158 - Minimally invasive pediatric pulmonary valve replacement approach for young children with congenital heart disease
  • Company #4157 - Intraoperative imaging technology to provide surgeons with real-time assessment of tissue microstructure
  • Company #4156 - An emergency airway and ventilation system
  • Company #4155 - Technology to monitor real-time changes in lung health throughout the entire episode of care
  • Company #4154 - The first definitive and truly minimally invasive solution to treat gallstone disease
  • Company #4153 - Digital medicine substituting pain killers with brain entrainment technology Deep relaxation on demand & Longterm reduction of baseline pain
  • Company #4152 - Injectable medical device that accelerates the natural regeneration of cartilage, bone, and numerous interface tissues
  • Company #4151 - Implants and single-use instruments that improve the minimally invasive treatment of spinal fracture conditions
  • Company #4150 - Medical aesthetics technologies
  • Company #4149 - Transmucosal drug delivery platform for the treatment of chronic rhinosinusitis
  • Company #4148 - Disposable pulse oximetry sensor designed to be placed on the wing of the nose to monitor heart rate and blood oxygenation under low perfusion conditions
  • Company #4147 - Transcatheter technology for chordal repair in degenerative mitral regurgitation
  • Company #4146 - 1 - Disposable self-retaining illuminated retractor for improving the field of light in surgical cavities; 2 - cannulated reduction forceps that act as a universal guidance system for use in treating fractures for orthopedic patients
  • Company #4145 - Radiation dose monitoring platform for use in patients receiving cancer treatment
  • Company #4144 - Bio-engineered surgical implants for connective tissue repair
  • Company #4143 - Minimally invasive monitoring probe to measure blood oxygen levels in the brains of patients in intensive care units
  • Company #4142 - Proprietary inhaled insulin product to treat diabetes
  • Company #4141 - Software package that uses image analytics, advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics to plan robot-assisted surgeries
  • Company #4140 - Electroencephalography device which will make the diagnosis of neurological patients drastically more efficient
  • Company #4139 - A device that revolutionizes umbilical catheter securement to improve safety for neonates in the intensive care setting
  • Company #4138 - Surgical instrumentation that enable users to perform surgical tasks consistently in hard to reach locations
  • Company #4137 - Orthopedic and other medical Implants that are safe for the body and avoid second surgical interventions
  • Company #4136 - Precision headgear for remote non-invasive brain stimulation
  • Company #4135 - Next-generation devices for cancer tissue diagnostics
  • Company #4134 - Spinal implants to improve spinal fusion surgeries
  • Company #4133 - Advanced imaging technologies for use in spine surgery, brain surgery, orthopedic surgery, surgical navigation, emergency departments and radiation oncology
  • Company #4132 - Fluid management technology for improving outcomes in patients suffering from acute decompensated heart failure
  • Company #4131 - Technologies for diagnosis and treatment of microvascular obstructions in heart attack patients
  • Company #4130 - Ultrasound-based technology for the rapid, formulation-independent administration of therapeutics
  • Company #4129 - Products to reduce the burden of ischemia reperfusion injury in tissue grafting, organ transplant and other surgical indications
  • Company #4128 - Next generation orthopedic braces
  • Company #4127 - A personalized fertility test women can take at home
  • Company #4126 - Prosthetic percutaneous tricuspid valve replacement device
  • Company #4125 - Ultrasound-based, real-time monitoring systems for thermal ablation procedures
  • Company #4124 - Urine output measuring device for the ICU
  • Company #4123 - Advanced multi-diagnostic medical device for chronic care management and remote patient monitoring
  • Company #4122 - Oxygen face masks that provide superior CO2 sampling capabilities for anesthesia to address modern medical practice requirements
  • Company #4121 - We are developing a therapy for treating large and aggressive cancer tumours which are beyond treatment with conventional therapies.
  • Company #4120 - Wearable treatment for infant jaundice
  • Company #4119 - Catheter-based rhythm management solutions
  • Company #4118 - Devices for use in assisted reproductive technology (ART) procedures
  • Company #4117 - Technology combining artificial intelligence and protein biomarkers to determine a patient's 5-year risk of developing cancer
  • Company #4116 - A novel infusion set for use with insulin pumps for the intensive management of diabetes
  • Company #4115 - Imaging device that allows the real-time visualization of calcium ions released from demineralizing tooth surfaces, in routine dental practice
  • Company #4114 - An approach for profiling the biological mechanisms of the epigenome
  • Company #4113 - Technology for the treatment pelvic floor disorders in women
  • Company #4112 - Automated patient identification, positioning and management system for radiation therapy
  • Company #4111 - Minimally invasive degenerative disc replacement technology
  • Company #4110 - Virtual reality (VR) platform for surgeon training
  • Company #4109 - Products that help healthcare providers reduce contaminated blood cultures
  • Company #4108 - Catheter navigation technology
  • Company #4107 - Radiofrequency (RF) thermal treament for deep, solid tumors
  • Company #4106 - Esophageal protection device for use during cardiac ablation procedures
  • Company #4105 - Collagen-based implants for the treatment of tendon and ligament injuries
  • Company #4104 - Pumpless microfluidic multi-organ "human-on-a-chip" systems with fully integrated physiological functions, such as blood circulation and nerve connections
  • Company #4103 - Biophotonic technology using fluorescent light energy to stimulate the skin's own biological processes and repair mechanisms
  • Company #4102 - Spinal interbody spacers
  • Company #4101 - Technology to mine anonymized patient information using artificial intelligence, with data gathered from its own suite of digital therapeutics, vital sign-tracking apps and genome sequencing, to drive discovery research
  • Company #4100 - Health analytics platform that captures and analyzes passive, continuous behavior data to quantify health outcomes
  • Company #4099 - Non-radioactive, dual-tracer for mapping out lymph nodes in breast cancer patients undergoing mastectomy
  • Company #4098 - Steadiwear inc has developed the Steadi-One. A lightweight, compact and responsive exoskeleton that resists tremors in Essential Tremor and Parkinson's disease. It uses our novel & battery free technology to stabilize tremors (>2Hz) while allowing voluntary motion(<2Hz).
  • Company #4097 - Integrated digital solutions to improve the management of anaphylaxis
  • Company #4096 - Smart, multifunctional, handheld surgical system to enable smooth and precise movements
  • Company #4095 - Hand-held, portable, and inexpensive blood cell counting device for use in monitoring chemotherapy patients
  • Company #4094 - A nanoscale, ocular implant to stop blindness in Open Angle Glaucoma patients
  • Company #4093 - A smart clothes platform that lets the user measure and track vitals as well as activity, including a shoe insole to monitor patients' foot health
  • Company #4092 - A smart insole with an embedded autonomous glucose monitor
  • Company #4091 - Medical devices and diagnostics that harness the biological activity of nitric oxide to improve the management of both severe acute disease (such as sepsis) and chronic disease (such as diabetes)
  • Company #4090 - Next-generation aspiration catheter for treating ischemic stroke
  • Company #4089 - An accommodating intraocular lens for the ophthalmology market
  • Company #4088 - Catheter-based procedure for treating heart failure
  • Company #4087 - A remote patient monitoring solution for chronic leg wounds
  • Company #4086 - Medical device to accelerate patient recovery following abdominal surgery by removing the intestinal wall swelling that drives long patient stay
  • Company #4085 - Medical device-based treatment for premature ejaculation
  • Company #4084 - Real-time 3D intracardiac echocardiography technology platform
  • Company #4083 - Image-guided, single catheter system used to percutaneously create an arteriovenous fistula for hemodialysis access
  • Company #4082 - Blood diagnostics technology utilizing advanced computer vision and machine learning
  • Company #4081 - Procedure designed to directly treat the abnormal airway cells responsible for chronic bronchitis, with additional applications in lung cancer, COPD, asthma, and other pulmonary diseases
  • Company #4080 - End-to-end care management platform for multiple sclerosis and a full range of neurodegenerative diseases
  • Company #4079 - Wearable device and machine-learning algorithms to track the visual needs of cataract patients in their daily life
  • Company #4078 - Handheld, portable, immediate point-of-care blood analyzer
  • Company #4077 - Next-generation automated external defibrillators
  • Company #4076 - Single-shot cryoablation platform for the treatment of atrial fibrillation
  • Company #4075 - Diagnostics platform that can be connected to remote devices like smartphones for use in home by both healthcare professionals and patients for faster and more convenient access to health information
  • Company #4074 - Transcatheter, hemi-replacement mitral valve repair/replacement system
  • Company #4073 - Pre-operative patient profiling and shared decision making tools to improve the outcomes for total knee replacement patients
  • Company #4072 - At-home, mobile-connected flu diagnostic test
  • Company #4071 - Smartphone stethoscope which brings real-time visualization to heart and lung sounds
  • Company #4070 - Digital health technology that leverages advanced analytics and biomonitoring for early detection and diagnostic and treatment guidance to preempt the advance of disease
  • Company #4069 - Biotech products for high-efficiency sorting and isolation of single cells under standard culture conditions resulting in unperturbed phenotypes and high viability
  • Company #4068 - SELFA is a medical device company based on a semiconductor biosensor with extraordinary sensitivity, scalable multiplexing, simultaneous protein and nucleic acid quantitation.
  • Company #4067 - Opus KSD has successfully developed the SubQ It! Bioabsorbable Skin Closure System, for closing surgical incisions. The SubQ It! stapler inserts a patented bioabsorbable fastener subcutaneously, never piercing the external skin, offering the surgeon the speed and ease of use of a metal stapler and the patient lowered risk of infection and no need to return for staple removal.
  • Company #4066 - Direct to Consumer ovulation monitoring device operating on a Software as a Service model
  • Company #4065 - We build applications that understand massive amounts of unstructured data at a very high speed and learn from users to single out the information that is most important to them. We apply artificial intelligence and natural language processing to all clinical data to find eligible patients for clinical trials faster, accelerating recruitment exponentially and getting cures to the people quicker.
  • Company #4064 - CorInnova is developing a non-blood contacting biventricular cardiac assist device to treat end stage heart failure (HF).
  • Company #4063 - Wristband wearable that continuously and passively collects vital signs while streaming the data to an analytics platform
  • Company #4062 - Wearable sensory prosthesis to help patients with peripheral neuropathy and balance problems
  • Company #4061 - Proprietary laser-based 3D printing technology to create functional human organs and tissues
  • Company #4060 - Robotic devices designed to assist clinicians in minimally invasive surgeries, specifically focusing on surgeries in the head and neck
  • Company #4059 - Techniques to induce brainwave oscillations for the treatment of Alzheimer's disease symptoms
  • Company #4058 - Element-proof, 3D-printed, hygienic, breathable, and more comfortable orthopedic immobilization devices
  • Company #4057 - Devices for the safe endovascular treatment of common, and uncommon, cerebrovascular diseases and abnormalities
  • Company #4056 - Products for the diagnosis of lower respiratory infections
  • Company #4055 - A robotic platform for applications in neurosurgery, CMF surgery, head and neck surgery, urology and general surgery
  • Company #4054 - Smart eyewear with proprietary visual assistive AR (augmented reality) technology that instantly enhances vision
  • Company #4053 - Sleep medicine device
  • Company #4052 - Devices for the treatment of evaporative dry eye and related syndromes including meibomian gland dysfunction (MGD) and blepharitis
  • Company #4051 - Low-flow positive airway pressure device for the treatment of obstructive sleep apnea
  • Company #4050 - Surgeon-centered visualization technologies to improve efficiency and substantially enhances patient safety and surgical outcomes
  • Company #4049 - Implantable cardiovascular left ventricular assist device to treat congestive heart failure
  • Company #4048 - Neural interface technologies to help physically disabled patients reconnect with the outside world
  • Company #4047 - Digital therapeutics platform intended to aid individuals with neurologic injuries and diseases and improve walking
  • Company #4046 - Technology that uses nanomedicine to deliver genetic materials in primary cells in vitro and in vivo, enabling disease researchers to easily study gene function in disease
  • Company #4045 - Connected headband designed for EEG-based monitoring of brain activity during sleep
  • Company #4044 - The first ever digital brain biomarkers applying machine intelligence to human-computer interaction patterns, for use in diagnosing and treating neuropsychiatric and neurodegenerative conditions
  • Company #4043 - Software that uses deep learning and image databases to aid in evaluating mammograms
  • Company #4042 - Surgical products focused on maximizing outcomes and minimizing the most common complications in surgery
  • Company #4041 - In vitro diagnostic products for point of care testing
  • Company #4040 - 3D cardiac imaging system
  • Company #4039 - Percutaneous ventricular assist device (pVAD) for use in high-risk patients undergoing interventional procedures
  • Company #4038 - Implanted drug-device combination therapies to improve the lives of patients with uncontrolled neurological diseases
  • Company #4037 - A minimally invasive approach for the treatment of polycystic ovary syndrome (PCOS) related infertility
  • Company #4036 - Transcatheter-based tricuspid valve replacement system
  • Company #4035 - Molecularly-targeted probe to identify and remove multiple cancers during surgery, including lung, breast, ovarian, colorectal, and brain, among others
  • Company #4034 - Drug-device combination product to treat topical dermatological conditions
  • Company #4033 - Surgical robotic system that enables a novel and intuitive surgical approach for laparoscopic procedures
  • Company #4032 - Technology for treating brain tumors by combining a conformable collagen matrix with brachytherapy (radiation) seeds
  • Company #4031 - Immune-cell profiling technology for treating cancer more effectively
  • Company #4030 - Medical diagnostic device capable of rapidly diagnosing diseases in either a clinical setting or at home
  • Company #4029 - In vitro diagnostics and drug companion testing for hemostasis and thrombosis disorders
  • Company #4028 - Device for the postoperative management of dislocated intraocular lens
  • Company #4027 - Ischemic stroke treatment device
  • Company #4026 - Minimally invasive repair of tissue defects in organs and holes in the heart
  • Company #4025 - Cardiac rhythm management and neuromodulation therapies to address heart failure and cardiac arrhythmias by making novel use of the heart's transverse pericardial sinus
  • Company #4024 - Crossing and support catheters for use in the treatment of occlusive cardiovascular disease
  • Company #4023 - Technology that combines advanced software, functional brain imaging and an extensive library of clinical data to help physicians analyze up to 125 regions of the brain
  • Company #4022 - Diagnostic and therapeutic endoscopic products for the lower urinary tract
  • Company #4021 - Next-generation, highly performing, multi-dose, handheld, easy to use, inhaler to significantly improve symptoms for asthma patients
  • Company #4020 - Wound dressings to stop uncontrollable bleeding
  • Company #4019 - A platform for intra-arterial nerve mapping using an electrical stimulation approach that can be integrated with various procedures for multiple indications
  • Company #4018 - Medical imaging devices ergonomically designed for surgeons and physicians treating extremities in both surgical and clinical environments
  • Company #4017 - Urethral slings to treat female stress urinary incontinence
  • Company #4016 - Devices for minimally invasive surgery in the areas of cardiovascular, peripheral vascular, orthopedic, neurosurgery, obesity, gastroenterology, hematology, nephrology, gynecology, urology, and plastic surgery
  • Company #4015 - Rapid, point-of-care detection and quantification of pathogens, toxicity measurement and environment monitoring systems
  • Company #4014 - Device for micro-invasive carpal tunnel release surgery
  • Company #4013 - X-ray imaging systems that give the user the ability to acquire X-ray images wherever and whenever they are needed
  • Company #4012 - Acoustic cardiac monitoring platform to streamline cardiovascular disease screening and management
  • Company #4011 - Ventricular assist devices and technologies
  • Company #4010 - Medical technology enabling convenient clinical access to Boron Neutron Capture Therapy (BNCT), a promising, previously inaccessible cancer treatment
  • Company #4009 - Diagnostic platform provides culture-free characterization of bacterial and fungal pathogens and resistance mechanisms direct from patient specimens
  • Company #4008 - Sensor that enables real-time differentiation of various types of infections to reduce use of ineffective drugs
  • Company #4007 - Lab automation robotics technology
  • Company #4006 - Corneal tissue and devices to treat corneal blindness
  • Company #4005 - Artificial intelligence system for computerized analysis of biopsies
  • Company #4004 - Diagnostic system based on artificial intelligence for detecting lung and other types of cancer at an early stage
  • Company #4003 - Noninvasive, electronic wearable systems that measure and transmit real-time data about human sweat
  • Company #4002 - Accurate, personalized in vitro fertilization (IVF) treatment success prediction, using predictive analytics and machine learning
  • Company #4001 - Augmented reality software platform designed to improve visualization in cardiac surgeries and other interventional procedures
  • Company #4000 - Regenerative medicine, allograft-based products for use in orthopedic, cardiovascular, and other medical specialties
  • Company #3999 - Phototherapy technologies for the treatment of skin conditions such as psoriasis, atopic dermatitis (eczema), vitiligo and leukoderma
  • Company #3998 - Next generation medical devices for neurostimulation, initially for the treatment of drug-resistant epilepsy
  • Company #3997 - Device that provides postnatal treatment after Caesarean section deliveries
  • Company #3996 - A connected medical technology for assessing cardiovascular risk
  • Company #3995 - Healthcare technology data-capture platform that connects patients and healthcare professionals in real time
  • Company #3994 - Collagen and tissue components for use in regenerative medicine, including orthopedic, dental, wound care, and cardiovascular applications
  • Company #3993 - Next generation technology for vessel dilatation in cardiovascular interventions
  • Company #3992 - Devices for the endovascular management of cerebral aneurysms and stroke
  • Company #3991 - Software-enabled surgery technologies, including robotic surgery
  • Company #3990 - Advanced sensor technologies and AI-powered mobile health solutions for use in treating respiratory conditions
  • Company #3989 - Artificial intelligence-based stroke platform that leverages advanced deep learning to communicate time-sensitive information about patients straight to a specialist who can intervene and treat
  • Company #3988 - Hair restoration treatments and therapies
  • Company #3987 - Dermal immunotoxicological assay test
  • Company #3986 - Neuro-thrombectomy net device designed to treat acute ischemic stroke
  • Company #3985 - Synthetic soft tissue substitutes for aesthetic and reconstructive medicine
  • Company #3984 - Suture-based closure device that induces hemostasis of an arteriotomy following endovascular procedures
  • Company #3983 - Wireless implantable electronics to stimulate, steer and monitor bone growth
  • Company #3982 - Machine learning technologies that deliver actionable information for personalized breast health
  • Company #3981 - Surgical strategy for treatment of refractive error
  • Company #3980 - Surgical and topical adhesive materials
  • Company #3979 - Non-invasive cardiovascular health diagnostics through the measurement and monitoring of a patient's vascular endothelium
  • Company #3978 - System for measuring brain function to aid in the diagnosis of cognitive disorders
  • Company #3977 - Saliva-based fertility device and app
  • Company #3976 - Mobile medical device supporting concussion management with objective measures to revolutionize the way athletes and patients are monitored for signs of neurological and vestibular dysfunction
  • Company #3975 - Simple, non-invasive, blood test that identifies more than 26 different cancers earlier, more accurately, and with greater sensitivity and specificity, without producing any side effects in patients
  • Company #3974 - Wearable devices for epilepsy management
  • Company #3973 - Technology for locating surgical needles lost during surgery
  • Company #3972 - Nonsurgical ear molding device that corrects misshapen ears in newborns
  • Company #3971 - Non-invasive, oral diagnostic technology that will help clinical professionals detect and treat diseases sooner and enhance the practice of wellness management
  • Company #3970 - Point-of-care diagnostic device that leverages paper-based microfluidics technology to reduce cost and time of testing for over 40 diseases
  • Company #3969 - Microscopy system that provides an exact picture of cancer biopsies within seconds, providing essential biopsy quality evaluation to ensure an accurate final diagnosis
  • Company #3968 - A neurostimulation headset that accelerates the acquisition of muscle memory from athletic training
  • Company #3967 - Molecular diagnostics for oncology precision medicine
  • Company #3966 - Wearable, medication-free brain stimulation device to treat patients with depression
  • Company #3965 - Ultra-low power multi-channel programmable and implantable neurostimulation device to address numerous medical conditions
  • Company #3964 - Non-invasive sensors to improve the management of critically ill patients
  • Company #3963 - Remote patient monitoring solutions for chronic disease patients, including chronic heart and lung diseases
  • Company #3962 - Artificial intelligence-powered computational imaging device capable of detection and diagnosis of various diseases including skin cancer without the need for invasive procedures, for the purposes of diagnosis and treatment planning
  • Company #3961 - MRI-compatible patient entertainment and clinical team communications system for use during MR-guided interventions, thermal ablations, biopsies and other procedures
  • Company #3960 - Smart sensor system to remotely monitor and manage patients at risk of developing pressure-related injuries
  • Company #3959 - Functional Electrical Stimulation (FES) device for treatment of footdrop
  • Company #3958 - Next generation, nanotechnology-based brain-computer interface for use in deep brain stimulation, functional prosthetics, rehabilitation, among other medical applications
  • Company #3957 - Needle-free continuous glucose monitoring technology
  • Company #3956 - Technology for assessing liver function of patients with chronic liver disease
  • Company #3955 - Bioresorbable scaffold for ACL reconstruction
  • Company #3954 - AI-enabled stethoscope system
  • Company #3953 - Affordable, functional, personalized bionic hand prosthesis
  • Company #3952 - Left atrial appendage implant technology for the treatment of medication-resistant longstanding persistent atrial fibrillation
  • Company #3951 - Plug and play technologies for the worldwide enteral feeding market
  • Company #3950 - Proprietary technology designed to improve the safety and efficacy of interventional acute ischemic stroke therapy
  • Company #3949 - Immuno-oncology diagnostic tests for use in assessing the risk of relapse in colon and other cancer patients
  • Company #3948 - Microcatheters designed for embolization procedures of tumors and vascular aneurysms
  • Company #3947 - Photonics diagnostic assay to accurately predict risk of metastatic recurrence
  • Company #3946 - C. Light Technologies is a neurotech and machine learning company that uses novel eye motion technology to revolutionize the detection, monitoring, and treatment of neurodegenerative diseases (starting with multiple sclerosis). We apply advanced machine learning algorithms to the patterns of eye motion to provide objective and clinically actionable metrics in order to monitor disease progression and drug efficacy. With eye-tracking technology 120-150x better than commercially available pupil trackers, the TSLO generates 10+ data points that have never previously existed, which can be commoditized and advance medical science. Future Applications include: Alzheimer's, Parkinson's, and concussions.
  • Company #3945 - Wireless Capsule Endoscopy (WCE) technology for use in gastrointestinal diagnostic procedures
  • Company #3944 - Safe and accurate delirium (acute brain failure) monitoring
  • Company #3943 - Developing an innovative platform of oxygen therapeutics to treat life-threatening diseases where hypoxia plays a role.
  • Company #3942 - A cloud-connected vital signs monitoring system that rescues the under-monitored patients around the world.
  • Company #3941 - Innovative heart rate monitor for newborns providing a continuous, reliable and hands-free heart rate within minutes after birth. Reduces time spent in intensive care. Technology includes a single-use Cap which integrates a sensor and a reusable Display with wireless Modules.
  • Company #3940 - Improved outcomes for cancer patients using advanced imaging technology that doubles the resolution and contrast of today's mammography using less than half the x-ray dose and removes the need for painful breast compression.
  • Company #3939 - DermaTec's alcohol detection patch is unique in the alcohol detection marketplace for its multi-day usage, non-invasive application and its ability to provide a visual indication that someone has been drinking.
  • Company #3938 - Pulsed radiofrequency technology-based wearable device that provides relief of menstrual and lower-back pain
  • Company #3937 - The leading developer of Intrabodies for neurodegenerative diseases, leveraging the safety and effectiveness of antibody technologies to address unmet medical needs.
  • Company #3936 - Breath analysis diagnostic systems using advanced biomarker analytical technology and data analysis algorithms for next generation point of care diagnosis and management of disease.
  • Company #3935 - Wireless device to detect and alert the early onset presence of a Catheter Assisted Urinary Tract Infection.
  • Company #3934 - Interactive mobile application dedicated to the prevention of cardiovascular disease
  • Company #3933 - Standalone box that reveals invisible targets to Interventional radiologists, so that they can perform procedures faster and with more confidence.
  • Company #3932 - Endovascular Internal Shunt
  • Company #3931 - Advanced mechanical beds and technologies aimed to prevent and treat immobility-induced complications such as pressure ulcers (bedsores) and pulmonary complications.
  • Company #3930 - Smaller, safer blood pump to help infants and children with heart failure
  • Company #3929 - Wireless sensor system for reducing infection-related morbidity, mortality and re-admission in outpatients undergoing treatment for cancer, or in other patients
  • Company #3928 - Respiratory monitoring for the detection of opioid induced respiratory depression
  • Company #3927 - Biodegradable urological medical devices
  • Company #3926 - Surgical platform to enable holographic visualization of all medical imaging
  • Company #3925 - Minimally invasive alternatives to infants, children and adults who require interventions including pacemakers, defibrillators or cardiac ablation procedures
  • Company #3924 - Blood test which aids in breast cancer detection in women with dense breast tissue
  • Company #3923 - A self-contained hand-held medical diagnostic device being designed to measure all vital signs and help those with no medical training make more intelligent healthcare decisions
  • Company #3922 - Technologies and products which enable the production of the world's most-used diagnostic imaging isotope, technetium-99m, using local, hospital-based medical cyclotrons
  • Company #3921 - Line of patented, composite polymer medical devices for use in spinal surgery
  • Company #3920 - Game-based rehabilitation devices and exercises for patients with neurological, central nervous system, and musculoskeletal injuries such as stroke
  • Company #3919 - Catheters for the treatment of vascular disease above and below the knee
  • Company #3918 - Orthopedic and spinal implants, soft tissue fixation and augmentation products, human allografts, bone substitute materials and regenerative tissues and fluids to augment orthopedic surgeries and wound care
  • Company #3917 - Real-time ECG monitoring system to diagnose and remotely monitor cardiac patients
  • Company #3916 - Technology that applies artificial intelligence (AI) to cardiovascular imaging to help in the diagnosis and management of heart disease
  • Company #3915 - Synthetic nanofiber scaffolds that promote healing by mimicking the physical structures found naturally in the body
  • Company #3914 - Modular point-of-care, desktop applications for disinfection and sterilization in the healthcare environment
  • Company #3913 - Closed-loop bionic pancreas device for the management of diabetes
  • Company #3912 - Combined precision robotic and computed tomography (CT) imaging platforms
  • Company #3911 - Device-guided needling platform to enable reliable and less painful vascular access to the arteriovenous (AV) fistula commonly used by dialysis patients
  • Company #3910 - Portable nebulizer for use in administering medical cannabis to patients suffering from chronic lung conditions
  • Company #3909 - Biomarker discovery platform that enables researchers to identify markers for early detection of disease
  • Company #3908 - Hernia repair products to decrease complications and promote healthy tissue regrowth
  • Company #3907 - Vascular Genesis is building a vascular regeneration platform with its line of cell-free, synthetic scaffold products, eliminating the need for tissue donation, immune suppressants, and the ever-present risk of transplant rejection. Our first product offering is a resorbable arteriovenous (AV) graft for dialysis access. The graft will degrade over a scheduled period of time and allow the body to create a new native tissue fistula for continual dialysis access. The graft is designed to match the compliance of the native artery/vein to which it attaches. Its self-healing capabilities will allow it to achieve stasis (stop bleeding) faster than competing products.
  • Company #3906 - Scaffold-based orthopedic products that accelerate and improve the quality of repair at the site of a soft tissue injury
  • Company #3905 - Wound care products that provide a structure for tissue growth and promote faster healing of wounds
  • Company #3904 - Anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits for children
  • Company #3903 - VerteCore Technologies is a medical device development company which creates products addressing orthopedic niche markets. Thru creating innovative medical devices for ambulatory, non- surgical treatment of spinal disorders, we offer a novel approach to back and neck pain treatment, enabling rapid recovery while helping eliminate the need for hospitalization, drugs, and surgery. Three versions of the company's lead device have already been designed with the participation of leading physicians in the orthopedic field. Multiple Patent Pending statuses have been obtained and patent assignment provided into the company.
  • Company #3902 - Total ankle replacement prosthesis
  • Company #3901 - Advanced surgical devices for improving outcomes for orthopedic extremity procedures
  • Company #3900 - Devices for respiratory management
  • Company #3899 - Advanced cell-based therapeutics with a focus on Critical Limb Ischemia
  • Company #3898 - Technology focused on the detection and accurate, quantitative measurement of liver, gallbladder and pancreatic disease, including precancerous and cancerous states
  • Company #3897 - Artificial intelligence (AI)-based technology for the detection and diagnosis of disease, including cancer
  • Company #3896 - Precision medicine data platform enabling healthcare providers to use molecular profiling to diagnose and treat cancer patients
  • Company #3895 - Proprietary, premium medical devices at affordable prices across a wide variety of treatment and diagnostic disciplines
  • Company #3894 - Behind-the-ear nerve field stimulator that treats the symptoms of opioid withdrawal
  • Company #3893 - Machine learning (ML) applications for medical imaging analyses, allowing physicians and researchers to make more efficient and more accurate diagnoses
  • Company #3892 - Faceted bone screws for the trauma and orthopedic markets
  • Company #3891 - Simplifying sleep apnea diagnostics with acoustics.
  • Company #3890 - Pediatric dosing verification system to prevent accidental overdoses
  • Company #3889 - Wearable, textile 12-lead remote ECG monitoring technology
  • Company #3888 - Mobile-connected cervical cancer screening device
  • Company #3887 - 3D printed models of human organs and organ segments for use in simulated surgery
  • Company #3886 - Neuromuscular stimulation technologies for the treatment of chronic pain and musculoskeletal injuries
  • Company #3885 - An implantable, bioresorbable device to repair vascular abnormalities by facilitating organized new tissue growth from a patient's own cells
  • Company #3884 - MRI-compatible 12-lead ECG monitors and software that provide cardiologists visibility into a patient's health during an MRI
  • Company #3883 - Bioerodible implant designed to treat pain and inflammation after cataract surgery
  • Company #3882 - Medical smartphone case that incorporates patented wireless medical sensors and service platforms
  • Company #3881 - Personal device that predicts and prevents asthma attacks
  • Company #3880 - Novel left atrial appendage (LAA) intraatrial closure device and method to prevent stroke in atrial fibrillation patients
  • Company #3879 - Laparoscopic surgical devices for use in minimally invasive surgery (MIS)
  • Company #3878 - Medical device to improve the quality of life of those patients with hydocephalus and provide neurosurgeons with a new tool for aided-diagnosis and pathology follow-up
  • Company #3877 - A device designed to capture samples relevant to vascular function and coronary plaque progression, and map the biological processes of coronary artery disease (CAD)
  • Company #3876 - DNA testing and screening of genes connected to breast cancer, colorectal cancer and lung cancer
  • Company #3875 - Devices and techniques for the same-day upper (hand surgery) and lower extremity surgical market
  • Company #3874 - Ultra-sensitive, nanotechnology-based circulating tumor cell (CTC) capturing device for diagnosing, treating and monitoring cancer
  • Company #3873 - Cell-based therapies to treat intractable neurological disease
  • Company #3872 - Non-invasive, wearable bioelectronic platform that effectively targets autonomic nerve pathways important in a number of disease processes, while providing superior safety relative to pharmaceutical interventions
  • Company #3871 - Device to reduce the incidence of durotomies during revision spinal surgeries
  • Company #3870 -
  • Company #3869 - Voxello develops pioneering technology providing severely impaired patients the ability to communicate with caregivers and family effectively. Voxello developed the noddle® and noddle-chat to reduce adverse events, achieve better outcomes, and improve patient satisfaction while returning a sizable ROI to the hospital. Using any voluntary gesture such as a tongue click or minimal movement such as a head nod, a patient can access the nurse call and the noddle-chat, which is a speech generation device to communicate.
  • Company #3868 - A headset device which helps people achieve leaner, healthier bodies through vestibular nerve stimulation
  • Company #3867 - Advanced diagnostic medical devices and services for eye care
  • Company #3866 - Pneumatically controlled surgical assist robot platform
  • Company #3865 - Next-generation transcatheter aortic valve replacement (TAVR) technology
  • Company #3864 - Titanium truss implant designs for knee, hip, trauma and patient specific orthopedic procedures using cutting-edge 3D printing technology
  • Company #3863 - A wearable device to track blood pressure continuously
  • Company #3862 - Interventional medical devices focused on the field of cardiology such as DES, TMVR and intracranial stenting
  • Company #3861 - Catheter-based solution to treat mitral and tricuspid regurgitation
  • Company #3860 - Microcatheter devices for use in interventional cardiology and the treatment of peripheral vascular disease
  • Company #3859 - Medical exoskeleton designed to provide gait rehabilitation for people with mobility disorders
  • Company #3858 - Implantable neurostimulation systems to treat head pain
  • Company #3857 - Products for less invasive spine surgery
  • Company #3856 - Rapid point of care diagnostic assays and products, including epidemiological disease surveillance assays and other public health tools and clinical specimen collection devices to improve and facilitate remote collection of specimens for follow-up testing
  • Company #3855 - Point-of-care, low-cost diagnostic platform for the developing world that can quickly and easily diagnose malaria and hemoglobin disorders, such as sickle cell disease, from a drop of blood
  • Company #3854 - Extracorporeal blood-cleansing device designed to selectively remove bacteria, including multi-drug resistant strains, and endotoxin from circulating blood
  • Company #3853 - Fluorescence image-guided surgery platform solutions using high-definition cameras and tracers
  • Company #3852 - Innovative device and service solutions across the respiratory and anesthesia continua of care
  • Company #3851 - A medical device for the treatment of lymphoedema
  • Company #3850 - DermaSensor, Inc. is a connected device company that enables healthcare professionals to efficiently check for skin cancer by leveraging cutting edge technologies. The DermaSensor device is an affordable handheld tool that uses artificial intelligence and spectroscopy to evaluate skin lesions for potential skin cancer in a matter of seconds.
  • Company #3849 - Bioengineered sphincters using autologous progenitor cells that replace the dysfunctional internal anal sphincter, the root cause of fecal incontinence
  • Company #3848 - A proprietary platform technology to address joint pain and joint damage via biomechanical and bioactive implants
  • Company #3847 - Advanced soft tissue repair systems for ankle injuries
  • Company #3846 - Orthopedic braces, rehabilitation products, and portable vascular therapy, including the first FDA portable and tubeless sequential device with multiple pressure functions
  • Company #3845 - Medical aesthetic technology to treat skin laxity and focal aesthetic contour deformities in areas where visible scarring limits the use of traditional plastic surgery
  • Company #3844 - Transabdominal gastrointestinal stimulation technology for the treatment of gastrointestinal motility disorders including chronic constipation, irritable bowel syndrome with constipation and gastroparesis
  • Company #3843 - A convenient, low cost, non-invasive system that can be deployed rapidly in the hospital, clinic and home for monitoring and diagnosis of digestive disorders
  • Company #3842 - An occuder device for use in open general surgery procedures on tubular structures or vessels wherever a metal ligating clip is indicated
  • Company #3841 - Cerebral protection system to complement transcatheter aortic valve replacement (TAVR) procedures
  • Company #3840 - A device which allows the safe and easy delivery of large diameter vascular devices into the vascular system through the femoral artery
  • Company #3839 - Patient-oriented monitoring systems for before, after, and during surgery.
  • Company #3838 - Implantable device for treatment of chronic heart failure.
  • Company #3837 - Minimally invasive instruments for clearing occlusions, penetrating bone and tissue, and enabling the MRI–guided surgical procedure.
  • Company #3836 - Acute Compartment System (ACS) diagnostic system.
  • Company #3835 - Radio-Frequency Identification (RFID) for healthcare analytics.
  • Company #3834 - Device for the treatment of acute kidney injury.
  • Company #3833 - Image guided laser therapy for prostate cancer
  • Company #3832 - Bio-compatible, minimally invasive endovascular technologies.
  • Company #3831 - Portfolio of point-of-care diagnostic devices
  • Company #3830 - Diagnostic solutions
  • Company #3829 - Portable warm perfusion device intended to achieve better recovery of organs
  • Company #3828 - EEG recording system specifically for epilepsy monitoring and control
  • Company #3827 - Novel polymer-based devices to treat cancer using localized, low-dose-rate radiation
  • Company #3826 - hydrogel composed of extracellular matrix derived from porcine tissue
  • Company #3825 - Drug-coated balloon catheter designed to treat urethral strictures in men
  • Company #3824 - Patented process to covalently bond biologics or drugs onto any device or labware material, or to human tissue for targeted, non-systemic delivery.
  • Company #3823 - Diagnostic device to count blood cells.
  • Company #3822 - Medical device for the removal of galectin-3
  • Company #3821 - TracPatch Wearable medical device for pre and post-op patient monitoring, patient engagement, data analytics and post op cost reduction. Consensus also designs, markets and sells knee and hip replacement implants.
  • Company #3820 - Remote Catheter System
  • Company #3819 - POC testing devices.
  • Company #3818 - TAVR SmartGuidewire™ allows cardiologists to monitor valve function continuously throughout transcatheter aortic heart valve replacements (TAVR) procedure providing actionable data to cardiologists during valve positioning. The TAVR SmartGuidewire™ simplifies workflow offering direct savings to hospitals and the additional data collected may be used to improve patients outcomes.
  • Company #3817 - Smartphone based retinal screening system.
  • Company #3816 - Modular spinal fusion products for the surgical treatment of degenerative disc disease.
  • Company #3815 - Digital wound care management system designed to assess and monitor wounds
  • Company #3814 - Platform technology for the accurate imaging and placement of needles in vivo.
  • Company #3813 - Devices focused on diabetes management.
  • Company #3812 - Pressure-limited & computer-aided balloon catheter
  • Company #3811 - Implanted medical devices for severe urinary incontinence
  • Company #3810 - Wearable medical device able to accurately measure breathing and cardiac vital signs.
  • Company #3809 - Stimulation system for the treatment of neurologically caused impairment, such as visual field loss.
  • Company #3808 - Wirelessly powered, fully implantable mechanical circulatory support device.
  • Company #3807 - Provides minimally invasive and motion preserving spinal surgery technologies
  • Company #3806 - Noninvasive glucose monitor
  • Company #3805 - Minimally invasive products for use in diverse markets including breast health; soft tissue surgery, including small or fragile tissues and challenging surgical spaces, with endoscopy, laparoscopy, and robotics applications; bone marrow biopsy and harvest; interventional cardiology; and minimally invasive peripheral vascular procedures
  • Company #3804 - Natural and synthetic bone graft substitutes for use in the orthopedic, spine and dental surgery fields
  • Company #3803 - A novel microtechnology-based tissue anchorage system that allows for rapid, reproducible and robust wound closure
  • Company #3802 - Novel percutaneous solution intended to treat tricuspid regurgitation that seals the central gap between the native valve leaflets to prevent regurgitation
  • Company #3801 - Wearable sensor-based technologies to identify patients at risk of falls and in need of help and intervention, to quantify a patient's response to therapy and rehabilitation, and to assess patients for neurological disorders
  • Company #3800 - Implantable ultra thin-film cell delivery technology for diabetes management
  • Company #3799 - A single use, smart device that temporarily seals the needle access route into the lung before a biopsy takes place to prevent pneumothorax
  • Company #3798 - Single-use, disposable minimally invasive spine surgery access devices
  • Company #3797 - Real-time patient management platform integrates medical, cloud, and social networking technologies to enable new care coordination and delivery models
  • Company #3796 - Easy-to-use, hand-held drug-device combination product for use in the cessation of active and acute epileptic seizures
  • Company #3795 - Portable surgical microscope that is designed to be used in surgeries for treatable causes of blindness in low-income countries and under-resourced settings
  • Company #3794 - Technology for accurate, real-time localization of an Umbilical Venous Catheterisation (UVC) catheter tip
  • Company #3793 - Genomic sequence-based diagnostics products, including molecular rare disease diagnostics
  • Company #3792 - Wearable device that monitors the motor symptoms of patients with Huntington disease
  • Company #3791 - Intelligent, adaptive robotic mobilization system to support critically ill patients and their caretakers
  • Company #3790 - Personalized speech monitoring based on analysis of COPD patients' voice and breathing during voice calls
  • Company #3789 - Precision robotic guidance system with an initial focus on skin resurfacing
  • Company #3788 - Devices for the orthopedic trauma/bone fracture market
  • Company #3787 - Catheter technologies designed to make AFib ablation procedures safer and more efficient
  • Company #3786 - Device to manage peristomal skin complications for people with ileostomies
  • Company #3785 - At-home diagnostics for sexually transmitted diseases
  • Company #3784 - Medical adherence device for patients taking self-injectable medications
  • Company #3783 - Proprietary, innovative, high-margin and cost effective spine implants and instruments
  • Company #3782 - Scaffold technology for the treatment and functional restoration and healing of damaged or diseased tissues
  • Company #3781 - Smartphone-based UVB treatment system for psoriasis, eczema and vitiligo
  • Company #3780 - Prescription digital therapeutics for substance use disorder (SUD)
  • Company #3779 - Lower-cost, smaller, lighter, more energy efficient proton therapy for the treatment of cancer
  • Company #3778 - Asthma management system that analyzes exhaled breath to determine lung condition and function
  • Company #3777 - Eye movement tracking technology to screen for concussions and monitor recovery, issue comprehensive core vision tests, or improve athletic performance by identifying vision strengths and weaknesses
  • Company #3776 - Gene-editing technology with the goal of permanently correcting the majority of Duchenne muscular dystrophy mutations, among other pediatric indications
  • Company #3775 - Insulin pump patch that is placed on the patient's body, that incorporates mobile connectivity capabilities
  • Company #3774 - Synthetic aortic and mitral heart valves
  • Company #3773 - Painless, personal health measurement device that is capable of multiple, simultaneous human fluid analytic measurements
  • Company #3772 - Alpha Tau Medical focuses on research, development, and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid tumors.
  • Company #3771 - Foot and ankle fixation implant systems
  • Company #3770 - Point-of-care device to non-invasively screen for urinary reflux in children
  • Company #3769 - A minimally manipulated, micro-fractured adipose tissue for autologous injection, that encourages the natural regeneration of tissue in many pathologies
  • Company #3768 - Safe, efficacious, and easy-to-use aesthetic technologies
  • Company #3767 - Implants for orthopedics, spine and trauma surgery
  • Company #3766 - Peripheral vascular and neurovascular embolization devices based on shape memory polymer foams
  • Company #3765 - Histologics manufactures and markets Internationally multi-patented evidence-based (proven) and burgeoning commercialized technology to acquire a-traumatic mucosal biopsies and perform less traumatic wound care debridement. This replaces traumatic sharp instruments with a patient friendly brush-biopsy approach. The devices employ a proprietary medical fabric "Kylon®", attached to several applicator devices to allow for minimally invasive trans-epithelial and dermal tissue sampling/biopsy and the automatic trapping of specimens for easy transport for laboratory analysis.
  • Company #3764 - Robotic systems for cochlear implantation surgery
  • Company #3763 - Advanced esophageal temperature monitoring technology
  • Company #3762 - Biomechanically activated, osteoinductive spinal fusion device
  • Company #3761 - Device that eliminates the difficult aspects of the Descemet's Membrane Endothelial Keratoplasty (DMEK) procedure for surgeons by modifying the surgical workflow and reallocating risk to skilled eye bank technicians
  • Company #3760 - Sensitive antibody tests for the early detection and treatment of diseases like HIV and type 1 diabetes
  • Company #3759 - LivOnyx Inc. is developing a rapid hand disinfection system to reduce healthcare associated infections (HAIs) using its proprietary, patented thinSpray technology and antiseptic LVNX-001. There is an unmet need for a hand hygiene solution that takes no more than 3-5 seconds, leaves hands dry, facilitates hand health, is portable to optimize workflow around the patient, and is effective against the pathogen Clostridium difficile, a leading cause of HAIs in hospitals.
  • Company #3758 - Laboratory-based assay for risk stratification and early detection of pancreatic cancer
  • Company #3757 - Next-generation, cartilage-protecting viscosupplement with significantly lengthened duration of efficacy compared to existing and in-development osteoarthritis joint injections
  • Company #3756 - A diagnostic test that analyzes live tissue and can determine a more accurate diagnosis for cancer patients, particularly those with breast cancer
  • Company #3755 - Glass-based bone cement for the repair of vertebral fractures
  • Company #3754 - Technology that automates the process of mounting tissue sections from a microtome onto slides - all in a compact, user-friendly unit that works with existing microtomes
  • Company #3753 - Novel catheter system that enables patients to receive hemodialysis in an improved manner
  • Company #3752 - Novel, proprietary, targeted MRI imaging agents for the early diagnosis of Alzheimer's disease and other neurodegenerative disorders
  • Company #3751 - Health apps which use a smartphone's built-in sensors to monitor different health biomarkers
  • Company #3750 - Next-generation sequencing-based genomic solutions in cancer immunotherapy, prenatal screening and metabolic diseases
  • Company #3749 - Next-generation sequencing to enable the broad and rapid detection of microbial cell-free DNA through a standard blood draw
  • Company #3748 - Microbiome-sequencing platform that identifies the microorganisms in an individual's gut, analyzes their activity and, using machine learning, provides nutritional recommendations to avoid chronic disease
  • Company #3747 - Devices for the interventional treatment of cardiovascular disease
  • Company #3746 - A novel device for the treatment of sepsis
  • Company #3745 - Biological implants with applications in facial reconstruction and various other areas including intervertebral disc repair and articular cartilage repair.
  • Company #3744 - Predictive technologies to individualize blood cancer therapy.
  • Company #3743 - Innovative therapies for serious liver disease.
  • Company #3742 - Proprietary devices for the collection, handling and processing of blood samples for testing and for therapeutic products.
  • Company #3741 - Advanced womens health technologies aimed at reducing the occurrence and associated cost of premature births.
  • Company #3740 - Electrophysiology recording system to guide cardiac ablation procedures
  • Company #3739 - A minimally invasive, disposable, retractor for use in laparoscopic surgery
  • Company #3738 - A minimally invasive, disposable, retractor for use in laparoscopic (keyhole) surgery
  • Company #3737 - Advanced wound care platform that provides rapid hemostasis in a clean, safe healing environment
  • Company #3736 - Minimally invasive technologies to treat colorectal diseases
  • Company #3735 - Smart intubation devices for use in intensive care
  • Company #3734 - Technologies for treating conditions of the pelvic floor and surrounding tissues
  • Company #3733 - A wearable, digital health product focused on heart failure evaluation and monitoring
  • Company #3732 - Transcatheter technology for the treatment of mitral regurgitation
  • Company #3731 - An all-in-one post-op wound care, sterile and disposable bra for use following breast surgery
  • Company #3730 - Spinal surgery systems, kyphoplasty/vertebroplasty products, and bone graft substitutes
  • Company #3729 - Microinterventional technology to treat cataract-induced visual impairment and blindness
  • Company #3728 - Ophthalmic surgery instruments, with a focus on vitreoretinal surgery
  • Company #3727 - An innovative new treatment for kidney stones
  • Company #3726 - 3D bioprinting technology, with a focus on therapeutics with near-term clinical applications
  • Company #3725 - Fast, simple and minimally invasive alternative treatment to first-line Benign Prostate Hyperplasia (BPH) medication and surgery
  • Company #3724 - A small non-mechanical (passive) subcutaneous implant device to enable the sustained release of proteins and peptides as well as small molecules
  • Company #3723 - Wearable technology that uses sensory augmentation to convert sound to touch for those who are deaf or hard of hearing
  • Company #3722 - Smartphone-based automated migraine management tool
  • Company #3721 - A wearable technology for identifying undetected hypoxic episodes in babies
  • Company #3720 - Technology that collects and analyzes speech and text samples to detect various health conditions early, before full-blown symptoms appear
  • Company #3719 - Muscle- and brain-controlled exoskeletons that can be used for rehabilitation and motion assistance
  • Company #3718 - Technology designed to provide continuous, real-time disinfection of air and surfaces in all types of environments
  • Company #3717 - Advanced drug delivery systems, and injectable and locally acting therapeutics for use in treating chronic, high-burden diseases
  • Company #3716 - Suture-mesh-anchor system designed to lift and support tissue during cosmetic and reconstructive procedures
  • Company #3715 - Catheter-based thrombectomy approaches to treat peripheral vascular disease
  • Company #3714 - Electrostatic precipitation-based system to eliminate surgical smoke and provide a continuously clear visual field during laparoscopic surgery
  • Company #3713 - Technology designed to target and treat the ectopic cardiac tissue that contributes to atrial fibrillation
  • Company #3712 - Pediatric-focused technologies designed to enable placement of tympanostomy tubes in an office environment
  • Company #3711 - MR-safe surgical navigation platform
  • Company #3710 - Advanced prosthetic technologies, including a robotic prosthetic arm for patients with forearm through shoulder-level amputations
  • Company #3709 - Medical imaging software platform for visualizing nerves in 3D from a standard MRI acquisition
  • Company #3708 - A smart exoskeleton that provides a seated and movement solution for children and adults with physical and movement disabilities
  • Company #3707 - Single-use, self-propelled endoscopes for use in colorectal procedures
  • Company #3706 - Healthcare wearables for Alzheimer's disease patients
  • Company #3705 - Compression stocking made from smart materials that mimics rhythmic calf muscle contractions and stimulates blood flow
  • Company #3704 - Tissue-imaging devices for use in preventing, diagnosing and curing underlying skin conditions, such as diabetic foot ulcers and pressure ulcers
  • Company #3703 - Shockwave device and generator technology delivered within the cardiovascular system to treat chronic total occlusions
  • Company #3702 - Hollow, metal microneedle drug and vaccine delivery system
  • Company #3701 - Wrist-worn continuous cardiac monitoring device, for use in heart failure patients
  • Company #3700 - Device that uses electrostatic precipitation to eliminate surgical smoke and provide a continuously clear visual field during laparoscopic surgery
  • Company #3699 - Highly sensitive diagnostic/liquid biopsy tests to molecularly characterize circulating tumor cells (CTC) in the blood
  • Company #3698 - Transcatheter mitral valve replacement (TMVR) implant with a fully transvenous delivery system
  • Company #3697 - Synthetic biomaterial with properties that mimic the structure and function of the hyaline cartilage that lines articulating joints, such as the hip, knee, shoulder and ankle
  • Company #3696 - A wearable glove device which mechanically stabilizes hand tremors in patients with Parkinson's disease and Essential Tremor
  • Company #3695 - A biopsy triaging system that can identify healthy and benign tissue specimens with high accuracy within seconds
  • Company #3694 - Companion diagnostic tests for breast, prostate and lung cancers to identify, before radiation therapy starts, which patients will develop severe late effects
  • Company #3693 - Cloth-based diagnostic monitoring nanosensor technology
  • Company #3692 - A mobile device designed to help users track and monitor their moles over time for early detection and diagnosis of skin cancer
  • Company #3691 - Interactive, intraoperative surgical playbook that promotes optimal teamwork in the operating room
  • Company #3690 - Next-generation transcatheter device to relieve left atrial pressure in heart failure
  • Company #3689 - Biologic drug monitoring and precision dosing tests and point-of-care devices
  • Company #3688 - Silk-based biomaterials designed to help regenerate human tissues, including in the vascular system, and then to degrade and be safely absorbed in the body
  • Company #3687 - Drug-device technology for treating pulmonary orphan indications, including the lethal orphan respiratory disease Bronchiolitis Obliterans Syndrome, which mainly affects lung transplant patients
  • Company #3686 - Technologies for blood-based detection and monitoring of circulating tumor DNA
  • Company #3685 - Drug-device combination therapy for patients with peripheral vascular disease
  • Company #3684 - A long-term, minimally invasive and reversible technology for bariatric surgery
  • Company #3683 - Medical cooling technologies with an initial focus on brain cooling and prevention of oral mucositis
  • Company #3682 - Minimally invasive coronary and peripheral devices to address specific unmet clinical needs in the treatment of complex vascular disease
  • Company #3681 - Transcatheter solutions for the less-invasive treatment of atrioventricular valve regurgitation
  • Company #3680 - Cell therapy drug-device technology for the treatment of severe cases of acute kidney injury
  • Company #3679 - Vascor is a pre-clinical company that has developed and patented a failsafe non-rotary implantable counter pulsation heart assist device that is powered by a transcutaneous energy transmission system. The Vascor Ventricular Assist Device (VAD) overcomes the shortcomings of existing devices, which will result in improved efficacy and safety for patients with advanced heart failure.
  • Company #3678 - AcuityBio's mission is to prevent post-surgical cancer recurrence in early stage cancer patients using localized drug delivery.
  • Company #3677 - Novel retinal treatments engineered to access specific small spaces in the eye and to provide unique drug distribution to tissues specifically involved in retinal diseases
  • Company #3676 - Next-generation targeted sequencing platform for use in oncogenic mutation detection
  • Company #3675 - Portable life support device that combines ventilation, oxygen, cough assist, suction and nebulization therapies for patients
  • Company #3674 - Digital, hand-held testing platform designed to detect viruses, bacteria, antibodies and pathogens
  • Company #3673 - Ultra-thin wearable mobile-connected patch for treating stress and anxiety
  • Company #3672 - Artificial intelligence platform that can spot visual abnormalities in medical scans
  • Company #3671 - Cloud-based, HIPAA-compliant information technology platform designed to manage data from implanted cardiac devices
  • Company #3670 - Diagnostic testing platform that distinguishes bacterial infections from viral infections, with the aim of combating antimicrobial resistance
  • Company #3669 - Patient-specific, molecularly targeted scientific and clinical evidence interpretation platform for cancer management
  • Company #3668 - Pre- and post-surgical patient care app, to help improve outcomes and lower complications and costs after joint replacement surgery
  • Company #3667 - 3D-printed titanium interbody implants specifically for spinal fusion surgery
  • Company #3666 - Inhalation delivery devices for both acute and chronic treatment
  • Company #3665 - Insulin delivery system for people living with Type 1 diabetes
  • Company #3664 - Clinically advanced proton beam therapy technology for use in treating cancer
  • Company #3663 - Novel bulk hydrophilic-based devices to improve venous access
  • Company #3662 - A technology combining ultrasound with blue light to target biofilm-based infections including acne
  • Company #3661 - Next-generation oximeter that will allow clinicians real-time monitoring of cellular oxygenation and perfusion
  • Company #3660 - Next-generation radiation therapy systems, particle accelerators and RF sources and components
  • Company #3659 - Self-test refractive eye screening tool powered by a smartphone
  • Company #3658 - Surface coating and drug delivery technologies using a unique, polymer-based platform, initially focused on the orthopedic implant market
  • Company #3657 - Robotic, artificial intelligence-based personal health companion device for sufferers of chronic diseases such as diabetes, arthritis, cancer and heart disease.
  • Company #3656 - Portable, non-invasive device to autonomously diagnose specific medical conditions
  • Company #3655 - Non-invasive, highly sensitive breath analysis technology that can detect a full range of diseases in their earliest stages, including lung cancer
  • Company #3654 - Wearable heart monitor technology
  • Company #3653 - Several novel safety features, which combined will revolutionize blood flow imaging in PET
  • Company #3652 - Blood-based biomarker assay developed to monitor and predict treatment response in cancer therapy
  • Company #3651 - Implantable device designed to interpret signals from the brain so paralyzed patients can control robotic limbs and exoskeletons
  • Company #3650 - Liquid biopsy and next-generation sequencing-based diagnostics technology for detecting cancer
  • Company #3649 - Comfortable wireless electronic patches for continuous health monitoring and information
  • Company #3648 - AioCare device is a personal, connected and ultra-portable spirometer with a dedicated mobile application for a smartphone. The device is capable of measuring all important and widely used spirometry parameters including: FVC, FEV1, FEV1/FVC, PEF, FEF 25-75, etc. Additionally, the device measures heart rate and ambient environmental conditions (temperature, humidity, and pressure). AioCare works with iOS and Android operating systems. It is designed for self-monitoring by patients suffering from asthma, COPD and cystic fibrosis. AioCare is also available for physicians to examine their patient's spirometry parameters in-hospital/outpatient settings, with examination results available in the application and the AioCare Health Cloud.
  • Company #3647 - Miniature screwless spine fusion implant
  • Company #3646 - Anastomotic closure device for laparoscopic bowel resection
  • Company #3645 - A home use device to accurately measure dilation and effacement of the cervix
  • Company #3644 - A portable, automatic system that significantly reduces the burden of performing peritoneal dialysis
  • Company #3643 - Accurate, easy-to-use, noninvasive monitoring device to diagnose heart failure in real time
  • Company #3642 - Real-time, non-invasive medical imaging to provide immediate visualization and quantification of blood flow and perfusion without injections/dyes, radiation or the need for direct patient contact
  • Company #3641 - Nanoparticle drug delivery technology to increase the ability of drugs to cross the blood brain barrier
  • Company #3640 - Wireless, mobile spirometer which connects to an app allowing improved patient, or patient-to-provider, integrated respiratory care management
  • Company #3639 - Patent pending, on-demand manufacturing system to deliver personalized therapies, ranging from wellness formulas to combinatorial drug therapies
  • Company #3638 - The only open, laparoscopic or robotic surgical simulation platform that activates animal organs inside realistic human mannequins to create a predictable environment for demonstration and learning
  • Company #3637 - Advanced hemodialysis system for use in the home and clinic
  • Company #3636 - Embolic protection technology that combines embolic protection and treatment into one device
  • Company #3635 - Health information technology that uses machine learning for predicting surgery complication risk and deploying risk modification interventions for surgeons
  • Company #3634 - Local anesthetic delivery systems for use in dentistry
  • Company #3633 - Orthopedic surgical training platform that offers highly realistic hand-based interactions in an immersive training environment containing cutting edge procedures and devices
  • Company #3632 - All-in-one hysteroscopy system enabling doctors to perform hysteroscopic procedures wth superior visualization in an office setting
  • Company #3631 - Implantable device that actively detects infection after joint replacement surgery, saving hospitals money and improving outcomes for patients
  • Company #3630 - Next-generation technologies that enable High-Definition Vision with eyeglasses for all age groups
  • Company #3629 - A technology platform that enables providers, payers, and life science companies involved in diagnosing and treating complex diseases such as cancer to optimize the outcomes of individual patients and lower the overall cost of the patient population served
  • Company #3628 - Dynamic fixation solutions for orthopedic extremity applications
  • Company #3627 - Cellular and acellular allografts
  • Company #3626 - Neural implants to treat intractable brain diseases
  • Company #3625 - Remote, real-time lung health monitoring and management
  • Company #3624 - Health technology real-world evidence (RWE) analytics solutions for payer/provider, biopharma and medical device customers
  • Company #3623 - Progenitor cell activation-based regenerative medicine technology for restoring hearing
  • Company #3622 - Accurate, accessible and non-invasive disease screening test to proactively treat cancer and other diseases at their most manageable stages
  • Company #3621 - A product designed to rapidly remove contrast dyes used in many cardiovascular diagnostic and interventional imaging procedures, that are known to be toxic to the kidneys
  • Company #3620 - Noninvasive sensor to quantify presence of biomarkers in blood
  • Company #3619 - Computerized image correction and image guidance direction technology for hip arthroplasty, trauma, knee replacement, and other common orthopedic procedures
  • Company #3618 - Blood-based "liquid biopsy" tests for the early detection of cancer, including lung, breast and bladder cancer
  • Company #3617 - Smart spinal implant systems that treat patients without external intervention
  • Company #3616 - Hardware, disposables, and a companion app for men to use at home to assess sperm count and take control of their fertility
  • Company #3615 - Blood testing products for monitoring neurodegeneration in brain diseases
  • Company #3614 - Wearable first response hemorrhage control systems designed to treat traumatic injury in situations where advanced medical support is unavailable
  • Company #3613 - Hand-held biosensor devices that can quickly detect bacteria in fluids
  • Company #3612 - Disposable, wearable insulin pump unit
  • Company #3611 - Wearable, wireless sensor for monitoring core body temperature
  • Company #3610 - Disposable, radiopaque adhesive products for use in radiotherapy to help identify the skin boundary, and in surgical localization, both pre and intraoperatively, to improve the accuracy of medical procedures
  • Company #3609 - Lab consumable that automates fluid dispensing, dilution rate, and single cell capture, while easily integrating with industry standard pipetting systems
  • Company #3608 - Machine learning algorithms that analyze brain MRIs to predict which patients with mild cognitive impairment (MCI) will progress to dementia within one year
  • Company #3607 - Noninvasive blood analysis through the eye, for analysis of glucose and other parameters
  • Company #3606 - Implant used to prevent blindness due to ocular over-pressurization in glaucoma
  • Company #3605 - Patient-specific medical implant intended for reconstruction of cranial defects
  • Company #3604 - Instruments and catheters for clinical, monitoring and surgical applications for brain pathology indications
  • Company #3603 - A proprietary implantable chronic heart failure therapy system that uses the patient's own thoracic musculature to improve cardiac filling and output
  • Company #3602 - System used to clean poorly prepped colons during colonoscopies
  • Company #3601 - Synthetic bone graft for use in orthopedic and spinal surgery
  • Company #3600 - Technology to provide physicians rapid insight into clinical infections
  • Company #3599 - Technology that enables functional brain imaging at higher temporal and spatial resolution than current EEG or MEG
  • Company #3598 - EEG monitoring products for emergency departments, critical care units and local neurology care offices that stream real-time data to cloud-based servers
  • Company #3597 - Noninvasive, point-of-care test that detects the antibody immunoglobulin E (IgE) in tears, for use in diagnosing allergic conjunctivitis
  • Company #3596 - Biomarker-based diagnostic tool for identifying acute neurodegenerative conditions including traumatic brain injury (TBI)
  • Company #3595 - Bluetooth-connected pen cap for insulin injector pens that automatically tracks doses and other related information
  • Company #3594 - Robots that use pulses of xenon-based ultraviolet light to disinfect hospital rooms
  • Company #3593 - The first non-invasive diagnostic biofeedback tool to help neonatal intensive care unit (NICU) clinicians identify and treat an infant's ability to feed safely and efficiently
  • Company #3592 - A high throughput laboratory solution that quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens
  • Company #3591 - Expandable, minimally invasive spinal implants
  • Company #3590 - Injectable glucose sensor for the treatment of Type 1 Diabetes
  • Company #3589 - Breathalyzer for use in clinical diagnostics and precision medicine with applications in cancer, inflammatory and infectious disease
  • Company #3588 - Device platform designed to change the way illness is tested and treated
  • Company #3587 - A tissue-engineered heart graft developed to treat heart failure
  • Company #3586 - Nanoaerosol inhaler drug delivery device
  • Company #3585 - Artificial intelligence and computer science technology for the prevention of heart disease and stroke
  • Company #3584 - Innovative medical devices based on robotics technologies, including a lumbar exoskeleton to rehabilitate back pain patients
  • Company #3583 - Novel catheter systems designed to improve targeted cancer treatments through natural flow dynamics
  • Company #3582 - Flexible instrumentation for use in orthopedic surgery
  • Company #3581 - Diagnostic test for early acute Lyme disease
  • Company #3580 - A differentiated dissolvable hydrogel used for cell separation and expansion in research and clinical applications
  • Company #3579 - Predictive computation and artificial intelligence technology to help clinicians accurately plan and rehearse stent placements inside blood vessels
  • Company #3578 - Wireless, needle-implantable biosensor platform for real time, continuous metabolite monitoring
  • Company #3577 - Inexpensive, electronically controlled, inflatable incubator constructed to decrease the number of premature child deaths
  • Company #3576 - Novel medical devices for the worldwide ophthalmic surgery market
  • Company #3575 - Third-generation biosensors, including for use in the continuous measurement of glucose in the interstitial fluid
  • Company #3574 - Easy-to-use and compliant 'click-connect' stenting system to treat venous and arterial diseases
  • Company #3573 - Computer simulation technology for interventional cardiology procedures, for use in coronary artery stenting and transcatheter aortic valve implantation (TAVI) and to optimize cardiac device design and/or procedures
  • Company #3572 - A novel orthopedic implant for thumb base arthritis
  • Company #3571 - A device to provide long lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options
  • Company #3570 - Interventional neuroradiology technology to treat ischemic stroke
  • Company #3569 - Bioelectronic medicine technology to treat a wide range of chronic diseases via the use of miniaturized, implantable devices that can modify electrical signals that pass along nerves in the body, including irregular or altered impulses that occur in many illnesses such as arthritis, diabetes and asthma
  • Company #3568 - Ventricular tachycardia treatment system that uses saline-enhanced radiofrequency ablation
  • Company #3567 - Products for sample preparation in the field of electron microscopy with a special focus on Correlative Light and Electron Microscopy
  • Company #3566 - Blood glucose monitoring systems
  • Company #3565 - In vitro diagnostics and point-of-care testing technology
  • Company #3564 - Computer-assisted medical devices for future-facing laparoscopic surgeries
  • Company #3563 - Minimally invasive drug delivery system that can be used to introduce a variety of therapeutic agents to the eye through controlled, sustained release to the tear film
  • Company #3562 - Measuring devices for osteoporosis screening and diagnosis
  • Company #3561 - 3D bioprinting and tissue engineering technology
  • Company #3560 - Therapeutic ultrasound-based devices for use in oncology drug delivery throughout tumors, including to those areas that lie farthest from blood vessels
  • Company #3559 - Implantable biosensor technology designed to serve as a real-time monitoring system, using living cells to assess cellular function in vivo
  • Company #3558 - Brainwave-controlled robotic prosthesis
  • Company #3557 - Indwelling urinary catheter designed to reduce catheter-associated urinary tract infections
  • Company #3556 - Cellular therapies and tissue engineering, with a focus on bone, skin, and cartilage regeneration.
  • Company #3555 - Amniotic stem cell fluid and amniotic membrane patches, and autologous stem cell kits that use a patient's own stem cells, for use in orthopedics and wound care
  • Company #3554 - Telehealth virtual care platform offering patients convenient access to care while improving clinician efficiency
  • Company #3553 - Patent-pending technology that combines therapeutic ultrasound and electrostimulation for chronic wound care
  • Company #3552 - A connected insulin tracker for diabetics who use insulin pens
  • Company #3551 - Devices for minimally invasive gastrointestinal procedures, including an endoscope stabilizer
  • Company #3550 - Advanced tissue-to-bone reattachment systems
  • Company #3549 - Catheter fixation technology that allows patients to shower autonomously with a connected intravenous catheter, increasing patient comfort and reducing costs
  • Company #3548 - Resorbable, biocompatible surgical device solutions, including a novel sprayable adhesion barrier
  • Company #3547 - Battery-powered, portable scanner to help emergency room staff quickly assess heart problems in patients with chest pain
  • Company #3546 - Smart wearable multi-sensor hip protector system that detects impending falls
  • Company #3545 - Advanced vascular diagnostic medical devices that are intended for use in a variety of medical applications
  • Company #3544 - Real-time, wireless ECG monitoring platform
  • Company #3543 - The first automated and wearable clinical medical device for earwax removal
  • Company #3542 - A glove for post-surgical hand and wrist rehabilitation as well as stroke rehabilitation, designed for cloud-based, home-based therapy
  • Company #3541 - Combined microfluidics and lab-on-a-chip technology to increase the chance of success for in vitro fertilization
  • Company #3540 - Fetal probe which emits light pulses resulting in an acoustic wave response which accurately measures the baby's brain oxygenation levels
  • Company #3539 - Surface enhanced Raman spectroscopy-based, ink-jet printed diagnostics platform for the detection of a wide variety of drugs and narcotics
  • Company #3538 - Sensor technology for predicting the body's individual fat burn based on measurements taken in the breath
  • Company #3537 - Pre-hospital stroke identification--an ECG for the brain.
  • Company #3536 - Microscopy-based diagnostic tool designed to diagnose the various causes of vaginal inflammation presenting with discharge, itch, or pain
  • Company #3535 - Medical scalp cooling device to reduce the risk of chemotherapy-induced hair loss
  • Company #3534 - Hip and knee replacement products
  • Company #3533 - Neurovascular products designed to treat hemorrhagic stroke
  • Company #3532 - Site-specific delivery systems for the treatment of gastrointestinal diseases and disorders
  • Company #3531 - A non-invasive medical device that prevents looping within the colon during colonoscopies by exerting pressure on the patient's lower abdomen
  • Company #3530 - Pluripotent stem cell-based treatments for a range of cardiovascular, neurodegenerative, and other diseases
  • Company #3529 - Low cost, non-invasive, transabdominal fetal pulse oximeter
  • Company #3528 - Cost-effective tool for lung biopsy
  • Company #3527 - The FIND system is a proprietary platform technology that uses ultrasound guidance and robotic assistance to ensure rapid, successful, and precise needle insertion. The FIND system is designed to suggest targets (e.g. a blood vessel, tumor) and after physician confirmation, robotically (autonomously) insert the needle.
  • Company #3526 - A medical device company that designs and develops specialized orthopedic solutions for the aging population (Orthogeriatric patients).
  • Company #3525 - Reinvented surgical robotics with the creation of a prototype for a transportable, compact and precise surgical robotic system. This system allows for higher precision-to the cellular level-and now provides tactile feedback to the surgeon's hand as well as new previously unavailable surgical movements. It also will prove effective in new surgical fields beyond hysterectomy and prostatectomy.
  • Company #3524 - Design Mentor introduces the VentriFlo™ True Pulse Pump designed to mimic physiological characteristics of the human heart in an easy to use, reliable, compact, and economical package for use in patients from pediatrics to adults. This versatile system delivers a true physiologic pulse to patients where current short-term pumps cannot.
  • Company #3523 - Breakthrough approach to every component of the molecular imaging process (cardiac and other).
  • Company #3522 - Excimer lasers for the treatment of dermatologic and cardiovascular diseases
  • Company #3521 - Developed a next- generation lung diagnostic that transforms the diagnosis and monitoring of lung disease.
  • Company #3520 - Innovative technologies to treat patients with sleep apnea.
  • Company #3519 - The HD Nursing Falls Program is a comprehensive predictive analytics solution addressing the costly and complex safety issue of patient falls with a demonstrated record of success.
  • Company #3518 - Multiple advanced surgical technologies and techniques.
  • Company #3517 - A publicly traded life science company based in Richmond, Virginia that develops and commercializes Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood based on a novel detection platform
  • Company #3516 - Ecmictics is developing an in vitro diagnostic device that address the unmet need for microbial analysis in several markets including research, environment protection, and healthcare.
  • Company #3515 - Syringe dosage confirmation device
  • Company #3514 - ConcentRx is a preclinical stage company with a patented Immunotherapy developed for Ovarian, Breast and Lymphoma. Outside of the body we activate a patient's or a donor's white cells with a proprietary and specific activation protocol to induce enrichment and selection of NK-T cells home to and target selectively tumor cells. Prior to infusion into the patient the NK-T cells are allowed to take up a tumor lysis agent for selective killing of the tumor cells. In preclinical animal models of disease our therapy is active against chemo therapy resistant cells of multiple tumor types and reduces the recurrence of disease.
  • Company #3513 - Provides experienced physicians for patient advocacy, navigation services, and research to help people with eldercare concerns, challenging medical situations, and diagnostic dilemmas.
  • Company #3512 - ARC is harnessing the power of cutting edge medical sensor technology to revolutionize non-invasive vital sign measurement solutions to significantly improve efficiency and the patient experience.
  • Company #3511 - Wearable devices for orthotics and prosthetics, including a smart strap for scoliosis braces
  • Company #3510 - FDA approved, wearable, dry electrode based real time ambulatory ECG for long term monitoring of at risk population
  • Company #3509 - Software technology to aid doctors in endoscopic procedures, that incorporates cutting edge video manipulation, computer vision and machine learning
  • Company #3508 - Valve replacement technology to replace poorly functioning valves in the veins of legs and to treat advanced vein disease
  • Company #3507 - Patient monitoring platform which can track medication adherence and measure lung functioning
  • Company #3506 - Cloud-connected respiratory therapy and training platform
  • Company #3505 - Smart, mobile medication dispenser
  • Company #3504 - An integrated approach for the treatment of stroke, that includes digital patient monitoring, neuromodulation/bioelectric therapy, and tissue regeneration to heal brain tissue damage
  • Company #3503 - Fertility tracking wristband
  • Company #3502 - Easy-to-use, and effective controller to torque, spin, and oscillate guidewires, catheters, and other medical devices; first application is for use in less-invasive tissue resection of uterine polyps
  • Company #3501 - Precision medicine data analysis platform that applies deep learning to massive amounts of clinical, genomic and patient-generated data to uncover hidden patterns
  • Company #3500 - Mimetis Biomaterials designs, manufactures and commercializes 4th generation biomimetic bone graft substitutes for dental and orthopedic indications.
  • Company #3499 - Proprietary software tools for quantitative analysis of ECGs in biomedical and drug safety research
  • Company #3498 - Proprietary genomic assays for the detection of women's pelvic cancers and related conditions
  • Company #3497 - Transdermal patch for the pediatric delivery of antihistamines
  • Company #3496 - Cordless medical device designed to provide practitioners with strength and precision when injecting dermal fillers and Botulinum Toxin
  • Company #3495 - Point-of-care diagnostic system for use in the diagnosis and management of male infertility
  • Company #3494 - Cultured cell technology that uses the patient's own skin cells to generate living, tissue-engineered skin for the treatment of severe burns
  • Company #3493 - Cost-effective high-definition laparoscopy solutions
  • Company #3492 - A combination device for the controlled, versatile and measured production of regenerative therapy products for multiple indications
  • Company #3491 - Proprietary poly-4-hydroxybutyrate-based surgical scaffolds for use in aesthetic plastic and reconstructive surgery
  • Company #3490 - Non-invasive, focused transcranial magnetic stimulation-based medical device for the treatment of mild to moderate Alzheimer's disease
  • Company #3489 - Universal donor cellular therapies for treating patients with life-threatening hematological disorders and cancers
  • Company #3488 - Dynamic robotic exoskeletons and prostheses with futuristic levels of performance
  • Company #3487 - Devices for carpometacarpal (CMC) repair
  • Company #3486 - Topical micro-droplet drug delivery system for use in the treatment of glaucoma, allergic eye disease, dry eye and other eye diseases
  • Company #3485 - Non-invasive retinal scanner for early detection of Alzheimer's Disease
  • Company #3484 - A medical fabric with five key benefits: it promotes faster healing, reduces inflammation, alleviates musculoskeletal related pain, is antibacterial, and is highly sustainable
  • Company #3483 - Electrical stimulation-based anti-snoring device that addresses the causes, not just the symptoms
  • Company #3482 - Tissue retractor for the endoscopic removal of lesions in the gastrointestinal tract
  • Company #3481 - Products for optimizing the use of ionizing radiation in radiotherapy and radiology procedures through systematic in-vivo dosimetry
  • Company #3480 - Smartphone-enabled artificial pancreas technology for diabetes treatment to save lives, amputations, ocular and renal complications, and radically improve everyday life for patients
  • Company #3479 - Genetic sequencing-based clinical microbiome screening test
  • Company #3478 - An easy-to-use, effective functional electrical stimulation technology to help severely paralyzed stroke patients recover motor function in upper limbs, even years following a stroke
  • Company #3477 - Electronically controlled medical device designed to actively diffuse drugs through the skin, in an ionized form
  • Company #3476 - "GPS" technology to help needle positioning during percutaneous CT-based interventional radiology
  • Company #3475 - Non-invasive LED and laser treatments to stop vision loss in age-related macular degeneration, diabetic retinopathy and other ocular indications
  • Company #3474 - A skin patch which reminds patients simply, discreetly and effectively to take their medication on time
  • Company #3473 - Mobile, and personalized neurofeedback training system for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)
  • Company #3472 - Left ventricular assist system for patients with severe heart failure
  • Company #3471 - Products to aid laparoscopic and robotic surgeons in identifying the location of and monitoring the integrity of otherwise invisible nerves during minimally invasive pelvic surgery, including prostate surgery
  • Company #3470 - A minimally invasive single-use ophthalmic brachytherapy procedure for the treatment for Wet Age-related Macular Degeneration (Wet AMD) that can be performed in an outpatient setting
  • Company #3469 - Orally administered intestinal coating which mimics the therapeutic benefits of bariatric surgery on type 2 diabetes
  • Company #3468 - Fully-integrated, low cost, implantable, wireless, continuous glucose monitoring platform
  • Company #3467 - Arterial and venous thrombectomy devices
  • Company #3466 - Next generation medical imaging technology to enable minimally invasive surgical procedures
  • Company #3465 - Abdominal surgical instruments
  • Company #3464 - Lenses for patients with visual reading disorders associated with dyslexia, as well as an optical corrective solution for color blindness
  • Company #3463 - Forward-facing real-time imaging for vascular access
  • Company #3462 - The world's first completely non-contact vital sign scanner, utilizing technologies developed by NASA
  • Company #3461 - A digital health solution for improved asthma management
  • Company #3460 - A digestive anastomosis protection device designed to reduce complications and obviate the need for ostomies for colectomy patients
  • Company #3459 - Smartphone-based tear glucose sensor device
  • Company #3458 - Smart injection devices and connected software for monitoring, engaging and supporting patients taking injectable therapies
  • Company #3457 - 3D bioprinted synthetic tissue for testing, and bioprinted functional human liver tissue
  • Company #3456 - Non-invasive technology for regional hemodynamic patient monitoring, in anesthesiology and critical care
  • Company #3455 - Epigenetic male fertility test
  • Company #3454 - Medical devices intended to facilitate surgical planning, navigation, robotic automation, digital microscopy and informatics through an interconnected platform
  • Company #3453 - Novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers and venous leg ulcers
  • Company #3452 - Whole genome sequencing products and services for use in screening for inherited diseases including breast cancer (BRCA 1 and 2 genes), and assessing fetal health
  • Company #3451 - Coin-sized neurostimulator that can be placed just under the skin in the forearm to treat drug-resistant hypertension
  • Company #3450 - Micro laparoscopic device for single and continuous suturing via one action
  • Company #3449 - Tissue engineering alternative for insulin therapy in diabetes
  • Company #3448 - Sensor platform that can continuously monitor physiological state, including heart and respiratory rate, blood flow dynamics, and muscle activity, from a distance of up to several hundred meters
  • Company #3447 - A novel Terahertz sensor of unprecedented resolution, size, cost-effectiveness and reliability for use in multiple applications of remote sensing and imaging, such as hand-held body scanner
  • Company #3446 - Novel contrast agents that enable precise tumor detection and monitoring using CT imaging
  • Company #3445 - Device that measures the Functional Residual Capacity (FRC) of the lungs without causing breathing interruptions and without requiring patient cooperation
  • Company #3444 - Technology that combines reflective pulse oximetry with an improved algorithm to enable constant and precise vital signs measurement non-invasively
  • Company #3443 - Magnetic Resonance Imaging (MRI) based, non-invasive neuromarkers, particularly for neurodegenerative diseases and brain disorders
  • Company #3442 - Knotless tissue repair and attachment devices
  • Company #3441 - Promaxo is a medical technology company that develops and commercializes office-based modular MRI and MRI based technologies. The Company is currently focused on advancing the solutions for prostate disease management and other urology and pelvic conditions.
  • Company #3440 - Therapeutic, noninvasive wearable that computer-controls the upper airway, for the treatment of sleep apnea
  • Company #3439 - Neoscope2020 has developed Family of Single Use, NeoscopeTm /NeoflexTm- Digital Video Endoscopic System for Digital Video Cystoscopy, Hysteroscopy, Ureteroscopy, Bronchoscopy, Arthroscopy, 3D Laparoscopy & other Minimally Invasive Diagnostic & Therapeutic Endoscopic procedures.
  • Company #3438 - Low cost disposable unit dose inhaler for use in hospitals, schools, institutional care, and emerging international markets
  • Company #3437 - Monitoring system that uses a urinary catheter to deliver real-time, actionable data on urine output, core temperature and intra-abdominal pressure
  • Company #3436 - Non-viral technology that allows a safe local sustained production of therapeutic proteins in the eye to address a wide range of ophthalmic diseases
  • Company #3435 - Silk-based medical technology for the repair of soft tissue defects
  • Company #3434 - A simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, including those suffering from sepsis and shock
  • Company #3433 - Products for the treatment of chronic debilitating diseases such as Type 1 diabetes using therapeutic cells transplanted into an implanted medical device
  • Company #3432 - Genetic tests for ovarian, breast and other types of hereditary cancer
  • Company #3431 - 3-D in situ gene sequencing technology
  • Company #3430 - Artificial airway management technology
  • Company #3429 - Minimally invasive treatment for BPH
  • Company #3428 - Less-invasive total shoulder replacement product designed to require less bone removal and faster patient recovery
  • Company #3427 - Prospective motion correction optical imaging technology for optimizing MR imaging
  • Company #3426 - Colorectal surgery technology aiming to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas
  • Company #3425 - Glaucoma drainage device that provides personalized pressure control to help stop the progression of glaucoma
  • Company #3424 - Anatomical 3D printed surgical simulators derived from raw patient CT scan or MRI data, for medical education and patient-specific preoperative planning
  • Company #3423 - 3D medical imaging software algorithms that use real-time 2D fluoroscopic image data to locate the precise three-dimensional (3D) location of catheters, for use in catheter-based atrial and ventricular mapping
  • Company #3422 - A medical device to cure fungal nail infections
  • Company #3421 - A patient handling robot that assists caregivers to mobilize frail patients in acute care and long term care settings
  • Company #3420 - Perfluorodecalin patch designed for laser tattoo removal
  • Company #3419 - Woman-controlled, non-invasive and rapidly reversible contraceptive products
  • Company #3418 - Advanced infusion set for the treatment of type 1 diabetes that combines continuous glucose monitoring (CGM) and insulin infusion into a single device
  • Company #3417 - State-of-the-art, clinically validated sensor that can measure important health parameters of mom and baby from conception to birth
  • Company #3416 - A comprehensive health management platform for diabetes patients that combines mobile, cloud, and data analytics
  • Company #3415 - Simulated surgical training through a free mobile app
  • Company #3414 - Smartphone-based technology for mobile vision screening in children
  • Company #3413 - Smartphone-based medical grade fetal wellness monitor for home use
  • Company #3412 - Bone regenerating, load-bearing implants to treat severe fractures and conditions such as trauma and tumors that result in extensive bone loss
  • Company #3411 - Therapeutic tampon that efficiently relieves menstrual pain (dysmenorrhea)
  • Company #3410 - Electronic oral drug delivery technology
  • Company #3409 - Saliva-based diagnostic tests that collect, preserve and isolate all components of saliva including blood cells
  • Company #3408 - Rapid diagnosis of drug‐resistant bacterial infections using whole genome sequencing and machine learning, to reduce the test time from days to hours
  • Company #3407 - Paper-based low-cost wearable technology for respiration monitoring
  • Company #3406 - A tissue scaffolding matrix that will eliminate antibiotic resistant bacteria from wounds and simultaneously promote regeneration in a safe manner
  • Company #3405 - Advanced ophthalmic medical imaging tools that improve the early detection and diagnosis of chronic diseases in the clinic setting
  • Company #3404 - Stem cell-based treatments for genetic and age-related muscle degenerative diseases with unmet medical needs
  • Company #3403 - Surgical guidance tools to improve accuracy and completeness of cancer surgical procedures
  • Company #3402 - Regenerative medicine products and medical devices for use in orthopedic and neurological surgery
  • Company #3401 - A closed-loop catheter system for use in the delivery of liver cancer treatment
  • Company #3400 - A streamlined surgical solution for tendon repair that improves strength, smoothness and patient satisfaction
  • Company #3399 - A credit-card sized rescue inhaler for asthmatics
  • Company #3398 - Device for safe vascular access in dialysis patients
  • Company #3397 - Handheld device for precise ureter identification during minimally invasive surgery
  • Company #3396 - Human stem cell-based medical solutions for the treatment of diabetes and neurodegenerative diseases, such as ALS and Multiple Sclerosis
  • Company #3395 - Programmable electrical stimulation devices for the treatment of chronic wounds, bone growth and peri-prosthetic (implant) infections
  • Company #3394 - Non-invasive genetic diagnostics focused on early-stage cancer detection
  • Company #3393 - Orthotic products to improve the quality of life for patients with Parkinson\'s and other neurodegenerative diseases
  • Company #3392 - Portable health monitor that tracks health metrics such as ECG, heart rate, blood pressure and blood oxygenation noninvasively
  • Company #3391 - RF-based bloodless liver resection and tumor ablation surgical tools
  • Company #3390 - A device for monitoring pulmonary congestion in heart failure patients
  • Company #3389 - System for removal of gaseous and solid embolic material emanating during bypass heart surgeries
  • Company #3388 - Technologies to help guide minimally invasive procedures, with an initial focus on cardiovascular procedures
  • Company #3387 - Safe, easy to use, noninvasive drug-free alternatives for the palliative management of pain associated with numerous chronic and acute conditions including the temporary relief of minor muscle and joint pain and stiffness associated with arthritis
  • Company #3386 - Surgeon-designed solutions for MIS and minimally disruptive access for the treatment of complex spinal pathology
  • Company #3385 - Nondrug, noninvasive, and painless microcurrent therapy for the healing of injured tissues in the body
  • Company #3384 - A smart watch that serves as a remote monitoring device for patients suffering from chronic diseases or age-related debilitating conditions such as Parkinson\'s disease or dementia
  • Company #3383 - A catheter lock solution for the prevention of catheter-related bloodstream infections and maintenance of catheter patency in tunneled, cuffed, central venous catheters used for vascular access in hemodialysis patients, among other applications
  • Company #3382 - A product for patient ambulation in the acute care setting that eliminates the need to transfer equipment from one device to another and makes it possible for just one nurse to safely ambulate a patient
  • Company #3381 - Moist heat and cooling relief packs made specifically to provide comfort and convenience to breastfeeding women
  • Company #3380 - Simplified, lower-cost treatment options for patients diagnosed with infertility
  • Company #3379 - Radiofrequency tissue ablation technology
  • Company #3378 - Products which address ophthalmic conditions, and cancer diagnostics
  • Company #3377 - Ophthalmic surgery devices for treating patients with glaucoma
  • Company #3376 - Next-generation medical devices for achieving safer, stronger, and more durable tendon repair
  • Company #3375 - Medical device products for cardiovascular, orthopedics, anaesthesiology, nephrology and critical care applications
  • Company #3374 - Magnetic particle imaging technology
  • Company #3373 - Voice-based technology platform for monitoring and diagnosing mental and physical health
  • Company #3372 - Precision cancer analysis
  • Company #3371 - Machine learning algorithms that analyze medical data to improve how diseases, including the eye diseases diabetic retinopathy and age-related macular degeneration, are detected and treated
  • Company #3370 - Minimally invasive surgical (MIS) technology designed to greatly enhance the capabilities of all MIS instruments and endoscopes
  • Company #3369 - Multi-biomarker technology platforms to detect cancer earlier than traditional tests
  • Company #3368 - Evidence-based, non-drug-based, personalized behavioral medicine, including a digital sleep improvement program, via web and mobile
  • Company #3367 - The world's first, comprehensive, integrated drug discovery, translational research, drug development and delivery platform to protect, repair, and restore hearing
  • Company #3366 - An avatar-based, emotively driven clinical platform that helps clinicians better manage their chronic care patients
  • Company #3365 - A web-based platform to make a Stanford-developed post-cardiac surgery program available at home in a bid to increase patient compliance
  • Company #3364 - A mobile sensor platform to help laboratories improve compliance via data analytics and sensor tracking for samples that require close monitoring
  • Company #3363 - Wireless technology for monitoring and quantitatively measuring alcohol intoxication
  • Company #3362 - Next-generation universal robotic system for minimal access surgery
  • Company #3361 - Clinically validated cognitive therapeutics, assessments, and diagnostics that look and feel like high-quality video games
  • Company #3360 - Wearable biomechanical stimulation technology to prevent osteoporosis
  • Company #3359 - Non-invasive, laser-based medical device that measures peripheral blood flow
  • Company #3358 - Non-invasive solutions for the treatment of kidney stones
  • Company #3357 - An implantable biochip to monitor a patient's health after surgery
  • Company #3356 - Targeted apheresis cartridge for treating preeclampsia, a leading cause of maternal and fetal death
  • Company #3355 - Technology for the measurement and analysis of urine output in ICUs, which is a leading indicator of Acute Kidney Injury (AKI)
  • Company #3354 - Surgical devices for improving outcomes for orthopedic extremity procedures
  • Company #3353 - Surgical solutions that use or complement its patented porous polyetheretherketone (PEEK) technology to address critical clinical needs in spine procedures
  • Company #3352 - Medical devices that enable clinicians to personalize patient treatment through accurate image-guided procedures, including a magnetic resonance imaging (MRI) agent that has been encapsulated within an implantable, biocompatible shell
  • Company #3351 - Oral device for the treatment of snoring and sleep-disordered breathing
  • Company #3350 - Biophotonic or low-level light therapy for a variety of skin and conditions such as acne, anti-aging, and to relieve arthritic pain, muscle and joint pain and stiffness
  • Company #3349 - A proprietary speech enhancement device specifically designed for critical care patients to optimize a patient\'s natural voice while eliminating background noise
  • Company #3348 - A simple, patented and innovative medical device designed to facilitate discreet and comfortable rectal administration of liquids or medications, for use in hospice, palliative care and home health settings
  • Company #3347 - Innovative solutions for the minimally invasive treatment of valve disease; initially, of mitral valve disease
  • Company #3346 - Simplified, high quality and high value knee implant systems
  • Company #3344 - Breast cancer prognostic technology
  • Company #3343 - Epigenetic biomarkers for early detection and monitoring of cancer, including a urine-based test for detecting bladder cancer
  • Company #3342 - Physical rehabilitation tool for patients recovering from joint replacement
  • Company #3341 - Artificial blood vessels using cellulose and an external support made of nitinol as an alternative to harvesting blood vessels for coronary artery bypass graft surgeries
  • Company #3340 - Breast biopsy device that allows a physician to obtain high quality samples without an expensive tool or capital equipment
  • Company #3339 - Near bedside immune dysfunction diagnostic device that quantifies multiple (greater than 6) serum cytokines using small blood volumes
  • Company #3338 - Breakaway valve technology to prevent unwanted disconnection of medical tubing from patients
  • Company #3337 - Handheld imaging device designed to help position and guide a spinal needle for lumbar punctures, anesthesia, and epidurals
  • Company #3336 - Real-time analytics to improve clinical outcomes in the intensive care unit (ICU)
  • Company #3335 - Green Sun Medical was founded to develop innovative treatments to address Adolescent Idiopathic Scoliosis and Kyphosis. We are developing a dynamic orthotic that will aid in correcting these spinal deformities. The Green Sun Medical device is the first orthotic to address directly the complex biomechanics of Adolescent Idiopathic Scoliosis (AIS). Additionally Bluetooth connected sensors will allow patients and physicians to ensure proper treatment is being provided.
  • Company #3334 - Continuous patient monitoring via a wearable wristband that uses non-invasive optical sensors to capture cardiovascular and respiratory data directly from arterial signals
  • Company #3333 - Augmented-reality surgical visualization system
  • Company #3332 - Virtual refracting platform for diagnosing vision disorders and procuring customized eyeglasses
  • Company #3331 - Cloud and mobile-based diabetes management platform
  • Company #3330 - Objective, noninvasive screening tool for early-stage diagnosis of autism
  • Company #3329 - Xenoskin product derived from porcine donors that can be used to treat human patients suffering with severe burn injuries in both civilian and military settings around the globe
  • Company #3328 - Lower cost bCPAP system to safely treat infants in developing countries with respiratory distress
  • Company #3327 - Technology that combines medical and deep learning to create computer-aided diagnostic tools to optimize the workflow of overloaded radiology departments
  • Company #3326 - Implantable, bioresorbable medical device to functionally regenerate a damaged esophagus
  • Company #3325 - Proprietary virtual reality techniques to treat underserved visual disorders in an interactive and engaging manner that works almost three times faster than current solutions
  • Company #3324 - Platform regenerative technology to engineer tissue, by returning blood flow to dying organs
  • Company #3323 - A single-use disposable, flexible endoscope to reduce infections that can occur during the 60 million endoscopies performed every year
  • Company #3322 - Non-surgical, minimally invasive procedure to recover in vivo blastocysts from a woman\'s uterus for preimplantation genetic screening and diagnosis, as an alternative to in vitro fertilization
  • Company #3321 - Solutions for the management of post-surgical fluid accumulation and the prevention of seroma
  • Company #3320 - Device to stimulate the muscles in the lower extremities to decrease the occurrence of hospital-acquired deep venous thrombi (DVT) more effectively than the current standard, and slow the severe disuse atrophy experienced by extended-care patients
  • Company #3319 - Wearable wrist monitor that replaces the traditional call button in hospitals and nursing care facilities
  • Company #3318 - Bioabsorbable cardiovascular valves and vessels designed to allow Endogenous Tissue Restoration
  • Company #3317 - PhotoniCare is a medical device company that has developed a low-cost, handheld imaging platform that uses light to see through tissue. Our first product on this platform is a device that can see through the eardrum to visualize the middle ear without cutting the eardrum open. We have subsequent products in ophthalmic, dental, and consumer applications.
  • Company #3316 - Laparoscopic surgery system that facilitates safer and more efficient MIS procedures at a lower cost than conventional laparoscopic systems
  • Company #3315 - A mucosal surveillance system based on gastric impedance spectroscopy for a non-invasive continuous monitoring of ischemia in critical ill patients at ICU
  • Company #3314 - Products to treat conditions that affect the bones, joints and soft tissues of the foot and ankle
  • Company #3313 - Reusable, reposable and single-use surgical instrumentation and specialty devices
  • Company #3312 - Drug delivery hydrogel to treat chronic and acute inflammation
  • Company #3311 - Web-based software technology that can analyze brain chemical measurements from MRIs to allow for the rapid diagnosis of brain disease
  • Company #3310 - Miniaturized injectable neuromodulation/electroceutical technology to treat patients with chronic illnesses
  • Company #3309 - A genomic diagnostic platform that includes includes assays for both tissue and bodily fluids, and a liquid biopsy test, to enable physicians to better select targeted cancer therapies
  • Company #3308 - Lightweight exoskeleton systems for wheelchair-bound individuals and others with paraplegia and other lower limb disabilities
  • Company #3307 - A benchtop genomics testing device for high-yield extraction and purification of nucleic acids from a wide range of sample types
  • Company #3306 - Thermo-acoustic enhanced ultrasound imaging technology
  • Company #3305 - Machine learning-based automated analysis of millions of real-time and retrospective anonymized, indexed images to allow for early identification of disease, and implementation of decision support tools for population health and risk management
  • Company #3304 - HIL Applied Medical is developing ultra-compact, high-performance systems for cancer Proton Therapy.
  • Company #3303 - Contactless biometric sensors for wearables
  • Company #3302 - A sensor product for the incontinent elderly
  • Company #3301 - Wearable armband sensor for all day blood pressure monitoring
  • Company #3300 - Device and mobile app for sleep induction
  • Company #3299 - Therapeutic approach to address cognition-related conditions such as Alzheimer\'s disease and Dementia, Traumatic Brain Injury (TBI), Stroke and ADHD
  • Company #3298 - Next-generation embolic protection device for reducing the risk of stroke and other complications during catheter-based structural heart procedures
  • Company #3297 - Subcutaneous implantable cardioverter defibrillator (ICD) for the treatment of life-threatening sudden cardiac arrest
  • Company #3296 - Unique and non-invasive neurostimulation technologies to treat neurological symptoms caused by disease or trauma
  • Company #3295 - A connected headband designed to improve sleep
  • Company #3294 - Device that continuously monitors a patient IV for early detection of peripheral IV infiltration and extravasation events
  • Company #3293 - Rapid, non-invasive liquid biopsy test that analyzes live, circulating tumor cells directly from patient blood to enable early-stage cancer diagnosis
  • Company #3292 - Molecular and immunoassay diagnostics with lab-like performance
  • Company #3291 - Camera-based, vital sign monitoring technology for secure room environments such as police custody areas, mental health institutions and prisons
  • Company #3290 - Cloud-connected glucose meter
  • Company #3289 - Minimally invasive spine surgery products
  • Company #3288 - Digital health products including activity trackers, weighing scales, thermometers, blood pressure monitors and home monitors
  • Company #3287 - Digital health and imaging solutions for the early detection of breast cancer
  • Company #3286 - Aesthetic medical devices to remove sagging skin without surgery or scarring
  • Company #3285 - Aesthetics and medical dermatology products based on the science of plasmonic resonance
  • Company #3284 - Nanotechnology drug delivery platform
  • Company #3283 - Spinal orthobiologics product allowing for intra-procedural collection and preparation of autologous platelet-rich plasma and fibrin, to facilitate new bone formation during fusion
  • Company #3282 - Medical implants and instruments for spinal fusion
  • Company #3281 - A simple, inexpensive device for in-office vertebral augmentation
  • Company #3280 - Functional electrical stimulation (FES)-based rehabilitation cycling equipment to improve the health and functional ability of people with paralysis
  • Company #3279 - A system of immobilization and rehabilitation for orthopedics and musculoskeletal injuries
  • Company #3278 - Mobile-based concussion management system
  • Company #3277 - An early embryo viability assessment test that uses imaging technology to track and evaluate embryo development, with the goal of improving the high failure rate of in vitro fertilization
  • Company #3276 - The world\'s first all-in-one smartphone case glucose meter
  • Company #3275 - Cost-effective, rapid diagnostics for Neglected Tropical Diseases (NTDs) such as Dengue fever in developing countries
  • Company #3274 - Machine learning-based, web and mobile-linked retinal analysis technology for the early detection of diabetic retinopathy, a major cause of blindness
  • Company #3273 - A patented technology that analyzes a sample of a patient's breath as a screening tool for lung cancer
  • Company #3272 - Wearable robotics suit to enhance the human musculoskeletal system for a wide range of applications
  • Company #3271 - Implantable neurostimulation technology for the treatment of chronic neurological conditions
  • Company #3270 - Implantable stimulation system and a robot-assisted training program to rehabilitate individuals with spinal cord injury
  • Company #3269 - A fully absorbable medical device platform targeting treatment of coronary and peripheral artery disease
  • Company #3268 - Digital depth gauge for the orthopedics and spine surgery market
  • Company #3267 - Cloud-based computed-aided diagnostics to the detection of breast cancer
  • Company #3266 - A portable radiological imaging device that combines planar X-ray with low-dose 3D capability/ digital tomosynthesis
  • Company #3265 - In vitro diagnostic test for the measurement of Glycated CD59 (GCD59) with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification of complications risk and as a clinical trial test for pharmaceutical development
  • Company #3264 - Virtual reality systems to help stroke victims recover
  • Company #3263 - Transcatheter mitral valve repair technology
  • Company #3262 - Next-generation planar silicon extra-cellular neuron-based sensor probe with adaptive, dynamically restructuring architecture and ability for learning, with the ultimate goal of building a neural network similar to brain structure
  • Company #3261 - Real-time detection of sports-related concussion
  • Company #3260 - Focused ultrasound surgical tool technology for rapid, precise, automated, and bloodless surgeries
  • Company #3259 - Wearable sensor with predictive analytics to guide health pregnancy outcomes
  • Company #3258 - Technology that leverages Google Glass to increases situational awareness in the operating room
  • Company #3257 - Cutting-edge artificial intelligence solutions that learns from medical samples and structures to continuously improve the results of image analysis
  • Company #3256 - Clinically verified medical software for the objective, automated detection of heart defects
  • Company #3255 - A wearable, digital health device designed to monitor important physiological parameters and adjust behaviors known to impact pregnancy health, in order to reduce rates of premature birth
  • Company #3254 - Optical and acoustic imaging and sensing technology for surgical guidiance and diagnosis
  • Company #3253 - A matrix comprised of both human amniotic membrane and umbilical cord for use in regenerative medicine
  • Company #3252 - Highly reliable, low-cost noninvasive fetal monitoring device
  • Company #3251 - Xenogenic biologic tissue matrices for soft tissue reinforcement, regenerative and vascular applications outside of structural heart
  • Company #3250 - Organ-on-a-chip technologies involving living human cells in micro-engineered environments, as an alternative to current cell culture or animal-based testing methods
  • Company #3249 - Transcutaneous osseous integrated skeletal implant technology for anchoring artificial limbs
  • Company #3248 - Next-generation lung and heart therapies
  • Company #3247 - Ingestible device that measures motility of the gastrointestinal tract
  • Company #3246 - DNA tests to help physicians decide what drugs and dosages to prescribe based on a patient\'s genetic profile
  • Company #3245 - Transcatheter aortic valve replacement (TAVR) device
  • Company #3244 - Vibrational spectroscopic technology blood testing device aimed at improving consumer wellness
  • Company #3243 - Disposable, magnetically levitated centrifugal blood pump/ventricular assist device
  • Company #3242 - Eyeglasses that can automatically refocus to assist those with presbyopia, via a liquid crystal layer that enables a changeable refractive index
  • Company #3241 - Ophthalmic imaging systems for use in newborns
  • Company #3240 - Genomic tests for prostate and other urologic cancers
  • Company #3239 - Intravenous catheter-based phrenic-nerve-pacing system for preserving the integrity and strength of the diaphragm muscle in critically ill patients who require mechanical ventilation
  • Company #3238 - Point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results
  • Company #3237 - Polymer-based bioresorbable scaffold intended to match the ease of delivery of Bare Metal Stents and Drug Eluting Stents
  • Company #3236 - A medical device for treatment of cardiac arrhythmias based on a proprietary cryotechnology
  • Company #3235 - Noninvasive cardiovascular functions monitoring technology
  • Company #3234 - A proprietary synthetic biodegradable technology platform for surgical hemostats and sealants
  • Company #3233 - Cancer pre-screening test for lung and colon cancer
  • Company #3232 - Smartphone-based, artificial pancreas solution that automatically controls insulin delivery, virtually eliminates hypoglycemia and dramatically improves blood glucose levels in diabetic patients
  • Company #3231 - Data analytics system that enables earlier intervention and better outcomes by predicting potentially catastrophic events like emergent intubation, hemorrhage, and severe sepsis in hospital patients
  • Company #3230 - The world\'s first \"reverse needle\" subcutaneous access port
  • Company #3229 - A cryoplasty balloon dilatation system
  • Company #3228 - Personalized medicine-based system that enables the assessment and repair of previously unusable donor lungs
  • Company #3227 - AI-based tools to identify or rule out strokes or traumatic brain injuries in emergency rooms and ambulances, using deep learning software, patient data and CT scans to help physicians better target intracranial bleeding
  • Company #3226 - Surgical navigation technologies that directly addresses the major issues associated with current systems: their difficulty of use, and lengthy setup time
  • Company #3225 - Optical imaging technology to allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with the surface of the skin
  • Company #3224 - A proprietary point-of-care genetic testing technology for rapid and ultra-sensitive detection of biomolecules, for detecting infectious diseases, drug resistance and early-stage cancer
  • Company #3223 - Implantable neurostimulation systems for the relief of various chronic diseases and disorders
  • Company #3222 - Biomaterials including hyaluronic acid-based injectable hydrogels useful for multiple clinical applications such as treating osteoarthritis
  • Company #3221 - Self-retaining support technology for the treatment of pelvic organ prolapse (POP), anterior vaginal wall, apex and uterine prolapse in women
  • Company #3220 - An external support device for arteriovenous fistulas
  • Company #3219 - Steerable catheter to reduce complications and risks associated with the prenatal diagnostic CVS (chorionic villi sampling) procedure
  • Company #3218 - Electrical stimulator to promote motility in critically ill, enterally fed patients
  • Company #3217 - A guidewire technology that significantly improves endovascular navigation and eliminates or reduces the need for multiple catheters and guidewires required during invasive peripheral vascular procedures
  • Company #3216 - Non-invasive platform (hardware, software and analytics) for diagnosing, tracking and advancing the treatment of neurological diseases as well as conditions like Traumatic Brain Injury (TBI), via the capture and analysis of eye-movements at the microsaccade level
  • Company #3215 - Virtual reality software for minimally invasive robotic-assisted surgery
  • Company #3214 - Rapid diagnostic tests for the early detection of infectious and chronic diseases in low and middle-income countries and other settings
  • Company #3213 - Handheld point-of-care products for the screening and monitoring of mild brain injury
  • Company #3212 - Real-time, guided navigation assistance for the blind, using wearable devices such as Google Glass and Vuzix
  • Company #3211 - Digital retinal imaging diagnostic designed to help detect Alzheimer\'s disease-related symptoms such as retinal plaque
  • Company #3210 - Compact 12-lead ECG system that is hospital quality, digital, wireless, and mobile friendly, and designed for long QT screening in newborns
  • Company #3209 - Flexible and miniature fiber-optic sensors that can be integrated in conventional wound dressings for an in situ monitoring of the healing process in real-time
  • Company #3208 - Patient-specific implants using highly flexible production processes such as 3D printing
  • Company #3207 - Robotic assistance system for spinal fusion surgery
  • Company #3206 - Instrument to deliver insulin discretely as a substitute for insulin pens and syringes
  • Company #3205 - An orthopedic biomaterial technology intended to replace current knee ligament reconstruction methods, and accelerate healing and recovery
  • Company #3204 - Cellulose-based material to prevent fibrosis following surgery/soft tissue repair
  • Company #3203 - Non-invasive, active thermography-based diagnostic device for the early-stage detection of skin cancers
  • Company #3202 - Diagnostic sensor devices that patients can use themselves to measure the concentration of specific analytes in their blood anytime, anywhere
  • Company #3201 - Therapeutic ultrasound-based treatments for brain tumors
  • Company #3200 - Efficient and non-invasive cardiac current density mapping technology
  • Company #3199 - Innovative cancer treatment system that incorporates advanced on-board imaging/planning; delivers the right amount of energy automatically to the right tissue with fewer dedicated staffing requirements
  • Company #3198 - A robotic, electromagnetic catheter steering system for treating cardiac arrhythmias
  • Company #3197 - The world\'s first patient-specific joint resurfacing treatment aimed at providing lasting pain relief and mobility restoration; combines advanced 3D-imaging technology with implant technology
  • Company #3196 - A unique expanding bolt device for hip fracture fixation
  • Company #3195 - Developing two regenerative medicine products: 1-a bone graft substitute that can help to repair large defects in bone by encouraging the growth of bone tissue in areas of damage; and 2-a technology which repairs damage to joints by stimulating the body\'s stem cells to regenerate bone and cartilage
  • Company #3194 - A mouth splint device with integrated sensors and wireless capabilities intended to revolutionize the diagnosis and management of tooth grinding
  • Company #3193 - Device for removal and retrieval of polyps in the colon
  • Company #3192 - Digital diabetes management solution consisting of smart hardware and software
  • Company #3191 - Surgical simulation technology for mobile devices using modern video game technologies
  • Company #3190 - Precision medicine/genetic testing and liquid biopsy technology
  • Company #3189 - Non-invasive analytics-based products and services primarily for diagnosing coronary artery disease
  • Company #3188 - Transcatheter aortic valve stenosis treatment as a facilitator for or a replacement for transcatheter aortic valve replacement (TAVR)
  • Company #3187 - Rapid, minimally invasive, and clinically proven system for harvesting bone marrow from a single puncture under local anesthesia
  • Company #3186 - Undisclosed neuromodulation technology
  • Company #3185 - A universal blood test to identify early-stage cancers in people with no symptoms of the disease
  • Company #3184 - Cerebral embolic protection for transcatheter aortic valve replacement (TAVR), cardiovascular percutaneous interventions and surgical procedures
  • Company #3183 - Device for detecting and preventing diabetic foot ulcers
  • Company #3182 - Urinary catheterization valve designed to avoid incorrect positioning of urinary catheters
  • Company #3181 - Medical devices for treatment of venous insufficiency, the cause of varicose veins and more serious symptoms, via an ablative technique
  • Company #3180 - Targeted temperature management technology
  • Company #3179 - Diagnostic tests for neurodegenerative and other diseases such as cancer
  • Company #3178 - Pulsed electric field technology to treat solid tumors
  • Company #3177 - Chronic severe headache treatment technology
  • Company #3176 - Mobile 3D imaging technology
  • Company #3175 - Zelegent is developing a Single-Use Kit used by Otolaryngologists to perform a minimally invasive office procedure to shorten and stiffen the soft palate to treat snoring.
  • Company #3174 - Real-time lesion visualization monitoring tool for use during cardiac ablation procedures
  • Company #3173 - Bioelectrical signal therapy device to treat chronic wounds
  • Company #3172 - Oral trans-membrane drug delivery technology, for use in insulin delivery in diabetes, among many other applications
  • Company #3171 - Technology that applies proven angioplasty retention and navigation technologies to endourology
  • Company #3170 - Mobile/wearable health platform for monitoring mental activity, that derives proven and robust biomarkers from EEG sampled via two (dry) electrodes only
  • Company #3169 - Hand-held high resolution 3D scanner for capturing, planning and simulating of cosmetic and dermatological procedures
  • Company #3168 - Compact, total artificial heart device with one moving part, designed to take over the complete function of a patient's failing heart
  • Company #3167 - An autoinjector that is safe and easy to use in all patient populations; to provide a less contaminating environment for the storage of all drugs including fragile biologics; and to significantly improve the quality and reliability of autoinjectors
  • Company #3166 - Electromagnetic tomography technology for use in detecting various functional and pathological conditions, including malignancies in the breast, liver, and lung; tissue blood content/flow; hypoxia; ischemia; infarction; compartmental injury; stroke; and brain trauma
  • Company #3165 - Technologies for making cardiac procedures less invasive by replacing hand suturing with sutureless techniques through use of memory metals, like nitinol, as well as tissue glue
  • Company #3164 - An implant designed to cure glaucoma, the leading cause of irreversible blindness in the world
  • Company #3163 - Small, extremely compact urinary catheter for use by urinary incontinence patients
  • Company #3162 - Implantable device for the treatment of benign prostatic hyperplasia
  • Company #3161 - Interactive live 3D holography for medical imaging applications, including cardiovascular
  • Company #3160 - Neurovascular medical devices
  • Company #3159 - Computer-aided detection software to detect retained surgical items and identify implantable medical devices on medical images
  • Company #3158 - Platform for surface modification of medical implants, including in the areas of orthopedics, spine surgery, cardiovascular, dental, women's health (breast implants), and others
  • Company #3157 - Catheters based on a unique bending technology, enabling extensive steering abilities in micro diameter and conventional catheter wires and tubes
  • Company #3156 - Neurothrombectomy device for the treatment of acute ischemic stroke
  • Company #3155 - Wearable device for the drug-free treatment of nausea and vomiting associated with morning and motion sickness
  • Company #3154 - Clinical 4D Flow MRI platform to radically improve the process of diagnosing and staging cardiovascular disease and oncology
  • Company #3153 - Temporary, swallowable gastric balloon device for the treatment of obesity
  • Company #3152 - Natural, invisible, rechargeable devices for mild to moderate hearing loss
  • Company #3151 - Devices for in vitro diagnostics and point-of-care testing, including the first device to integrate blood gases, electrolytes and CO-oximetry in one hand-held analyzer
  • Company #3150 - Continuous glucose monitoring system for Type 1 and Type 2 diabetes that includes a disposable patch, a watch and a smartphone app
  • Company #3149 - Compact microwave hyperthermia technology for treating cancer
  • Company #3148 - Low-cost, wireless blood glucose monitor that connects to mobile devices using a patent-pending acoustic technology
  • Company #3147 - A stick-on patch coated with a thin film of nanomaterial containing a sensor to measure respiration, to aid in the detection of pneumonia in developing countries
  • Company #3146 - Medical diagnostic equipment for early detection of pneumonia, the primary cause of child mortality in the developing world
  • Company #3145 - Subcutaneous implanted device for vascular access in chronic care patients
  • Company #3144 - Simple and safe gastrointestinal minimally invasive Endoscopic Mucosal Resection (EMR) and/or Endoscopic Sub-mucosal Dissection (ESD) system
  • Company #3143 - The world\'s first gold-standard-based method for Intraocular Pressure (IOP) measurement in the lying down position
  • Company #3142 - Cloud-based platform that utilizes advanced brain signal processing and big data analytics for mobile, continuous monitoring and management of brain health and wellness
  • Company #3141 - A state-of-the-art, compact, imaging colposcope for medical applications in order to eliminate the inherent subjectivity of cervical exams
  • Company #3140 - A radiation shielding system that will enable a profound reduction in the total radiation exposure to the physicians and medical staff working in the cath lab
  • Company #3139 - Nasal drug delivery device platform for local, systemic and central nervous system indications
  • Company #3138 - Platform robotic technology for needle steering in minimally invasive interventional procedures, such as biopsies and ablations
  • Company #3137 - A guided intubation system
  • Company #3136 - Noninvasive, wearable brain neuromodulation technology which provides solution for the millions who suffer from migraine and depression
  • Company #3135 - Semi automatic guided intravenous access device
  • Company #3134 - Smart clothing that incorporates biometric monitoring including heart rhythm, breathing, oximetry and blood pressure into the fibers
  • Company #3133 - Life-saving innovative devices for treatment of chest trauma and for thoracic/abdominal drainage
  • Company #3132 - Next-generation micro-robotic-assisted medical technologies
  • Company #3131 - Nonsurgical delivery technology and stent product for the treatment of otitis media with effusion
  • Company #3130 - A platform technology enabling correct monitoring of fluid level in each lung, to prevent the major cause of acute heart failure hospitalization
  • Company #3129 - Arthroscopic device for rotator cuff repair
  • Company #3128 - Compact, safe, and less expensive flow cytometry device that is designed for lab research but shows great promise for point-of-care application
  • Company #3127 - Gene therapy treatments for congestive heart failure and type 2 diabetes
  • Company #3126 - Ophthalmic drug delivery technologies using porous silicon photonic crystals
  • Company #3125 - A biomaterial scaffold for cardiac repair for heart attack patients who currently have very limited treatment options
  • Company #3124 - An ultrasound device for stroke, analogous to an automated external defibrillator (AED) for heart attacks
  • Company #3123 - Lab-on-a-chip testing device for cancer
  • Company #3122 - The world\'s first single-use cannabis pod and vaporization system
  • Company #3121 - Wearable, cloud-based devices to monitor patients for heart conditions including arrhythmia and atrial fibrillation
  • Company #3120 - Single port orifice robotic surgical system for use in minimally invasive surgery, including colorectal surgery
  • Company #3119 - ePatch® is a state-of-the-art cardiac and vital signs monitoring technology platform to assure your high quality data recording - just \"wear and forget\". The small lightweight, discreet body-worn patch sensor platform is CE-marked and FDA-cleared with focus on secure clinical data acquisition and ease of use for both healthcare professionals and the patients. DELTA plan to spin-out the ePatch® business into a separate entity.
  • Company #3118 - Minimally invasive instruments for image-guided, beating-heart surgery
  • Company #3117 - Technology that focuses on removing infectious pathogens and toxins from circulating blood
  • Company #3116 - Products and services based on personalized 3D printing for patients with musculoskeletal tumors
  • Company #3115 - Virtual Reality and Image Guidance software for use by surgeons in consulting with patients, planning complex surgical procedures, and for use in combination with medical imaging to navigate during surgery and review the procedure post-operatively
  • Company #3114 - A diagnostic test to diagnose and identify the cause of ocular allergies
  • Company #3113 - Blood-based test to track the health of organ transplants in patients, including heart transplants
  • Company #3112 - Technology that employs the emerging science of machine/deep learning to make medical diagnostics and imaging faster, more accurate, and more accessible
  • Company #3111 - Advanced disposable speculums that employ a high powered LED illuminator, designed to enhance women\'s healthcare
  • Company #3110 - Percutaneous vascular closure devices for sealing of puncture sites following treatment involving a large bore sheath
  • Company #3109 - A unique and proprietary solution for tinnitus suppression based on electrical stimulation of the cochlea
  • Company #3108 - A minimally-invasive, implantable pacemaker for congestive heart failure patients
  • Company #3107 - Technology for measuring and monitoring real-time cardiac motion, for use in treating heart failure
  • Company #3106 - Advanced and accessible ovarian cancer diagnostic technologies to address a global unmet need
  • Company #3105 - A self-contained head device to prevent and treat Alzheimer\'s Disease with electromagnetic waves
  • Company #3104 - Cardiac-related medical devices that address the need of up to 75 million Rheumatic Heart Disease patients worldwide, primarily young patients in developing countries
  • Company #3103 - A novel Drug Coated Balloon (DCB) technology utilizing cytostatic Sirolimus with a long-term drug release instead of cytotoxic Paclitaxel
  • Company #3102 - The world\'s first system for creating a percutaneous Deep Vein Arterialization of the foot for the treatment of End Stage Critical Limb Ischemia
  • Company #3101 - Patient-specific surgical planning and custom instrumentation for shoulder and hip surgery
  • Company #3100 - A multiport catheter to deliver cancer drugs directly into tumors, including into the brain
  • Company #3099 - Fashionable, smart-digital garments with interwoven sensors nonobtrusively measuring vital signs of hospital-grade quality
  • Company #3098 - Thrombectomy catheter to speedily extract thrombus in a single session, from patients who present with venous thrombo-embolism
  • Company #3097 - Cost-effective interventional devices for the minimally invasive treatment of peripheral artery disease
  • Company #3096 - Novel modification of the common endo-tracheal tube to prevent airway emergencies in the OR and decrease mechanical ventilator duration in the ICU
  • Company #3095 - All-in-one, meter-free, smartphone app-based blood glucose monitoring system that uses colorimetric measurement technology
  • Company #3094 - High-performance miniature wirelessly networked in vivo devices that enable paradigm shifts and breakthroughs in minimally invasive surgery (MIS)
  • Company #3093 - India's first MedTech innovation platform, anchored by state-of-the-art R&D facilities and a network of national and global partners, to drive such innovation, and transform healthcare globally.
  • Company #3092 - Non-invasive blood glucose measurement sensor technology for mobile, tabletop and wearable applications
  • Company #3091 - Wearable device and smartphone app to treat dental sleep disorders like bruxism (teeth grinding)
  • Company #3090 - A microneedle array subcutaneous drug injection device allowing more effective and painless injection of vaccines, medical drugs, cosmetics, and hair growth supplements, as well as accurate measurements of various health indicators including glucose and cardiac biomarkers directly in blood capillaries under the skin surface
  • Company #3089 - Transcatheter mitral valve replacement (TMVR) support structure for the treatment of mitral regurgitation
  • Company #3088 - Digital healthcare products for the cardiovascular market focused on improving the utilization of coronary angiography data to ratify measurement-based medicine in the cath lab
  • Company #3087 - Percutaneous solutions for treating functional tricuspid valve regurgitation (FTR)
  • Company #3086 - Biologically integrated sensors intended to enable continuous monitoring of body chemistry
  • Company #3085 - A cost-effective, high-speed liquid biopsy technology platform for the isolation and detection of circulating tumor cells from human blood; for use in cancer diagnosis, monitoring of cancer patients during treatment, as well as the development of better targeted therapies
  • Company #3084 - Novel therapeutic technologies employing controlled microwave ablation
  • Company #3083 - An ultrasonic drug delivery platform delivering drugs to skin, tissues and organs at concentrations hundreds of times higher than IV, for use in curing serious skin and soft tissue infections including MRSA, and chronic wounds for patients who have received but failed standard treatment
  • Company #3082 - External, adhesive, hypoallergenic foam device for treating female stress urinary incontinence
  • Company #3081 - Minimally invasive, disposable, retractor for use in laparoscopic surgery
  • Company #3080 - Imaging device for surgeons to immediately visualize and assess "quantified" bloodflow during surgery to identify and reduce complications and save lives in bypass, other cardiovascular, transplants, plastics, and other therapies
  • Company #3079 - Device for objective real-time monitoring and analysis of skin disorders and drug effects
  • Company #3078 - Minimally invasive surgical solution for the treatment of glaucoma
  • Company #3077 - Safety scalpel with a suture-trimming groove, which both improves safety and can eliminate the need for suture-trimming scissors; and semi-passive retraction, which automatically retracts the blade when the button is released
  • Company #3076 - Non-invasive neuromodulation products designed to treat Major Depressive Disorder and other diseases of the Central Nervous System (e.g., Autism, Parkinsons Disease, Anxiety, Post Traumatic Stress Disorder)
  • Company #3075 - A suite of rapid, mobile diagnostic test readers for advancing diagnostic accuracy and access, as well as a lens-free holographic microscope, and handheld analyzers for blood count, allergens, and mercury contamination
  • Company #3074 - Cryoablation technologies that create continuous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia
  • Company #3073 - Methods to access the naturally occurring growth factors found within allograft tissue, for use in aesthetics, spine, orthopedics and dermatology
  • Company #3072 - Sub-sternal pacemaker system designed to avoid the implantation of hardware inside or on the heart to provide bradycardia therapy
  • Company #3071 - Bioresorbable bone graft products for a broad range of spinal surgical applications
  • Company #3070 - Biosensor technology to enable the early detection of cancers and other diseases
  • Company #3069 - Next-generation infusion management system to improve patient safety and workflow efficiency
  • Company #3068 - Radiofrequency and microwave-enabled system for tissue dissection, resection, ablation and coagulation, for applications including therapeutic endoscopy, laparoscopic surgery and tumor ablation
  • Company #3067 - A line of bioinstrumentation products including physiological monitors and patient-centered diagnostic and therapy systems, for use in treating movement disorders such as Parkinson\'s disease, integrated with wireless, remote, and web-based applications
  • Company #3066 - Implantable neural interface capable of recording and stimulating in the human central nervous system, for use in treating neuropsychiatric disorders such as Major Depressive Disorder and PTSD
  • Company #3065 - Endoscopically delivered, outpatient, reversible combination gastric balloon-duodenal barrier device for weight loss in morbidly obese patients
  • Company #3064 - Medical robotics platform that integrates the latest advancements in robotics, micro-instrumentation, endoscope design, sensing, and data science
  • Company #3063 - Drug delivery technology that simplifies patient self-administration of biologic drugs, by coupling a standard 3mL syringe with an external pressurized water chamber, resulting in a simple one-step reconstitution process
  • Company #3062 - Four technologies: 1-anti-coagulum cardiac ablation catheter; 2-orthopedic tissue tension sensor; 3-anti-biofilm urological catheter; and 4-a smart inhaler
  • Company #3061 - Therapeutic hypothermia technology that circulates cold fluid in the aerodigestive tract and rapidly cools the blood in the arteries traveling to the brain, to prevent and treat ischemic brain injury caused by surgery, cardiac arrest, stroke or trauma
  • Company #3060 - Medical device to treat amblyopia (lazy eye) in children and adults
  • Company #3059 - An image-guided interventional probe that seeks to significantly improve both the safety and efficacy of interventional radiology, cardiology, interventional oncology, pulmonology, and urology procedures
  • Company #3058 - A surgical platform designed to magnetically retract and maneuver tissue and organs, eliminating the need for a dedicated trocar and shafted instrumentation that can clutter the operative field
  • Company #3057 - Stents with a built-in sensor that are able to more accurately measure peripheral artery blood flow and alert doctors if flow is becoming restricted
  • Company #3056 - Robotic-assisted surgical system intended to significantly advance current endoscopic surgeries
  • Company #3055 - A hand-held biosensor designed as a powerful, low cost point of care tool for reducing the cost and time required to triage and treat critical care patients, particularly with regard to real time access to critical diagnostic tests
  • Company #3054 - Rapid point-of-care breath test for detecting active tuberculosis, and other respiratory diseases
  • Company #3053 - Electromagnetically driven guidewire system that safely improves the success rate for crossing chronic total occlusions in the vasculature
  • Company #3052 - Laptop-based device for non-invasively monitoring hemodynamics that can be used for the assessment of certain asymptomatic and unrecognized cardiac conditions
  • Company #3051 - Non-invasive platform technology that can treat conditions of brain ischemia such as cerebral artery vasospasm, ischemic stroke, and traumatic brain injury
  • Company #3050 - MRI-compatible treadmill that enables cardiovascular exercise stress testing in an MR environment
  • Company #3049 - Non-invasive continuous blood pressure monitoring system
  • Company #3048 - A skin patch device to treat various ischemic indications using remote conditioning via nerve receptors
  • Company #3047 - Cell therapy products for use in treating large patient populations where the standard of care involves significant costs and potentially complicated procedures, such as advanced chronic kidney disease
  • Company #3046 - Hand-held scanner that captures more than 33 health metrics, including commonly monitored vital signs, in under one minute
  • Company #3045 - Hand-held, app-connected device that tracks cardiovascular health
  • Company #3044 - AIT has a nitirc oxide (NO) generator and delivery system. The device generates NO from ambient air and can deliver it to a patient's lungs via a breathing circuit and mask or through a ventilator. The device is powered through any standard electrical outlet and should, upon certain regulatory approvals, be used anywhere in the hospital or at home.
  • Company #3043 - A secure solution to intravenous (IV) line dislodgement and removal, that utilizes a patented \"breakaway\" technology to create a necessary separation in the IV tubing after its subjected to a certain threshold of tension
  • Company #3042 - A device technology to treat bradycardia, a condition where the resting heart rate is under 60 beats per minute
  • Company #3041 - Swallowable biodegradable capsule-based solution for the treatment of obesity, in which the expanding capsule creates pressure on the gastric wall, sending satiety signals to the brain of the user
  • Company #3040 - Novel, transurethral, natural orifice, radiofrequency-based renal denervation devices to ameliorate treatment-resistant hypertension and associated diseases
  • Company #3039 - DNA sequencing-based oncology diagnostics products and services
  • Company #3038 - Health monitor for sleeping infants that allows parents to view their child's vital signs in real time, via a sensor product and app
  • Company #3037 - Wireless basal thermometer that connects to a corresponding fertility tracking app, to be used by women as a tool to ease conception
  • Company #3036 - Heat-based incision system for use in cataract surgery
  • Company #3035 - An airway intubation system for use in ambulances, surgical centers, emergency rooms, or operating rooms that combines multiple tools into one easy-to-use solution
  • Company #3034 - Medical devices to treat tinnitus
  • Company #3033 - Embolic protection catheter for use in aortic heart procedures
  • Company #3032 - Home-use conception assistance device
  • Company #3031 - Battery-operated gravity IV fluid flow monitor to provide accurate infusions for patients
  • Company #3030 - The first catheter-delivered mitral valve based on non-stent-based anchoring technology, via the company's approach of anchoring a tissue mitral valve to the native mitral valve annulus
  • Company #3029 - Aesthetics products, including a dermal filler for the correction of facial acne scars
  • Company #3028 - A device for the treatment of sleep apnea and other breathing disorders
  • Company #3027 - A one-time ablation treatment modality for the treatment of hypertension and other disease
  • Company #3026 - Aortic endografts for the treatment of dilative aortic lesions such as aneurysms and dissections
  • Company #3025 - A robotic-assisted surgery platform for performing a structured, tailor-made, non-linear sternotomy in the cardiothoracic surgery field as well as for other hard tissues\' incision needs in the neurosurgery and orthopedic fields, having a predetermined pattern and depth
  • Company #3024 - A smart and simple hand held operating system that combines the advantages of robotics with the benefits of affordable hand held instruments, for use in minimally invasive surgery
  • Company #3023 - A deflectable, stiffness controlled, one handle guided, multi-disciplinary guidewire for use in treating complex cardiac and peripheral lesions
  • Company #3022 - A clot retrieval device for the treatment of acute ischemic stroke and occlusions in peripheral vessels
  • Company #3021 - A process of 3D bio-printing of living human cells for use as implants or grafts targeting use in reconstructive surgery (including breast) and wound care
  • Company #3020 - Medical device to deliver drugs via tear ducts for patients with glaucoma and other eye diseases
  • Company #3019 - A single-use hybrid catheter for various medical applications that require precise and safe material removal, including lead extraction, the treatment of peripheral artery disease, and gastrointestinal resection and ablation procedures
  • Company #3018 - High-tensile strength collagen for ligament and tendon repair
  • Company #3017 - A proprietary Chitosan-Hyaluronate hybrid hydrogel for use in orthopedics and rheumatology applications
  • Company #3016 - Innovative stem cell-based solutions for immune system regeneration, including for use in dramatically improving the outcome of bone marrow transplantation
  • Company #3015 - Orthopedic implant to treat deformities related to hallux valgus (bunions)
  • Company #3014 - A wireless neurostimulation device for the treatment of peripheral neuropathic pain
  • Company #3013 - Fiber-optic technology that is integrated into laparoscopic and endoscopic laser-based surgical tools to enable intuitive, simple and precise laser surgery
  • Company #3012 - High intensity focused ultrasound-based medical devices for the treatment of atrial fibrillation (AF)
  • Company #3011 - A portable aerosol drug delivery system for systemic and local targeting, designed either for pulmonary or nasal application (portable nebulizer)
  • Company #3010 - An external scaffold for saphenous vein grafts which aims to drive a significant change in the coronary artery bypass graft surgery paradigm by creating a hybrid conduit which combines the benefits of both arterial and venous grafts
  • Company #3009 - A programmable consumer-focused device that is designed to monitor a person\'s cardiovascular system, and provide the data online
  • Company #3008 - Neuromodulation technology that uses non-invasive electrical pulses to address neurological motor disabilities, such as paralysis, muscle weakness and muscle tone disorders
  • Company #3007 - An affordable, non-invasive medical device (ring placed on the finger) enabling the rapid and painless testing for four major STDs: syphilis, gonorrhea, trichomoniasis and chlamydia infection
  • Company #3006 - A novel smart stent with remote and non-invasive in situ monitoring capabilities providing doctors with a simple tool to anticipate stent-related complications and tailor the follow-up treatment to the needs of the individual patient
  • Company #3005 - Tissue expansion technology aimed at reducing pain and recovery time for patients undergoing breast or burn reconstruction surgery
  • Company #3004 - The first non-hormonal, medical device treatment for vaginal dryness and atrophy in breast cancer survivors
  • Company #3003 - First-of-its-kind medical device/digital health technology for hot flashes in women
  • Company #3002 - Genetic diagnostic tests for pediatric neurology disorders
  • Company #3001 - Nanoparticle delivery system loaded with a powerful blend of antioxidants for skincare and other dermal applications, as well as for treating acute spinal cord injury
  • Company #3000 - Fully developed, patented and FDA-cleared platform technology that transforms the method for performing guaiac fecal occult blood testing (gFOBT)
  • Company #2999 - A permanently integrated smart device that provides the interface between an amputated stump and any prosthesis
  • Company #2998 - Point of care, handheld device that uses specially developed biochips and supporting software to diagnose a range of diseases
  • Company #2997 - Smart healthcare device for mobile diagnosis of epileptic seizures
  • Company #2996 - Robotics solutions for vascular pathologies
  • Company #2995 - A device to allow surgeons to perform pelvic organ prolapse (POP) repair in a standardized, repeatable, safer, cost-effective with minimally invasive manner
  • Company #2994 - Nonsurgical solution for the treatment of benign prostatic hyperplasia (BPH)
  • Company #2993 - SweetBio is revolutionizing the healing of dental and chronic wounds through our Manuka honey-incorporated, biodegradable medical devices.
  • Company #2992 - Hip implant system for young patients that preserves bone over time
  • Company #2991 - Device for the treatment of venous disease in medical office setting, with combination of two complementary techniques, steam and radiofrequency
  • Company #2990 - Incubators employing LED phototherapy to cure jaundice in newborn babies
  • Company #2989 - A guiding system that allows surgeons to precisely place screws into vertebrae, reducing the mistakes from going free-hand
  • Company #2988 - Home-based, patented, patch-based sleep monitoring technology that collects and stores sleep data and provides an accurate diagnosis of sleep-disordered breathing
  • Company #2987 - A continuous transthoracic echocardiography system to acquire continuous, repeatable ultrasonic views of the heart without an attending sonographer; will include software to calculate ejection fraction, stroke volume and cardiac output by analyzing the continuous stream of heart images
  • Company #2986 - Portable device for the non-invasive monitoring of cardiopulmonary diseases, particularly those that impact hospital re-admissions
  • Company #2985 - Ultra-small cameras for medical endoscopy applications, including cancer detection
  • Company #2984 - Next-generation accommodative lenses
  • Company #2983 - Platform magneto-optical technology (magnets and lasers) that can be used to quantitatively diagnose any disease with a known antibody response in one minute with one drop of blood from a fingertip, with applicability to the developing world
  • Company #2982 - A disposable cartridge technology for complete blood count (CBC) testing in two minutes
  • Company #2981 - Device to reduce the incidence of brain injury after stroke
  • Company #2980 - Technology to improve the short- and long-term patency of arteriovenous fistulas and grafts for patients with end-stage renal disease, with a one-time procedure
  • Company #2979 - Connected medical devices to improve the quality of life for people dealing with spinal cord injury and disease
  • Company #2978 - Cordless, disposable continuous positive airway pressure device for treating obstructive sleep apnea
  • Company #2977 - Sleep monitoring system
  • Company #2976 - Biotechnology platform for the cloning of patient-specific stem cells from which major diseases can be modeled, key regulators discovered, and small molecules and biologics validated across patient cohorts
  • Company #2975 - Neurological device therapies that deliver therapeutics directly into specific regions of the brain
  • Company #2974 - Polymer-based foam to control intra-abdominal bleeding
  • Company #2973 - 3D printing technology for use in the medical device and other industries
  • Company #2972 - High-intensity electrical muscle stimulation to treat atrophy following surgery
  • Company #2971 - Injectable, synthetic adhesive solution that both repairs bone and stabilizes metal implants
  • Company #2970 - Over-the-counter fertility diagnostic device that measures the presence of two hormones, estradiol and progesterone
  • Company #2969 - Magnetic resonance imaging system intended for the assessment of the margins of excised breast lumps taken from breast cancer patients undergoing breast-conserving surgery or lumpectomy procedures
  • Company #2968 - Blood tests for early screening and diagnosis of cancer and autoimmune diseases using its proprietary nanoparticle-enabled technology
  • Company #2967 - Technology to extract skin biomarkers in a non-invasive manner (no skin biopsy required), enabling non-invasive molecular testing for skin cancer and other skin diseases
  • Company #2966 - An active sleep position sensor that gently trains positional apnea patients not to sleep on their back
  • Company #2965 - Continuous and non-invasive pain monitoring device
  • Company #2964 - Balloon catheter designed to cross obstructive lesions including chronic total occlusions in a safe and reliable manner
  • Company #2963 - A reversible inferior vena cava filter
  • Company #2962 - Five devices under development: 1-long-term implantable vascular access device; 2-disposable tissue ablation devices, including renal denervation for hypertension; 3-a percutaneous device to treat carpal tunnel syndrome; 4-a self-anchoring short-term catheter; and 5-a disposable infusion pump
  • Company #2961 - Undisclosed intraocular lens technology
  • Company #2960 - A cloud-connected platform for diabetes management that interacts with wearable insulin delivery and glucose monitoring devices, collecting data passively and personalizing therapy via a secure smartphone app
  • Company #2959 - Biomarkers for the early detection and screening of cancer, with an initial focus on ovarian cancer
  • Company #2958 - Wearable, single-use, disposable sensors that provide a continuous early warning system for wound infections that allows patients to seek treatment sooner
  • Company #2957 - A portable, mobile pediatric device that automates vitals measurement
  • Company #2956 - Biodegradable implantable balloon device used to alleviate pain in rotator cuff syndrome
  • Company #2955 - Insulin injector pen that uses a Bluetooth link to connect to a patient's smartphone
  • Company #2954 - Water vapor treatment for abnormal uterine bleeding
  • Company #2953 - Micro-size implantable neuromodulation device to treat overactive bladder syndrome
  • Company #2952 - Ergonomic surgical positioning system for arm adduction, for use in robotic, ENT, neurological (spine and brain), vascular, and bariatric surgical procedures
  • Company #2951 - All-in-One Bluetooth Low Energy/Apple iBeacon Glucometer and Mobile/Cloud-based applications
  • Company #2950 - Commercially practical linear accelerators for use in particle cancer therapy, neutron cancer therapy, neutron-based imaging for inspection and security, and lower cost medical isotope production
  • Company #2949 - On-demand, patient-specific CPAP masks manufactured via 3D scanning and printing
  • Company #2948 - A device and procedure for the in-office treatment of middle ear infections with immediate pain relief and without systemic antibiotics
  • Company #2947 - Digital clinical assessment tools to assist health professionals in detection of and treatment for patients with mild to moderate brain disorders
  • Company #2946 - Digital microscopy technology for enabling in vivo histology for tumor resection guidance and early-stage tumor diagnosis
  • Company #2945 - Bioartificial pancreas medical device for the treatment of type 1 diabetes
  • Company #2944 - Catheters to help treat patients with severe coronary and peripheral arterial disease
  • Company #2943 - A guidewire and balloon catheter combination device to treat chronic total occlusions
  • Company #2942 - Minimally invasive spine surgery products
  • Company #2941 - Point-of-prescription test for bacterial infections that guides the treatment of antibiotics
  • Company #2940 - Novel diagnostics for respiratory disease
  • Company #2939 - A turnkey biopsy system that uses three-dimensional (3D) imaging to map the prostate gland and identifies clinically significant cancers with up to 97% accuracy
  • Company #2938 - Surgical tool designed for minimally invasive specimen removal in laparoscopic surgery
  • Company #2937 - An anesthetic actuator control system for use in preventing intra-neural injection and subsequent nerve injury
  • Company #2936 - A guided, disposable, swallowable capsule for the treatment of obesity
  • Company #2935 - Contactless, laser-based device that assesses arterial stiffness by measuring the speed at which pressure waves travel along the vessel, as a predictor of cardiovascular risk and vascular treatment success
  • Company #2934 - Automatic positive airway pressure-based device for the treatment of obstructive sleep apnea
  • Company #2933 - The world\'s first handheld telemedicine physical examination device
  • Company #2932 - An electrophysiology-based software application that helps to identify patients at high risk of sudden cardiac death
  • Company #2931 - A new extrusion method for catheter-based medical devices, allowing in-built lubricity on the inside and outside surface of an extrusion
  • Company #2930 - An assistive brain-computer interface technology that can be used by people suffering from pathologies such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, traumatic or ischemic injury, to enable them to communicate
  • Company #2929 - Pain-free glucose meters for diabetes management
  • Company #2928 - Neuromodulation-based interventional therapies for type 2 diabetes
  • Company #2927 - Accommodative intraocular lens (IOL)
  • Company #2926 - Ultrasound-based, needle-free drug delivery technology to improve the treatment of bladder cancer
  • Company #2925 - Removable nasal stent following sinus surgery
  • Company #2924 - Robotic external fixation system for trauma, bone lengthening and congenital deformities correction
  • Company #2923 - Video laryngoscope that intends to change the standard of care for airway management
  • Company #2922 - Low-cost, energy-efficient fluid purification technology and fluid handling systems for healthcare providers, with an initial focus on hemodialysis and surgical irrigation fluids
  • Company #2921 - Genome-wide DNA sequence technology for human disease diagnostics
  • Company #2920 - The first power delivery system adapted for long-term mechanical circulatory support (i.e., VADs, artificial hearts, kidneys)
  • Company #2919 - Molecular diagnostics technology, focused on personalized medicine and non-invasive cancer testing
  • Company #2918 - Microscope technology that employs precise robotics and computer vision to provide understanding of the structure, function, and malfunction of normal and pathological tissues in 2D and 3D
  • Company #2917 - Minimally invasive device solution for noncompressible torso hemorrhage, incurred during military operations and other trauma
  • Company #2916 - The world\'s first wearable artificial lung
  • Company #2915 - Rapid point-of-testing handheld nuclear magnetic resonance spectrometer used in the early diagnosis of ovarian cancer, tuberculosis, tumor profiling and other indications
  • Company #2914 - Platform technology for the early detection of disease that leads to cancer, including cervical cancer
  • Company #2913 - Female sexual arousal and enhancement technology
  • Company #2912 - Closed-loop implantable insulin pump solution for patients with Type 1 and 2 diabetes
  • Company #2911 - Clip-on, web-based attachments to turn smartphones into medical devices, and web service portal
  • Company #2910 - A novel method of generating and delivering ionizing radiation in the form of low energy X-rays, for medical device sterilization
  • Company #2909 - Low-profile enteral feeding device
  • Company #2908 - Wireless coplanar energy transfer for ventricular assist devices (VADs), for the treatment of congestive heart failure
  • Company #2907 - Advanced tissue welding enabled by cold plasma
  • Company #2906 - Optimizing fluid management and acute renal care
  • Company #2905 - Minimally invasive, incision-free, mesh-free repair for pelvic organ prolapse
  • Company #2904 - Bioactive coral-based bone graft substitute material
  • Company #2903 - All-suture, \"all-inside\" meniscus repair system
  • Company #2902 - Minimally invasive device for treating adolescent scoliosis
  • Company #2901 - A sensor-based epidural placement system for quicker, safer and more accurate epidural injections
  • Company #2900 - Medical ophthalmic devices for the treatment of corneal edema
  • Company #2899 - Electronic hand hygiene compliance system for use in healthcare facilities
  • Company #2898 - Localized and precise drug delivery platform to allow for acute dosing to ameliorate the side effects of systemic dosing
  • Company #2897 - Minimally invasive solutions for treating bone fractures and providing bone stabilization, utilizing implantable \"flexible-to-rigid\" materials
  • Company #2896 - Advanced catheter technologies to meet the increasing demand for improved post-operative pain management
  • Company #2895 - Handheld, blood-testing platform for HIV and other infectious and non-communicable diseases in remote health settings
  • Company #2894 - Diagnostic tests for the noninvasive assessment of diabetes risk, progression and complications, along with preeclampsia
  • Company #2893 - A bioabsorbable flow diverter device designed to treat coronary artery aneurysms in children non-surgically
  • Company #2892 - Antibiotic coating for bone repair
  • Company #2891 - MRI-safe artificial cervical disc
  • Company #2890 - A bio 3-D printer manufacturing system for three-dimensional tissue products
  • Company #2889 - UV LED-based medical treatment devices to treat ailments ranging from Vitamin D deficiency to multiple sclerosis
  • Company #2888 - The world\'s first wrist pulse oximeter without a fingertip probe enabling comfortable, remote and continuous monitoring of blood oxygen level, pulse rate, bit-to-bit variation and activity
  • Company #2887 - Real-time iPad app-based monitoring system for surgical blood loss
  • Company #2886 - Totally absorbable vascular filter for the prevention of pulmonary embolism
  • Company #2885 - Non-invasive, drug-free solution for treating the symptoms of panic disorder
  • Company #2884 - Encapsulated stem cell-derived islet therapy for Type I diabetes
  • Company #2883 - Implantable transcutaneous energy transmission-based hearing systems
  • Company #2882 - Device for measuring transepidermal water loss to assess alterations of the skin barrier, which indicates clinical indications such as allergies, atopic dermitis, psoriasis, ichthyosis, desquamation, wound healing or carcinoma
  • Company #2881 - A coating technology for bone grafts that can induce stem cell proliferation and achieve better remodeling
  • Company #2880 - Minimally invasive device for sinus floor augmentation
  • Company #2879 - Self-contained, fully portable Extra Corporeal Membrane Oxygenation (ECMO)/ExtraCorporeal Life Support (ECLS) system
  • Company #2878 - A device to improve the efficacy and safety of intubation even when performed by less-experienced practitioners in emergency situations
  • Company #2877 - Noninvasive therapies for alleviating chronic pain through innovative neuromodulation techniques
  • Company #2876 - A miniaturized stimulus application/response sensing probe with a disposable microtip for diagnosing Small Fiber Neuropathy
  • Company #2875 - A treatment for breast lumpectomy sites with a fluid-filled balloon heated for 10 minutes, as alternative to six weeks of radiation
  • Company #2874 - A radiofrequency-based breast tumor localization system for marking non-palpable breast tumors for surgical removal
  • Company #2873 - Medical devices for use in neurosurgery
  • Company #2872 - Repositionable chest tube allows for drainage of unwanted fluid in body without multiple tubes, reducing pain, recovery time, and costs
  • Company #2871 - Device for clean and contained Fecal Microbiota Transplantation for the treatment of Clostridium Difficile infections
  • Company #2870 - Movement tracking and gait profiling technology company with solutions for medical gait analysis, security, and virtual training platforms
  • Company #2869 - Affordable, surgical drill products for use in orthopedic surgery
  • Company #2868 - Technology for the real-time detection of internal bleeding complications from vascular access procedures
  • Company #2867 - Point-of-care diagnostics for the early detection of infectious diseases, with an initial focus on HIV
  • Company #2866 - Device that separates blood constituents and isolates cells with high purity and elevated efficiency, for use in cancer therapy monitoring
  • Company #2865 - Trauma fixation products for osteoporosis, and soft tissue repair implants
  • Company #2864 - Implantable long-term hemodynamic monitoring technology for use in congestive heart failure patients
  • Company #2863 - Molecular diagnostics technology for the detection of infectious disease, with an initial focus on meningitis
  • Company #2862 - Functional EMG technology for the diagnosis and treatment of soft tissue injuries
  • Company #2861 - Needle-free blood drawing device
  • Company #2860 - Next-generation walking crutches to reduce underarm pain and fatigue
  • Company #2859 - Implantable closed loop neuromodulation technology to improve the treatment of chronic pain, Parkinson's disease, epilepsy and other debilitating disorders
  • Company #2858 - Robotic exoskeleton technology for users with mobility impairments
  • Company #2857 - A genomic sequencing test to detect ovarian and endometrial cancers, using cervical fluid obtained during routine Pap tests
  • Company #2856 - Cloud-integrated medical equipment technologies for the early detection and diagnosis of cervical cancer
  • Company #2855 - Focused on the isolation, expansion and delivery of specialized adult stem cells for research, diagnostic and clinical use
  • Company #2854 - Bone fixation implants for the hand and foot
  • Company #2853 - Handheld Doppler ultrasound medical device to rapidly and accurately diagnose middle ear infections (otitis media) in children and adults
  • Company #2852 - Inexpensive phototherapy technology for the treatment of newborn jaundice
  • Company #2851 - Next-generation-sequencing (NGS)-based molecular diagnostics
  • Company #2850 - Affordable \"transition\" oral appliance for use in treating sleep apnea
  • Company #2849 - Devices for the treatment of hypertension
  • Company #2848 - Bio-absorbable orthopedic implants
  • Company #2847 - Image-guided medical devices for use in difficult venous access situations
  • Company #2846 - Electromechanical drain system for managing inter-cranial pressure
  • Company #2845 - Medical devices in intravenous access, ENT diagnostic and interventional radiology
  • Company #2844 - Automated, high-precision diabetic control systems for hospital and surgical care
  • Company #2843 - A minimally invasive device for fast and efficient harvesting of large volumes of stem cells from bone marrow
  • Company #2842 - Novel imaging scanners and microscopes that incorporate nanodiamonds to reduce background noise more than 100-fold over current cancer detection methods and to improve visualization deeper into the body
  • Company #2841 - Implantable neural tissue constructs with micropatterned scaffolds that guide neurite connections in three dimensions and replicate neuroanatomy using a patient\'s own neural stem cells
  • Company #2840 - Transvascular, catheter-based technology to treat pulmonary hypertension
  • Company #2839 - Easy-to-use cloud-connected device that has the potential to predict the onset of an asthma attack
  • Company #2838 - A cost-effective set of instruments designed to provide easier, safer, and faster care for a range of outer-ear procedures
  • Company #2837 - A platform of proprietary instruments and devices to facilitate the performance of water-aided endoscopy (WAE) of the gastrointestinal tract
  • Company #2836 - Female lower urinary tract diagnostic catheter that incorporates a visualization port
  • Company #2835 - Office-based procedure to relieve urinary obstruction related to benign prostatic hyperplasia (BPH)
  • Company #2834 - Novel chest drainage technology
  • Company #2833 - Advanced imaging technology to assist physicians in the real-time evaluation of tissue microstructure in cancer surgery
  • Company #2832 - Image-guided interventional augmented reality technology to enable accurate real-time biopsy under CT/MRI
  • Company #2831 - Technology that turns tissue grafts into replacements for the ACL, the central ligament in the knee
  • Company #2830 - Biodegradable, nanotechnology-based thin film devices for sustained delivery of therapeutics for the treatment of ophthalmic diseases
  • Company #2829 - An implant intended to prevent a contra-lateral hip fracture in patients at risk due to bone fragility linked to osteoporosis or cancer
  • Company #2828 - Acoustic monitoring of coronary artery diseases of the heart
  • Company #2827 - Novel precision molecular diagnostics that are reliable, highly sensitive, low cost, and work with both tissue and liquid biopsy samples
  • Company #2826 - Multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies
  • Company #2825 - Patient-specific 3D simulation technology for cardiovascular interventions such as transcatheter valve implantation
  • Company #2824 - Diagnostic products developed to predict the probability of cancer metastasizing, with a focus on breast, prostate, lung and colorectal cancers
  • Company #2823 - Genomics sequencing platform
  • Company #2822 - Two clinical diagnostics platforms: 1) One that stratifies lung cancer patients into subtypes, and 2) a hypoxia signature diagnostic which has the potential to identify patients that respond to anti-angiogenesis therapies in lung, brain and breast cancer
  • Company #2821 - Products combining novel drugs and devices in the treatment of cardiopulmonary diseases
  • Company #2820 - Technology designed to dramatically improve the process and lower the cost of treatment of communicating hydrocephalus
  • Company #2819 - Implantable medical device to help prevent loss of vision resulting from glaucoma
  • Company #2818 - Catheter-based therapy to reduce the chance of strokes in patients with atrial fibrillation by preventing blood flow and clot formation in the left atrial appendage
  • Company #2817 - Electronic medical eyewear device for improving the vision of persons afflicted with Age-related Macular Degeneration
  • Company #2816 - Wearable medical device for patients with Essential Tremor
  • Company #2815 - A suite of diagnostic biomarkers to measure and predict cancer tumor growth patterns
  • Company #2814 - Microfluidics-based diagnostic testing of blood biomarkers, with an initial focus on enabling hospitals to efficiently triage chest pain patients in the emergency room (ER) setting
  • Company #2813 - Wearable technology combining patent-pending micro sensors, algorithms and data collection to monitor bio-signals such as breathing, heartbeat and motion
  • Company #2812 - Blood-based diagnostic tests for Alzheimer\'s disease and ALS (Lou Gehrig\'s disease)
  • Company #2811 - Transarterial delivery systems for super-selective cancer therapy
  • Company #2810 - Handheld biosensor-based complete blood count diagnostic platform for use in local testing centers and patients\' homes
  • Company #2809 - Noninvasive, electrode-based fetal and maternal monitoring system
  • Company #2808 - Inhaler devices for the delivery of inhaled medications, for people with asthma and chronic obstructive pulmonary disease (COPD)
  • Company #2807 - Tissue transillumination technology to assist with the accurate placement of peripheral intravascular (IV) catheters
  • Company #2806 - Cranial support technology for newborns designed to aid in the prevention of hospital-acquired pressure ulcers and deformational plagiocephaly
  • Company #2805 - Molecular diagnostics focused on personalized medicine in the areas of cardiovascular disease, neuropsychiatric disorders and pain
  • Company #2804 - Nanotechnology-based rapid diagnostic solutions for use in applications including critical care and emergency medicine
  • Company #2803 - Medical products addressing the problem of sedation-induced airway collapse
  • Company #2802 - Ophthalmologic technology (unspecified)
  • Company #2801 - Surgical navigation system designed to reduce radiation exposure to patients and caregivers during endovascular procedures
  • Company #2800 - Wound closure medical device products, targeting surgeries in the OR and trauma in emergency departments
  • Company #2799 - Medical device for improving the safety of hemodialysis/vascular access, specifically venous needle dislodgement
  • Company #2798 - Non-invasive, non-medication treatment for acid reflux into the throat and lungs
  • Company #2797 - Dynamic, functional, patient-specific orthopedic surgery planning and simulation technology, focused initially on total knee and hip arthroplasty
  • Company #2796 - Single-use, pre-sterilized, and disposable orthopedic surgery kits for use in bone fixation procedures
  • Company #2795 - Health IT and patient monitoring platform that enables \"deep integration\" into emergency medical records, analytics and population health systems
  • Company #2794 - Catheter-based tools to treat atrial fibrillation
  • Company #2793 - Wireless, micro-technology, drug-free neuromodulation device for relief of chronic pain
  • Company #2792 - Medical device to optimize the safe handling of hazardous medications
  • Company #2791 - Smartphone plug-in thermometer
  • Company #2790 - Implantable shunt for the treatment of congestive heart failure
  • Company #2789 - Visual prostheses to restore vision to people with retinitis pigmentosa and age-related macular degeneration
  • Company #2788 - Micro-pump technologies for drug delivery
  • Company #2787 - A novel, disruptive solution for the treatment of fecal incontinence
  • Company #2786 - Point-of-care biologic, platelet-rich plasma-based treatments for cardiovascular disease and intermittent claudication
  • Company #2785 - Accurate, sensitive, noninvasive diagnostic tools for monitoring organ transplant recipients
  • Company #2784 - Implantable micro electro-mechanical systems (MEMS) sensors that couple to a handheld reader, enables wireless and direct measurement of intraocular pressure for the management and treatment of glaucoma
  • Company #2783 - Optical technology to measure red blood cell membrane chemistry and provide feedback about the three to four month history of blood pressure control and the resulting harmful effects of hypertension
  • Company #2782 - A software-plus services platform to allow organizations to capture and analyze patient-reported outcomes that better measure what works in the real world and compare treatment effectiveness for targeted patient populations
  • Company #2781 - Injectable microgel for the treatment of chronic lower back pain caused by early-stage degenerative disc disease
  • Company #2780 - Advanced medication adherence solutions powered by facial recognition and motion-sensing technology
  • Company #2779 - A minimally invasive esophageal cardiac vital signs monitoring system
  • Company #2778 - A device that provides real-time monitoring of a patient\'s position in bed, in order to facilitate regular repositioning and prevent or reduce the incidence of pressure ulcers
  • Company #2777 - Newly formed medical device company focused on developing and commercializing technologies that deliver energy to the body for healing and pain.
  • Company #2776 - Technologies that enable development of biologic wound dressings integrated with antibacterial silver nanoparticles
  • Company #2775 - Compact, mobile phone-connected ultrasound scanner that can provide vivid images quickly and cheaply, and that will eventually be able to use beams of concentrated sound to perform some types of surgical procedures
  • Company #2774 - A compliance and feedback monitoring system attached to a scoliosis brace
  • Company #2773 - Blood autotransfusion device for use in the developing world, with an initial focus on sub-Saharan Africa
  • Company #2772 - Ultrasound-based technology for detecting clot formation in a rapid manner following surgical anastomosis
  • Company #2771 - Bone fusion and osseointegration technologies for sufferers of back injuries, fractures, degenerative diseases, and other orthopedic, craniomaxillofacial and dental disorders
  • Company #2770 - Home-monitoring system for people with sleep disorders
  • Company #2769 - A non-invasive method to effectively deliver drugs and other therapeutic payloads to the inner ear
  • Company #2768 - A device to record, document and track mechanical, optical and dosimetric measurements, for use in quality assurance measurements of medical accelerators used in radiation therapy
  • Company #2767 - Breath-based analysis devices for application in disease diagnosis and management
  • Company #2766 - Transcatheter aortic valve implantation (TAVI) device
  • Company #2765 - Custom-fit abdominal aortic aneurysm endografts
  • Company #2764 - Four-dimensional respiratory diagnostic imaging technology
  • Company #2763 - A passive, catheter-delivered implant for the treatment of drug-resistant hypertension
  • Company #2762 - Search, analytics and imaging solutions to healthcare enterprises that are seeking to improve quality and lower the costs of diagnosis and treatment
  • Company #2761 - A wireless marker tag and detection system that helps locate breast abnormalities and predict margins during surgical excision
  • Company #2760 - Low-cost diagnostic test for the early detection of heart attack
  • Company #2759 - Regenerative medicine technology utilizes scans of patients\' bone defects and their own stem cells to engineer personalized bone grafts
  • Company #2758 - Medical device for producing gaseous nitric oxide to treat chronic diabetic foot ulcers
  • Company #2757 - A personalized, neuroscience-based sound therapy for use in temporarily relieving the symptoms of tinnitus
  • Company #2756 - Next-generation access technologies used in cardiac electrophysiology procedures for the treatment of heart rhythm disorders including atrial fibrillation
  • Company #2755 - Implants and single-use instrumentation for use in extremity surgery
  • Company #2754 - Electro-magnetic-based technology for the treatment of diabetic foot ulcers
  • Company #2753 - Continuous glucose monitoring via a wireless wearable sensor
  • Company #2752 - Spinal implant devices
  • Company #2751 - A treatment system that utilizes a proprietary topical formulation of riboflavin (vitamin B2) combined with ultraviolet-A light for strengthening collagen in corneas weakened by disease, or from prior surgical intervention
  • Company #2750 - A low-cost, noninvasive diagnostics technology to measure arterial stiffness as a predictor of cardiovascular disease
  • Company #2749 - Safety syringe system with passive needle safety
  • Company #2748 - Low cost, wireless, disposable gamma probe for use in radio-guided surgical procedures such as sentinel node biopsy and parathyroid localization
  • Company #2747 - A single-use, disposable device which delivers a dose of a drug in powder form intranasally, with applications including the treatment of pain, cancer, migraines, epilepsy, and delivering vaccines
  • Company #2746 - A wireless, hand-held device that connects to any electrocardiogram (ECG) machine to diagnose atrial fibrillation (AF) and other major cardiac conditions in primary care, acure care and hyper-acute care settings
  • Company #2745 - Cell capture technology and system to allow for the harvesting stem cells in high numbers from blood or adipose lipoaspirate
  • Company #2744 - The first companion diagnostic transdermal patch, focused initially on smoking cessation
  • Company #2743 - Injectable biomaterial technology for the treatment of chronic lower back pain caused by degenerative disc disease
  • Company #2742 - Medical device to treat patients with chronic edema and fluid overload
  • Company #2741 - Device which addresses neointimal hyperplasia, the blockage of vessels by scar tissue, as a result of vascular graft surgery
  • Company #2740 - Biological scaffold and stem cell-based organ replacement products to address the chronic shortage of organs for transplantation
  • Company #2739 - Interventional neuroradiology devices and delivery systems for the minimally invasive treatment of conditions including intracranial aneurysms
  • Company #2738 - Smartphone-enabled otoscope for remote diagnosis of pediatric ear infections, and other optical attachments for the diagnosis of other conditions
  • Company #2737 - Computerized, needle-free drug delivery technology for use in delivering injectable biologics, including large molecule biologics, for the treatment of chronic diseases
  • Company #2736 - Point-of-care and near-patient molecular diagnostics platforms for the delivery of low cost, high-performance, and mass-deployable solutions for DNA and protein-based diagnostic testing
  • Company #2735 - Pocket-sized digital ultrasound tool that connects to a smartphone app to let women hear, record, and share their fetus\' heartbeat
  • Company #2734 - Mobile solution for respiratory patients that incorporates an inhaler sensor and smartphone application to track real-time adherence and lung function through an engaging patient interface
  • Company #2733 - Sensorized glove to help stroke patients regain hand motor function after a stroke
  • Company #2732 - Trigeminal nerve stimulation technology for a variety of neurologic and psychiatric disorders, including epilepsy, depression, attention deficit hyperactivity disorder (ADHD) and post-traumatic stress disorder (PTSD)
  • Company #2731 - A vascular embolization device aimed at the peripheral vascular embolization market, for the treatment of several conditions/diseases including cancer, internal hemorrhage, aneurysms and venous disease
  • Company #2730 - Microfluidic technology that address key biological analysis protocols, from sample preparation for next-generation sequencing to genotyping and cell screening
  • Company #2729 - Heparosan polymer-based drug delivery system
  • Company #2728 - Advanced signal processing technology designed to provide enhanced real-time, precise and uninterrupted information for clinical decision-making during electrophysiology studies and ablation procedures
  • Company #2727 - Wound care platform that accelerates wound healing by enhancing blood flow, oxygenation and therapeutic efficacy, all at a lower cost
  • Company #2726 - Validated neural network algorithm (using a smartphone app) that accurately diagnoses obstructive sleep apnea (OSA) via analysis of snore recordings
  • Company #2725 - A wireless, electrode-based, electronic maternal-fetal monitor sensor replacement system that measures labor contractions and the heart rates of both mother and child
  • Company #2724 - Biological testing, assay and imaging technologies, based on a novel red to near infrared fluorescence enhancing detection platform
  • Company #2723 - A neuromodulation-based treatment for tinnitus
  • Company #2722 - Wireless, single-use, web-connected sensor to monitor patient position and turning protocols, to help reduce the risk of developing pressure ulcers/injuries
  • Company #2721 - Respiratory monitoring technology
  • Company #2720 - Combined saline infusion sonohysterography and endometrial biopsy device, for the treatment of abnormal uterine bleeding
  • Company #2719 - A web-based preclinical optical imaging system that transforms current small animal optical imaging platforms into devices that can acquire quantitative 3D images
  • Company #2718 - A device that helps stroke survivors recover the function of dysfunctional hands
  • Company #2717 - Low cost, portable breast cancer screening device
  • Company #2716 - Medical devices to treat female pelvic floor disorders
  • Company #2715 - Organ-on-a-chip microfluidic technology for testing of new drug compounds
  • Company #2714 - Clinical cancer genomics technology that harnesses the emerging potential of circulating DNA analysis - a liquid biopsy - to detect, monitor and treat cancer
  • Company #2713 - Lower urinary tract dysfunction diagnostics
  • Company #2712 - Microfluidic channel device for cleaning blood and stem cells in the cryopreservation process, for use in bone marrow transplantation; also allows blood to be frozen for longer periods
  • Company #2711 - Wearable chest patch biosensor that captures clinical-grade biometric measurements in a continuous, configurable and non-obtrusive manner
  • Company #2710 - Digital inhaler sensor and smartphone app to measurably improve respiratory health
  • Company #2709 - A maternal heartbeat-conveying system to comfort babies in the neonatal intensive care unit
  • Company #2708 - Hand-held inhaler device for controlled cannabis dosage for the treatment of pain
  • Company #2707 - Wearable artificial kidney device for the treatment of end-stage renal disease, as an alternative to hemodialysis
  • Company #2706 - Inflatable vaginal insert for use in treating fecal incontinence
  • Company #2705 - Disposable carbon dioxide insufflation system that reduces pain and decreases recovery time associated with colonoscopy
  • Company #2704 - A mobile, single-unit compression device that uses shape memory alloy fabric to deliver compression to patients\' legs, helping to prevent deep vein thrombosis
  • Company #2703 - 3-D printed orthotic devices for disabled children
  • Company #2702 - Positron emission tomography (PET) scanners with superior imaging capabilities that can be miniaturized and coupled with magnetic resonance imaging (MRI)
  • Company #2701 - We create smart, connected visual assessment solutions for women's health clinicians to screen for cervical cancer and replace expensive and time-consuming laboratory tests with point-of-care AI-based decision support.
  • Company #2700 - Device for self-collection of blood samples
  • Company #2699 - Novel access system for the minimally invasive treatment of certain cardiac conditions, or arrhythmias, in which there is abnormal electrical activity in the heart
  • Company #2698 - Miniaturizing Automated External Defibrillators into both an ultra-portable form and into a highly compact wearable form so that they can be carried in a pocket/purse or worn clipped to a belt (by medical staff, First Responders and at-risk patients), or else worn under clothing by the patients who are most at-risk of a Sudden Cardiac Arrest
  • Company #2697 - Microendoscopic system that enables in vivo visualization of cellular structure in muscle and connective tissues with broad applications ranging from noninvasive imaging of the skin to improving the treatment of amytrophic lateral sclerosis (ALS)
  • Company #2696 - Innovating and commercializing breakthrough technologies in consumer electronics and wound care
  • Company #2695 - Online engine for teaching anatomy and physiology to students, physicians, and patients
  • Company #2694 - Effective, efficient, and economic ultrasound breast cancer screening modality for the 25M US women who are underserved by mammography each year. A proprietary, FDA-Cleared, device aimed at creating a new multi-billion dollar world-wide market
  • Company #2693 - Obstructive Sleep Apnea
  • Company #2692 - Various infusion devices
  • Company #2691 - Non-invasive electromagnetic anti-inflammatory for use in treating a wide range of neurodegenerative diseases as well as traumatic brain injury
  • Company #2690 - Glaucoma drainage device (GDD) whose aperture is externally adjustable to achieve precision in intraocular pressure (IOP) control over the life of the device
  • Company #2689 - Wireless solution for chronic disease management and reliable sharing of medical information
  • Company #2688 - A medical device developer, manufacturer and marketer in China focused on fast-growing and high-margin product segments, with leading market positions in infusion products and orthopedic implant products
  • Company #2687 - A portfolio of products for the prevention of surgical site infection (SSI)
  • Company #2686 - Implants for the correction of foot and ankle deformities
  • Company #2685 - Compressive device for post dialysis bleeding, anti disconnection device, \"on/off\" vascular access kit, and developing other new technologies
  • Company #2684 - Designing and developing innovative software-driven technology for the clinical early detection and prevention of skin cancer
  • Company #2683 - A single-use, fully disposable medical device utilizing innovative shape-memory alloy technology to enable identification of cardiovascular structures during standard flouroscopic imaging
  • Company #2682 - Foot/Footwear Sterilization System
  • Company #2681 - Providing industry-leading dental equipment such as imaging systems and practice management solutions for dental and oral health professionals
  • Company #2680 - Various technologies in the growing market of human augmentation systems
  • Company #2679 - SafeSnips platform is a vessel and tissue imaging technology that integrates into minimally invasive surgical tools
  • Company #2678 - Quality manufacturers of CPR, First-Aid, and Respiratory devices
  • Company #2677 - Advanced interventional medical devices with initial applications in Ear Nose Throat (ENT) space
  • Company #2676 - A device for hydrophilic guidewire control, as an alternative to a torque device
  • Company #2675 - A technology for harvesting autogolous, adipose-derived stem cells for use in treating knee, back and joint pain, arthritis or ligament or tendon injuries
  • Company #2674 - The first antibacterial catheter to be self-sterilizing while residing in a patient
  • Company #2673 - Pharmacological materials including mesenchymal stem cells into a bioengineered polymer gel topically applied to non-healing wounds in all clinical care settings
  • Company #2672 - Microfluidic bioreactor technology to produce the world\'s first donor-independent human platelets from human induced pluripotent stem cells
  • Company #2671 - Effective and cost competitive proprietary scaffold technology for the healing of chronic wounds, that incorporates oxygen and pro-regeneration molecule delivery
  • Company #2670 - A barrier film medical device platform which separates adjacent organs from adhering to each other after surgery
  • Company #2669 - Transdermal drug delivery technology
  • Company #2668 - Smart contact lens to continuously monitor blood glucose data and transmit the data to a mobile device
  • Company #2667 - Cost-effective vein visualization tool that increases the ability of nurses, physicians, and caregivers to locate and easily access veins for IVs, shots and blood samples
  • Company #2666 - Magnetic intra-ureteral stent that employs a proximity sensing system to allow surgeons to more precisely localize and avoid the ureter during pelvic and colorectal surgeries
  • Company #2665 - A diagnostic biomarker that can be applied to a breast cancer patient\'s tumor sample to predict whether she would benefit from taxane-based chemotherapy
  • Company #2664 - Carbon nanotube fiber technology to treat ventricular arrhythmia
  • Company #2663 - Proprietary products for single-cell analysis and characterization using picodroplets
  • Company #2662 - Neuro diagnostic information device with a particular focus on concussion (mTBI) and Alzheimer\'s disease
  • Company #2661 - Transcatheter mitral valve replacement system to treat patients with mitral regurgitation
  • Company #2660 - Left ventricular assist devices based on membrane wave technology
  • Company #2659 - Affordable portable, power-free, surgical instrument sterilization
  • Company #2658 - A fast, secure closure system for intravenous access catheters that eliminates blood loss, cross contamination and reduces nursing labor
  • Company #2657 - Hand-held, integrated, real-time, nanoparticle-based diagnostic device to detect staph and other bacterial infections at the point of care in 30 minutes or less
  • Company #2656 - Embolic microspheres and delivery system for the peripheral vascular treatment of disorders such as uterine fibroids, hepatocellular carcinoma and benign prostatic hyperplasia
  • Company #2655 - Biocompatible, rice-grain sized, subdermal implant with a proprietary nanoporous membrane to provide long-term, constant-rate delivery of therapeutic macromolecules for up to a year
  • Company #2654 - An orthopedic table extension to assist surgeons in performing minimally invasive direct anterior hip replacement surgery
  • Company #2653 - Collagen replenishment therapies for soft tissue therapeutic applications
  • Company #2652 - Biomedical devices for delivering anesthesia
  • Company #2651 - Disposable electroencephalography (EEG) and cerebral function monitoring (CFM) products for term and preterm infants
  • Company #2650 - Catheter device that enables chemotherapy delivery in a targeted manner, reducing patient side effects and improving treatment efficacy
  • Company #2649 - Tissue-engineered nerve grafts for repairing damage to the peripheral and central nervous systems, involving peripheral nerve injury, spinal cord injury, traumatic brain injury and stroke
  • Company #2648 - Low cost, simple-to-use, handheld laboratory for 15-minute diagnosis of disease at the patient\'s side
  • Company #2647 - Electrical-based treatment to remineralize tooth defects/decay
  • Company #2646 - Small, portable temperature control device to meet the needs of users of medications such as insulin
  • Company #2645 - Breast cancer detection tools that are non-radiological and affordable
  • Company #2644 - Allograft technology to be used with autogenous bone graft material and supplemental fixation for the treatment of complex orthopedic and neurological spinal disorders
  • Company #2643 - Biomaterial for use in ocular surface repair; suitable for battlefield blast wound injuries and the growing elective phorefractive keratectomy procedure market
  • Company #2642 - User-friendly, non-invasive glucose monitor that continuously tracks blood glucose levels and trends painlessly, in a wristwatch format
  • Company #2641 - Low-cost, smarter pedicle probe for the accurate placement of pedicle screws in spinal fusion surgery
  • Company #2640 - Device for intubated hospital patients that prevents ventilator-associated pneumonia
  • Company #2639 - Early detection, over-the-counter breast cancer test to identify protein in urine
  • Company #2638 - Neurostimulation-based therapy for the treatment of Obstructive Sleep Apnea
  • Company #2637 - 1-Single cell gene expression and genome sequencing; 2-non-invasive tests for heart transplant rejection, and 3-approaches to sequence and analyze an individual\'s immune system
  • Company #2636 - Products to prevent acute cellular injury following an ischemic event or as a preventative adjunct in vascular surgery by employing therapeutic hypothermia
  • Company #2635 - Non-invasive perfusion imaging technology for use in the early identification of poorly perfused tissue that has an increased risk for necrosis or delayed healing, both in and outside the operating room
  • Company #2634 - A diagnostic technology designed to greatly improve the speed and accuracy of Western blot, a technique widely used in molecular biology labs
  • Company #2633 - High-throughput microfluidic chip platform for simple and effective delivery of material into cells
  • Company #2632 - Polymer-based liquid bandage product
  • Company #2631 - Regenerative medicine (musculoskeletal deficiencies) technologies and diagnostic medicine (oncology and cardiology)
  • Company #2630 - Vascular access products that address the need for a safe, reliable and robust means for hemodialysis administration
  • Company #2629 - A novel hemostatic device capable of stopping high-flow arterial bleeding from non-compressible wounds, for use in treating life-threatening wounds on the battlefield
  • Company #2628 - Ultrasound-based renal denervation system for the treatment of resistant hypertension
  • Company #2627 - Therapeutic temperature management technology to prevent or limit brain and tissue damage following an ischemic event
  • Company #2626 - Minimally invasive, image-guided surgical tool for beating heart mitral valve repair for degenerative mitral regurgitation
  • Company #2625 - Novel diagnostic products to support patient stratification personalized therapies and the clinical development of new drugs for the treatment of microbiome-related diseases such as inflammatory bowel diseases and metabolic diseases (diabetes and obesity)
  • Company #2624 - A system for hysteroscopic intrauterine tissue removal, including fibroids (myomas) and polyps
  • Company #2623 - A minimally invasive implant for the treatment of Obstructive Sleep Apnea (OSA)
  • Company #2622 - Angioplasty dual-balloon system to address the limitations of currently used PTA balloons in the treatment of peripheral vascular disease
  • Company #2621 - A device for use in scarless laparoscopic procedures
  • Company #2620 - A non-surgical implant to divert bile fluids and help in the resolution of type 2 diabetes
  • Company #2619 - An easy-to-use trocar with a built-in closure device, for use in laparoscopic surgery procedures
  • Company #2618 - Targeted nanoparticle tumor ablation
  • Company #2617 - Blood pressure device used in screening for peripheral artery occlusive disease via measurement of Ankle Brachial Pressure Index
  • Company #2616 - Variable-stiffness microcatheter designed to accelerate interventional procedures by allowing clinicians to more rapidly navigate small, tortuous blood vessels
  • Company #2615 - Laparoscopic devices for closure of port site punctures
  • Company #2614 - Hydrogel wound care solutions and drug delivery technologies
  • Company #2613 - Dry powder inhaler that uses advanced technology to overcome the drawbacks of current inhalers, for use in the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease (COPD)
  • Company #2612 - A system that clears surgical smoke from the visual field and prevents its release into the operating theater during laparoscopic surgery
  • Company #2611 - The world\'s first affordable, handheld 3D medical scanner, for use in orthotics, prosthetics and plastic surgery, among other applications
  • Company #2610 - A wearable device to enhance breathing in patients with chronic obstructive pulmonary disease (COPD)
  • Company #2609 - An innovative diagnostic to detect lymphedema, a side effect of breast cancer surgery impacting nearly 50% of all breast cancer survivors
  • Company #2608 - Radio Frequency Ablation (RFA) for breast cancer
  • Company #2607 - A battery-powered wristband device that restores agility and independence to individuals suffering from debilitating neuropathic disorders, such as the effects of stroke and aging
  • Company #2606 - A high-strength biodegradable surgical adhesive that can be used inside the human body to seal wounds within seconds
  • Company #2605 - A mask for unobstructed breathing while patients undergo tracheostomy surgery
  • Company #2604 - A drug-releasing gel scaffold for the non-surgical repair of chronic tympanic membrane perforations
  • Company #2603 - Novel ENT medical device which allows tympanostomy tubes (grommets) to be placed safely and quickly in an office setting, eliminating the need for general anesthetic and costly OR time
  • Company #2602 - Technology for testing biomarkers and performing multi-analyte immunoassays
  • Company #2601 - A medical device clinically proven to assist patients with Parkinson\'s disease speak louder and communicate more effectively
  • Company #2600 - An integrated, droplet-based desktop DNA sequencer system
  • Company #2599 - Next-generation sequencing assays that analyze T cells and B cells, which are critical components of the adaptive immune system's defense against disease
  • Company #2598 - Bioresorbable, biocompatible drug-loaded embolic beads that block blood vessels supplying tumors or fibroids without causing long-term blockage of the blood vessels of healthy tissue
  • Company #2597 - Non-invasive neuromodulation and brain stimulation technology
  • Company #2596 - Proprietary methods to perform patient-specific genetic analyses of cancer using digital characterization and monitoring technologies
  • Company #2595 - Biomarker tests to identify individuals at risk of cognitive decline, Alzheimer\'s disease and other dementias
  • Company #2594 - Spine implants and instruments to treat cervical degenerative disc disease through indirect decompression and fusion
  • Company #2593 - A healthcare IT tool for assisting nurses and doctors in helping newborns with a billion dollar addressable market, with significant big data opportunities
  • Company #2592 - The first non-implantable, catheter-based therapy to treat the valvular pathophysiology of chronic venous insufficiency in the deep veins
  • Company #2591 - A robotic surgical device for the treatment of benign prostatic hyperplasia that utilizes a blue light laser-based water jet to cut and cauterize tissue
  • Company #2590 - Hand hygiene compliance monitoring system for healthcare workers
  • Company #2589 - Class II and Class III medical devices used in spinal surgical procedures, including spinal fixation systems, implants, and instruments
  • Company #2588 - Test that enables comprehensive sequencing of cancer tumor DNA using a simple blood test without the need for a biopsy
  • Company #2587 - Miniaturized implantable neuromodulation technology; lead products are directed toward a number of clinical indications including the treatment of chronic pain and overactive bladder
  • Company #2586 - Platform technology capable of making multiple, direct, real-time measurements to create a 3-D map of vascular structures in the body. Initial application is 3-D mapping of the aortic valve complex to provide critical information to guide Transcatheter Aortic Valve Replacement (TAVR)
  • Company #2585 - Non-invasive device for prevention and treatment of acute and chronic kidney disease
  • Company #2584 - Advanced visualization technology for surgery
  • Company #2583 - Wound treatment system which facilitates timely cleaning of trauma wounds such as road rash
  • Company #2582 - Technologies that minimize peak skin interface pressures to prevent and expedite treatment of pressure ulcers/sores
  • Company #2581 - Point-of-care device that can rapidly detect and diagnose trauma-induced coagulopathy
  • Company #2580 - Diagnosis devices that measure ocular motility
  • Company #2579 - State-of-the-art products for corneal cross-linking of corneal collagen fibers by combined riboflavin/UVA illumination for the treatment of progressive keratoconus
  • Company #2578 - Corneal lens implant for the treatment of presbyopia, the age-related loss of the ability to read or focus on near objects
  • Company #2577 - Ophthalmic surgical devices and instrumentation
  • Company #2576 - Ophthalmic drug delivery technology
  • Company #2575 - Endoscopic vein harvesting technology
  • Company #2574 - A technology which involves a series of self-assembling magnets for incision-less bypass procedures within the digestive system
  • Company #2573 - Noninvasive solutions for people with sleep disordered breathing, that work by creating expiratory positive airway pressure
  • Company #2572 - Molecular diagnostic device for the rapid detection of sepsis or other infection, to reduce unnecessary antibiotic use, and boost patient outcomes and healthcare facility efficiency
  • Company #2571 - Antimicrobial orthopedic implants for the prevention and treatment of bone-based infections
  • Company #2570 - Temporary cardiac pacing device to treat reversible symptomatic bradycardia
  • Company #2569 - Cam Med is developing the Evopump, the first truly bandage-like, actively controllable patch pump for delivering one or multiple injectable medications.
  • Company #2568 - Synthetic bone substitute
  • Company #2567 - Hand-held device and secured web service-based platform enabling anyone anywhere to perform an accurate physical examination for remote diagnosis
  • Company #2566 - One-step, point-of-care diagnostic that uses proprietary chemistry to measure enzymes to help clinicians determine how to treat chronic (or non-healing) wounds
  • Company #2565 - Biomaterials that stimulate the regeneration of bone by a novel mechanism known as osteoinductive nanoarchitecture
  • Company #2564 - Simple fluid flow control module that can be incorporated within finished medical products, such as intravenous infusion pumps, enteral feeding devices, and patient monitoring systems
  • Company #2563 - Injectable silk hydrogel for the treatment of osteoarthritis
  • Company #2562 - Molecular diagnostics test focused on detecting sepsis in critical care patients
  • Company #2561 - Optical imaging technology used during cancer surgery
  • Company #2560 - An innovative infusion pump which will provide totally accurate delivery of prescribed drugs to people suffering from chronic illnesses such as diabetes and neurodegenerative diseases
  • Company #2559 - An FDA Class I, external neuro-stimulation medical device clinically shown to immediately reduce the blood pressure of hypertensive patients, via controlled cold therapy
  • Company #2558 - Image-guided non-invasive brain stimulation
  • Company #2557 - Handheld, portable solutions for wound care, orthopedic care and real-time data capture, analytics and reporting
  • Company #2556 - A user-friendly and resource-effective, self-screening method to detect HPV, chlamydia and gonorrhea, and reduce rates of cervical cancer
  • Company #2555 - Technology for controlling patient temperature in order to more effectively implement mild therapeutic hypothermia, maintain operative normothermia, and treat fever
  • Company #2554 - Electrosurgical devices for tissue dissection and skin contraction, with applications in general and cosmetic surgery
  • Company #2553 - Portable dispenser and badge system for healthcare workers that allows point-of-care hand hygiene, along with real-time data to drive behavior change
  • Company #2552 - Wearable, clinical-grade vital signs monitoring technology to help people proactively understand their bodies and improve health, with applications ranging from cardiac disease and hypertension monitoring to stress
  • Company #2551 - High-definition imaging for precision venous access
  • Company #2550 - A simple surgical tool, similar to a suture applier, for transvaginal uterine artery ligation
  • Company #2549 - Arterial closure device for the large arterial punctures encountered in transvascular procedures such as abdominal aortic aneurysm repair and heart valve replacements
  • Company #2548 - Alternative to continuous positive airway pressure (CPAP) therapy for the treatment of obstructive sleep apnea (OSA)
  • Company #2547 - Proprietary laboratory instrument that automates time-sensitive, labor-intensive steps in an in vitro fertilization (IVF) laboratory
  • Company #2546 - Minimally invasive intelligent monitoring device for the detection of sepsis in the intensive care unit (ICU)
  • Company #2545 - Extremity orthopedic products to restore motion while relieving pain
  • Company #2544 - Non-invasive, electromagnetic therapies to regenerate tissue and organs that have been damaged by age or disease
  • Company #2543 - Technology for the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care
  • Company #2542 - Injectable tissue liquid marker used to improve accuracy in the radiation treatment of patients with cancer
  • Company #2541 - Next-generation implantable neurostimulation devices, with an initial focus on spinal cord stimulation
  • Company #2540 - Medical device for the minimally invasive, transcatheter treatment of structural heart valve disease and mitral regurgitation in patient segments that cannot undergo standard cardiac surgery
  • Company #2539 - Therapeutic use of local skin mechanical stimulation to increase blood flow and heal chronic wounds
  • Company #2538 - Products to dramatically reduce medical radiation exposure without changing user image quality or workflow
  • Company #2537 - The first biologically guided radiation therapy system for treating solid tumors throughout the body
  • Company #2536 - A three-dimensional surgical marker that dramatically improves visualization of the treatment area for radiation planning and therapy
  • Company #2535 - Single-use medical device to treat postpartum hemorrhage (PPH) by specifically addressing uterine atony
  • Company #2534 - Implantable nanomedical scaffold intended for medical applications including soft tissue repair
  • Company #2533 - Whole-body hyperthermia treatment for ovarian cancer
  • Company #2532 - A molecular diagnostics test to predict the likely success of radiation therapy in cancer patients
  • Company #2531 - Convenient, accurate and pain-free glucose reading which does not require the collection of blood
  • Company #2530 - Blood test to stratify ischemic stroke patients by cause, leading to timely diagnosis and treatment, resulting in cost savings and improvement in patient outcomes
  • Company #2529 - Technology that integrates robotics and ultrasound imaging to enable real-time, markerless targeting for radiation therapy
  • Company #2528 - Non-invasive, battery-operated, and self-administered migraine therapy device worn on the back of the head at the onset of, or during, a migraine to relieve pain
  • Company #2527 - Drugs targeting the Transglutaminase 2 (TG2) pathway to treat multiple disease indications, with an initial focus in celiac disease
  • Company #2526 - Bio-active ferrofluids that aid in the diagnosis of cancer and cardiovascular disease
  • Company #2525 - Adenosine-based therapeutic skin patch for a variety of large market indications, including: arthritis, crohn\'s disease, psoriasis, diabetes, diabetic nephropathy, infectious diseases, glaucoma, asthma, atherosclerosis, cancer, and cardiovascular stress imaging
  • Company #2524 - Drug that normalizes abhorrent activity in the hippocampus to treat/prevent Mild Cognitive Impairment (MCI), early Alzheimer\'s disease (AD), and other memory disorders
  • Company #2523 - Pipeline of specialty generic drugs that have an embedded drug delivery technology to make the formulation very challenging/complex, in order to provide significant barriers to competition
  • Company #2522 - Small molecules for the treatment of antibiotic resistant bacterial infections
  • Company #2521 - System for lithotripsy-enhanced dilation of lesions, including calcified lesions in the peripheral vasculature and aortic valve stenosis, via a deliverable balloon catheter platform
  • Company #2520 - Drugs for ovarian cancer and other advanced solid tumors
  • Company #2519 - Adenoviral-based technology platform for the rapid development of oral vaccines that can target any viral or bacterial protein antigen
  • Company #2518 - Small molecule cancer drugs for genetically-defined populations
  • Company #2517 - 1-Extended-release implant that replaces the need for glaucoma patients to use daily eye drops and 2-A platform that offers a unique ability to design monodisperse particles of large or small molecules in order to develop next-generation ocular therapies
  • Company #2516 - Optical biomarker system that can provide earlier and more accurate detection of most cancers by detecting molecular changes in nuclear structure, which are not detectable by conventional pathology
  • Company #2515 - Immunotherapy platforms to treat a variety of high-risk cancers: 1-Chimeric antigen receptors (CAR) technology that targets cell surface antigens that are expressed on cancer cells and 2-T cell receptors (TCR) technology that detects alterations in intracellular proteins present in tumor cells
  • Company #2514 - Disruptive DNA-sequencing technology based on a simple label-free proprietary technology, enabling fast, accurate, and low-cost genetic testing
  • Company #2513 - Immunotherapies for the treatment of cancer, fibrosis, hypercholesterolemia/atherosclerosis, and inflammatory diseases
  • Company #2512 - Coating made of a superelastic shape memory alloy (SMA) spacer fabric that expands in vivo to improve osseointegration with hip, knee, shoulder, elbow, and spine implants
  • Company #2511 - Surgical lighting system to provide surgeons with a simple, high quality illumination source for deep cavity surgical procedures
  • Company #2510 - 1-System to reduce the amount of dye (contrast) injected during commonly performed heart procedures, thus protecting kidneys from damage known as contrast induced nephropathy (CIN) and 2-A percutaneous technology that allows physicians to deliver targeted doses of antibiotics to the lower limb in patients with diabetes suffering from advanced foot infections
  • Company #2509 - Miniature, wearable, non-invasive device that utilizes body-penetrating microwave radar technology to remotely monitor the optimal combination of chronic heart failure (CHF) patient clinical parameters (e.g. lung fluid level, heart rate, breath rate, posture)
  • Company #2508 - Device for simplifying peritoneal dialysis in the treatment of patients with severe chronic kidney disease
  • Company #2507 - 1-Single-use device that adds a visual dimension to locating a fistula and 2-A valve system that can selectively turn on/off the flow of blood to the arteriovenous (AV) graft during/after dialysis sessions
  • Company #2506 - Non-invasive clinically-proven breathing techniques that can be used by patients in the comfort of their homes to alleviate the symptoms of chronic pulmonary problems such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea
  • Company #2505 - Precision microblade system for the minimally invasive treatment of cellulite in the office setting
  • Company #2504 - Generic Class III medical devices with an emphasis on the musculoskeletal therapeutic areas of rheumatology, physiatry, orthopedics, and sports medicine
  • Company #2503 - Surgical navigation system that provides real-time computer-assisted guidance during the dental implant process with more accuracy and at less cost than the current standard of care
  • Company #2502 - Wearable body movement and physiologic monitors for infants
  • Company #2501 - Holographic medical visualization software that uses existing medical image datasets to create virtual reality environments of patient-specific anatomy
  • Company #2500 - Line of surgical instruments and equipment
  • Company #2499 - Laser technology that provides unprecedented precision and control for the removal of delicate tissues during microsurgical procedures
  • Company #2498 - Fully bioresorbable scaffold, which is designed to afford the strength of metal stents to assist the artery during the remodeling process following an interventional procedure, without leaving behind a permanent implant with inherent clinical limitations
  • Company #2497 - Drugs for the treatment of inflammation-related disorders and solid tumors
  • Company #2496 - Genetically-engineered stem cells to repair and replace damaged heart tissues resulting from heart attack/heart failure
  • Company #2495 - Surgical and transcatheter valve repair and replacement devices for the treatment of the most prevalent heart valve diseases - mitral valve regurgitation and tricuspid valve regurgitation
  • Company #2494 - 1-Disruptive percutaneous radio frequency (RF) device that can ablate tissues with a degree of unmatched precision and 2-A flexible endoscope for the destruction of localized lung tumors via RF ablation
  • Company #2493 - Drug for the treatment of chronic pruritus
  • Company #2492 - Finger sleeve device that delivers mechanical and electrical stimulation to the finger to inhibit the sensation of sharp pain, with applications in diabetes (lancet pricks), arthritis, hand injuries, and wound healing
  • Company #2491 - Therative (fka DermaCare) (Closed) Easy-to-use, hand-held device specifically targeted for the treatment of mild-to-moderate inflammatory acne
  • Company #2490 - Satori Pharmaceuticals has closed its doors after running into safety problems in preclinical research of its lead program for Alzheimer\'s disease Read more: Satori Pharmaceuticals shuts down after failure of Alzheimer\'s drug - FierceBiotech http://www.fiercebiotech.com/story/satori-pharmaceuticals-shuts-down-after-failure-alzheimers-drug/2013-05-30
  • Company #2489 - Highly scalable ultrasound systems that allow doctors to upgrade models easily without buyback situations
  • Company #2488 - Vascular closure system that uses a proprietary medical adhesive to close the saphenous vein, thereby eliminating the need for surgery, ablation, anesthesia, or the use of harsh chemicals to treat venous reflux disease
  • Company #2487 - 1-Formulations based on the isolation and purification of Eicosapentaenoic (EPA), 2-Soft gelatin encapsulation for the delivery of lipid-based drugs, and 3-Supplements for dental and women\'s health
  • Company #2486 - Minimally invasive endodontic technology for complete 3D root canal cleaning and shaping using a single instrument
  • Company #2485 - Rapamycin-related drugs to slow the aging process and potentially ward off aging-related diseases such as Alzheimer\'s
  • Company #2484 - Pipeline of potent anti-infective agents that can be delivered directly to the lung by inhaled administration, for the treatment of life-threatening lower respiratory tract viral and fungal infections
  • Company #2483 - Single-use, implantable arterio-venous shunt that provides a unique, non-surgical approach for patients who need vascular access
  • Company #2482 - Programmable implantable drug pump that is differentiated from existing technology through its new and innovative features
  • Company #2481 - Next-generation diagnostic instrument based on the ultra-high speed, high-resolution Fourier-Domain Optical Coherence Tomography (FD-OCT) technology that will have significant benefit for patients with retina conditions
  • Company #2480 - Portfolio of reprofiled, low-risk, and/or orphan products targeting ocular surface diseases, glaucoma/glaucoma surgery, and retinal diseases
  • Company #2479 - Transformative technology to improve vein performance and longevity in coronary artery bypass grafts (CABG)
  • Company #2478 - Non-invasive fetal electrocardiograph (fECG) monitor that is designed to report fetal heart rate (FHR) data equivalent to the gold standard fetal scalp electrode (FSE) in addition to novel ECG metrics intended to provide obstetricians a deeper understanding of fetal/maternal health and management
  • Company #2477 - Second-generation intra-luminal intestinal liner that mimics the effects of bariatric surgery in causing remission of Type 2 Diabetes accompanied by weight loss and is endoscopically implanted via a 30-minute procedure, without the need for surgery
  • Company #2476 - Advanced wound care products
  • Company #2475 - Disease-modifying therapies for Alzheimer\'s, Parkinson\'s, Huntington\'s, Amyotrophic Lateral Sclerosis, and other neurodegenerative diseases
  • Company #2474 - Hormone receptor-targeting technology to develop cancer therapies
  • Company #2473 - Oral, small molecule drugs to address the underlying causes of chronic and severe, non-malignant blood-based diseases and genetic disorders for which there are currently no effective cures and only extremely limited therapeutic options
  • Company #2472 - Regenerative medicine device company developing a unique plant protein-based skin scaffold wound dressing to replace human and animal sourced products to address the advanced wound care market
  • Company #2471 - Hormone therapies for the treatment and prevention of breast cancer and endocrine-related disorders, especially those affecting post-menopausal women and aging men
  • Company #2470 - Therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level
  • Company #2469 - Small molecule drugs for the treatment of inflammatory and autoimmune diseases and organ transplant rejection, based on the specific inhibition of calcium release-activated calcium (CRAC) channels
  • Company #2468 - Next-generation catheter-based devices for the treatment of cerebral aneurysms
  • Company #2467 - Unique set of compounds to protect hearing and silence tinnitus
  • Company #2466 - Single \"soft\" but permanent gelatin microshunt implant to provide significant, long-term intraocular pressure (IOP) control, which may reduce the risk of glaucoma disease progression and associated vision loss in mild, moderate, and refractory glaucoma patients
  • Company #2465 - Advanced prescription medications which have differential and therapeutically meaningful advantages to health care professionals and their patients
  • Company #2464 - Computer diagnostic system that enables easy use of genetic sequencing to screen for a variety of diseases
  • Company #2463 - Continuous medical-grade electrocardiogram, heart rate, heart rate variability, levels of physical activity, variations in body temperature monitoring and wireless data transmission for patients
  • Company #2462 - Mobile health products and services to help healthcare professionals monitor and diagnose cardiovascular and other patients in a more efficient, accurate, and cost-effective manner
  • Company #2461 - Non-invasive blood glucose measurement device
  • Company #2460 - Highly accurate molecular diagnostic tests for known and novel mutations that cause inherited genetic disorders, and a proprietary and advanced preimplantation genetic screening test
  • Company #2459 - Proprietary technology focused on rapid, robust isolation of clinically actionable genetic biomarkers from blood, urine and cerebrospinal fluid for diagnosis, monitoring and companion diagnostic applications
  • Company #2458 - Proprietary class II orthopedic and spine products, including an interbody fusion device sprayed with titanium plasma
  • Company #2457 - Low-cost, portable ventilators
  • Company #2456 - Molecular imaging technology to detect cancer in real-time during surgery, such as during breast cancer surgery
  • Company #2455 - Forward osmosis technology that allows intravenous solutions to be made using any kind of water (except sea water) at the point of care with no electricity, with an initial application in disaster relief
  • Company #2454 - Sparo has developed Lift Pulmonary Rehab a digital, home-based rehab program designed for seniors, helping increase energy and endurance, reduce shortness of breath, and improve quality of life.
  • Company #2453 - Three-dimensional (3D) nanofiber scaffolds for use in regenerative medicine and 3D cell culture
  • Company #2452 - A simple blood test that provides accurate early diagnosis of lung cancer
  • Company #2451 - Robot-assisted brain ultrasound head trauma screening device for use in measuring intracranial pressure in pre-hospital settings
  • Company #2450 - Minimally invasive, needle-delivered neuromodulation devices for the gastrointestinal tract that replicate the therapeutic efficacy of bariatric surgery with minimal cost and risk
  • Company #2449 - Adhesive drug-delivering patch aimed at reducing pain and error when self-delivering drugs
  • Company #2448 - MicroRNA-based therapeutics and diagnostics to treat lung, ovarian, colorectal and prostate cancers
  • Company #2447 - A sensor device intended to reduce complications due to improper management or dosing of anticoagulation drugs; the device will collect a patient\'s blood sample at home, then transmit data to the cloud - an algorithm would analyze the data and alert a doctor depending on the results
  • Company #2446 - Smartphone-based autorefraction vision test technology
  • Company #2445 - Portable, non-invasive, non-mydriatic eye pre-screening device that can detect diabetic retinopathy, cataracts, glaucoma, cornea problems and refractive errors
  • Company #2444 - Remote heart monitoring technology
  • Company #2443 - Venipuncture automation system
  • Company #2442 - Stethoscope accessory connected to portable devices for mobile heart sound, three-lead electrocardiogram, and cloud-based diagnostic support
  • Company #2441 - Portable stroke detection device for use in the emergency room to improve triage times and enable faster diagnosis and treatment
  • Company #2440 - Noninvasive, low-resistance medical device to help increase blood flow and reduce pain and swelling in the lower extremities, in patients with poor circulation
  • Company #2439 - Outpatient, endoscopically delivered, stent-like device that mimics gastric bypass surgery for the treatment of obesity and type 2 diabetes
  • Company #2438 - Sensor technologies used in biometric impact measurement for sensing traumatic brain injury (TBI), such as in high-impact sports; data transmitted wirelessly to sports officials and to secure cloud database
  • Company #2437 - A molecular and cellular approach to treating diabetes, in which autologous liver cells are converted into functional insulin-producing cells
  • Company #2436 - A novel device therapy for treating hypertension
  • Company #2435 - Single-use organ preservation device to improve donor organ quality and extend donor organ preservation times
  • Company #2434 - Drug-like small-molecule compounds that are non-sedating, for the treatment of seizures resulting from epilepsy and other abnormal central nervous system (CNS) conditions
  • Company #2433 - New antimicrobial products designed to prevent healthcare acquired infections with a focus on surgical site infections (SSIs) and catheter-related bloodstream infections (CRBSIs)
  • Company #2432 - New approach for the oral delivery of large drug molecules (peptides, proteins, antibodies, RNAi therapies, and select vaccines), which to date can only be delivered through injections
  • Company #2431 - Step down therapies that will enable patients to leave the hospital earlier and complete their medicinal regimens in the comfort and convenience of their own homes
  • Company #2430 - Next-generation vaccines for high-value unaddressed targets in infectious and emerging diseases, namely HCV, HPV, HSV, and HIV
  • Company #2429 - Specialty pharmaceuticals targeting numerous indications with large markets and clear unmet medical needs of anal-rectal problems
  • Company #2428 - Vaccines and specialty biologics for the prevention and treatment of infectious and neurodegenerative diseases
  • Company #2427 - Small molecule drugs, modeled upon endogenously-occurring fatty acid signaling mediators, to treat diseases associated with kidney injury, inflammation, and metabolic disorders
  • Company #2426 - Replication proficient virus-like vesicle (VLV) platform technology for the development of vaccines to prevent/treat Hepatitis B virus (HBV) and other viral and bacterial diseases
  • Company #2425 - New solutions for the diagnosis and treatment of inflammatory bowel disease (IBD)
  • Company #2424 - New oral drug for treating Type 2 diabetes, with additional benefits of lower triglycerides and weight loss
  • Company #2423 - Systems and customized disposables to deliver intraperitoneal hyperthermia (IPH)
  • Company #2422 - Anastomotic devices for gastrointestinal surgery
  • Company #2421 - Unique medical imaging instruments that provide retinal, anterior, otoscopic, and dermatoscopic imaging with one hand-held device
  • Company #2420 - Absorbable implant made from highly purified collagen with a porous structure to treat acute and chronic meniscus injuries
  • Company #2419 - Suite of clinical applications for enhanced visualization and analysis using practical strain imaging to enhance, standardize, and streamline interpretation and reporting of echo studies, with initial applications in cardio oncology, stress echo, and right ventricle (RV)
  • Company #2418 - Next-generation drug-eluting stents and bioresorbable scaffold systems to optimize local drug delivery and provide a safe and effective treatment for cardiovascular disease
  • Company #2417 - Continuous, wearable, wireless monitoring to better diagnose cardiac arrhythmias such as atrial fibrillation (Afib)
  • Company #2416 - Neuromodulation devices and rehabilitative technologies that help improve lives and restore function for those living with central nervous system (CNS) disorders and peripheral pain
  • Company #2415 - Drug-eluting stents, bare metal stents, guiding and diagnostic catheters, PTCA and CTO balloon catheters and guidewires
  • Company #2414 - Orthopedic devices for the treatment of vertebral compression fractures (VCFs) caused predominately by osteoporosis, that differ from conventional balloon kyphoplasty in many ways
  • Company #2413 - Minimally invasive solutions for treating traumatic spinal pathologies
  • Company #2412 - Adaptive prosthetics that monitor, analyze, and react in real-time to changes in patient physiology, alignment, and gait
  • Company #2411 - 1-Gelatin-based topical absorbable hemostatic products for surgical use and 2-Miniature electromechanics used in devices for minimally invasive surgery and drug delivery
  • Company #2410 - Next-generation robotic exoskeletons that augment human strength, endurance, and mobility, for use in gait training and rehabilitation
  • Company #2409 - Synthetic DNA production for specialty chemical compounds and drug development
  • Company #2408 - 1-Allogeneic cardiac-derived cells (CDCs) aimed at attenuating and potentially improving heart damage resulting from heart failure (HF) and 2-Dual natriuretic peptide receptor agonist to prevent patients from an acute episode of HF following hospital discharge
  • Company #2407 - Cost-effective, rapid, and user-friendly detection of Glycosylated albumin (GA) and non-glycosylated Albumin, as markers of glycemic control for Type 2 diabetes
  • Company #2406 - Biological therapies for tendon, cartilage, and soft tissue repair and regeneration
  • Company #2405 - Four cell lines from which multiple therapeutic product candidates may be selected for development indications in the fields of neurology (including spinal cord injury), oncology (including autologous dendritric cells), orthopedics, and cardiovascular therapy
  • Company #2404 - High-resolution, protein-based retinal prosthesis for the restoration of vision and improvement in the quality of life for patients with retinal degenerative diseases
  • Company #2403 - Airway management and patient positioning devices for use during surgery
  • Company #2402 - Noninvasive skin closure systems intended as an alternative to sutures and staples; initial applications include OB/GYN, general surgery, spine surgery and pacemaker implantations
  • Company #2401 - Orthopedic products for reconstructive surgery of toes and surgical instruments for the implantation of orthopedic products
  • Company #2400 - Cerebral vascular protection systems for use during transcatheter aortic valve replacement (TAVR), other endovascular procedures and surgical aortic valve replacement
  • Company #2399 - Hand-held, single-operator, image-guided medical robotics vascular access platform for point-of-care central venous catheter placement
  • Company #2398 - Nanotechnology-enabled photothermal therapy for advanced skin cancer
  • Company #2397 - High-quality, modular prosthetic limb sockets that are cost-saving, comfortable, adjustable and accommodating
  • Company #2396 - Portable, non-invasive technology for the treatment of migraine
  • Company #2395 - Non-invasive thoracic fluid status monitor that provides actionable and accurate data for guiding the management and treatment of several chronic medical conditions
  • Company #2394 - Fibrin-based hemostatic technology platform with a rapidly dissolvable and absorbable delivery mechanism that accelerates the clotting cascade by adding robust clot-forming proteins to an injury site, stopping bleeding faster and potentially saving lives
  • Company #2393 - Implantable drug-device combination therapy for gliomas, one of the most lethal forms of brain cancer.
  • Company #2392 - Technology platform for enhanced remote disease management of patients with active implanted medical devices, that leverages wireless technology and a proprietary set of implantable sensors
  • Company #2391 - Diagnostic test for detecting autoimmune and inflammatory disorders such as lupus and for diagnosing strokes, brain injury or other trauma, using a single drop of blood
  • Company #2390 -
  • Company #2389 - Office-based device and nonsurgical procedure to improve nasal breathing, reduce snoring, and replace invasive surgery
  • Company #2388 - Device technology for the treatment of sudden cardiac death
  • Company #2387 - Less invasive approach to achieving endovascular femoral artery bypass (EFAB) that is designed to match the performance and safety of an invasive surgery for long segment occlusions
  • Company #2386 - Blood-based diagnostic tests for different types of cancer, including colorectal
  • Company #2385 - Person-centered medical devices, including a deep pressure therapy vest, for individuals with autism, ADHD, and anxiety-based disorders
  • Company #2384 - Nanotechnology-based medical devices in orthopedic, dental, cardiovascular, and other medical markets
  • Company #2383 - Intermittent cold compression device for athletic recovery, which uses using a proprietary sequential compression wrap and cold gel pack to direct edema away from the extremities and towards the heart, promoting venous return
  • Company #2382 - Saliva-based personal blood glucose monitoring technology for diabetes
  • Company #2381 - Ventricular assist device (VAD) technology
  • Company #2380 - Retinal implant system designed to help treat degenerative eye conditions such as retinitis pigmentosa and macular degeneration
  • Company #2379 - Wireless, wearable sensor technologies for assessing, monitoring and providing feedback on lower back movement, to improve pain and functional outcomes for back pain patients
  • Company #2378 - Cancer diagnostics and prognostics tissue analysis technology which analyzes whole slide digital images with multiplexed fluorescence, with an initial focus on Barrett's Esophagus and future applications in lung, colon, and breast cancer
  • Company #2377 - Minimally invasive implantable neurovascular devices for the treatment of brain aneurysms and stroke
  • Company #2376 - Biodegradable sealants and adhesives for use in surgery and wound closure, with a key focus on minimally invasive surgery
  • Company #2375 - Clinical genetic tests for hereditary disorders, including oncology (including BRCA1/BRCA2 for breast cancer), cardiology, neurology and pediatric medicine
  • Company #2374 - Fully automated, complex molecular diagnostics platform
  • Company #2373 - Small hearing aid device incorporating a smartphone app so that patients can personalize the device to their unique hearing profile and environment
  • Company #2372 - Production platform to generate unit doses of molecular imaging drugs for positron emission tomography (PET) at the point-of-use, in a way that is more convenient, versatile, and significantly less expensive than current methods available
  • Company #2371 - Revolutionary nanosensing technology that will deliver earlier disease diagnosis, improve therapy programs, and better manage and prevent chronic diseases
  • Company #2370 - Bio-artificial cartilage resurfacing product to treat osteoarthritis (OA), with several advantages over existing alternatives
  • Company #2369 - Non-invasive biophotonics-based system which consists of a primary multi-LED light device and a topical photo converter gel for use in dentistry, dermatology, and chronic wound treatment
  • Company #2368 - Next-generation RNA interference (RNAi)-based therapeutics to reach previously undruggable intracellular disease targets, including cancer
  • Company #2367 - Medical grade hydration powder as a safe and better-tasting alternative to conventional oral rehydration system (ORS) and pediatric formulas
  • Company #2366 - Line of fast-acting, over-the-counter (OTC) medications, formulated as a dissolvable powder, for on-demand relief from headaches, aches and pains, heartburn, allergies, and upset stomach
  • Company #2365 - Disease-modifying drugs for Alzheimer\'s disease (AD) and other neurodegenerative disorders
  • Company #2364 - Implantable, bio-degradable, collagen-based drug delivery system for the sustained-release of glaucoma medication
  • Company #2363 - Low-cost flow cytometer cell sorters that analyze and sort without damaging the cell
  • Company #2362 - Microshunt implant for primary open angle glaucoma
  • Company #2361 - Wrist-worn monitor that collects heart rate, skin, ambient temperature, movement tracking, and sleep data
  • Company #2360 - Highly accurate computer-based visual cognitive test to help physicians predict Alzheimer's disease three to six years before symptoms appear
  • Company #2359 - Optical imaging technology that permits rapid, detailed assessment of the vasculature for low-cost diagnostic purposes
  • Company #2358 - Non-invasive, non-imaging system that enables physicians to identify the onset of cardiovascular disease at the earliest stages of development by measuring endothelial dysfunction
  • Company #2357 - Implantable surgical reconstruction products to be used in general surgery applications
  • Company #2356 - Computer-assisted system for faster, more accurate, and simpler joint replacement surgery
  • Company #2355 - Device that provides heart failure (HF) patients with regular monitoring of fluid status within their home setting, thereby providing physicians with improved information with which to manage the disease
  • Company #2354 - Implantable system that delivers electrical pulses at night, during sleep, to restore a more normal breathing pattern and improve cardiovascular health in patients with Central Sleep Apnea (CSA)
  • Company #2353 - Ocular surface technology that speeds recovery and immediately returns significant functional vision to patients after LASIK or PRK
  • Company #2352 - Innovative neuromodulation systems designed to advance the rehabilitation and recovery of individuals suffering with paralysis
  • Company #2351 - The first patented, non-contact, non-invasive, continuous vital signs monitoring technology
  • Company #2350 - Innovative solutions for vascular interventions
  • Company #2349 - Thrombectomy device that can treat both coronary and peripheral arteries, with numerous advantages over currently available devices
  • Company #2348 - Small molecule drugs that combine the best aspects of both irreversible inhibition and reversible non-covalent target inhibition
  • Company #2347 - Orally stable peptides for diseases that are currently being addressed only by injectable biologics
  • Company #2346 - Regenerative amniotic tissue-based products for use in the ophthalmology, optometry, musculoskeletal, and wound care markets
  • Company #2345 - Proteomic platform that can accurately measure more than 1,100 proteins in a broad concentration range with minimal volume requirements
  • Company #2344 - Novel cell replacement therapies as potential long-term diabetes treatments to reduce the risk of hypoglycemia and diabetes-related complications
  • Company #2343 - Adeno-associated virus (AAV) gene therapy technology for the treatment of orphan muscle diseases
  • Company #2342 - An inflatable balloon retractor for use in laparoscopic procedures, to effectively and gently retract the abdominal organs such as the intestines during surgery
  • Company #2341 - Orthopedic healing and biologics technologies, including bone stimulation devices and osteoarthritis injection treatments
  • Company #2340 - A non-invasive sleep hypoglycemia alert system
  • Company #2339 - Cancer diagnostics and screening tests for prostate, breast and ovarian cancer
  • Company #2338 - The first continuous, noninvasive respiratory monitor for use in anesthesia/operating room, post-op recovery, procedural sedation and intensive care hospital settings
  • Company #2337 - Osmotically-driven, self-expanding device inserted at the ostium of the maxillary sinus, to restore functional sinus drainage and ventilation while minimizing patient discomfort in the treatment of chronic sinusitis
  • Company #2336 - An access wire system that enables quick access to challenging peripheral vascular anatomy, in carotid and renal interventions, interventional oncology and endovascular aneurysm repair
  • Company #2335 - Minimally invasive surgical retractor system for use in micro-endoscopic discectomies; incorporates fiber optic lighting, translucent retractor blades, full medial access, and an expandable field of view
  • Company #2334 - A minimally invasive rotator cuff implant intended to provide a new treatment option for patients with small tears and improve the treatment of patients with large tears
  • Company #2333 - A novel treatment for Dry Eye; extremely small device is placed adjacent to the lacrimal gland and stimulates endogenous tear secretion, thus providing symptomatic lubrication as well as protecting the cornea from erosion, punctate keratopathy, ulceration, neovascularization, and possible scarring
  • Company #2332 - Minimally invasive, catheter-based devices, with an initial focus on delivering an alternative to current ablation and drug therapies for atrial fibrillation (AF)
  • Company #2331 - Biocompatible products for bone and soft tissue regeneration, fulfilling needs in the orthopedic, spine and dental markets
  • Company #2330 - Scar-free laparoscopic surgery tools that enable surgery with extremely small incisions, leaving no visible scars and enabling assembly of complex tools inside the patient; requires minimal surgeon retraining
  • Company #2329 - Personalized health electronics technology; a smartphone-based monitor that analyzes, tracks and trends vital signs such as temperature, respiratory rate, oximetry, ECG, systolic blood pressure and diastolic blood pressure, in 10 seconds
  • Company #2328 - Non-invasive lung function imaging devices that allow clinicians to rapidly identify pulmonary-related issues across a broad patient population; the technology captures functional images of the lungs by analyzing chest wall movement, and translates this data into pulmonary function outputs
  • Company #2327 - Microscopy technology integrated in optoelectronic modules that attach to a research-grade optical microscope, for real-time 3D topography
  • Company #2326 - An off-the-shelf, cell-free hyaline cartilage regeneration product for use in repairing chondral and osteochondral defects in the weight-bearing joints such as the knee, hip, and shoulder; coral scaffold-based technology is implanted via a minimally invasive, single-step arthroscopic procedure
  • Company #2325 - Minimally invasive, blood-based diagnostics for the early detection and staging of Alzheimer\'s and Parkinson\'s diseases, via the detection of disease-specific autoantibodies; long-term goal is to develop a single protein microarray that can simultaneously screen for many diseases in one blood test that uses a single drop of blood
  • Company #2324 - A medical device for sternal protection during cardiac surgery; helps decrease bleeding from the divided sternum which results in increased morbidity and complication rates, and reduce trauma to and fractures of the sternum from the sternal retractor
  • Company #2323 - High-quality, biodegradable biomaterial products for use in tendon regeneration, soft tissue repair, spinal cord repair, neuroregeneration, and cardiovascular applications including stents; company also provides a design, development and fabrication service for customized biomaterial solutions for medical device, pharmaceutical and other manufacturers
  • Company #2322 - Personalized stem cell therapy using adipose-derived stem cells, as well as somatic cells (e.g., chondrocytes, fibroblasts); also researching the use of autologous growth factors for use in reconstructive medicine and tissue repair, including cartilage and skin regeneration, and bio-ophthalmics
  • Company #2321 - Non-invasive, intrauterine device for monitoring vital signs for fetuses of obese mothers, starting with fetal heart rate (FHR), using proprietary light-based technology; FHR is displayed on existing bedside equipment
  • Company #2320 - Diagnostic tests for lung, breast, prostate and colorectal cancer, among other illnesses, that help individuals monitor their health status and detect diseases early by measuring the body\'s unique response (its \"immunosignature\") to a given disease or disease state, rather than measuring the pathogen directly
  • Company #2319 - Handheld breast self-examination scanning device that utilizes very low-level light (photons) to create a digital map of the breast with GPS-like precision
  • Company #2318 - An autologous percutaneous arteriovenous fistula (AVF) creation device for hemodialysis access
  • Company #2317 - Biomaterials technology for use in tissue sealing and hemostasis
  • Company #2316 - Miniaturized robotic sealing and stapling technology
  • Company #2315 - Low cost, portable digital joint replacement surgical guidance instrument to calculate and display real-time measurements of implant position and alignment, with an initial focus on hip replacement
  • Company #2314 - System for the interventional treatment of vascular thrombus and emboli
  • Company #2313 - Radiofrequency balloon catheter system designed to treat atrial fibrillation
  • Company #2312 - Portfolio of drugs for the treatment of diabetes, hypertriglyceridemia, and dyslipidemia
  • Company #2311 - Heat-stable vaccines that can be shipped and stored without refrigeration
  • Company #2310 - New generation of broad spectrum anti-nausea, anti-vomiting, and anti-motion sickness drugs that are effective across multiple emetic stimuli, with reduced or no anxiety-related side effects
  • Company #2309 - Drugs for treating diseases with high unmet need, including orphan products
  • Company #2308 - Antibody-based cancer medicines
  • Company #2307 - Small, lightweight, and flexible self-adhesive strips that measure physiological parameters simultaneously and record the results or transmit them to tablets, computers, or wearable devices
  • Company #2306 - Intra-operative monitor for real-time blood perfusion assessment which addresses a critical need in the peripheral vascular disease (PVD) market
  • Company #2305 - Non-invasive, bioelectronics magnetic stimulation device for the treatment of neurological disorders, with advantages over existing treatment options, including lower cost and more precise stimulation
  • Company #2304 - Range of products and methods for minimally invasive endoscopic spinal surgery
  • Company #2303 - Full range of orthopedic immobilization and cast room products
  • Company #2302 - Real-time 3D volumetric imaging of the heart during aortic valve repair, mitral valve repair, and atrial fibrillation (AF) ablation
  • Company #2301 - Portable, full-body enclosure that uses elevated barometric pressure therapy for reducing pain, inflammation, and swelling from a number of disorders, with no known side effects and with many advantages over hyperbaric oxygen therapy (HBOT), including cost
  • Company #2300 - Improved fixation products for orthopedic surgery
  • Company #2299 - 1-Brachytherapy bone cement that accurately provides radiation therapy directly to the bone tumor site in a single procedure, while simultaneously restoring bone strength and 2-Bone-cutting device with retractable blades that is capable of passing through a cannula to access the inner vertebral body for void creation
  • Company #2298 - Hip, knee, and shoulder joint replacements made with advanced materials
  • Company #2297 - Handheld radio frequency (RF) reader that can detect markers embedded in the body, with applications in: pre-operative image-guided tumor localization and monitoring of endotracheal tube position
  • Company #2296 - Externally applied, non-invasive device that maintains an open airway in sedated or anesthetized patients without the need for airway instrumentation
  • Company #2295 - Next-generation device to treat mitral regurgitation without open-heart surgery and with the flexibility to adjust post-implantation
  • Company #2294 - 1-Smart implantable infusion pump that enables local drug delivery with the potential to avoid elimination by the liver, 2-Nano-biosensor for the early detection of tumor biomarker VEGF-165 as well as viable pathogenic bacteria (E. coli O157:H7), 3-Intelligent tool for use during brain surgery, 4-Implanted infusion device for stimulating bone growth during spinal fusion procedures, and 5-Drug-dispensing dental implant for use with many different medications to treat a wide variety of conditions
  • Company #2293 - Marker with a pre-inked tip that places highly accurate marks on the cornea for Premium Toric intraocular lens (IOL) cataract surgery
  • Company #2292 - 3D image-based surgical guides that make guided surgery technically and economically feasible for all dental implant surgeons
  • Company #2291 - Cost-effective, high-resolution, positron emission tomography (PET) scanner to detect tumors of small size, with higher resolution (1-2 mm) and higher sensitivity (x10) than features currently unmet by the market
  • Company #2290 - Intravenous sensor specifically for tight glycemic control (TGC) in the critical care market
  • Company #2289 - Nano sensor device for ultra-fast low-cost genome sequencing, with applications in: point-of-care diagnostics, predictive diagnostics, personalized diagnostics, and prognostics
  • Company #2288 - Off-the-shelf treatments based on tissue engineering and progenitor cell science to treat patients suffering from intervertebral disc diseases
  • Company #2287 - Multiple small molecules that are osteoinductive for musculoskeletal tissue regeneration
  • Company #2286 - Genetic tests and tools to help people make better treatment and lifestyle choices
  • Company #2285 - Drugs with a regenerative mechanism of action to restore neurological function and improve quality of life for patients with spinal cord injury and neurotrauma
  • Company #2284 - Drugs to treat chronic inflammatory diseases by blocking the cycle of injury and response
  • Company #2283 - Medical device that increases the concentration of cancer cells in urine samples, so that deadly bladder cancer may be detected earlier; is a belt-shaped device that is placed over a patient\'s abdomen and controlled, low-energy, painless vibrational energy is applied directed towards the bladder
  • Company #2282 - Patented \"Digestible Balloon\" technology for the treatment of obesity; produced from food grade materials, the capsules are easily ingestible and self-inflate within the acidic environment of the stomach, and will not pass beyond the stomach for several weeks; preclinical technology promises the simplicity of pharmaceutical dosage with the weight loss profile of bariatric techniques
  • Company #2281 - Patient-friendly, precisely controllable medical solutions for the treatment of skeletal deformities, including for the complication-prone, uncomfortable limb-lengthening procedure
  • Company #2280 - Solution for targeted delivery of fluids, including radiopaque material and therapeutic agents, to selected sites in the peripheral vascular system at high concentration to specific visceral organs - safely and without perfusion overlap to other organs; targets include pancreatic cancer
  • Company #2279 - Non-invasive prenatal diagnostics to diagnose fetomaternal hemorrhage (FMH), a devastating and poorly understood pregnancy complication, and to bring time-intensive tests from the lab bench to the patients\' bedside
  • Company #2278 - Cost-effective, high-resolution, positron emission tomography (PET) scanner technology for breast cancer detection; other medical applications for the technology include tumor early detection, improved clinical molecular diagnosis, disease progression and drug efficiency
  • Company #2277 - A catheter used to remove stroke-related intracerebral hemorrhage blood clots in the brain in minutes and improve patient outcomes, that is compatible with familiar neuronavigation imaging equipment; the tip includes an ultrasound proximity sensor to help surgeons avoid healthy brain tissue
  • Company #2276 - Blood collection device that is indicated to reduce the frequency and unnecessary expense of blood culture contamination when collecting blood specimens, and the added costs of false-positive tests
  • Company #2275 - Advanced body-worn digital healthcare information devices for cardiology, respiratory and other complex disease states
  • Company #2274 - Electro-mechanical intracranial pressure shunt platform that greatly advances the control of cerebrospinal fluid (or lumbar) drainage due to acute hydrocephalus, traumatic brain injury, tumors and infections, while minimizing the most frequent mechanical causes of device failure
  • Company #2273 - Portable, self-contained strep throat screening technology that tests patients in 30 seconds, in any setting and for less than a third of the cost of a doctor\'s appointment; future applications may include testing for influenza, chlamydia, gonorrhea, HIV, and other infections
  • Company #2272 - Minimally invasive, leadless implantable cardioverter defibrillator (ICD) technology designed with pediatric patients in mind; employs two shock plates implanted on the front pectoral muscle on the right side of the chest and the rib area on the left side of the chest which are connected externally to a battery and generator, with GPS and Bluetooth capabilities
  • Company #2271 - Information technology to enable hospitals to share underutilized non-emergency medical equipment and instrumentation between locations within a multi-hospital network
  • Company #2270 - Non-invasive intracranial pressure monitor for use in neurosurgery, neurology, emergency medicine, and critical care; first product is an earbuds-like disposable unit that is placed in the patient\'s ears - the device generates an acoustic signal that is circulated through the head and then is picked up in the other ear using an acoustic sensor - data generated from the signal can then be analyzed in real-time from a tablet or smartphone
  • Company #2269 - Early pregnancy predictive blood test given at 15 weeks for pre-eclampsia, a disease of late pregnancy characterized by the concomitant occurrence of hypertension and proteinuria, leading to restricted blood supply to the fetus
  • Company #2268 - Optical coherence tomography (OCT) technology to provide breast surgeons and pathologists with near real-time imaging of a cancer tumor for assessment of tumor margins during breast-conserving lumpectomies
  • Company #2267 - An implantable intraocular lens (IOL) to treat presbyopia and restore youthful vision to anyone over the age of 45 without spectacles, contact lenses and LASIK; procedure is exactly like modern cataract surgery and requires no new surgical skills
  • Company #2266 - Post-operative oncology pathology platform using state-of-the-art gel-based biomaterials to stabilize and encapsulate tissue; for uniform tissue sectioning; for rapid formalin fixation; and to preserve specimens without damaging tissue structure
  • Company #2265 - Cryoablation technology that is capable of treating hypertension by denervation of the renal artery; is superior to heat technologies due to its clinical safety, ease of use and lower cost
  • Company #2264 - A miniaturized, point-of-care (POC) diagnostics platform; initial test panels target the chronic disease management market including diabetes, heart disease, thyroid function and chronic kidney disease, with a finger prick of a patient\'s blood, and clinical results within minutes
  • Company #2263 - A device for greatly reducing the pain of both lancet and insulin injection procedures in daily diabetes management; can be used for initiation of intravenous lines, blood draws and intramuscular injections for vaccines
  • Company #2262 - Ultrasound guidance of neurosurgery catheter placement, using a small ultrasound transducer placed on the distal end of a catheter coupled with a display and microprocessor built into an ergonomic handle; enables surgeons to place a ventricular catheter into a patient\'s brain with dramatically increased precision
  • Company #2261 - An intuitive system which will enable surgeons to harvest autologous bone graft (autograft) utilizing a minimally invasive approach
  • Company #2260 - Automated lumbar drainage system for cranial and spinal surgery
  • Company #2259 - Rapid and label-free chip-based biological assay platform for measuring clinical and point-of-care (POC) samples within minutes, ranging from allergy testing to cancer diagnostics; technology is fully arrayable, potentially allowing hundreds of tests to be run simultaneously on a single chip
  • Company #2258 - Product lines include: 1-Orthopedic implant technology, including demineralized bone matrix, sponge, allograft, and calcium phosphate products to help stimulate bone regrowth; 2-An adult stem cell line targeting patients with spinal cord injuries, orthopedic injuries and traumatic wounds; and 3-An electrically conductive surface for polymer implants traditionally used in spinal surgery
  • Company #2257 - Catheter technology platform designed to combine lung imaging - using the world's smallest surgical camera - physiologic metrics, in vivo diagnostics, recannulation and in vivo drug delivery into a micro invasive surgical solution for lung cancer and other pulmonary diseases such as asthma
  • Company #2256 - Sterile, single-dose, injectable medications in prefilled, vacuum-triggered, one-handed, single-use, auto-retractable and auto-disabled syringes; designed to improve patient and caregiver safety while reducing risk and liability in the healthcare setting
  • Company #2255 - A synthetic class of diagnostic and therapeutic agents with antibody-like properties, called protein-catalyzed capture agents (PCCs), which offer the promise of improved selectivity, superior binding affinity, fully synthetic composition and low molecular weight compared to monoclonal antibodies, the current standard for identifying biomarkers in most diagnostics platforms - and in many therapeutic uses
  • Company #2254 - Vascular occlusion and embolization devices
  • Company #2253 - In vitro blood stem cell toxicity testing
  • Company #2252 - Platform technology that has the power to detect and stage a range of diseases or medical conditions from a simple blood sample, enabling early diagnosis and personalized health management
  • Company #2251 - Third-generation biological drugs built upon the concept of \"signal converter proteins\" (SCPs) - a unique class of multi-functional therapeutic agents that are capable of converting signals sent from one cell to another
  • Company #2250 - 1-A non-denaturing process for the controlled release of therapeutic proteins and 2-Lipid nanocapsules for targeted and controlled delivery of poorly water-soluble drugs
  • Company #2249 - Broad pipeline of seven unique humanized monoclonal antibody programs spanning indications including: cancer, inflammatory disease, bone diseases, and ophthalmology
  • Company #2248 - Pipeline of products based on a validated platform of allogeneic expanded adipose-derived stem cells (eASCs) targeting autoimmune and inflammatory diseases
  • Company #2247 - Selective translation regulators for the treatment of cancer and other serious diseases
  • Company #2246 - Next-generation DNA synthesis technology that allows for the high-throughput, automated production of DNA constructs at lower cost and higher accuracy than previous methods on the market
  • Company #2245 - New approach to combination chemotherapy, based on synergistic drug ratios
  • Company #2244 - Inhaled antibiotics to treat serious, hospital-acquired respiratory infections with highly antibiotic-resistant organisms
  • Company #2243 - Engineered autologous T cell therapy (eACT), designed to restore a patient\'s immune system by recognizing and eradicating tumors
  • Company #2242 - Pipeline of therapeutics for rare autoimmune diseases from a new class of proteins (Physiocrines) that act as extracellular signaling molecules to orchestrate cellular homeostasis in response to stress
  • Company #2241 - Miniature, temperature-insensitive alternative to the EpiPen(R) for food and sting allergies
  • Company #2240 - 1-Small, non-invasive plastic insert worn under the eyelid and capable of delivering drugs 24/7 for months at a time and 2-Controlled ophthalmic antibiotic delivery via a hydrogel polymer contact lens device based on nanosphere technology
  • Company #2239 - Fully biodegradable drug-eluting stents (DES) aimed at solving existing problems of in-stent restenosis and late-stage thrombosis
  • Company #2238 - Patient-friendly, self-contained, compact, and wireless system which is worn around the chest or abdomen, as an alternative or adjunct treatment for Obstructive Sleep Apnea (OSA)
  • Company #2237 - Very unique, manually operated device to help patients more easily and effectively regain their range of motion, muscle tone, limb stability, and balance following: knee replacement surgery, ACL reconstruction, ligament /tendon repairs, arthroscopy surgery, meniscus repair, or joint manipulation
  • Company #2236 - The only portable, passive stretching device that uses generated muscular force to accurately measure passive tension and stress relaxation, in order to provide diagnostic information about muscles
  • Company #2235 - Tissue suturing device with safety shield to ensure that the user is protected from the needle at all times
  • Company #2234 - Manually expandable pessaries suitable for frequent/daily removal and reinsertion by the patient without the need for a doctor\'s visit, to treat pelvic organ prolapse (POP)
  • Company #2233 - 1-Tissue-adhesive and active agent delivery technology that is unlike other muco adhesives due to its strong and long-lasting adherence properties and 2-Tetracycline fiber for the treatment of periodontal disease
  • Company #2232 - Next-generation bioabsorbable cardiac stent, made with a unique nanoceramic coating, that is not thrombolytic, resists cellular adhesion, and improves patient safety
  • Company #2231 - Disposable miniature pressure sensor that is half the inside diameter of standard angioplasty guidewires, allowing it to be inserted into the guidewire, to provide high fidelity blood pressure measurements in the cath lab
  • Company #2230 - Disposable procedure glove with an embedded sensor to improve the diagnosis of prostate cancer by enabling the use of PSA density as a marker
  • Company #2229 - Next-generation light delivery solutions that enhance photodynamic therapy (PDT) treatment efficacy, patient experience, and physician ease-of-use, for the treatment of oral cancers, non-melanoma skin cancer (NMSC), and other dermatological conditions
  • Company #2228 - Safe and effective device with antimicrobial properties that can be inserted into the urethra in minutes at any doctor\'s office, to reduce or eliminate leakage for the treatment of stress urinary incontinence (SUI)
  • Company #2227 - Minimally invasive products that will transform catheter ablation into a first-line treatment for patients with atrial fibrillation (AF)
  • Company #2226 - Wireless at-home patient monitoring system that does not require patients to own a PC or enter data, yet provides health care professionals with easy access to activity/vital signs in real time
  • Company #2225 - Minimally invasive implant that will address the challenge of obtaining and maintaining secure bone fixation
  • Company #2224 - Ergonomic scalpel handle design to give surgeons greater control and precision without forcing the hand into awkward or uncomfortable positions
  • Company #2223 - Neuromodulation system for the treatment of acute heart failure syndrome
  • Company #2222 - Three-dimensional (3D) cell culture products that mimic the human cellular environment, for drug discovery research and testing, with the potential to replace or reduce the use of animals in pharmaceutical testing
  • Company #2221 - Unique, optimized, high-throughput pharmacology platform that is able to systematically identify new indications for small molecule therapeutics
  • Company #2220 - Non-invasive solutions to dramatically improve in vitro fertilization (IVF) outcomes
  • Company #2219 - Oral testosterone (T) replacement product
  • Company #2218 - Therapies to reverse protein energy wasting in end-stage renal disease
  • Company #2217 - Therapies for patients with chronic diseases in nephrology and oncology
  • Company #2216 - Technologies that reformulate adult pharmaceuticals for the pediatric market
  • Company #2215 - New drug for treating adrenal cancer
  • Company #2214 - Immunotherapeutic agents for the treatment of cancer, viral infections, and inflammatory and autoimmune diseases
  • Company #2213 - Implantable technology for direct delivery of therapeutic compounds to the site of brain injury
  • Company #2212 - Dry powder formulations for various therapeutic molecules, including: antibiotics, corticosteroids, nucleic acids, and insoluble and soluble molecules
  • Company #2211 - Small, cell-permeable RNAi pro-drugs that can enter many different cell types and deliver on the promise of RNAi therapeutics for a wide range of diseases
  • Company #2210 - Technology designed to provide real-time, high-resolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer
  • Company #2209 - Selective and programmable nanomedicines to maximize active pharmaceutical ingredient concentrations in diseased tissues
  • Company #2208 - Ganaxolone, a neurosteroid to treat children and adults suffering from refractory epilepsy, post-traumatic stress disorder (PTSD), and fragile-X syndrome
  • Company #2207 - Pipeline of antibody agents directed to costimulatory targets for the treatment of cancer
  • Company #2206 - 1-Proprietary delayed-release formulation of the most prescribed diabetes medicine in the world, Metformin and 2-Over-the-counter (OTC) products for weight loss and pre-diabetes
  • Company #2205 - Proprietary recombinant polypeptide that, when genetically fused to a therapeutic payload of interest, extends the half-life of proteins and peptides in a tunable manner
  • Company #2204 - New business model for the clinical development and registration of pharmaceutical products, to accelerate the availability of new and innovative drugs into the world\'s major markets
  • Company #2203 - Small molecule therapeutics to treat multi-drug resistant bacterial infections
  • Company #2202 - Oral histone deacetylase (HDAC) inhibitor that inhibits cancer-relevant HDAC enzymes, which contribute to epigenetic alterations driving cancer growth and drug tolerance
  • Company #2201 - Implantable meniscus replacement and regeneration device
  • Company #2200 - Microprocessor-based, disposable intravenous (IV) injection port for automated recordkeeping in the perioperative period and the subsequent retrieval and analysis of that data to improve patient safety
  • Company #2199 - 1-Easy-to-use, wrist-worn activity monitor that records all movement, not just steps and 2-A social and rewarding group activity program to track daily movement against a group goal
  • Company #2198 - Intrauterine device (IUD) inserter that vastly simplifies the insertion procedure, while significantly reducing the complications inherent with current insertion techniques for female contraceptives; especially for use in the developing world
  • Company #2197 - 1-Electro-optic technologies and analytic methods that rapidly detect and quantify bacteria in fluids in real-time, and 2-A family of instruments that provide screening for urinary tract infections (UTIs)
  • Company #2196 - Camera-enabled needle technology to fundamentally improve orthopedic diagnostics and therapeutics by enabling instant and accurate office-based procedures
  • Company #2195 - Devices for the treatment of female infertility caused by fallopian tube dysfunction
  • Company #2194 - Radiofrequency ablation device for treating overactive bladder in women
  • Company #2193 - Implants for unmet needs in the treatment of mitral valve disease, with applications in percutaneous catheter-based intervention and minimally invasive or open-heart cardiac surgery
  • Company #2192 - Minimally invasive catheter-based system that allows physicians to create an arterio-venous fistula to deliver hemodialysis to patients suffering from kidney failure
  • Company #2191 - Cryogen-based Global Endometrial Ablation (GEA) technology to quickly and safely achieve tissue ablating temperatures in a single-use, self-contained, hand-held device
  • Company #2190 - Non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses
  • Company #2189 - Non-invasive oximeter for the quantitative measurement of cerebral tissue oxygen levels to enable clinicians to identify and quickly react to dangerously low brain oxygen levels, as well as monitor the oxygenation of other tissues, such as muscle and abdominal tissues in newborns
  • Company #2188 - Minimally invasive, regenerative implant technologies for the spine
  • Company #2187 - Synthetic cartilage implant designed to replace or repair worn or damaged cartilage
  • Company #2186 - A humanized monoclonal antibody with a unique mechanism of action, which is being developed for the treatment of Inflammatory Bowel Disease (IBD), Rheumatoid Arthritis (RA), and other autoimmune diseases
  • Company #2185 - An advanced, continuous, automatic, and real-time breath-testing platform that enables the detection of the Helicobacter pylori bacteria, assessment of liver function across a range of clinical conditions, and gastric emptying
  • Company #2184 - A line of innovative consumer-oriented ear products based on a drug delivery system that addresses the inherent limitations of ear drops
  • Company #2183 - Proprietary technology for the oral delivery of drugs presently administered by way of injection
  • Company #2182 - 1-Diagnostic assays for the practical delivery of personalized medicine and 2-Companion diagnostics (CDx)
  • Company #2181 - Non-invasive "liquid biopsy" approaches for cancer screening, diagnosis, staging, personalized medicine and treatment monitoring
  • Company #2180 - Computer-based systems that provide a quick, accurate, non-invasive, and low-cost method for the early detection of Alzheimer\'s Disease (AD) and for precise measurement of disease progression
  • Company #2179 - Platform technology that enables local, targeted delivery of botulinum toxin (Botox) and other potent macromolecules across the skin without patches, needles or other invasive procedures
  • Company #2178 - Biologic medicines primarily for the treatment of oncology and inflammatory diseases
  • Company #2177 - First-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors
  • Company #2176 - Drug design strategies delivered via unique dermal product solutions to treat neurological and a variety of other disorders
  • Company #2175 - Ambient Assisted Living System (AALS) that monitors a senior\'s daily activity by observing usage of any 3 electrical appliances, such as: a microwave, television, or lamp
  • Company #2174 - Fractional flow reserve (FFR) guidewire that provides an easier, more effective, and more affordable way to obtain FFR measurements during coronary catheterization procedures
  • Company #2173 - Dental and orthopedic implant products
  • Company #2172 - Devices for diagnosing and treating swallowing disorders
  • Company #2171 - External tissue expansion devices for the wound care market
  • Company #2170 - Personal hygiene product for the discreet protection of accidental bowel leakage
  • Company #2169 - Technology for the minimally invasive treatment of tricuspid and mitral regurgitation
  • Company #2168 - Home-use devices incorporating a proprietary platform technology for the treatment of obstructive sleep apnea (OSA) and other sleep-related disorders
  • Company #2167 - Minimally invasive device-based therapy for treating Type 2 diabetes
  • Company #2166 - A bioresorbable scaffold for treating peripheral artery disease (PAD) in the superficial femoral artery (SFA)
  • Company #2165 - Minimally invasive treatment for nasal valve collapse
  • Company #2164 - Non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology and rheumatology
  • Company #2163 - Anti-bacterial barrier technology to reduce recurrent urinary tract infections (UTIs) in women
  • Company #2162 - Pulmonary vein implants for treating atrial fibrillation (AF)
  • Company #2161 - Passive, wireless, microsize stimulator platform for neurophysiology treatment therapies
  • Company #2160 - A temporary wound closure device to control severe bleeding within seconds of application at the point-of-injury
  • Company #2159 - Quality spine products for treating serious orthopedic medical conditions in a cost-effective manner
  • Company #2158 - Minimally invasive energy-based treatment approach (electroporation) that causes tumor tissue to become up to 1000-fold more porous and capable of absorbing certain chemotherapy drugs without damaging healthy tissues
  • Company #2157 - Neurostimulation technology for the treatment of chronic respiratory insufficiency from: 1-spinal cord injuries, 2-muscular dystrophies (such as Amyotrophic Lateral Sclerosis, ALS, Lou Gehrig\'s Disease); also for use in a short-term intensive care setting
  • Company #2156 - A suite of products to meet the range of challenges of ischemic stroke, including: 1-a next-generation device that addresses a major limitation of stent-based clot retrieval and 2-a unique, single-lumen catheter designed to enhance the introduction and removal of interventional devices
  • Company #2155 - A pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation (AF) in patients with heart failure and reduced left ventricular ejection fraction (HFREF)
  • Company #2154 - Pipeline of novel, targeted biologics and targeted small molecules for oncology, with initial discoveries based on the modulation of apoptotic pathways
  • Company #2153 - Sales and service for a wide array of diagnostic cameras designed to match the needs of the eye-care industry, including: fundus imagers, confocal microscopes, microperimeters, ultrasound scanners, and corneal topographers
  • Company #2152 - IW001 is targeted to idiopathic pulmonary fibrosis (IPF) patients who have autoimmunity against collagen V (40% of all 200,000 IPF patients). IW001 modulates the anti-collagen V immune response and is Phase 2 ready.
  • Company #2151 - Unique and proprietary iron cobalt magnetic nanoparticles that have significant advantages over and directly replace magnetic iron oxide NP currently consumed by globally installed and new in vitro diagnostic systems
  • Company #2150 - Non-invasive treatment to correct presbyopia; patients use personalized contact lenses and eye drops for only five days to be lens free for up to 12 months
  • Company #2149 - Disruptive platform with wide applicability across numerous types of cancers: 1-first-generation system that utilizes electromagnetic irradiation to induce regional hyperthermia and 2-second-generation system that utilizes magnetic nanoparticles in conjunction with the first-generation system to deliver superior treatment
  • Company #2148 - Pipeline of advanced yet affordable systems for blood diagnostics: 1-a benchtop system for hospitals/clinics to screen blood for various parameters, 2-a handheld system to be used at home for patients who are on blood thinning therapy, and 3-a handheld system for multiplexed clinical diagnostics
  • Company #2147 - Devices based on proprietary shape memory polymer (SMP) materials, with an initial application in the cerebral aneurysm market
  • Company #2146 - Superficial radiotherapy (SRT) device that safely and cost-effectively treats non-melanoma skin cancers and keloids in hospitals and private practice settings
  • Company #2145 - Sensor to non-invasively and continuously assess patient metabolic status with the goal of bringing ICU level monitoring capability to patients in the emergency department and outside the hospital
  • Company #2144 - Modular intraocular lens (IOL) to optimize vision in cataract surgery
  • Company #2143 - Wireless portable EEG and other stimulation devices used in monitoring and enhancing brain health
  • Company #2142 - Laparoscopic abdominal port closure device that will bring significant ease of use and cost benefits to the surgeon and enable the surgeon to impart beneficial clinical outcomes to their patients
  • Company #2141 - All-in-one blood glucose system containing: the meter, 25 strips, and a lancing device in an integrated, stylish design and the size of a mobile phone
  • Company #2140 - Non-invasive at-home treatment for stress, urge, and mixed female urinary incontinence (UI)
  • Company #2139 - System to reverse coronary atherosclerosis by transforming a patient\'s own plasma into an atherosclerotic reversal agent
  • Company #2138 - New class of active hemostat to replace thrombin in a range of device formulations for the control of surgical bleeding
  • Company #2137 - Broad-spectrum extracorporeal device that can remove bacteria, bacterial toxins, parasites, viruses, and pro-inflammatory mediators from a patient\'s blood directly, quickly, and simultaneously
  • Company #2136 - Low-cost in vitro antibiotic sensitivity test for use at the point-of-care and designed to deliver results in less than an hour, allowing the correct antibiotic to be prescribed in one hour versus waiting one to four days for lab culture testing results
  • Company #2135 - Revolutionary technology to assess core brain activity using a non-invasive sensor that detects micro-movements of the human eye
  • Company #2134 - Table top blood analyzer that will allow hospital blood bank directors to learn the quality of blood in storage, which is currently unknown
  • Company #2133 - A broad portfolio of injectable drug delivery systems which are designed for pharmaceutical manufacturers to fill with their injectable drugs and vaccines
  • Company #2132 - Platform that identifies the master switches for disease genes, opening a whole new approach to novel therapeutics for cancer and other diseases
  • Company #2131 - Blood-based test to enable the earlier diagnosis of Autism Spectrum Disorders (ASDs)
  • Company #2130 - Convenient two-component subcutaneous drug delivery system suitable for patient self-administration
  • Company #2129 - Unique bioactive and coating-free coronary stent as an alternative to drug-eluting stents (DES) with the potential to increase patient safety while allowing a significant reduction in Dual Anti-Platelet Treatment (DAPT) time
  • Company #2128 - 1-Point-of-care platform and a pipeline of novel diagnostic tests, including those for prostate cancer, total PSA, Vitamin D, and Alzheimer\'s disease, 2-Drugs to treat a wide variety of conditions, and 3-Dry powder inhaler product platform for use in treating respiratory diseases
  • Company #2127 - 1-New, non-invasive diagnostic system to detect early-stage Alzheimer\'s Disease (AD) and 2-Drugs for AD and Fragile X Syndrome
  • Company #2126 - Cell-based technologies for treating a range of major clinical diseases including inflammatory and immunologic conditions, diabetes and its complications, orthopedic spine conditions, cardiovascular disorders, bone marrow transplantation, and eye diseases
  • Company #2125 - Image-guided therapy systems which deliver detailed visual information to clinicians during the course of various traditional surgical procedures, including neurological, cardiovascular, cerebrovascular, interventional, and spine
  • Company #2124 - Bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea
  • Company #2123 - Sample-to-result technology and products that provide multiple-pathogen diagnoses of infectious diseases
  • Company #2122 - An ultrasound device for the non-invasive treatment for refractory glaucoma
  • Company #2121 - Devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders
  • Company #2120 - Biomarker test kit for rheumatoid arthritis (RA) treatment
  • Company #2119 - Novel surfactant therapies, as well as effective and efficient modes of delivery, to advance a new standard in respiratory critical care
  • Company #2118 - A high-intensity, non-focused therapeutic ultrasound catheter system for remote tissue ablation for the treatment of hypertension by renal denervation (RDN)
  • Company #2117 - Broadly applicable molecular diagnostics and immunodiagnostics solutions (instruments, analytical techniques, chemistries, sample preparation and other innovative tools) with high-value clinical assay menus
  • Company #2116 - A new standard-of-care in cancer surgery providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients
  • Company #2115 - A rapid, user-friendly, real-time, and cost-effective technology platform that provides for accurate intraoperative placement of hip & knee implants and is compatible with all currently marketed implants
  • Company #2114 - A selective-heating technology to combine the clinical benefits of heat (hyperthermia) and chemotherapy for more effective, safer, and less expensive cancer treatments
  • Company #2113 - Class of antibody-derived therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases including inflammation, hematology, oncology, and pulmonary disease
  • Company #2112 - Personal genome service that enables users to: search and explore genes contributing to their personal characteristics, such as lactose intolerance, athletic ability, and food preferences; learn how the research studies relate to their genomes; compare their profiles to family and friends; and discover their genetic roots
  • Company #2111 - Technology enables the gentle and selective extraction of excess mesenteric visceral fat, which has been associated with insulin resistance
  • Company #2110 - Neural-like cells derived from bone marrow for autologous brain transplantation in patients with highly debilitating neurodegenerative diseases, such as Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease and Multiple Sclerosis
  • Company #2109 - Human cell-based therapies for the treatment of retinal and neural degenerative diseases such as macular degeneration, Parkinson\'s Disease (PD), and Multiple Sclerosis (MS)
  • Company #2108 - 1-Line of proprietary drugs that are approved by the Ministry of Health of Russian Federation and 2-Contract manufacturing of generic antibiotics and specialty pharmaceuticals
  • Company #2107 - Next-generation bio-regenerative implant coatings for orthopedic and dental applications
  • Company #2106 - Catheter-based system for the minimally invasive replacement of the aortic valve for the treatment of Congestive Heart Failure (CHF)
  • Company #2105 - A nitinol mesh sleeve that, when placed over a saphenous vein graft during coronary artery bypass grafting (CABG) surgery, is designed to improve the structural characteristics and long-term performance of the vein graft
  • Company #2104 - A suite of accessory devices to address the clinical needs of emerging interventional cardiology procedures, such as transcathether aortic valve replacement (TAVR)
  • Company #2103 - MR-guided, noninvasive focused ultrasound therapy for the use in an expanding number of neurosurgery, oncology, gynecology and other indications
  • Company #2102 - A unique disposable Peristaltic Feeding Tube (PFT) that is monitored and controlled 24/7 by a bedside Control & Monitoring Unit (CMU), capable of preventing reflux, and expected to significantly lower the occurrence of VAP (Ventilator Associated Pneumonia) in ventilated patients
  • Company #2101 - Stenting solutions for coronary and vascular systems, bifurcation stenting, and biliary stenting
  • Company #2100 - Drugs utilizing a proprietary platform based on the atomic interaction network analyses of proteins to prevent and treat infectious and other major diseases
  • Company #2099 - Compounds for the treatment of amyotrophic lateral sclerosis (ALS), Huntington\'s disease (HD), epilepsy, and neuropathic pain
  • Company #2098 - New classes of cancer drugs that have unique modes of action
  • Company #2097 - 1-Non-invasive molecular diagnostic assay to diagnose color blindness far more accurately and thoroughly than existing tests and 2-Gene therapy to treat color blindness
  • Company #2096 - Bioabsorbable vascular closure technologies for large diameter interventional procedures
  • Company #2095 - Range of high-quality calibrators, proficiency sera, and liquid stable quality controls for the clinical diagnostics market
  • Company #2094 - Pedicle-screw-based posterior elastic stabilization system that is intended to work like a damper, absorbing shocks, unloading the disc and facet joints
  • Company #2093 - 1-Femtosecond laser-based workstation for ophthalmic surgery on the crystalline lens, such as cataract surgery; 2-A patented presbyopia reversal procedure; and 3-Products for tissue and cell handling in pharma, biotech, and research
  • Company #2092 - New modality for the management of COPD symptoms using an innovative and proprietary pressure pulses protocol carried into the lungs over a low-pressure airstream
  • Company #2091 - Non-invasive neurostimulation platform for specific medical indications, beginning with nicotine and narcotic addictions
  • Company #2090 - Non-invasive Transcutaneous Electrical Nerve Stimulator (TENS) device indicated for symptomatic relief and management of chronic, intractable pain, and adjunctive treatment in the management of post-surgical and post-traumatic pain
  • Company #2089 - Next-generation surface treatments for dental and orthopedic implants
  • Company #2088 - Compact, microchip-based optical coherence tomography (OCT) system that can produce dynamic, real-time, high-resolution diagnostic images for physicians to perform a non-invasive optical "digital biopsy" of tissues
  • Company #2087 - Device that determines real-time and exact liver function measurement at the patient\'s bedside via simple breath analysis
  • Company #2086 - Disruptive implants that allow a natural spine balance after surgery through a dynamic fusion philosophy with the goal of improving the functional outcome and avoiding adjacent level degeneration
  • Company #2085 - System that combines the best of low-dose X-rays and automated ultrasound to enhance a clinician\'s ability to detect breast cancer
  • Company #2084 - Next-generation \"mini\" ventricular assist device (VAD) with a fundamentally different layout to minimize blood damage and the risk of thrombus formation, at a significantly reduced cost per pump
  • Company #2083 - Novel access stabilization and closure device to facilitate the transapical delivery of prosthetic heart valves, left ventricular assist devices (LVADs), and other large therapeutic devices
  • Company #2082 - Arterial puncture closure device that achieves closure by applying a biocompatible implant to both the inside and the outside of the puncture site in the femoral artery at the level of the arterial wall
  • Company #2081 - Female sterilization device that can be implanted hysteroscopically in a gynecologist\'s office and provide immediate closure of the fallopian tubes, with no need for continued use of other contraceptives nor any confirmatory procedures at a follow-up visit
  • Company #2080 - Next-generation implantable electrodes for Deep Brain Stimulation (DBS) in major neurological indications such as Parkinson\'s disease (PD) and depression
  • Company #2079 - Next-generation, ultra-fast, and easy-to-use DNA testing device capable of \"real-time\" Polymerase Chain Reaction (PCR)
  • Company #2078 - Platform that utilizes a blood-based proteomic assessment of disease-specific exosomes or microvesicles for a variety of prenatal and oncology conditions
  • Company #2077 - New, \"purification free\" approach to Human Leukocyte Antigen (HLA) typing that enables faster, easier-to-use, and significantly less costly genetic testing products
  • Company #2076 - The only technology that has the sensitivity to detect every gene in the human transcriptome in situ and simultaneously quantify multiple mRNA transcripts at a single cell level
  • Company #2075 - In vitro diagnostics platform for medically important gene signatures, including a new application for intrinsic subtyping of breast cancer
  • Company #2074 - Entirely disposable, battery-powered sample preparation devices that efficiently lyse any cell type and simultaneously extract DNA or RNA
  • Company #2073 - Novel protein drug for the treatment of Graves\' Orbitopathy (GO)
  • Company #2072 - MicroRNA-based therapeutics for cancer
  • Company #2071 - Deuterium-substituted compounds that can be developed more quickly and less expensively than conventional new chemical entities (NCEs), and with less risk
  • Company #2070 - Disease-modifying replacement peptide for the treatment of complications associated with diabetes
  • Company #2069 - Drug discovery platform that provides an atomic-level, three-dimensional (3-D) understanding of interactions between drug candidates and their bacterial targets to enable the design of antibiotics with enhanced characteristics
  • Company #2068 - Redox-based drugs targeting rare- or orphan-inherited mitochondrial respiratory chain diseases that are highly debilitating, life-threatening, and have no FDA- or EMA-approved drugs available to treat them
  • Company #2067 - 1-Prescription-only nutraceutical for the clinical dietary management of the metabolic processes associated with mild-to-moderate Alzheimer\'s disease (AD), 2-A drug for the treatment of Parkinson\'s disease (PD), and 3-A drug that addresses mitochondrial dysfunction in Huntington\'s disease (HD)
  • Company #2066 - Monoclonal antibody for the treatment of chronic migraine that is capable of reducing both frequency and severity of migraines without debilitating side effects
  • Company #2065 - Cloud-based SAAS solution for comprehensive remote physiological monitoring, with a focus on arrhythmia detection
  • Company #2064 - Non-surgical, fully reversible gastric balloon device for weight loss
  • Company #2063 - Women\'s health products for the prevention of Human Papillomavirus (HPV) and Sexually Transmitted Diseases (STDs)
  • Company #2062 - System for the transvaginal delivery of large and small molecule drugs, with an initial target in women\'s reproductive endocrinology disorders and follow-on applications in diabetes, obesity, and infectious disease
  • Company #2061 - Reusable, modular sterilization tray system that saves surgical departments time and money, while reducing the potential risk of infection from contaminated instruments
  • Company #2060 - System that can vacuum out kidney stones (smaller than 10mm) from a patient\'s urethra in just ten seconds, at the physician\'s office
  • Company #2059 - Technology to detect diabetic foot ulcers before they develop - an insole with sensors that gathers and wirelessly transmits continuous information about a patient\'s feet
  • Company #2058 - Robust and cost-effective multi-parameter patient monitoring technology that allows individuals, doctors, caregivers and family members to remotely and collaboratively manage a patient\'s health and wellness 24/7
  • Company #2057 - Minimally-invasive implant for the treatment of hand osteoarthritis, as an early-stage alternative to chronic drug therapies and irreversible joint replacement surgery
  • Company #2056 - Advanced wound care dressings with a unique cross-linked polymer composition that can first store, then release, water or other aqueous-based materials - at controllable rates
  • Company #2055 - The first dental laser technology that delivers on the promise of hard and soft tissue ablation with speed and precision
  • Company #2054 - Revolutionary, next-generation bi-modal platform technology which fundamentally changes the utilization of conventional ultrasound both as a modality for diagnostic imaging and as an active screening method
  • Company #2053 - Implantable devices for the treatment of knee osteoarthritis
  • Company #2052 - Non-invasive highly-differentiated cortical stimulation technology to help treat and diagnose centralized chronic pain, such as fibromyalgia
  • Company #2051 - Next-generation image-guidance device to: 1-Find small or deep tumors which cannot yet be easily spotted by ultrasound and 2-Allow needle-guided interventions to be done without the need for expensive, cumbersome external tracking devices that are currently used
  • Company #2050 - Minimally invasive, catheter-based approach focused on Carotid Body Modulation(TM) (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes, and renal failure
  • Company #2049 - A crystal form of zirconium silicate designed to treat patients with kidney and liver disease
  • Company #2048 - Cutting-edge computational technologies to identify drug candidates against previously inaccessible biological targets
  • Company #2047 - Non-surgical, injectable products for: 1-selective, non-ablative, local fat reduction and 2-the treatment of symptomatic exophthalmos
  • Company #2046 - The first and only once-yearly, injection-free, GLP-1 therapy for the treatment of type 2 diabetes
  • Company #2045 - Quantitative, objective molecular tests to help enable more effective management of patients with autoimmune and inflammatory diseases, such as rheumatoid arthritis (RA)
  • Company #2044 - Human induced pluripotent stem cell (iPSC) lines and tissue cells for in vitro drug development, in vivo cellular therapeutics, and stem cell banking
  • Company #2043 - Second-generation nitroxyl (HNO) chemistry platform to develop drugs for the treatment of acute and chronic heart failure
  • Company #2042 - Pipeline of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications
  • Company #2041 - Dental implants consisting of a titanium threaded rod that is treated in a way (at the molecular level), whereby bone grows into the titanium, allowing the rod to provide a highly secure base, and eliminating the potential for bone deterioration that occurs when partials or bridges are placed in the mouth
  • Company #2040 - Deployable surgical fixation technologies for mesh placement in hernia repair
  • Company #2039 - An economical, programmable, advanced therapeutic bed system to treat pressure ulcers, accelerate healing, and improve patient comfort
  • Company #2038 - Third-generation, fully synthetic bone graft substitute that is not pharmacological in nature and does not contain any human or animal derived components
  • Company #2037 - Next-generation software solution that provides more accurate contouring of lesions and organs than any current competitive method
  • Company #2036 - Wearable sensor-based technologies and sensory substitution systems that provide consumers with quality solutions to better cope with disease and improve overall quality of life
  • Company #2035 - Micro sensors mounted on fibre optics for diagnostic uses in dentistry, urinalysis, blood analysis, glucose testing, and coronary artery disease (CAD)
  • Company #2034 - Extremely compact system for real-time direct cochlear nerve monitoring during skull base surgeries
  • Company #2033 - A simple and robust lab-on-a-chip capable of performing hundreds of distinct parallel assays over a small surface area, with minimal patient sample and without compromising performance
  • Company #2032 - Patient handling systems for multi-modality suites including: intra-operative MRI\'s, hybrid OR\'s, MR/ANGIO and image-guided radiation therapy suites - to simplify the therapy/imaging transitions, improving ROI from the hospital\'s most expensive assets
  • Company #2031 - A portable and disposable suit for treating hypothermia that can draw heat off of the body in a much more rapid process than either gel pads or cooling blankets
  • Company #2030 - Wireless, wearable disposable electrode patch to measure the electrical activity from the stomach, small intestine and colon to help identify and diagnose the causes of functional disorders of the GI tract
  • Company #2029 - Handheld, compact, and portable gamma camera systems that can be used with existing MRI systems or on their own
  • Company #2028 - In vitro diagnostic test to diagnose coronary heart disease in asymptomatic individuals and to predict pathological events in patients with existing cardiovascular disease
  • Company #2027 - Plant-based manufacturing platform for ultra-low-cost monoclonal antibodies, protein drugs, and vaccines with applications for human immunodeficiency virus (HIV) and cancer - for as little as one-tenth of the manufacturing cost of other biopharmaceutical production systems
  • Company #2026 - Technology to kill the deadly superbug Methicillin Resistant Staphylococcus Aureus (MRSA) in homes and healthcare facilities
  • Company #2025 - Novel technology platform of anti-bacterial compounds based on a family of antimicrobial peptides that are active against multidrug resistant strains
  • Company #2024 - Bio-production of chemical molecules using micro-algae to mass produce lipids, pharmaceuticals, and cosmetics, among other non-medical applications
  • Company #2023 - Genetic tools to develop more precise, non-invasive tests for cancer and hard-to-diagnose forms of Down syndrome and markers for autism
  • Company #2022 - Technology to isolate personalized human cells from skin, human airways, and the gastrointestinal tract using minimally-invasive approaches and non-embryonic sources
  • Company #2021 - Novel drugs and molecular diagnostic products to target cancer, central nervous system (CNS), and infectious diseases
  • Company #2020 - A specialty diagnostics laboratory with a growing menu of proprietary, internally developed tests focused on rheumatology for more accurate, efficient diagnosis and better disease management
  • Company #2019 - Suite of multiplex immunoassay products and services for protein biomarker discovery, development, and analysis
  • Company #2018 - Circulating tumor cell (CTC) technology to provide more frequent and effective monitoring of cancer progression by proactively measuring tumor biology and intelligently adjusting therapy as necessary throughout a patient\'s treatment lifecycle
  • Company #2017 - Software and associated services that allow clinicians to translate DNA sequence data into verified biomarkers
  • Company #2016 - Non-invasive, non-radiogenic breast health screening device that is able to discover problems at stages far earlier than any other accepted screening methodology
  • Company #2015 - New wheelchair wheels that are twice as easy to push as the standard and can be added on to most existing wheelchair frames
  • Company #2014 - Real-time, 3-D imaging of internal organs and tissues during surgical procedures such as laparoscopy and arthroscopy, enabling surgeons to remove diseased tissue without damaging healthy neighboring tissue
  • Company #2013 - A fully integrated, disposable strip and adaptor device that, when combined with a smartphone, has the potential to replace existing self-powered glucose meters and increase patient usage in diabetes management
  • Company #2012 - Microfluidic technology that offers an alternative to painful and invasive biopsies by capturing rare circulating tumor cells (CTC) from whole blood
  • Company #2011 - Bioresorbable implants for bone and tissue regeneration
  • Company #2010 - Non-invasive prenatal/first-trimester microarray test that finds small amounts of genetic material that traditional testing such as karyotyping cannot detect
  • Company #2009 - Drug-device combination product to address vascular bypass failure in arterio-venous graft (AVG), arterio-venous fistula (AVF), peripheral arterial bypass graft (PABG), and coronary artery bypass graft (CABG) procedures
  • Company #2008 - A peri-ocular ring designed for extended drug delivery and reducing elevated intraocular pressure (IOP) in glaucoma patients
  • Company #2007 - Transcatheter mitral valve implant for the treatment of mitral regurgitation
  • Company #2006 - 1-A leg-worn motor assistance device for use in rehabilitation, and 2-a medical rehabilitation anti-gravity treadmill that provides accurate, safe, and comfortable partial weight-bearing therapy while promoting normal gait patterns
  • Company #2005 - Endovascular stapling device offering physicians a minimally invasive treatment option for peripheral artery disease (PAD)
  • Company #2004 - Drugs that block Cav3.2 for the treatment of neuropathic pain, chemotherapy-induced neuropathy, and tremor
  • Company #2003 - Small molecule bromodomain inhibitors, a new class of epigenetic modulators of gene expression, to treat cancer and other serious disorders
  • Company #2002 - Platform of gamma-secretase modulators for the prevention of neurodegenerative conditions, such as Alzheimer\'s Disease (AD)
  • Company #2001 - Drugs to treat serious neurological and psychiatric diseases, for which no other treatment exists, such as Tourette syndrome (TS) and Lesch-Nyhan syndrome (LNS)
  • Company #2000 - Small molecule therapeutics to treat hemoglobin disorders
  • Company #1999 - Novel Toll-like receptor 8 (TLR8) therapeutics for the treatment of cancer, respiratory, and autoimmune diseases
  • Company #1998 - New generation of multi-functional antibody drug conjugate combination therapeutics and bifunctional antibody-based therapeutics for targeted cancer therapies that will significantly extend the clinical impact of current oncology therapeutic approaches
  • Company #1997 - 1-Drugs to treat cancer and infectious disease using chemical induction of dimerization (CID), a drug-based remote control technology that extends the physician\'s reach beyond the point at which a treatment has been administered and 2-A cell therapy safety switch, permitting the rapid elimination of cells in the event of toxicity
  • Company #1996 - Technologies designed to achieve positive outcomes for people with upper limb deficiencies, including: 1-electronic prosthetic hands and fingers and 2-passive silicone prostheses that can match the skin tone/contours of natural fingers, hands, and entire arms
  • Company #1995 - MacuCLEAR is in P3 clinical trials to prove efficacy of its novel eyedrop for treating dry AMD.
  • Company #1985 - Minimally invasive, non-surgical products for: acne scars, cellulite reduction, circumference reduction, facial contouring, fractional skin resurfacing, muscle lifting, skin rejuvenation, skin tightening, and wrinkle reduction
  • Company #1984 - Novel and inexpensive sensor technology that measures breath profiles with applications in: respiratory rate monitoring, lung cancer screening, and asthma monitoring/management
  • Company #1983 - Patented \"non-linear\" platform that allows large implants and instruments to be inserted into the body through a small incision, turning most conventional spine procedures into user-friendly minimally invasive spine surgery (MISS)
  • Company #1982 - 1-Excellagen(R) is a topical gel for wound care management and 2-Generx(R) is a DNA-based angiogenic biologic intended for the treatment of coronary artery disease
  • Company #1981 - Drug-releasing polymer-coated bone grafts used during orthopedic surgeries
  • Company #1980 - Next-generation treatment for stress urinary incontinence (SUI): a single incision office-based treatment that vastly reduces complications while retaining the efficacy of the sling
  • Company #1979 - Photodynamic therapy for psoriasis, cutaneous T cell lymphoma (CTCL), and other skin diseases
  • Company #1978 - The most affordable patient kiosk and sign-in system on the market to improve office efficiency and HIPAA compliance
  • Company #1977 - New designs for IV catheters to improve efficiency, increase patient comfort, and save providers money
  • Company #1976 - Automated ultrasound CT scanner that provides high resolution (sub-millimeter) whole breast images with unique visual and growth information about the bulk properties of tissues and physical structures within the breast
  • Company #1975 - The world\'s first electronic \"AutoFocal\" Intraocular Lens (IOL) that is designed to give patients a complete visual range, providing effective near, intermediate, and distance vision
  • Company #1974 - Revolutionary disposable product to rapidly and painlessly close deep wounds, such as lacerations and surgical incisions, as an alternative to sutures, staples, tissue adhesives, and other wound closure products
  • Company #1973 - Vascular access device that provides reliable, repeatable access with fewer complications, by allowing physicians to maintain access in an occluded vein and eliminate the need to compromise an additional vein
  • Company #1972 - Real-time, easy-to-use, non-radioactive, and cost-effective monitoring of kidney function
  • Company #1971 - Disruptive cancer treatment technique with the ability to treat tumors without surgery, general chemotherapy, and radiotherapy
  • Company #1970 - Closure product for large incision surgeries such as cesarean and hysterectomy, that reduces adhesions, tissue damage, and operative time
  • Company #1969 - Surgical robotic platform with Adjustable Remote Center of Motion (ARCM) technology, to bring safe, reliable, customized, and affordable robotics to the operating theater
  • Company #1968 - A less invasive approach to carpal tunnel surgery (CTS) designed to minimize surgical trauma, scarring, post-operative pain, and patient recovery time
  • Company #1967 - Minimally invasive devices to address the unmet clinical need for improved complex (bifurcated) aneurysm therapy
  • Company #1966 - Surgical tools for pediatric inner ear procedures
  • Company #1965 - Rebossis is the worlds first resorbable and replaceable cottony flexible synthetic bone material
  • Company #1964 - Dental implants that merge proprietary nanotechnology materials with human cell biology, for greater short- and long-term stability with minimally invasive techniques, as an alternative to traditional systems
  • Company #1963 - Non-invasive treatments that destroy solid tumors of advanced-stage skin cancers, including melanoma, Merkel cell lymphoma, and cutaneous T-cell lymphoma
  • Company #1962 - Highly customizable force measurement devices to improve diagnosis and more safely and effectively treat patients suffering from stress urinary incontinence (SUI), with the potential for other surgical applications as well
  • Company #1961 - Materna strives to reduce the incidence of childbirth-related injuries to women during vaginal delivery
  • Company #1960 - Next-generation aerosol delivery system for direct-access of high-dose lung disease drugs, including anti-infectives, biotherapeutics, and cytotoxics, as an alternative to intravenous administration
  • Company #1959 - Personalized and highly selective therapeutic compounds and combination therapies that target the molecular aberrations that cause cancer and the emerging resistance mechanisms that make it increasingly difficult to treat
  • Company #1958 - Next-generation antibiotics, with an IV-to-oral step down option, to help address the global problem of emerging infections caused by multi-drug resistant (MDR) organisms
  • Company #1957 - Best-in-class protein-based drugs, with a lead candidate that is specifically designed for topical ophthalmic administration to treat ocular diseases including dry eye and severe ocular allergy
  • Company #1956 - Topical eye drop for the treatment of neovascular age-related macular degeneration (AMD), diabetic retinopathy, and potentially diabetic macular edema (DME)
  • Company #1955 - A triple reuptake inhibitor to treat adult attention deficit hyperactivity disorder (ADHD) that provides improved efficacy and reduced drug abuse liability
  • Company #1954 - Next-generation anti-depressant drug designed to improve efficacy and address the leading causes of drug discontinuation
  • Company #1953 - Small-molecule drugs for the treatment of hormone-dependent cancers, which have become resistant to existing first-generation anti-hormonal agents
  • Company #1952 - A new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules, to address protein-protein interactions and other previously undruggable targets
  • Company #1951 - Full-line of transfusion diagnostic products, including: 1-ABO Rh blood typing reagents; 2-a range of monoclonal rare antisera; 3-a range of reagent red blood cells; 4-enhancement media; and 5-specialty products
  • Company #1950 - Best-in-class intra-articular (IA) drugs that address unmet medical needs in osteoarthritis (OA) treatment and are delivered to the site of the disease for sustained delivery
  • Company #1949 - Proprietary botanical pharmaceuticals derived from East Indian Sandalwood oil (EISO) for safe, painless, and scarless treatment of viral diseases that are also effective in eliminating reoccurrence
  • Company #1948 - A new inhaled drug to prevent the progression of, or reverse, both adult and pediatric pulmonary arterial hypertension (PAH)
  • Company #1947 - Safe and effective vaccines for the treatment of infectious diseases, especially in emerging economies
  • Company #1946 - New class of small molecule glycan-targeted drugs to address substantial unmet needs, including: lysosomal storage, oncology, inflammation, and other diseases
  • Company #1945 - New generation of biopharmaceuticals, based on engineered human proteases, that can provide higher efficacy and lowered dosing
  • Company #1944 - Next-generation platform and extension products that greatly improve the speed and efficiency of the isolation and capture of purified stem and progenitor cells that are resident within normal blood or placental/cord blood, bone marrow, or adipose tissue
  • Company #1943 - Orthodontic treatment system that enables doctors to pro-actively plan tooth movement on digital models and customize prescriptive archwires for precise and efficient treatment, while reducing treatment time by 34%
  • Company #1942 - A self-contained, leadless cardiac pacemaker system to eliminate the leads and surgical pocket required by conventional pacemakers, thereby removing the associated complications of infection and mechanical lead failure
  • Company #1941 - 3D cell-based assays to create better in vitro prediction of complex biochemical responses, with a focus on evaluation of drug toxicity and efficacy prior to use in human clinical trials
  • Company #1940 - Fully automated pill crusher which turns even the hardest pills into a fine powder, with the simple push of a button
  • Company #1939 - Arthroscopic surgical technology that enables surgeons to place stitches in very tight joint compartments, while protecting sensitive surrounding structures such as nerves, arteries, and cartilage
  • Company #1938 - Custom-fit orthotic that provides stability and movement assistance to weakened muscles without the use of powered mechanisms, to help individuals with severe mobility impairments to be more mobile, independent, and confident
  • Company #1937 - Devices that provide simple and effective local delivery of therapeutic agents to inhibit and treat active infections around surgical implants
  • Company #1936 - System that measures motion and analyzes shifts in attention state, to objectively and accurately assess the severity of three core symptoms of attention-deficit hyperactivity disorder (ADHD): hyperactivity, inattention, and impulsivity
  • Company #1935 - Minimally invasive renal denervation technology designed to help reduce blood pressure for people with uncontrolled hypertension
  • Company #1934 - Human membrane allograft for surgical use, derived from the inner lining of the placenta
  • Company #1933 - Wound covering products, derived from amniotic tissue, for a broad range of clinical applications: 1-A patch for use in vivo to provide a physical barrier to protect tendons and nerves at the surgical site and 2-A liquid for use in vivo to fill soft tissue defects
  • Company #1932 - Technology to identify and purify egg precursor cells (EggPCs), thereby improving egg quality and increasing the success of in vitro fertilization (IVF)
  • Company #1931 - A new class of drugs based on advancements in synthetic modified messenger RNA (mRNA) molecules
  • Company #1930 - Technologies and services to support and simplify human cell reprogramming, growth, and differentiation
  • Company #1929 - Next-generation multiplexing system that leverages advances in silicon photonics technology to: reduce or eliminate sample preparation, provide scalable multiplexing for both proteins and nucleic acids from a single small sample, and achieve excellent sensitivity
  • Company #1928 - Unique multi-target approach to reducing pathologic deposits of misfolded proteins, for the treatment and prevention of chronic neurodegenerative diseases
  • Company #1927 - Next-generation in vitro diagnostic systems that generate results at previously unseen levels of speed, sensitivity, and specificity
  • Company #1926 - Molecular diagnostic (MDx) technologies including: 1-Near-point-of-care (POC) platform that can analyze for dozens of infectious diseases in one rapid, self-contained, simple-to-use, and low-cost test; 2-Multiplex panel assays; and 3-Rapid sample preparation methodologies for customizable DNA/RNA extraction and purification
  • Company #1925 - Next-generation synthetic bone graft substitutes with optimized handling, reliability, and consistent surgical performance; for use in a broad range of non-load bearing osseous repair defects
  • Company #1924 - Technology that works by measuring and analyzing the light reflected off of the skin to make an accurate pressure ulcer (PU) diagnosis regardless of skin color and independent of the clinician\'s skill level
  • Company #1923 - Non-invasive, continuous monitor for the early detection of cerebral fluid accumulation due to stroke, traumatic brain injury (TBI), or brain surgery
  • Company #1922 - Interatrial Septal Device (IASD) for the treatment of congestive heart failure
  • Company #1921 - Externally delivered ultrasound energy to ablate the renal nerves, as a non-invasive, single-treatment, non-pharmacological approach to control drug-resistant hypertension
  • Company #1920 - Strip-based diagnostic test that will quickly and cost-effectively provide a definitive determination of whether a patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma
  • Company #1919 - Disruptive technology with the potential to transform the standard of care for root canal procedures
  • Company #1918 - Implantable, programmable pump designed to deliver therapeutic drugs into the spine, for the treatment of chronic intractable pain and the management of severe spasticity
  • Company #1917 - Catheter-based nonimplant left atrial appendage (LAA) closure device in patients with atrial fibrillation
  • Company #1916 - Physiological and biomechanical monitoring technology that enables loved ones to stay in their home longer while family, friends, and medical practitioners can remotely monitor their physiological state
  • Company #1915 - Unique retractable over-the-wire guidance system to assist in optimal atraumatic intravenous catheter delivery, designed for greater first attempt success and increased dwell times
  • Company #1914 - 1-Automated robotic delivery system that can securely transport one patient\'s prescription or an entire unit\'s scheduled doses on-demand from the pharmacy to the nurses\' station and 2-A web-based medication tracking system that uses a combination of passive RFID, barcodes, biometrics, remote monitoring, and/or secure delivery carts to keep the pharmacy in touch with all orders, while meeting all compliance regulations
  • Company #1913 - Platform for surgery to be performed through a patient\'s mouth or other natural orifices, rather than the abdomen, for less pain, shorter hospital stays, reduced risk of wound infection, and no external scars
  • Company #1912 - Percutaneous mitral valve replacement system
  • Company #1911 - Ultrasound system, specifically for patients with dense breast tissue, where the effectiveness of mammography may be limited
  • Company #1910 - Sustained release drugs for treating tardive dyskinesia (TD) and other movement disorders
  • Company #1909 - Compounds that possess a low risk of side effects, for central nervous system (CNS) disorders, including: schizophrenia, major depressive disorder (MDD), pain, traumatic brain injury (TBI), multiple sclerosis (MS), autism (Fragile X), anesthesia, and post-traumatic stress disorder (PTSD)
  • Company #1908 - Adeno-associated virus (AAV) delivered follistatin protein that is safer and more targeted, to increase muscle strength and improve the quality of life of muscular dystrophy patients
  • Company #1907 - Small molecule drug candidates that modulate the sphingosine 1-phosphate (S1P) pathway in new and different ways, for the treatment of diseases such as cancer and fibrosis
  • Company #1906 - Innovative platform for the rapid generation of monoclonal antibody therapeutics for the treatment cancer and age-related macular degeneration (AMD)
  • Company #1905 - Small molecule that increases the natural production of erythropoietin (EPO) and causes a controlled, gradual rise in hemoglobin in patients with anemia
  • Company #1904 - New class of pentraxin therapeutics to treat rare fibrotic diseases, including: idiopathic pulmonary fibrosis (IPF), myelofibrosis, and fibrovascular retinal diseases
  • Company #1903 - Tests that measure and analyze important genomic variants affecting the metabolism and response to behavioral health medications in individual patients
  • Company #1902 - Formulation platform technology that provides tamper-resistant extended release drug delivery, for the treatment of chronic pain
  • Company #1901 - Low-cost, high-value terpenes as therapeutics for infectious & cardiovascular diseases, oncology, and metabolic disorders
  • Company #1900 - Molecular diagnostic tests to target rare forms of cancer, including pediatric cancers
  • Company #1899 - Highly selective qPCR reagents that provide an increased level of confidence and convenience for the detection of key cancer mutations
  • Company #1898 - Molecular diagnostic assays that will enable new paradigms in the treatment of diseases as diverse as infection, auto-immune disease, and cancer
  • Company #1897 - Proteomics-based biomarker discovery that leads to superior data, better results, and improved diagnostics
  • Company #1896 - 1-Tests for preimplantation genetic diagnosis (PGD) performed during in-vitro fertilization in order to select embryos with the highest probability of becoming healthy children; 2-Conception testing following miscarriage in order to understand the cause; and 3-Non-invasive prenatal testing to determine paternity or detect genetic disease
  • Company #1895 - The first women\'s bra that recruits stem cells to breast tissue, for enlargement without surgery. Cells are recruited via an electrical homing signal from the woman\'s own fat tissue and bone marrow
  • Company #1894 - 1-The first heart pacemaker that recruits stem cells to damaged heart tissue and converts them to muscle and 2-Electrical stimulation device to treat wounds secondary to peripheral limb ischemia, foot ulcers, and other slow healing wounds
  • Company #1893 - Next-generation, hand-held, low-powered ultrasound brush that delivers proprietary anti-aging ingredients to reduce wrinkles
  • Company #1892 - Catheter-based lung denervation device for treating chronic obstructive pulmonary disease (COPD)
  • Company #1891 - Regional cerebral thermal therapy (RCTT) device to treat insomnia and sleep disorders
  • Company #1890 - The first self-contained disposable blood test to measure the level of proteins (disease biomarkers) from a single droplet of finger-pricked blood to diagnose, monitor, and manage a variety of medical conditions, including: heart failure, cancer, osteoporosis, critical pregnancy, and infectious diseases
  • Company #1889 - Breast cancer screening system with very high sensitivity (95% at 1 cm) that checks for abnormalities using three proven methods: advanced thermal profiling (ATP), optical spectroscopy, and ultrasound
  • Company #1888 - Completely portable systems that provide high-quality computed tomography (CT) images wherever needed, including: the clinic, Intensive Care Unit (ICU), Operating Room (OR), and Emergency Room (ER)/Trauma Department
  • Company #1887 - Significantly improved accuracy, sensitivity, and convenience in trace and sub-trace analyses using mass spectrometers and a patented technology platform, to aid in understanding some of the complex underlying factors that trigger or accelerate many diseases
  • Company #1886 - Non-surgical office-based treatments that addresses common bladder disorders such as: stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction, and lower urinary tract symptoms (LUTS)
  • Company #1885 - Robots that allow doctors to actually see and respond to patients in ICUs and emergency rooms remotely, giving physicians the ability to perform routine duties, such as patient rounds, via a web interface
  • Company #1884 - 1-Large and small molecules designed to amplify the body\'s innate ability to efficiently burn fuels like glucose and 2-Next-generation highly selective insulin sensitizers
  • Company #1883 - An approach to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications such as: central nervous system (CNS) disorders, cancer, inflammation & metabolic diseases, viral & bacterial infections, and orphan diseases
  • Company #1882 - Small molecule caspase activators for the treatment of cancer and other proliferative diseases
  • Company #1881 - High-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases such as: Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig\'s disease), Parkinson\'s disease, Alzheimer\'s disease (AD), and multiple sclerosis (MS), as well as lysosomal storage disorders such as Fabry\'s disease and Gaucher\'s disease
  • Company #1880 - Small-peptide therapeutics for metabolic diseases such as: obesity, diabetes, and gastrointestinal (GI) functional disorders like diabetic gastroparesis (DG)
  • Company #1879 - Entirely new class of naturally occurring human supercharged proteins that function inside of cells, to address a broad spectrum of previously undruggable targets, with potential applications for inflammatory, infectious, and ophthalmic diseases
  • Company #1878 - An improved and more predictable bioavailability, as compared to currently available Omega-3 products, for the treatment of lipid disorders (dyslipidemia) and hypertriglyceridemia
  • Company #1877 - Small molecule drugs that will provide well-tolerated therapies for cancer, preneoplastic conditions, and other diseases of pathologic proliferation, including inflammation and viral diseases
  • Company #1876 - Compounds that leverage the therapeutic potential of Omega-3 fatty acids and other clinically validated compounds to create new medicines for the treatment of: inflammatory bowel disease (IBD), severe hypertriglyceridemia & dyslipidemia, multiple sclerosis (MS), chronic kidney disease (CKD), psoriasis, and an ultra-orphan metabolic disease
  • Company #1875 - Compounds to treat pain, epilepsy, and other nervous system disorders such as: anxiety, autism, migraine, schizophrenia, and bipolar
  • Company #1874 - Ready-to-use pharmaceuticals, delivered through patient-friendly injection devices, that will eliminate reconstitution, simplify administration, and ease the pain of injections
  • Company #1873 - NSAID formulations, which have the potential to reduce the serious and common gastrointestinal (GI) side-effects caused by virtually all existing NSAIDs
  • Company #1872 - 1-Closure device that utilizes a conformable, water-soluble polyethylene glycol (PEG) sealant, which dissolves within 30 days, leaving nothing behind but a healed femoral artery and 2-A radial compression band that achieves quick and effective hemostasis, while protecting the ulnar nerve and providing a comfortable experience for the patient
  • Company #1871 - Portable oxygen concentrator that makes its own oxygen from surrounding air, thus never running out of oxygen; for use primarily with chronic obstructive pulmonary disease (COPD) patients
  • Company #1870 - Accurate, wearable body monitoring systems for: diabetes management, sleep disorder treatment, weight loss, and elderly care assistance
  • Company #1869 - A therapeutic vaccine with companion diagnostic and monitoring tool, to improve celiac disease management
  • Company #1868 - Simple blood tests to predict the risks of preterm birth, preeclampsia, and other pregnancy complications
  • Company #1867 - An antibody that blocks the calcitonin gene-related peptide (CGRP) pathway to prevent migraine headaches
  • Company #1866 - Products that support transcatheter interventions for the heart
  • Company #1865 - A recombinant protein to treat X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disorder that can be life-threatening
  • Company #1864 - New avenue of nucleotide therapeutic drug discovery via modulation of cellular miRNA to treat a wide range of diseases, including cancer, fibrosis, inflammation, and infectious and degenerative diseases
  • Company #1863 - New generation of fully recombinant, protease-activated monoclonal antibodies that can achieve unprecedented levels of tissue-specific targeting
  • Company #1862 - Biology and chemistry platforms for the development of small molecule drugs to stop Alzheimer\'s disease and other CNS-related conditions
  • Company #1861 - Neuromonitoring devices to prevent nerve damage in all types of surgical procedures
  • Company #1860 - Ocular microinjection platform for non-surgical, targeted delivery of drugs and proteins into the suprachoroidal space
  • Company #1859 - Biomaterials for post-surgical adhesion prevention, scar prevention, wound care, and tissue reconstruction
  • Company #1858 - A custom fit, rehabilitative body suit that offers instantaneous back pain relief, trains and conditions the body to prevent or rehabilitate from back injuries, and increases the overall long-term health of the spine
  • Company #1857 - Micro-catheter platform that uses a proprietary microfluidic design for the delivery of drug/active molecules directly to the central nervous system for the treatment of difficult/chronic neurological conditions
  • Company #1856 - Unique diagnostic and monitoring technologies: 1-\"Smart Optic Capillaroscope\" for non-invasive diagnostics of early disorders in the smallest vessels-capillaries; 2-\"Hemodynamic Lab\" for simultaneous diagnostics of the whole vascular system; and 3-\"Meteolaboratory with Feedback Effect\" for controlling influence of meteorological factors on the human organism
  • Company #1855 - Novel gold microparticle-based technology for the treatment of moderate to severe acne
  • Company #1854 - Combination hand-held, single-cell detection device and imaging agent that aims to provide surgeons a better view of cancer cells in real time during tumor removal surgeries
  • Company #1853 - Drugs to improve health for patients by modulating disease-associated long non-coding RNA (lncRNA), thereby restoring normal expression of individual targeted genes
  • Company #1852 - Revolutionary topical antifungal with: exceptional potency, the ability to penetrate the nail, a dual mode of action, and exemplary safety profile
  • Company #1851 - First-in-class, small molecule compounds that successfully manage and treat chronic pain, by inhibiting P2X3 receptors
  • Company #1850 - Fully synthetic and targeted vaccines that induce an antigen-specific immune activation or an antigen-specific immune tolerance for therapeutic and prophylactic applications
  • Company #1849 - Protein therapeutics with extremely high target binding specificity for the treatment of cancer and immune-mediated diseases
  • Company #1848 - Nanopharmaceuticals optimized to make drugs more effective and with fewer side effects
  • Company #1847 - Fatty acid synthase (FASN) inhibitors with pharmaceutical properties that overcome the shortcomings of earlier generations of inhibitors, for the treatment of chronic hepatitis C virus (HCV) and pancreatic, prostatic, breast, and colorectal tumors
  • Company #1846 - The first vaccine to demonstrate efficacy in reducing the mortality of otherwise highly lethal bloodstream infections due to either Candida or S. aureus (including MRSA)
  • Company #1845 - Drugs for the treatment of depression, anxiety, epilepsy, pain, glaucoma, spasticity, and a variety of other CNS-related conditions
  • Company #1844 - Decision support software, integrated with vital sign monitoring equipment in hospital ICUs/EDs, to provide novel insights into a patient\'s current status and future trajectory
  • Company #1843 - A laser procedure that removes the brown pigment (melanin) from the top layer of the iris, in order to change human eye color (to blue) permanently
  • Company #1842 - Technology that will allow hospitals to consolidate the multiple types of infusion pumps used throughout their organization into a single type of device
  • Company #1841 - Diagnostic tests for the early identification of newborns suffering from critical oxygen supply deficit during birth (Asphyxia), a major cause for brain injury, often followed by life-long disability
  • Company #1840 - Non-invasive series of genetic tests, designed to offer valuable insights into the biology of patients with mood disorders and to support the development of personalized medicine
  • Company #1839 - Minimally invasive, image-guided breast biopsy and tissue removal technologies
  • Company #1838 - Biomaterial and regenerative medicine products for ophthalmological applications: ologen(R) Collagen Matrix, BioCornea, and Biolens
  • Company #1837 - New antibacterial drugs that target multi-drug resistant pathogens
  • Company #1836 - Targeted nanoparticles that selectively accumulate at disease sites and minimize the damage to healthy tissues for the treatment of cancer, cardiovascular conditions, and inflammatory diseases
  • Company #1835 - A fully-implantable continuous glucose monitoring system that utilizes fluorescence sensing technology
  • Company #1834 - Biological therapies targeting bone loss, blood and muscular weakness disorders, cancer, and rheumatoid arthritis
  • Company #1833 - Innovative protein, peptide, and antibody drug candidates for the treatment of cardiovascular disease, diabetes, muscle wasting, and obesity
  • Company #1832 - Therapeutic antibodies discovered and optimized using somatic hypermutation (SHM)
  • Company #1831 - Microfluidic automation systems used for rapid DNA analysis
  • Company #1830 - Therapeutics aimed at cellular targets in cancer metabolism, e.g., IDH1, IDH2, and PKM2
  • Company #1829 - Innovative therapeutics for cardiovascular disease and autoimmune/inflammatory diseases that are based on targets with established proof of concept and can offer advantages over existing therapies
  • Company #1828 - Epidural needle guidance device utilizing automated 3D navigation
  • Company #1827 - Orthopedic plate and screw systems for large and small bone fragments
  • Company #1826 - A glaucoma-detection technology that superimposes images of the posterior pole of the eye to show changes over time
  • Company #1825 - Discreet sensors placed throughout the home for the purpose of monitoring elderly individuals
  • Company #1824 - A pain management patch comprising a dressing and skin-friendly adhesive
  • Company #1823 - Diagnostic assays for joint fluid analysis; these technologies use a lateral flow immunoassay design and are used to rapidly detect the causes of joint pain
  • Company #1822 - Innovative nerve-stimulating therapies for debilitating chronic low back pain
  • Company #1821 - Orthopedic devices
  • Company #1820 - Intraurethral devices including a prostatic urethral stent and a urethral measurement device to enable the selection of proper stent sizes
  • Company #1819 - Portable x-ray technologies for medical applications
  • Company #1818 - Portable oxygen concentrator for active respiratory patients
  • Company #1817 - Develops polymer composite products for biomedical applications, including clear braces for orthodontic patients
  • Company #1816 - An electrical stimulation device that targets the weak/dysfunctional lower esophageal sphincter in order to treat severe Gastro Esophageal Reflux Disease (GERD)
  • Company #1815 - A cost-effective, efficient system for the production of ophthalmic lenses
  • Company #1814 - External radiation therapy technology
  • Company #1813 - A novel, short-peripheral intravenous (IV) catheter featuring a pre-assembled, closed design with high-pressure extension tubing, a multi-use flow control clamp, and stabilization technology
  • Company #1812 - A highly articulated, multi-link robot that enables the performance of minimally invasive surgery
  • Company #1811 - Lenses that address vision problems associated with higher-order aberrations of the eye, improving vision, contrast acuity, nighttime driving vision, and color dullness
  • Company #1810 - A continuous glucose monitoring device
  • Company #1809 - Offers technologies for drug delivery systems, including complex release products, fast-dispersing dosage forms, and biodegradable polymers for custom release profiles in implants
  • Company #1808 - Intracorneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly while maintaining distance vision
  • Company #1807 - A three-layered biological patch, called the LeucoPatch, which can be derived without additives from the patient's blood within 20 minutes; used for chronically non-healing and debilitating wounds
  • Company #1806 - Nanotechnology-based Point-of-Care products for the collection and screening of blood, urine, or oral fluids
  • Company #1805 - Small molecule drug candidates directed at ion channel targets to repurpose existing therapies for atrial fibrillation
  • Company #1804 - Novel spherical nucleic acid (SNA) constructs exhibiting biocompatibility and versatility as intended therapeutics to treat heart disease, cancer, skin conditions and bacterial infection
  • Company #1803 - Novel therapeutic intended to treat dry age-related macular degeneration and prevent blindness
  • Company #1802 - Drugs based on technology which emulates human physiology and predicts clinical outcomes upfront
  • Company #1801 - First-in-class oncology therapeutics to treat female and male cancers utilizing membrane-disrupting peptides to target cancer cells without harming healthy tissue
  • Company #1800 - Blended active glycolic acid used in cosmetic and beauty products
  • Company #1799 - Novel DNA-based immunotherapies to treat HIV
  • Company #1798 - Research and development of innovative biotechnologies
  • Company #1797 - Catheter-based medical technologies for the treatment of cerebral aneurysm and other cardiovascular disease
  • Company #1796 - Formulations for lymphatic delivery of highly lipophilic pharmaceuticals
  • Company #1795 - Reformulation of existing pharmaceuticals to provide more targeted results, lessen the risk of side effects and reduce patient costs; lead product is an oral form of an existing IV-only cancer drug
  • Company #1794 - Therapeutics intended to treat diabetes, diabetic complications, and kidney disease through the inhibition of blood vessel growth, preventing hyperglycemia-induced damage to proteins and tissues
  • Company #1793 - Novel formulations of existing pharmaceuticals to expand applicable patient populations and therapeutic uses
  • Company #1792 - Affordable analytical instruments, biomanufacturing systems, and consumable labware products for biological research and drug discovery
  • Company #1791 - Novel therapeutic to treat age-related macular degeneration and prevent blindness
  • Company #1790 - Cell-based nuclear receptor reporter assay technology used in drug development that allows for the storage and preservation of cells for later use
  • Company #1789 - Innovative combination drug therapies to treat overactive bladder and urinary incontinence
  • Company #1788 - Targeted UV phototherapy device to treat dermatological diseases including eczema, psoriasis and vitiligo
  • Company #1787 - SMaRT RNA technology intended to treat a broad spectrum of diseases including HIV, hemophilia and dyslipidemia
  • Company #1786 - Sustainable chemicals using unconstrained metabolism technology for reaction flexibility
  • Company #1785 - Novel, first-in-class therapeutic utilizing beloranib to treat severe obesity
  • Company #1784 - Technology that enables Innovative reformulation of previously approved therapeutics to expand indications or improve safety
  • Company #1783 - Budesonide-based therapy for the treatment of eosinophilic esophagitis
  • Company #1782 - Optical measurement instruments using back-scattering interfermetry to detect molecular interaction assays and assist in developing drug applications
  • Company #1781 - Innovative platform that optimizes DNA to produce in vivo therapeutics with multiple indications
  • Company #1780 - SideView Mono trocar for single access laparoscopic surgery
  • Company #1779 - A patented electro-chemical technology for coating teeth with a high concentration of target materials that last for long periods of time, and include the following applications: (1) Fluoritray, a non-invasive, painless tooth fluoridation, producing a thick protective Fluoroapatite layer lasting for more than one year, reducing sensitivity and significantly improving resistance to bacteria and the acidic mouth environment; and (2) UltraWyte, for superior tooth whitening
  • Company #1778 - Patent-pending T-Loc(TM) Technology, used for the treatment of fractures and injuries to the shoulder joint and allowing precise, reproducible surgeon-controlled tensioning and low-profile, knotless fixation
  • Company #1777 - Molecular diagnostics technologies that perform directed analyses of cell-free DNA in blood and are used to provide safe, highly accurate, and affordable prenatal tests for maternal and fetal health
  • Company #1776 - A novel, disposable device used for intra-abdominal pressure monitoring in patients that are receiving gastric feeding, require safe monitoring of gastric residual volume, or are being screened for intra-abdominal hypertension
  • Company #1775 - Cost effective, non-invasive point of care diagnostics that use bio-sensor chips to provide direct, digital, state of the art sensitivity (fM - pM) and selectivity through proprietary semiconductor processing of CNT FETs and may be used to diagnose a variety of diseases and related health risks
  • Company #1774 - Highly compact intensity-modulated proton therapy medical system powered by a dielectric-wall accelerator and intended for use in oncology patients; features a revolutionary design with a substantially smaller structure and greater flexibility than other accelerators
  • Company #1773 - Spiral Laminar Flow (SLF) prosthetic grafts are used to reproduce the body's natural blood flow patterns and treat cardiovascular disease
  • Company #1772 - Novel MRI scanner to diagnose disease and provide real time guidance of thermal energy procedures such as lesion biopsies and tumor treatments
  • Company #1771 - Minimally invasive ultrasound device that allows for rapid evaluation of fallopian tubes to assess fertility at point of care
  • Company #1770 - A unique single surgery solution for articular cartilage repair using a patented cell isolation and cell combination technique, in a cost-effective and minimally instrumented therapy
  • Company #1769 - A second-generation biomimetic coating comprised of 2 protein components (FN and SDF-1α) which may be applied to cardiovascular prostheses in order to help avoid tissue rejection and subsequent device failure
  • Company #1768 - Non-invasive system to detect and alert users of sleep-time hypoglycemia for the monitoring of type 1 diabetes
  • Company #1767 - Innovative products designed to alleviate pain and enhance physical comfort in those affected by illness, disability, injury, pressure and poor ergonomics
  • Company #1766 - Oral active molecule therapeutic to improve memory and learning in patients with Alzheimer\'s Disease
  • Company #1765 - Novel cervical collar used in emergency situations to immobilize the neck while chemically cooling to lower brain temperature to slow metabolism, improve cell membrane stability and reduce inflammation
  • Company #1764 - Diagnostic test for lung cancer using biological olfactory sensor arrays
  • Company #1763 - Medical isotopes and cancer treatment elements used in thyroid and respiratory cancer therapies
  • Company #1762 - Novel small molecules and monoclonal antibodies for the treatment of vascular disease and to enhance wound healing, specifically diabetic macular edema and inflammatory bowel disease
  • Company #1761 - In vivo positron emission tomography imaging agents to detect cancer and autoimmune disease
  • Company #1760 - Novel therapeutics to remove acetaldehyde and other toxic aldehydes that impair protein function and cause mutation in DNA
  • Company #1759 - First-in-class subunit-selective NMDA receptor modulators to treat neuropsychiatric diseases, specifically schizophrenia and Alzheimer\'s
  • Company #1758 - Novel anti-angiogenic cancer therapy that inhibits blood supply to prevent tumor growth
  • Company #1757 - G protein-coupled receptor therapeutics to combat multiple sclerosis
  • Company #1756 - Novel therapy to treat iron overload caused by chronic transfusion therapy
  • Company #1755 - Blood-based molecular diagnostics that track multiple biomarkers for early diagnosis of a variety of diseases including cancer and Alzheimer's
  • Company #1754 - Magnetically targeted drug delivery system enabling patient specific delivery options to treat peripheral artery disease
  • Company #1753 - First-in-class oral therapeutic to disrupt the natural course of lactose intolerance by stimulating lactose-metabolizing bacteria in the colon and offering long-term symptom relief
  • Company #1752 - Molecular test to detect pathogens and bacteria that can lead to nosocomial infections
  • Company #1751 - Novel non-invasive test to asses infertility and egg quality in women through the use of genetic biomarkers
  • Company #1750 - Aneurysm embolization system that promotes rapid, peri-procedural stasis in wide neck ruptured and unruptured aneurysms, taking the place of traditional coils
  • Company #1749 - Novel monoclonal antibody therapies targeting receptor tyrosine kinases to treat cancers
  • Company #1748 - Small molecule therapeutics to treat cardiometabolic diseases including dyslipidemia/hypercholesterolemia and diabetes
  • Company #1747 - Novel front-line therapies for the treatment of inflammatory bowel disease, specifically ulcerative colitis
  • Company #1746 - Novel therapeutics to treat diseases affecting mucosal tissue
  • Company #1745 - Oral therapeutics that inhibit the breakdown of calcitonin for the treatment and prevention of osteoporosis and related bone disease
  • Company #1744 - Comprehensive portable device to provide point-of-care diagnostics for a variety of diseases
  • Company #1743 - Point-of-care molecular diagnostic device utilizing electrochemicals to provide rapid, enzyme-free detection of nucleic acids for infectious disease
  • Company #1742 - Peptide-based immunotherapy intended to treat and prevent pancreatic cancer by targeting mutated ras genes
  • Company #1741 - Orthobiologic implant to fill bone voids utilizing parathyroid hormone peptides to prevent further bone loss in osteoporosis and spinal injuries
  • Company #1740 - Noninvasive fractional flow reserve device analyzer that uses computed tomography images to determine arterial blood flow and pressure, allowing better diagnosis of ischemic stenosis
  • Company #1739 - Selective small molecule histone deacetylase inhibitors to treat multiple myeloma with possible indications for inflammatory, neurodegenerative, infectious and genetic disease
  • Company #1738 - Small molecule therapeutics for acute central nervous system disorders; the company\'s lead product is intended to reduce brain swelling and hemorrhage resulting from ischemic and traumatic injury
  • Company #1737 - Innovative aortic valvuloplasty balloon for the treatment of calcific aortic stenosis
  • Company #1736 - Novel allogeneic cell graft with copper chelator technology for use in bone marrow transplants to treat leukemia and lymphoma in patients without an available familial donor
  • Company #1735 - Sophisticated implants and surgical tools featuring a biomechanically-compliant nail for the fixation of hip fracture in third age patients suffering from osteoporosis
  • Company #1734 - Novel screening technology based on oncoproteins to differentiate benign infection from true disease and detect cervical cancer and other cancers associated with human papillomavirus (HPV)
  • Company #1733 - Novel therapeutics that inhibits translation of neurotoxic proteins for the treatment of neurodegenerative disorders, including Alzheimer\'s and Parkinson\'s
  • Company #1732 - Innovative refractive ophthalmologic surgery technologies and instruments for flapless epithelial surface removal and the treatment of keratoconus
  • Company #1731 - Colorimetric blast dosimeter provides immediate information as to the level of blast exposure relative to brain injury via a color change imaging technology
  • Company #1730 - iRaise Sinus Lift System, a minimally invasive alternative to the sinus lift procedure - the most traumatic and difficult procedure performed in the dental clinic today
  • Company #1729 - Non-invasive medical devices and mobile health applications utilizing acoustic respiratory monitoring technology to improve the management of chronic respiratory diseases including asthma and COPD
  • Company #1728 - Small molecule oral therapeutic that combats osteoporosis and builds bone by inhibiting the activity of the Sclerostin protein
  • Company #1727 - Breakthrough implantable stimulation system that uses neuromodulation to treat refractory epilepsy
  • Company #1726 - Ultrasound instrument that combines light and doppler technology to monitor the efficacy of advanced breast cancer therapies; also offers a light-only version for home health
  • Company #1725 - Oncology and companion diagnostics with special capabilities in the area of mRNA and miRNA
  • Company #1724 - Biocompatible, biodegradable, collagen-based drug delivery implants to treat and prevent wound infection and manage pain
  • Company #1723 - Novel implantable and external brain stimulation devices for the treatment of neurological disorders
  • Company #1722 - Portable, ex vivo organ perfusion system designed to preserve donor organs, such as hearts, in a near-normothermic and beating state from retrieval to transplantation
  • Company #1721 - Innovative drug candidates to reduce intraocular pressure and treat retinal diseases
  • Company #1720 - Osteoporosis treatment through novel nasal spray
  • Company #1719 - Technologies for genetic analysis preparation to predict disease risk and drug response
  • Company #1718 - Novel first-in-class pharmaceuticals to improve vascular access in renal and vascular diseases
  • Company #1717 - Small molecule therapies for neurodegenerative diseases
  • Company #1716 - Topical mechlorethamine gel therapy for the treatment of early stage mycosis fungoides, a type of Cutaneous T-Cell Lymphoma
  • Company #1715 - Novel oral therapeutics to treat cancer, chronic kidney disease, chronic obstructive pulmonary disease (COPD), and neurodegenerative disorders
  • Company #1714 - Antithrombotic therapies for use in acute and subacute care
  • Company #1713 - Inhaled therapies to treat and prevent respiratory conditions including infections, progressive diseases, and allergic rhinitis
  • Company #1712 - Therapeutics to treat disease-associated pain and inflammation
  • Company #1711 - Novel electronic whole-genome sequencing employing solid-state technology
  • Company #1710 - Novel prescription products targeting reduced submental fat
  • Company #1709 - Antibiotics focused on Riboswitches (RNA drug targets) to treat drug resistant fungal and bacterial pathogens
  • Company #1708 - Novel therapeutics for the treatment of drug addiction and smoking cessation through reduction of craving function in brain
  • Company #1707 - Gene-, protein-, and serum-based biomarker analysis technology to identify potential cancer
  • Company #1706 - Novel therapeutic antibodies for the treatment of infectious disease, cancer and inflammation
  • Company #1705 - Automated microfluidic systems and instrumentation for single-cell analysis
  • Company #1704 - Natural color dental implants to restore function and aesthetics
  • Company #1703 - Antiviral pharmaceuticals that bind to caspids to treat HIV and HBV
  • Company #1702 - Live tumor cell processing platform for predictive testing which uses functioning signaling profiles to guide cancer therapy
  • Company #1701 - Novel molecular therapies for the treatment and prevention of metabolic disease associated with altered mitochondrial function
  • Company #1700 - High concentrate Omega-3 fatty acids for use in pharmaceuticals, developed from algae
  • Company #1699 - Novel molecules to target chronic T-cell mediated inflammatory diseases
  • Company #1698 - Point-of-care blood and urine analyzer to detect infectious disease and test blood levels; lab-quality results available within minutes of testing
  • Company #1697 - Atraumatic, self-retaining surgical tissue retractors for thyroidectomy and related procedures that feature low profile, disposable designs
  • Company #1696 - Vertical lumbar traction system to realign spine, reduce disc herniation and lower back pain
  • Company #1695 - The Duette(TM) Bladder Protection Catheter is designed to reduce the clinically confirmed, common adverse effects of traditional Foley catheters, including the occurrence of catheter-associated urinary tract infections (CAUTI)
  • Company #1694 - Biopolymer implants, biomaterials and therapeutics to repair damaged heart structure and treat congestive heart failure
  • Company #1693 - DNA-based diagnostic tests used to detect diseases and conditions affecting women, such as endometriosis, infertility, and pre-term labor
  • Company #1692 - Brain Anaesthesia Response (BAR) monitoring system to improve existing EEG technology and reduce intra-operative awareness
  • Company #1691 - High-quality reconstructive total joint implants for the hip and knee
  • Company #1690 - Whole-Body Thermometry (WBT) advanced medical diagnostic device for non-invasive analysis, including tissue signature disorder recognition
  • Company #1689 - Technology that enhances the efficacy of current standard-of-care pharmaceuticals used in major psychiatric disorders with a high unmet medical need
  • Company #1688 - Innovative technologies for patient monitoring to include neurological, cardiovascular and pain management indications
  • Company #1687 - Novel biomaterials that can be used in a wide array of tissue reconstruction applications, including but not limited to: urology, dermatology, osteoarthritis, and podiatry
  • Company #1685 - 1-A ratcheting 2.7mm percutaneous access grasper and 2-An electrosurgical pencil which lights up the surgical site with 3 bright LEDs powered by two Li-ion batteries contained within the pencil
  • Company #1684 - Enhanced therapeutics for health maintenance, disease prevention, and the treatment of certain cancers, infectious diseases, and Central Nervous System (CNS) disorders
  • Company #1683 - Novel allogeneic cell-derived biomaterials that do not require synthetic scaffolds and are used to regenerate cardiovascular and other soft tissues
  • Company #1682 - Automated devices for Remote Ischemic Conditioning (RIC), a non-invasive protocol that simply enables powerful innate protection in cardiovascular and stroke applications
  • Company #1681 - 1-TRC105 is a Phase 2 monoclonal antibody that binds CD105 (endoglin), a membrane receptor on endothelial cells that is required for angiogenesis; it is expected to complement chemotherapy and treatment with VEGF inhibitors, including Avastin(R) or Lucentis(R). 2-TRC102 is a Phase 2 ready small molecule inhibitor of base excision repair that reverses resistance to antimetabolite and alkylating agent chemotherapies
  • Company #1680 - Aerosol drug delivery systems, aimed predominately at the critical care respiratory market
  • Company #1679 - Innovative instrument to simplify insertion of artificial spinal disc implants
  • Company #1677 - ICDR, a simple yet sophisticated Internal Cavity Drug Retention system for controlled and highly effective delivery of therapeutic agents into the bladder. Based on advanced materials technologies, the ICDR system improves drug bioavailability and reduces toxicity, significantly enhancing treatment potential, safety, and compliance.
  • Company #1676 - Point-of-care device that efficiently extracts adult stem cells from a small sample of autologous adipose tissue in a fully enclosed and automated process
  • Company #1675 - Disposable medical device to improve stroke risk during heart bypass procedures
  • Company #1674 - A pioneering ozone-oxygen-vacuum system for healing chronic, hard-to-heal wounds. The technology is non-invasive and medically proven for diabetic foot, PVD, venous ulcers, and more.
  • Company #1673 - EpiLert is a wireless, watch-like device providing real-time ALERT to CAREGIVERS of an ongoing epileptic seizure
  • Company #1672 - Resin-based vehicles that quickly deliver medications transmucosally to the bloodstream and formulations that treat such conditions as smoking cessation, anxiety, chronic breakthrough pain, and migraines
  • Company #1671 - A high-resolution, small field-of-view gamma camera, optimized to perform BSGI/MBI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake
  • Company #1670 - Self-adjustable vaginal ring pessary to treat urinary incontinence and genital prolapse without drugs
  • Company #1669 - Molecular cytology solutions, including a thyroid fine needle aspiration analysis gene expression product
  • Company #1668 - Next generation G-protein coupled receptor-biased ligand pharmaceuticals which are intended to limit adverse drug effects
  • Company #1667 - Novel biotherapeutic technologies featuring self-contained subcutaneous delivery mechanisms
  • Company #1666 - Ultra-sensitive immunodiagnostic systems for use in research and in vitro diagnostics
  • Company #1665 - Therapeutics based on natural killer cells (NKT), a subset of immune cells, intended for the treatment of autoimmune and inflammatory diseases in addition to asthma, cancer, and dermatitis
  • Company #1664 - Innovative antibiofilm catheter lock technology to reduce infection associated with indwelling catheters
  • Company #1663 - Patient-specific epigenetic therapeutics utilizing small molecule histone methyltransferase (HMT) inhibitors for the treatment of cancer
  • Company #1662 - Expanding hydraulic implant for use in lumbar spinal fusion procedures
  • Company #1661 - Novel small molecule therapies for respiratory disorders
  • Company #1660 - Novel diagnostics utilizing protein-based biomarker technology focused on acute renal failure/kidney injury
  • Company #1659 - Targeted oral therapeutics to correct mineral metabolism and metabolic disorders
  • Company #1658 - Proprietary implant technology featuring a hypoglossal nerve stimulation system for the treatment of obstructive sleep apnea (OSA)
  • Company #1657 - Cosmetic and drug delivery systems based on nanotechnology
  • Company #1656 - Innovative therapies utilizing pepducins to modulate G-protein receptors, thereby expanding treatments for cancer, diabetes, inflammation, and regenerative medicine
  • Company #1655 - Therapeutics for the treatment of post-operative and chronic pain
  • Company #1654 - Novel ophthalmic therapies to treat ocular diseases
  • Company #1653 - Third-generation transcatheter aortic valve prosthesis (TAVR) with increased safety, greater ease-of-use, and longer durability
  • Company #1652 - Ultrasonic devices for non-invasive fat removal from the chin, arm, and eye-bags and for skin tightening
  • Company #1651 - The Rx Timer Cap is a patented \"smart cap\" with a built-in LCD timer that fits common prescription vials and lets patients know exactly how long it has been since they last took their medication
  • Company #1650 - Sutureless, adjustable mitral annuloplasty toolset for surgical and robotic procedures
  • Company #1649 - A novel biodegradable annuloplasty ring for heart valve repair, approved for use in pediatric patients
  • Company #1648 - The first home-based telemonitoring system for patients with age-related macular degeneration, the leading cause of blindness in people over age 50 in the western world
  • Company #1647 - A nanotechnology-enabled portfolio of therapeutic products for use in medical applications
  • Company #1646 - Proprietary technology for decellularizing biological organs/tissues to create an extra-cellular matrix retaining its original architecture, mechanical properties, and vascular network - suitable for scaffold transplantation or growing new functional organs/tissues by recellularization
  • Company #1645 - A battery-powered device which lifts and acquires a healthcare patient weighing up to 500 lbs. - without any caregiver\'s touching, logrolling, or lifting - and transports them to the next destination, then gently discharges them onto the desired horizontal surface
  • Company #1644 - The patented EXMI technology uses pulsed magnetic fields that penetrate up to 7,5 cm into the body, stimulating nerves (neuromodulation), contracting muscles (rehabilitation), treating pain/depression, and increasing blood flow
  • Company #1643 - Requiring only one drop of blood, the proprietary LBIdx(TM) Plasma Thermogram(TM) tests will significantly improve the clinical diagnosis and monitoring of autoimmune disease and cancer, vastly improving patient outcomes
  • Company #1642 - New gene-based medicines to treat \"dominant\" genetic diseases, particularly for the eye
  • Company #1641 - Technology that provides an immediate cardiovascular risk prediction for major chronic diseases, such as diabetes. The method is convenient, easy-to-use, and validated. It measures tissue accumulation of Advanced Glycation End products (AGEs) by means of fluorescence techniques. AGEs play a key role in the pathogenesis of many age-related diseases, such as diabetes and cardiovascular disease.
  • Company #1640 - An oral delivery platform for medications, food supplements, and other soluble substances that is easy-to-use, friendly, inexpensive, and requires no third-party assistance
  • Company #1639 - Ventritek 105 is a novel medical device that provides full treatment for Stroke/SAH/ICH patients by replacing the current long and risky procedure
  • Company #1638 - An inhaler with variable dosage of Asthma medicine, based on a built-in exhaling measurement of the airway obstruction level
  • Company #1637 - The RGS Vertex360(TM), which competes with the Gamma knife in the non-invasive treatment of brain tumors, is a highly precise cobalt 60 radiation system that utilizes the OsiriX(TM) based Explorer 4D(TM) treatment planning system, also developed by the company
  • Company #1636 - Innovative central nervous system therapies; Allon is proceeding in a fully enrolled pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP)
  • Company #1635 - Vaccine platform technology for cancer and infectious diseases based on Listeria monocytogenes that has been engineered to be safe for use in humans and express specific disease antigens
  • Company #1634 - Easy to use, real-time, noncontact, thermal mapping systems to determine intrabody tissue temperatures
  • Company #1633 - Oncology drugs that utilize novel mechanisms of action
  • Company #1632 - Electronic stimulation technologies that maintain muscle strength during recovery in the intensive care unit or other periods of inactivity
  • Company #1631 - The fentanyl iontophoretic transdermal system (IONSYS), an investigational, pre-programmed drug delivery system comprising a compact, needle-free, self-contained system that provides patient-controlled analgesia for adult inpatients requiring post-operative opioid therapy
  • Company #1630 - Two novel technologies that boost immune responses, including a synthetic toll-like receptor agonist for use as an adjuvant to vaccines , and a viral vector that targets immature dendritic cells
  • Company #1629 - A molecular diagnostics test that examines somatic alterations in cancer-related genes by applying massively parallel sequencing to routine clinical specimens, enabling targeted therapy
  • Company #1628 - Nanofibers designed for use in tissue engineering, drug delivery, and wound care
  • Company #1627 - Vascular closure device that seals the femoral artery following cardiac catheterization
  • Company #1626 - An aerosolized long-acting muscarinic antagonist that treats chronic obstructive pulmonary disease (COPD)
  • Company #1625 - Novel metal abstraction peptide (MAP) platform technology that delivers platinum to cancer cells by incorporating it into cancer-targeting proteins, thereby improving treatment while limiting side effects and damage to healthy cells
  • Company #1624 - Long-acting, intravenous lipoglycopeptide used to treat acute bacterial skin and skin structure infections
  • Company #1623 - Innovative new topical therapies for dermatology applications, including photodynamic therapy for sebaceous gland disorders and small molecule therapeutics that treat acne, inflammatory skin diseases, and sebaceous gland hyperactivity
  • Company #1622 - Minimally invasive surgical devices for the treatment of sinusitis
  • Company #1621 - Novel drugs that treat cancer by targeting cellular protein homeostasis pathways
  • Company #1620 - A next-generation eye drop medication that uses Rho-kinase inhibitors to treat glaucoma
  • Company #1619 - Minimally invasive spinal disc regeneration technologies (SRTs) with a goal of biologically regenerating the tissues of the disc to restore the natural visco-elastic, biomechanical, and fluid characteristics of the inner core and outer tensil ring
  • Company #1618 - MedApps\' solutions utilize cloud computing to connect patients and professional care providers, enabling proactive healthcare delivery
  • Company #1617 - Novel 3D cell culture devices for stem cell, tissue engineering, cancer, and drug discovery applications
  • Company #1616 - Developing a whole-plant therapeutic, AMZ0026, that exhibits immunomodulator properties for the treatment of HIV/AIDS. Preliminary clinical studies in patients that are seropositive for HIV-1 have demonstrated a positive effect on CD4 and CD4/CD8 blood serum levels.
  • Company #1615 - A Leptin product as a novel hormone replacement therapy for Alzheimer\'s disease (AD) and/or as a preventative for those who are at risk
  • Company #1614 - EMMA (Electronic Medication Management Assistant) - a remote medication administration unit that is placed in a patient\'s residence to enable a healthcare professional (i.e., pharmacist or nurse) to remotely administer their oral medications
  • Company #1613 - Next-generation, low profile, pre-mounted and pre-packaged \"package-to-patient\" percutaneous transcatheter heart valve
  • Company #1612 - EPIFLO utilizes cutting-edge oxygen concentration technology to create tissue regenerative processes driving closure of delayed-healing acute or chronic wounds
  • Company #1611 - Drugs to treat dry Age Related Macular Degeneration (dAMD) and other vascular diseases of the eye, including Glaucoma, DME, and Diabetic Retinopathy
  • Company #1610 - Endoluminal device for incisionless treatment of obesity
  • Company #1609 - Double radiologists\' productivity and improve patient outcomes by using image processing software to detect and measure clinical findings and produce preliminary reports for the radiologist at the customer\'s site
  • Company #1608 - Developer of easy-to-use genetic tests (clinically validated DNA SNP patterns) that empower individuals to prevent certain chronic conditions and manage their existing health and wellness through actionable guidance
  • Company #1607 - A therapeutic for HIV that is divergent from current approaches, in that rather than fight against HIV\'s greatest strengths - mutation frequency & rate of replication - the drug exploits these \"strengths\" to cause viral population collapse
  • Company #1606 - A device that uses non-invasive ultrasound to disrupt the blood-brain barrier, for delivery of large molecule therapeutics to treat primary and metastatic brain tumors
  • Company #1605 - The company\'s testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology, and molecular genetic testing
  • Company #1604 - Developing healthier drugs from whole-plants. MAHDL, developed to elevate HDL-C, has undergone tests in man with positive results and has an IND from the FDA. Other whole-plant therapeutics are under development for dementia.
  • Company #1603 - ZeroFold, the lowest profile balloon available for improving deliverability and effectiveness of balloon angioplasty catheters
  • Company #1602 - A revolutionary technology to sterilize proteins in dehydrated formulations by irradiation (beta, gamma) or Ethylene Oxide
  • Company #1601 - Next-generation vaccines based on patented LAMP Technology that induce a strong and complete immune response, with applications in allergy, cancer, and infectious disease
  • Company #1600 - The world\'s first homozygous parthenogenetic stem cell lines that can provide therapeutic cells with the potential to be transplanted into hundreds of millions of individuals of differing ages and racial backgrounds with minimal risk of immune rejection
  • Company #1599 - A web-enabled, low level electromagnetic therapy system, that provides HealthCare providers in the Complementary and Alternative Medicine (CAM) marketplace with a device that improves both their Patients\' Health and their Business
  • Company #1598 - Bioluminescent (light producing) proteins and related substrates that can: 1-be used as an adjunct to surgery, including laparoscopy, 2-track the progression of disease and evaluate the effectiveness of therapy, and 3-diagnosis a disease process before there are symptoms or anatomical features such as tumors
  • Company #1596 - A patented ultrasound miniaturization technology which has enabled the creation of iPod-sized ultrasound pain therapy systems with operation times of up to 6 hours on a single cell phone battery
  • Company #1595 - Miniaturized, hand-held, instrument-mounted optical measurement and navigation systems for surgical applications
  • Company #1594 - Turnkey SaaS software solution that dramatically reduces errors, turnaround times, and costs of MRI, CT, and PET-CT diagnostic reports
  • Company #1593 - Fast-track development of novel drugs for an unmet medical need - Alzheimer\'s disease - with rapid payback on investment
  • Company #1592 - Technology platforms that improve surgical efficiency in complex orthopedic procedures such as total joint replacement, spinal fusion, and trauma fixation: 1-For medical device manufacturers, RepAssist(TM) reduces training costs, dramatically compresses the time it takes for new reps to provide value in the OR, and enhances rep efficiency with existing accounts. 2-For hospitals/surgery centers, Virtual Backtable(TM) significantly enhances OR team proficiency in organizing and utilizing instrumentation, independent of the team\'s experience level with the implant system or surgeon, resulting in improved surgical efficiency and higher surgeon satisfaction.
  • Company #1591 - Implantable devices that allow surgeons to reduce the morbidity of spinal deformity surgery with a procedure that is quicker, safer, and more cost-effective than existing techniques
  • Company #1590 - Minimally invasive, joint preserving treatment option for chronic knee osteoarthritis (OA) pain; an alternative to total knee replacement (TKR)
  • Company #1589 - Minimally invasive, fragment-specific system that effectively addresses a wide range of fracture types with fixation strength equivalent to that of locking plates
  • Company #1588 - Intra-articular ion channel modulators for the treatment of osteoarthritis (OA) in all synovial joints
  • Company #1587 - A breakthrough platform technology that provides highly porous (>65%), load-bearing orthopedic implants in both surface active (metal, ceramic) and resorbable materials
  • Company #1586 - Low-cost, point-of-care (POC) ELISA-based adjunctive screening kit specifically for oral cancer
  • Company #1585 - A neurostimulation technology to improve function and independence after stroke
  • Company #1584 - Novel portable diagnostic tool to detect a wide variety of protein analytes and un-amplified DNA at point of care
  • Company #1583 - Smart Medical Devices, Inc., a company founded by surgeons for surgeons, developed the revolutionary dual-motor SMARTdrill® to improve patient outcomes in orthopedic surgery. Only the SMARTdrill® measures depth, prevents plunge, measures bone density, reduces waste, provides real-time performance data, and uploads the data to a global bone database.
  • Company #1582 - An affordable drug delivery pump/patch that is cost-competitive with pre-filled pen injectors and offers a superior end-user experience
  • Company #1581 - A disruptive, non-invasive, and long-term neuro-monitoring technology with the potential to reduce stroke and damage from aneurysms, tumors, and other neurologic trauma
  • Company #1580 - A minimally invasive stent platform that offers safe, simple, and accelerated healing for the treatment of endoluminal diseases
  • Company #1579 - Pulse Flowmeter - a new patient monitor that provides a more sensitive indicator of blood loss or heart failure than monitoring blood pressure
  • Company #1578 - An ultrasensitive hand-held probe that is capable of detecting specialized, subcutaneously injected magnetic materials and is used to locate lymph nodes to support the diagnosis and treatment of cancer
  • Company #1577 - A non-invasive, accurate, and easy-to-use female fertility monitor
  • Company #1576 - A low-cost incision guide that is applied with an adhesive sticker before a medical scan and leaves behind an ink imprint of locational markings (such as a grid or ruler) on the patient\'s skin so that the surgeon can accurately correlate target locations with the medical image
  • Company #1575 - Technology that enables and facilitates seamless stenting of all coronary bifurcation disease scenarios
  • Company #1574 - A biopharmaceutical company with an extensive library of structurally diverse bioactive peptides with broad applications in the health, beauty, and pharmaceutical industries
  • Company #1573 - A spray-dried plasma product to improve the survival rate of patients suffering from blood loss
  • Company #1572 - A mechanical thrombectomy kit that will help restore blood flow and reduce hemorrhagic complications associated with acute ischemic stroke therapy
  • Company #1571 - Miniature infrared thermal imaging cameras combined with a spectroscopic infrared real-time in vivo analysis device for the early detection/accurate identification of internal lesions and tumors, as an add-on to existing endoscopes
  • Company #1570 - A unique lipid-soluble anti-oxidant heavy metal chelator that is safe and effective, for which the company is pursuing orphan drug approval
  • Company #1569 - ImplantLock, a device that enables a safe alternative to vertical bone augmentation or sinus lifting as well as immediate functional loading even after tooth extraction
  • Company #1568 - Advanced medical technology that combines CO2 laser capabilities with autologous stem cells to significantly improve cardiac output in patients with heart disease or heart failure
  • Company #1567 - A take-home conception aid system that is designed to address the growing unmet need of delayed/unsuccessful natural fertility that historically has had similar results to intrauterine insemination (IUI), yet can now be done in the privacy of the home
  • Company #1566 - Integrated molecular diagnostic system that is easy to use and requires little or no training
  • Company #1565 - Technologies that: 1-Temporarily plug body passageways with a thermo-transitioning gel that is delivered as a cold liquid, solidifies at body temperature, and is later flushed away and 2-Keep body passageways open with gentle passively dilating devices, as well with more rigid construction of an open design, to prevent eventual long-term blockage
  • Company #1564 - Non-invasive disposable device to automatically deliver a new therapy called *Remote Ischemic Preconditioning*, an adjunct to traditional treatments for heart attack and stroke that mitigates ischemia-reperfusion injury and has been clinically shown to reduce infarct size by 50%, without side effects
  • Company #1563 - Biologically compatible polymers that provide non-surgical regenerative therapies for treating chronic and acute episodes of pain
  • Company #1562 - The only device-based treatment for various conditions known to contribute to Preterm Rupture of Membranes (PROM) and Preterm Birth (the leading cause of infant death and morbidity within the 1st month of life)
  • Company #1561 - The first miniature and highly accurate guide for brain surgery that is fully MRI-compatible and gives the possibility to perform simultaneous bilateral procedures, in addition to being easy-to-use and cost-effective
  • Company #1560 - A hand-held device with a touch-screen interface that identifies a patient\'s preferred language and then collects his/her information, medical history, symptoms, and complaints, which are then summarized into the caregiver\'s language and can be accessed on the device/through a facility\'s electronic health records (EHR) system
  • Company #1559 - Innovative single-use surgical retractors designed to manage all MIS exposure needs in gynecological, digestive, visceral, and vascular surgery
  • Company #1558 - Small, discrete, and disposable device to reduce food intake
  • Company #1557 - Cartilage repair using cell therapy - true, 100% hyaline cartilage tissue, in a single procedure, using an off-the-shelf product
  • Company #1556 - Low-cost, next-generation digital mammography machines
  • Company #1555 - Genetic test for expectant mothers that detects spina bifida
  • Company #1554 - Hand-held, disposable device that transdermally removes spider and reticular veins without a sclerotherapy agent
  • Company #1553 - Needle-free silicone patch for vaccine delivery
  • Company #1552 - Next-generation PCR system that can provide absolute quantification of nucleic acid molecules, at higher resolution and lower target levels than the current standard, thereby identifying diseases earlier in progression
  • Company #1551 - ClearRing is a minimally invasive prostatic reshaping implant for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia
  • Company #1550 - Immediate detection and identification of bacteria in bodily fluids through optical spectroscopy with low quantities of material without bacteria culturing
  • Company #1549 - Temporary implantable ventricular assist device (VAD) that wraps around the heart and squeezes it to help pump blood
  • Company #1548 - Non-invasive nitric oxide gas (gNO) technology and iontophoresis drug delivery for treating diseases of the skin and nails
  • Company #1547 - Immunomagnetic cell capture system which isolates and removes pathogens directly from the blood in under 30 minutes
  • Company #1546 - Synthetic 3D extracellular matrices to support tissue growth for use in a wide range of regenerative medicine
  • Company #1545 - Small molecule plasma kallikrein inhibitors for the treatment of diabetic macular edema (DME)
  • Company #1544 - Prefilled, easy-to-carry epinephrine auto-injection device for people with severe allergies
  • Company #1543 - Micro-needle skin patch for delivery of the influenza vaccine
  • Company #1542 - Hand-held device that sublingually monitors changes in carbon dioxide (CO2) levels for the prevention of septic shock
  • Company #1541 - Minimally invasive memory polymer devices for use in peripheral vascular, non-vascular, and neurovascular applications
  • Company #1540 - Energy-based thermal surgery device that provides better soft tissue cutting and coagulation
  • Company #1539 - Aerosol-based inhaled insulin delivery device
  • Company #1538 - A light-based medical device in the form of an LED patch with a proprietary, optimized formulation of light which triggers local, controllable, and safe Nitric Oxide (NO) production to treat diseases triggered by underlying vascular dysfunction
  • Company #1537 - Implantable, wireless, intracranial pressure monitor for use in patients with tumors, prior strokes, and traumatic brain injuries (TBI)
  • Company #1536 - Self-expanding, fully removable, temporary inferior vena cava (IVC) filter used in conjunction with the placement of a central line for the prevention of pulmonary embolism
  • Company #1535 - The BNX(TM) (Beacon-Needle-eXchange) needle delivery system for use in gastrointestinal endoscopic procedures including: Endoscopic Ultrasound (EUS), Endoscopic Bronchial Ultrasound (EBUS), and Endoscopic Retrograde Cholangio-Pancreatography (ERCP)
  • Company #1534 - Low-cost mobile device and software that adapts smartphones into ECG machines
  • Company #1533 - Next-generation prefilled drug delivery devices, including prefilled syringes, auto-injectors, and IV systems, offering improved product performance at lower costs
  • Company #1532 - 3-D, real-time cardiac surgical imaging system
  • Company #1531 - Hand-held, non-contact vein illumination device for imaging veins just below the surface of the skin
  • Company #1530 - Miniaturized, continuously adaptable, left ventricular assist device (LVAD) for the treatment of heart failure
  • Company #1529 - Drugs to treat breast and other cancers by targeting cancer stem cells
  • Company #1528 - Biometric sensors for integration in wearable and hearable devices
  • Company #1527 - Drug therapy for the treatment of rare diseases such as hereditary inclusion body myopathy (HIBM)
  • Company #1526 - Compounds for oncology indications, including: 1-the prevention of A) chemotherapy-induced nausea and vomiting (CINV), B) post-operative nausea and vomiting (PONV), and C) chronic cough and 2-treatment for patients with non-small cell lung cancer (NSCLC) whose tumors express an Anaplastic Lymphoma Kinase (ALK) fusion protein
  • Company #1525 - Portable, self-contained system for the precise minimally invasive removal of diseased tissue, to restore natural tendon and soft tissue function in the elbow, knee, ankle, foot, and shoulder
  • Company #1524 - Thermal pulsation system for effective, in-office treatment of evaporative dry eye
  • Company #1523 - Non-invasive neuromodulation device that exposes the brain to an oscillating magnetic field, for the treatment of psychiatric and neurological disorders such as major depressive disorder and bipolar depression
  • Company #1522 - Real-time orthopedic surgery imaging system that will save valuable time for surgeons and hospitals, while improving surgery accuracy and patient safety
  • Company #1521 - An interactive, computer-assisted system utilizing image-guided robotics to enhance the quality of hair follicle harvesting during hair restoration surgery
  • Company #1520 - Wireless, non-invasive, and portable brainwave recording device for convenient at-home sleep monitoring and analysis to: 1-offer insight into the diagnosis and treatment of conditions such as Alzheimer\'s, autism, cancer, epilepsy, depression, and schizophrenia and 2-reveal how drugs affect the brain
  • Company #1519 - Implantable drug delivery device using nanochannel-based chip to control/modulate release
  • Company #1518 - Non-invasive device to alleviate the symptoms of subjective tinnitus that synchronously presents sound using headphones and tactile representations to an intra-oral array on the tongue
  • Company #1517 - A family of single-use devices that provide quantitative pressure measurements, while alleviating doubt and uncertainty during common medical procedures such as central line insertions, spinal taps, and epidurals
  • Company #1516 - Ozone technology for medical applications with initial focus on the treatment of spinal disorders related to herniated discs
  • Company #1515 - Bone anchorage technology for use in spine, trauma, and general orthopedics
  • Company #1514 - Non-systemically absorbed compounds for the treatment of diabetes and obesity, as an alternative to gastric bypass surgery
  • Company #1513 - Diagnostic tests that leverage the ability to extract clinically relevant information from maternal blood, including a non-invasive prenatal test to diagnose specific genetic and other inherited disorders
  • Company #1512 - Regenerative stem cell therapy to treat heart failure (HF), acute myocardial infarction (MI), angina, peripheral artery disease (PAD), and hard-to-heal wounds including burns, diabetic foot ulcers, venous stasis ulcers, and pressure ulcers
  • Company #1511 - A non-invasive hand-held system for accurately measuring circulating blood volume in real-time, to quickly identify and treat shock
  • Company #1510 - Device used to safely deliver epidural anesthesia during childbirth and other procedures
  • Company #1509 - Implantable neurostimulation device for the treatment of obstructive sleep apnea (OSA)
  • Company #1508 - Pressurized olfactory drug delivery device to bypass the blood brain barrier and deliver greater pharmaceutical concentrations
  • Company #1507 - Pancreatic islet cell transplantation as a potential cure for Type I diabetes
  • Company #1506 - Liver dialysis system that removes protein-bound toxins plus water-soluble toxins from blood and is more effective and cost-efficient than currently available therapies
  • Company #1505 - System that is capable of simultaneous quantitative and independent determination of up to 100 biomarkers in individual cells, not possible with existing technologies, for early disease diagnosis and monitoring of treatment efficacy
  • Company #1504 - Molecular testing that analyzes gene expression in airway epithelial cells to detect early signs of lung cancer
  • Company #1503 - Biocompatible surgical mesh with high tensile stiffness and strength, similar to native tendon, that is sutured over torn or degenerative tissue as a reinforcement to surgical repair to allow for rapid tissue in-growth
  • Company #1502 - Next-generation quantitative angiography
  • Company #1501 - A \"smart shirt\" that can count a patient\'s heartbeats through its sensors, record a medical quality electrocardiogram (ECG), and detect the respiration rate, body temperature, and position of the patient (standing, walking, lying, asleep, or fallen)
  • Company #1500 - Soft, flexible devices with tissue-like characteristics that can be used for health and wellness, cardiology, and neurology to make surgical diagnosis and treatment easier - based on a new generation of thin, conformal electronics technology that endures bending, twisting, and stretching without sacrificing performance
  • Company #1499 - Technology that manages the exit sites of central venous catheters by promoting the formation of a biological seal around the catheter that blocks the route for bacteria
  • Company #1498 - A non-invasive, optical brain monitor for monitoring hypnosis (depth of anesthesia) and level of sedation via direct non-invasive measurement of changes in deoxyhemoglobin (deoxy Hb)
  • Company #1497 - A disposable skin patch that provides diabetics with a painless, BLOODLESS, easy-to-use, and rapid method for monitoring glucose levels
  • Company #1496 - Developer of advanced biomedical devices that assemble scaffolding in such a way that mimics human tissue structure and directly influence cell behavior
  • Company #1495 - Revolutionary HyperQ technology based on advanced signal processing of the high frequency ECG signal, enabling more accurate results in the initial diagnosis of coronary artery disease (CAD)
  • Company #1494 - Optical Ultrasound Tomography(R) (OUT) identifies brain injuries, brain hematomas, malignant breast cancers, and Inflammatory Breast Cancer safely and quickly and displays 3D images in \"real time\" and can transmit the images to waiting hospitals and surgeons. The cameras are lightweight and portable, and can be mounted on a bedside providing continuous monitoring of hemorrhages and the flow of blood. They can be used in an ambulance, on the battlefield, on the Little League field, and in the ER.
  • Company #1493 - A scalable molecular diagnostic chip platform that will allow for the diagnosis of diseases in five minutes as well as in-home monitoring of conditions such as: profound venous thrombosis, embolisms, and myocardial infarctions (MI)
  • Company #1492 - Transcutaneous vagus nerve stimulation to treat patients suffering from drug-resistant epilepsy or other difficult-to-treat neurological and psychiatric disorders
  • Company #1491 - Implantable device consisting of a series of miniature magnetic beads, linked together to form a "bracelet" around the Lower Esophageal Sphincter (LES) for the treatment of gastroesophageal reflux disease (GERD)
  • Company #1490 - Wireless 3G cellular-enabled blood glucose meter that instantly transmits glucose values to a care-management server and provides instant feedback and coaching to patients with diabetes
  • Company #1489 - Accurate, ultra-low-cost whole genome sequencing by way of a simple, single-molecule detection process
  • Company #1488 - Drug therapy focusing on the carotid body for the treatment of sleep-related breathing disorders
  • Company #1487 - Deep brain stimulation probe technology for advanced and personalized treatment of degenerative or functional brain disorders, such as Parkinson\'s disease and dystonia
  • Company #1486 - Versatile, easy-to-use, accurate, and cost effective aorto-ostial stent positioning system to facilitate precise stent implantation in coronary and renal arteries
  • Company #1485 - Device that increases the size of skin grafts without the use of chemicals, biologics, or enzymes
  • Company #1484 - Immediate and permanent contraception implant for women to use as an alternative to surgical tubal ligation
  • Company #1483 - Tissue expander technology that allows both diagnostic and therapeutic capabilities never before available during tissue expansion
  • Company #1482 - Tendon repair device that utilizes a simple and familiar technique to ingeniously join tissue together, with broad applications across a range of surgical sub-specialties
  • Company #1481 - Novel solutions for wound closure
  • Company #1480 - Sternal closure system that maintains rigid fixation of the sternum in multiple directions of force and eliminates the common causes of sternal dehiscence
  • Company #1479 - Bioseparation technology, for use outside of the research lab, with broad applications from molecular diagnostics to transplant therapies
  • Company #1478 - Non-invasive system for the treatment of acute ischemic stroke and other vascular disorders using externally applied ultrasound that can be rapidly and easily deployed by virtually any emergency room staff
  • Company #1477 - Genomics-based diagnostic tests for obstructive coronary artery disease (CAD), cardiac arrhythmias, and heart failure (HF)
  • Company #1476 - Nicotinic receptor agonist compounds for the treatment of asthma and other inflammatory respiratory and non-respiratory diseases
  • Company #1475 - Femoral vascular access catheter that uses a longer and shallower angle arteriotomy, providing better site closure WITHOUT vascular closure implants
  • Company #1474 - Surgical instruments, medical lasers, and other medical devices
  • Company #1473 - Next-gen disruptive aesthetic medicine device technology; non-invasive and painless approach for skin-tightening, wrinkle-reduction using electromagnetic heat induction
  • Company #1472 - Cost-effective lab-on-a-chip system that anyone can use to get laboratory quality results in any location, within minutes, and with minimal training
  • Company #1471 - High resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate
  • Company #1470 - Proven patented technology platform that rapidly and accurately measures oxidative stress and oxidizability in blood and other biologic fluids, with multiple diagnostic applications
  • Company #1469 - Real-time pathology solution for cancer surgical guide, with microchip-based in vivo imaging systems
  • Company #1468 - A disposable, flexible conduit that provides a protective channel through which an endoscope is inserted for sinus surgery, to keep the introduction site open throughout the course of the procedure, thereby minimizing trauma along the nasal passageway
  • Company #1467 - Novel bilateral brain monitor with independent hemisphere indexing for the direct measurement of the effects of anesthetics and sedatives, which allows for patient-specific dosing
  • Company #1466 - Intelligent continuous glucose monitoring device utilizing recent innovations in microneedle and bluetooth technology, to provide a more accurate and pain-free method than what current devices offer
  • Company #1465 - Professional and home use devices for automated bladder assessment incorporating a novel, extremely compact, 3D ultrasound scan head and embedded image processing technology
  • Company #1464 - Ultrasound-based molecular imaging agents that can be used to: 1-diagnose and stage disease, 2-monitor response to therapy in the pharmaceutical research setting, and 3-elucidate the biology of disease processes in the basic science setting
  • Company #1463 - Portable brain sensing system to rapidly diagnose ischemic stroke at point-of-care; other indications include identification of brain trauma and cerebrovascular abnormalities and continuous monitoring of stroke patients
  • Company #1462 - Minimally invasive system for decompressing pinched nerves in the spine, based on highly maneuverable tools and a precise tissue-removal mechanism
  • Company #1461 - The VortexZDS(TM) indwelling urological catheter is designed to replace the Foley catheter and eliminate Urinary Tract Infections (UTIs); there is no retention balloon, thus, no to-and-fro movement across the meatus, where the biofilm forms
  • Company #1460 - Non-invasive real-time diagnostic tools for early detection, prevention, and management of Acute Kidney Injury (AKI) in critical care environments
  • Company #1459 - A unique permanent injectable bulking agent for the endoscopic treatment of GERD (chronic heartburn)
  • Company #1458 - Therapies for the treatment of acute wounds, chronic wounds, scarring, abnormal scarring, inflammation and pain, fibrosis, surgical adhesions, and orthopedic procedures
  • Company #1457 - A Percutaneous Tracheostomy (PT) system that simplifies the traditional PT technique to be used by more physicians OUTSIDE of the Operating Room (OR) and in faster times than current devices
  • Company #1456 - System for use in the collection of breast/nipple aspirate fluid for laboratory cytological testing
  • Company #1455 - Cardiac mapping catheters to analyze electrical heart activity for the diagnosis of cardiac arrhythmias
  • Company #1454 - Thermal infusion fluid warmer device that enables surgeons to manage and warm up to five fluids at once
  • Company #1453 - Next-generation insulin analogs for both the rapid-acting and long-acting insulin markets
  • Company #1452 - Infusion systems for the interventional radiology and interventional oncology markets, including for use in treating liver cancer
  • Company #1451 - Non-surgical, removable hearing device that transmits sound through the teeth for the treatment of single-sided deafness
  • Company #1450 - Transcarotid stent and neuroprotection system
  • Company #1449 - Next generation X-ray scintillator device that provides high resolution imaging
  • Company #1448 - Permeable, micro-porous, flexible, and user-friendly implants in tubular or patch shape for bone reconstruction and fracture repair in surgical procedures
  • Company #1447 - Flexible endoscopy and endoluminal surgery device
  • Company #1446 - Drug therapy for the treatment of inner and middle ear disorders
  • Company #1445 - In vivo optical imaging devices for real-time diagnosis in a broad range of applications
  • Company #1444 - Advanced neurodiagnostic technology system to identify and evaluate Alzheimer\'s disease, ADHD, and other cognitive disorders in an easy and noninvasive way
  • Company #1443 - Drug therapy by way of modulating the N-methyl-D-aspartic acid receptor for the treatment of depression and other central nervous system disorders
  • Company #1442 - Smartphone- and tablet-based ultrasound imaging systems
  • Company #1441 - Minimally invasive devices using radiofrequency (RF) energy for the treatment of gastroesophageal reflux disease (GERD) and fecal incontinence (FI)
  • Company #1440 - Portable, non-invasive device designed to offer transcutaneous pulsed electro-magnetic field stimulation therapy for treating post-operative pain and inflammation in superficial soft tissue
  • Company #1439 - Implantable electronic gastric stimulation device for the treatment of obesity
  • Company #1438 - High-intensity ultrasound energy for non-invasive reduction of arterial plaque
  • Company #1437 - Catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels
  • Company #1436 - Image-guided, robotically assisted platform using non-invasive and non-thermal technologies, capable of destroying tissue at a sub-cellular level
  • Company #1435 - Robotic and manual endoscopy devices for increased ergonomics during laparoscopic surgery
  • Company #1434 - Eye-tracking device for earlier diagnosis of Parkinson\'s disease and other neurological diseases
  • Company #1433 - Device that uses localized vibrations to reduce pain during injections
  • Company #1432 - Ingestible capsule for colorectal cancer screening
  • Company #1431 - Biologically active plastic surgical patch for rotator cuff and tendon injuries, designed to promote healing and formation of new bone
  • Company #1430 - Catheter-based drug delivery system for the treatment of vascular disease including thrombosis, inflammation, occlusions and restenosis
  • Company #1429 - Anti-infectives for the treatment of severe infectious diseases
  • Company #1428 - Device for the intraocular delivery of photoactive nanoparticles for the treatment of retinitis pigmentosa, macular degeneration, and diabetic retinopathy
  • Company #1427 - Venous stenting device and ablation technology for the treatment of chronic venous disease
  • Company #1426 - Devices that facilitate minimally invasive access to a beating human heart and the delivery of therapeutic options intended to treat complex cardiovascular diseases
  • Company #1425 - Customized Sound Therapy (CST) system for tinnitus therapy
  • Company #1424 - Artificial sphincter device for use in ostomy and stoma care
  • Company #1423 - Microcatheters for treating and preventing acute ischemic stroke
  • Company #1422 - Radiofrequency ablation system for the treatment of chronic low back pain
  • Company #1421 - Disposable device for the prevention of catheter-related infections from hemodialysis
  • Company #1420 - Single-use needle-free injection system for liquid medications
  • Company #1419 - Non-invasive Auto-Targeting Neurostimulation (ATN) device for high-stimulation pinpoint treatment of lower back pain
  • Company #1418 - Portable, patch-based device that delivers "slow release" ultrasound to treat localized pain and induce soft tissue healing
  • Company #1417 - Shape memory implants that restore motion and eliminate pain for patients requiring soft tissue repair, fracture fixation, or joint fusion
  • Company #1416 - Removable adhesion barriers for spinal, tendon, and nerve-related surgery to reduce post-operative scarring, pain, numbness, muscles weakness or limited motion
  • Company #1415 - Orthopedic implants for limb lengthening/correction/reconstruction
  • Company #1414 - Neurocatheter for the removal of blood clots in the brain
  • Company #1413 - Portable/mobile nuclear cardiology imaging system
  • Company #1412 - The first and only wire-independent embolic protection that uses any single guide wire of choice for the entire procedure and seamlessly integrates with standard workflow
  • Company #1411 - Single-use devices that will address epicardial access, protection, and treatment facilitating the electrophysiologist\'s ability to perform cardiac ablations more efficiently and with a higher degree of safety and effectiveness
  • Company #1410 - Irrigation devices for improved visualization during upper and lower gastrointestinal (GI) procedures
  • Company #1409 - DNA-testing platform that enables results from a wide variety of gene signatures to be delivered quickly, simply, and cost-effectively at the point-of-care (POC) within an hour
  • Company #1408 - Non-invasive medical devices to protect Diabetics who are susceptible to \"hypoglycemia\". FDA approved, the Diabetes Sentry is affordable, greatly improves the lives of patients wearing the device, and significantly reduces healthcare costs.
  • Company #1407 - High-stability, short-length expandable implants that eliminate the need for complex bone augmentation - shortening overall time to implantation and significantly lowering treatment costs
  • Company #1406 - System that cools cerebral spinal fluid to reduce injuries associated with spinal and cerebral ischemia
  • Company #1405 - Infection control technology that does something no other product can - protect and disinfect BOTH the needleless injection site and the end of the IV tubing male luer
  • Company #1404 - Biodegradable, inflatable balloon device which separates healthy organs from adjacent tumors receiving radiation therapy
  • Company #1403 - The first passive fetal movement monitor (detector, analyzer, and data logger) for expectant mothers to use at home
  • Company #1402 - A minimally invasive implantable pulse generator (IPG) to treat obese and type II diabetics by applying electrical stimulation to the duodenum
  • Company #1401 - Implantable artificial pancreas for the treatment of patients with Type I & Type II diabetes
  • Company #1400 - Non-invasive hand-held device that detects abnormal heart sounds and uses a smart-phone interface for the diagnosis of coronary artery disease (CAD)
  • Company #1399 - Aerosol technology which efficiently delivers therapeutics into the abdominal cavity of patients during surgery to combat post-surgical complications such as pain and adhesions
  • Company #1398 - Self-powered miniature pacemaker and leadless electrodes implantable through minimally invasive procedures; used to treat arrhythmia
  • Company #1397 - Innovative sutureless technology for blood vessel anastomosis
  • Company #1396 - Incubator with 12 fully owned portfolio companies and 20+ fully owned pipeline technologies, driven by unmet market needs
  • Company #1395 - Non-invasive patient monitoring solutions for cerebral and tissue blood flow
  • Company #1394 - Functional optical imaging technology for the early diagnosis and guided treatment of blinding retinal diseases and diseases of other organs of the body; it is the only optical imaging approach that allows visualization of the capillaries, non-invasively (without any contrast agent)
  • Company #1393 - A point-of-care diagnostic system for rapid, sensitive, quantitative biomarker panels that delivers laboratory-quality results in a clinic or doctor\'s office, within minutes
  • Company #1392 - Next-generation, cost-effective ophthalmic implants for patients suffering from glaucoma and corneal blindness
  • Company #1391 - Continuous glucose monitoring system using an intravascular, optical fluorescence-based sensor to support clinical implementation of tight glycemic control (TGC) in the intensive care unit (ICU)
  • Company #1390 - Non-invasive devices for continuous real-time evaluation of hemodynamic changes
  • Company #1389 - Grafts for small diameter (less than 5mm) artificial blood vessels in both peripheral and coronary applications
  • Company #1388 - 1-Deep brain stimulator (DBS) to treat movement disorders, 2-A hybrid auditory implant (HAI) to treat severe hearing loss
  • Company #1387 - Innovative hydrogel technology for tissue repair including cartilage, bone, and dermal of the knee, wrist, elbow, shoulder, and ankle
  • Company #1386 - An ophthalmic device company delivering Navigated Retinal Laser Therapy to address the unmet need for durable and cost-effective outcomes in the treatment of major vision-threatening retina diseases, primarily caused by a complication of diabetes
  • Company #1385 - Best-in-class platform to optimize genes and proteins in human therapeutics
  • Company #1384 - Cloud/web-based medical imaging data management software and infrastructure as services - to replace picture archiving communication system (PACS) at a significantly reduced cost
  • Company #1383 - Incubator with over 100 highly novel medical technology inventions spanning most medical markets
  • Company #1382 - The only minimally invasive cure for spinal stenosis that maintains the natural dynamics of the spine
  • Company #1381 - Technology to embed Nitric Oxide (NO), part of the innate immune system, into polymer medical devices to make them antimicrobial without the issues of antibiotic resistance
  • Company #1380 - Minimally invasive catheter-based system that safely, rapidly, and effectively removes thrombus and restores blood flow in the peripheral vasculature utilizing ultrasound energy to destroy clots, without harming adjacent healthy tissue or generating dangerous emboli
  • Company #1379 - 1-Effective cryosurgical tool that is simple and safe to use without cryogenic gasses or liquids for all medical office skin lesion removal needs, 2-Cervical freeze attachment for gynecology use, 3-Third-generation technology to accommodate cryosurgical treatments for prostate, liver & renal cancers and cardiac aberrant foci ablation
  • Company #1378 - Remote (wireless) continuous EEG (cEEG) brain monitoring of critical care patients that significantly reduces mortality rates, improves patient outcomes, and saves millions of dollars in patient care expense
  • Company #1377 - Atherosclerotic plaque dissolution through chemical means for treating occlusive and non-occlusive atherosclerotic disease that may reduce the need for permanent implants like drug-eluting stents (DES), while also potentially addressing plaque instability
  • Company #1376 - Non-invasive Raman spectroscopy system designed to aid medical professionals in the detection of skin cancer
  • Company #1375 - 1-Non-invasive in vitro diagnostic (IVD) blood test for the detection and/or monitoring of 14 different types of cancer, 2-Combination Immunogene Therapy (CIT) technology that could lead to a vaccine or possibly treat those already diagnosed with cancer
  • Company #1374 - A low-cost, clip-on eye-piece for mobile phones that mimics and replaces the expensive laser-based Shack-Hartmann wavefront aberrometers to diagnose the most common refractive eye disorders: myopia (nearsightedness), hypermetropia (farsightedness), astigmatism, and presbyopia (age-related visual impairment)
  • Company #1373 - Non-invasive, rapid assessment of dP/dt in Cardiac Resynchronization Therapy (CRT) for lead placement, lead optimization, and monitoring
  • Company #1372 - Patented, activated collagen product for the diabetes and wound care markets
  • Company #1371 - Interbody fusion spinal implant devices that incorporate a proprietary surface technology
  • Company #1370 - Anatomically appropriate orthopedic implants, unique instrumentation, and biologics for pediatric and small stature patients
  • Company #1369 - Proprietary medical devices and patient interfaces for the enhancement of patient safety through capnography monitoring
  • Company #1368 - 1-Adult stem cell collection and storage, 2-VSEL(TM) (very small embryonic-like) stem cells for tissue regeneration, 3-Contract cell manufacturing for clients around the world, Progenitor Cell Therapy, 4-Therapeutics such as a T-cell regulatory technology to treat disorders of the immune system, 5-A wound healing technology that uses autologous bone marrow-derived stem cells, 6-An autologous bone marrow-derived cell line selected to treat damaged heart muscle following AMI
  • Company #1367 - A business and technology research & development platform, dedicated to delivering innovative solutions for the musculoskeletal disorders industry
  • Company #1366 - Ellanse, the first dermal filler family offering a complete customized solution in medical aesthetics
  • Company #1365 - A peripheral nerve stimulation (PNS) system for patients suffering from severe, intractable pain
  • Company #1364 - Portable, disposable, non-powered suction device for negative pressure wound therapy (NPWT)
  • Company #1363 - Device that prepares 10 million micro-droplets per hour for use in drug discovery, genomics, molecular epidemiology, and proteomics
  • Company #1362 - Non-invasive imaging system for the early detection of pre-cancerous tissue and to guide early treatment intervention
  • Company #1361 - A handheld breath analyzer for the measurement of fat metabolism
  • Company #1360 - Portable pediatric vision screening technology
  • Company #1359 - Minimially invasive percutaneous implantable cardioverter defibrillator (PICD) for the treatment of cardiac arrhythmias
  • Company #1358 - A non-invasive, automatic analyzer that uses measurements of sweat gland activity to determine whether a patient is at risk for diabetes
  • Company #1357 - Compact, home-based device for male fertility assessment
  • Company #1356 - Device for the early detection, assessment, and monitoring of mild perceptual impairment (MPI), an early indicator of mild cognitive impairment
  • Company #1355 - Device providing sustained intravesical drug delivery for the treatment of Overactive Bladder (OAB), Interstitial Cystitis (IC), and other bladder conditions
  • Company #1354 - Percutaneously-inserted interspinous process fusion cages that provide for stabilization of the spine
  • Company #1353 - Implantable neurostimulation system for the treatment of obstructive sleep apnea (OSA)
  • Company #1352 - Physical and chemical resurfacing of orthopedic implants and stents which allows for drug elution without the use of a binding polymer
  • Company #1351 - Wireless, implantable heart device that allows Congestive Heart Failure (CHF) patients to monitor data using a handheld instrument
  • Company #1350 - Percutaneous vertebral augmentation (PVA) system for controlling bone cement delivery and leakage during spinal surgery
  • Company #1349 - Remotely controlled percutaneous catheter system for use in a wide range of interventional applications
  • Company #1348 - Novel and clinically validated percutaneous approach for the treatment of functional mitral valve regurgitation in the heart failure population
  • Company #1347 - Sutureless, anastomotic connectors to provide a controlled method of joining vessels
  • Company #1346 - Minimally invasive orthopedic device for the treatment of hip pain
  • Company #1345 - Handheld device for monitoring chronic disease home-care patients using a single drop of blood
  • Company #1344 - 1-Novel 510(k)-cleared XCOIL(TM) mechanical thrombectomy device initially targeting DVT and stroke patients and 2-Novel 510(k)-cleared EViTAR(TM) double-lumen, coaxial neurocatheters for intracranial delivery of small molecules, biologics, stem cells/gene-based therapies, and smart sensor enhancements
  • Company #1343 - Microwave-based soft tissue ablation system
  • Company #1342 - Implantable device to treat epilepsy by anticipating seizures and delivering intracranial drugs
  • Company #1341 - Injectable, synthetic bone subsitutes
  • Company #1340 - Transdermal iron patch to treat iron-deficiency anemia
  • Company #1339 - Implantable pacing and defibrillation device that detects the early onset of atrial fibrillation and chronic heart failure and delivers targeted medications
  • Company #1338 - Device for dry powder pulmonary delivery to treat patients with Parkinson\'s disease
  • Company #1337 - Peripheral arterial disease (PAD) therapeutic devices incorporating intravascular imaging
  • Company #1336 - A unique, non-invasive tool for the analysis of muscle function to assist in the evaluation and treatment of neck and back injuries and illnesses
  • Company #1335 - Vital signs monitoring device for use as an early congestive heart failure (CHF) crisis indicator at home, to avoid acute/expensive hospitalizations
  • Company #1334 - Novel bioresorbable regenerative scaffolds that provide 3D architecture for enhanced tissue repair
  • Company #1333 - Novel implantable ultrasound flow-measuring devices with flow data wirelessly transmitted from within the body
  • Company #1332 - Technology for nurses/pharmacy technicians/emergency responders to more safely and effectively vaccinate the public in the event of a biological or viral pandemic
  • Company #1331 - Modular, powered, proprietary articulating technology for endoscopes and laparoscopes, enabling surgical safety, flexibility, and procedural innovations
  • Company #1330 - Medical image viewing solution that enables physicians to access/view critical patient images/information from anywhere, without compromising the security/privacy of the data
  • Company #1329 - An elegant, user-friendly alternative to traditional eye dropper bottles that will allow multi-dose of preservative-free ophthalmic formulations
  • Company #1328 - The d-OSAB platform technology, used to treat ischemic stroke by delivering a precise, measured dose of oxidative stressor and comprising a monitoring system that determines the amount of stressor absorbed as well as a disposable device that maximizes contact with the fluid or blood
  • Company #1327 - The first non-toxic, long-lasting, environmentally safe, no-kill surface aimed at improving medical devices and addressing challenges with bacterial control and gaps in cleaning practices
  • Company #1326 - StimBrace addresses osteoarthritic knee pain by intelligently strengthening leg muscles to stabilize and brace the knee during real-world use
  • Company #1325 - Minimally invasive devices for endoscopic ultrasound-guided transluminal drainage of targeted areas within the gastrointestinal tract
  • Company #1324 - An expandable, funnel-shaped cannula for the removal of intravascular material during extracorporeal circulation
  • Company #1323 - Teraherz-based, real-time, video-rate imaging system
  • Company #1322 - A wearable blood collection device that uses Touch Activated Phlebotomy (TAP) technology to reduce the inconvenience of blood sampling and facilitate simpler diagnoses
  • Company #1321 - Radiofrequency (RF)-based detection systems to reduce the risk of retained surgical sponges, gauze and other supplies
  • Company #1320 - A corneal implant designed to treat nearsightedness
  • Company #1319 - A minimally invasive, green, laser-based technology for the treatment of benign prostatic hyperplasia (BPH), as an alternative to traditional TURP surgery
  • Company #1318 - An artificial silicone microchip, which stimulates retinal cones and rods to restore retinal function
  • Company #1317 - Automated bedside blood glucose monitor designed for use in the surgical intensive care unit
  • Company #1316 - A small, injectable ophthalmic implant containing multiple, laser-activated reservoirs designed for the on-demand, physician-controlled release of ocular drug therapies to the back of the eye
  • Company #1315 - A non-invasive, portable device that treats glioblastomas with low intensity, alternating electrical fields
  • Company #1314 - A bionic retina designed to restore sight to millions blinded by retinal degenerative diseases
  • Company #1313 - 1-Biochemical sensing technologies for continuous glucose monitoring and 2-Drug-delivery devices for osteoporosis management
  • Company #1312 - Less invasive technologies for the treatment of primary open angle glaucoma
  • Company #1311 - 1-A noninvasive long-term cardiac rhythm monitor and 2-A disposable electrocardiography (ECG) monitor for use for up to 30 days
  • Company #1310 - Devices for arthroscopy, hip, knee, and spine surgery, in addition to radiofrequency identification (RFID) tracking technology
  • Company #1309 - A percutaneous implant for mitral valve repair
  • Company #1308 - Capsule-based hydrogels to reduce food intake in obese patients
  • Company #1307 - Novel, implantable cardiovascular device for the treatment of a prevalent cardiovascular condition
  • Company #1306 - Whole-body imaging technology for orthopedic applications
  • Company #1305 - Advanced surgical devices for ear, nose, and throat (ENT) surgery
  • Company #1304 - An innovative whole-breast ultrasound imaging system to address the increasing challenge of breast cancer detection, particularly for women with dense breast tissue
  • Company #1303 - Radiofrequency (RF)-based device for the treatment of congestive heart failure (CHF)
  • Company #1302 - A wireless, touch-screen insulin pump featuring a blood glucose meter, food library, and an activity monitor
  • Company #1301 - Synthetic cartilage technology for joint repair
  • Company #1300 - A vertebral restoration system that uses spine-specific osteogenic biomaterials to restore vertebral stability
  • Company #1299 - Advanced long-term hemodialysis and peritoneal dialysis catheters
  • Company #1298 - Portable and advanced point-of-care diagnostics equipment
  • Company #1297 - Endovascular aneurysm repair (EVAR) device that has versatility to adapt to unique, challenging anatomies and leverages basic interventional techniques for a simple, intuitive delivery similar to that of a peripheral procedure
  • Company #1296 - A wireless, remote-controlled tissue expansion technology for women undergoing breast reconstruction after mastectomy
  • Company #1295 - User-friendly, simple, and needle-free transdermal delivery system that can deliver a broad range of compounds, including: peptides, proteins, small molecules, and vaccines
  • Company #1294 - Brachytherapy device for gynecological cancers
  • Company #1293 - Ophthalmic implant for improved vision in patients with end-stage age-related macular degeneration (AMD)
  • Company #1292 - Small, disposable, discreet, and very convenient alternative to CPAP for obstructive sleep apnea (OSA) patients
  • Company #1291 - A wearable, battery-operated, bionic leg - used as a robotic aid during therapy sessions, until the patient recovers their gait so they can walk/continue to improve without it
  • Company #1290 - Surgical films, meshes, sutures, and other products constructed from a new class of absorbable biomaterials
  • Company #1289 - Advanced sealants and anti-adhesion agents for use in vascular and general surgery
  • Company #1288 - Devices to treat diseases and injuries of the foot and ankle, resulting in faster ambulation, superior cosmesis, and less pain
  • Company #1287 - Benchtop-based positron emission tomography (PET) imaging system
  • Company #1286 - Minimally invasive orthopedic surgery system that features an intramedullary implant for fusion or fixation of the sacroiliac (SI) joint
  • Company #1285 - Magnetic technology used to dissolve blood clots following a stroke
  • Company #1284 - P.L.E.A.S.E.(R) (Precise Laser Epidermal System) - a novel transdermal delivery device for high molecular weight drugs, that can be used by medical personnel or the patient
  • Company #1283 - Technology platform that uses physical vapor deposition, thin film technology, and thin film metals to produce stents and other implants that feature greater biocompatibility
  • Company #1282 - Laparoscopic devices for single-port surgery and natural orifice transluminal endoscopic surgery (NOTES)
  • Company #1281 - Device that stimulates the urinary bladder electrically in order to modulate key renal functions, thus, breaking the vicious cycle of cardio-renal interaction in congestive heart failure (CHF) patients
  • Company #1280 - Global endometrial ablation system that uses radiofrequency argon plasma energy contained in a silicone membrane to treat heavy menstrual bleeding
  • Company #1279 - A two-step treatment for ischemic stroke patients that provides rapid reperfusion as well clot capture and retrieval
  • Company #1278 - Transcatheter cardiac valve replacement technology
  • Company #1277 - Laser system that uses an integrated ocular measurement technology and short-pulse laser to perform surgical incisions for refractive cataract surgery
  • Company #1276 - Advanced surgical field illumination technologies to improve surgeon visualization and reduce fatigue in less-invasive surgery
  • Company #1275 - An all-in-one dialysis device that makes clean water, produces dialysate, takes blood pressure and delivers medication
  • Company #1274 - Deep brain stimulation (DBS) technology for the treatment of Alzheimer\'s disease (AD) and Mild Cognitive Impairment (MCI)
  • Company #1273 - External fixation system that uses specialty clamps to: reduce the construct weight, enable greater flexibility for the surgeon, and reduce operating times
  • Company #1272 - Cryotherapy medical devices that use extremely cold liquid nitrogen to ablate benign and cancerous tissues inside the aero-digestive tract
  • Company #1271 - Disposable device to provide fast, objective measurement of vaginal cervical length, which assists in the determination of whether the patient is undergoing preterm labor
  • Company #1270 - Optical sensing technology for non-invasive pH monitoring of stored platelets
  • Company #1269 - Software allowing physicians to remotely monitor vital signs using smartphones and hybrid tablet devices such as the iPhone, BlackBerry, Android, Windows Mobile devices, and iPad/Android-based tablets
  • Company #1268 - Patch-based technology that delivers a weekly, low-dose contraceptive to women
  • Company #1267 - Integrated system that monitors the activity of patients and caregivers in long-term care environments and features a proprietary fiberoptic sensor to detect patient movement, thereby detecting falls and helping to prevent pressure ulcers
  • Company #1266 - Remotely operated, in vivo, miniature robotic products for laparoscopic surgery
  • Company #1265 - Highly deliverable balloon-expandable stents
  • Company #1264 - Integrated system comprising reusable and disposable devices, components, and software to enable magnetic resonance imaging (MRI)-guided neurological procedures
  • Company #1263 - Devices used to assist in the introduction and advancement of endoscopes in the upper and lower gastrointestinal (GI) tract
  • Company #1262 - A comprehensive vital signs monitoring platform for bedside, ambulatory, or transport applications
  • Company #1261 - 510(k) cleared device using acoustic reflectometry to continuously monitor breathing tubes for placement, movement, and obstruction, enabling adverse event prevention
  • Company #1260 - Platform of technologies used to lower intraocular pressure (IOP) for glaucoma patients
  • Company #1259 - Paddle that measures the mechanical properties of breast tissue during mammography, reducing pain and discomfort
  • Company #1258 - Implantable neurostimulation device to treat autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn's disease and others
  • Company #1257 - Repositionable transcatheter aortic valve replacement system
  • Company #1256 - Technology to treat cardiac arrhythmias
  • Company #1255 - Diagnostic system for hematology and HIV-immune monitoring in developing countries
  • Company #1254 - Bronchoscopically placed nitinol coil for lung volume reduction
  • Company #1253 - Controlled electrical pulses delivered to nerve clusters to improve swallowing function and control in patients with acute dysphagia
  • Company #1252 - Hand-held device that applies extreme cold to the skin as a way to temporarily treat pain and smooth wrinkles
  • Company #1251 - Hand-held device that deactivates the axillary glands using electromagnetic energy, thereby eliminating the problem of excessive underarm sweating
  • Company #1250 - Hand-held point-of-care and home-based testing devices that measure blood viscosity for patients taking Warfarin
  • Company #1249 - 3D scanning technology that measures ear canal shape and tissue compliance
  • Company #1248 - Bioabsorbable drug-eluting stent for chronic sinusitis patients
  • Company #1247 - Catheter securement system that features a small anchor placed subcutaneously
  • Company #1246 - Wireless systems to enable remote safety and wellness monitoring for geriatric patients
  • Company #1245 - An intravascular continuous glucose monitor comprising a single-use catheter and sensor system that enables direct measurement of plasma glucose in flowing blood
  • Company #1244 - Non-invasive Raman spectroscopy based in vivo diagnostic research and application to wellness, medical, and narcotic products
  • Company #1243 - The DISTALOCK Intramedullary Nail and Drill System uses an innovative approach to facilitate the accurate placement of locking screws used to stabilize the rod-like implants, or nails, used for long bone fractures
  • Company #1242 - Drug-eluting balloon product for cardiac and peripheral arteries
  • Company #1241 - Advanced vascular closure device designed to reduce the time to hemostasis
  • Company #1240 - Low-energy electrical stimulation device to treat abnormal cardiac rhythm
  • Company #1239 - Combines imaging technology and advanced algorithms to assess early embryo viability at the 4-cell stage
  • Company #1238 - Radiofrequency-based ablation catheter for atrial fibrillation (AF) that features integrated microwave radiometry technology
  • Company #1237 - Non-surgical treatment for post-partum laxity of the vaginal introitus
  • Company #1236 - Intravenous (IV) catheter system which substantially increases successful IV insertions and provides top-of-class passive needle safety; also applicable to many other vascular access applications where higher success rates and less vessel trauma are important
  • Company #1235 - Spine implant system that stabilizes and restores the spinal anatomy of persons that have suffered a vertebral compression facture (VCF)
  • Company #1234 - 1-Trans-nasal catheter for real-time imaging of atrial fibrillation (AF) ablation procedures; 2-Intra-cardiac catheter for real-time image guidance of percutaneous valve and other structural heart repair procedures; 3-High-definition intravascular ultrasound (IVUS) system, with near-OCT image resolution; and 4-Image-guided, endoventricular injection catheter for stem cell and/or biological agent therapy for congestive heart failure (CHF)
  • Company #1233 - Next-generation solution for patent foramen ovale (PFO) closure that directly treats the pocket of the PFO (in-tunnel closure), while minimizing the impact to the atrial spaces
  • Company #1232 - Device therapies for diseases and conditions of the eye that employ a proprietary hydrogel platform technology
  • Company #1231 - Hand-held intra-operative surgical probe used in diagnosing, staging, and treating breast cancer, to reduce residual cancer/repeat surgery after breast cancer lumpectomies
  • Company #1230 - Effective antimicrobial coatings and compounds that are broad-spectrum and fast-acting against clinically relevant pathogens, including multi-drug resistant strains such as MRSA
  • Company #1229 - Next-generation drugs with better efficacy and safety, plus longer duration of action, for rheumatoid arthritis, anemia, organ transplants, and blood diseases
  • Company #1228 - Next-generation extracellular matrix (ECM) products for advanced wound healing and tissue regeneration, with improved handling, strength, resorbability, and infection control over existing products
  • Company #1227 - Low-cost disposable devices that enable efficient and patient-friendly delivery of colonoscopy and colon prep services at convenient care settings on a walk-in basis
  • Company #1226 - System that provides a new direction in dialysis, through a new mode of access through two implantable ports that allow safe repeated access into arteries and veins, so that the dialysis process works with the natural direction of blood flow
  • Company #1225 - Polymer-based liquid bandage with antimicrobial properties to: cover intact skin or minor cuts, scrapes, burns, and minor irritations of the skin; help keep them clean and dry; and help protect them from infection
  • Company #1224 - Disruptive diagnostic platform, using an innovative multi-modality approach, to advance cardiovascular health assessment for the prevention of heart attack and stroke
  • Company #1223 - Fixation with compression technology that offers significant improvement over existing products with applications in small & long bone, spine, and the sternum
  • Company #1222 - First spinal instrumentation system developed specifically to restore healthy kinematics in lumbar flexion for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis
  • Company #1221 - A portable pneumatic compression system for the treatment of venous and arterial insufficiency, to be used in the hospital, secondary care facility, and home
  • Company #1220 - Revolutionary portable device to provide easy and efficient screening methods for early detection of age-related macular degeneration, diabetic maculopathy, and other types of retinal disease in the human eye
  • Company #1219 - A proprietary drug delivery platform that uses human Alpha-Fetoprotein (AFP) to deliver selective chemotherapy, avoiding damage to normal cells
  • Company #1218 - Orthopedic implants for the reconstruction of distal extremities
  • Company #1217 - Implant fault detection and monitoring technology
  • Company #1216 - Leak-proof, rupture-proof breast implant technology, with the potential to replace all existing saline and gel implants
  • Company #1215 - Next-generation non-invasive portable ultrasound system for the treatment of fat, skin, and other plastic surgery and dermatology applications at all anatomical sites - without anesthesia and surgery
  • Company #1214 - Highly multiplexed real-time PCR-based assays for the accurate detection of hospital-acquired antibiotic resistant bacteria such as MRSA, MSSA, and pathogens causing Sepsis and gastrointestinal infections
  • Company #1213 - 24-hour intraocular pressure monitoring of glaucoma patients by a telemetric, implantable micro sensor
  • Company #1212 - Electrochemical biosensors for the in-hospital diagnostics, home health care, and consumer diabetes markets
  • Company #1211 - New medical grade preservative that is non-toxic and capable of preserving urine, blood, plasma, and serum at room temperature; designed and used by the space program
  • Company #1210 - Molecular diagnostics and therapeutics for back-related and joint-related pain
  • Company #1209 - Technology that can detect in real time an acute myocardial infarction and derive a 12-22 lead ECG with only 3 leads or 5 electrodes
  • Company #1208 - Minimally invasive surgical suturing devices, using standard type curved needles and all standard sutures, for conventional and single-port laparoscopy, urogynecology, cardiac surgery, and endoscopic interventional therapies, including NOTES
  • Company #1207 - IVC filter utilizing unique anchoring technology that allows for optimal placement during implantation, superior migration resistance in vivo, and easy retrieval after the threat of PE has been eliminated
  • Company #1206 - Effective, reliable use of autologous adult stem cells (ASCs) to enhance fusion in spine and orthopedic surgery
  • Company #1205 - Fail-safe and inexpensive system that employs a technology to prevent errors in the intravenous administration of drugs and blood transfusion
  • Company #1204 - Device that applies gentle pulsing sonic forces, in combination with standard orthodontics, to move teeth faster through accelerated bone remodeling
  • Company #1203 - Forward-looking intravascular ultrasound (FLIVUS) catheters that can determine correct stent size and placement through a field of view which extends beyond the catheter tip
  • Company #1202 - Lightweight and portable system with unsurpassed fluid balance accuracy for blood purification and fluid management
  • Company #1201 - Single-use, disposable \"sensing embedded\" surgical glove 1-to accurately map cervical length/dilatation during pre-term/full-term labor, 2-as a tool in general surgery, and 3-as a tool in telemedicine
  • Company #1200 - Reagents for use in non-invasive MRI, PET, and optical imaging
  • Company #1199 - Non-invasive device that acts as a robotic physical therapist for treating chronic head and neck pain
  • Company #1198 - Genomic Expression have made RNA sequencing actionable in oncology: we are finding the best drug for the patient and the best patient for the drug
  • Company #1197 - Patient monitoring system providing real-time continuous information via four physiological parameters - sensed at the tissue level, reflecting the patient\'s systemic metabolic state
  • Company #1196 - Prevention and treatment of osteoporosis-related fractures
  • Company #1195 - A unique, simple-to-use, single-use inhaler device to address major unmet needs in the respiratory and drug-delivery fields; specifically, the acute treatment of asthma and COPD
  • Company #1194 - Regenerative medicine implant to repair knee cartilage damage
  • Company #1193 - Bioceramics for the treatment of post-myocardial infarction (MI), mitral valve regurgitation, applications to coronary and peripheral stents, and other technologies
  • Company #1192 - Cost-effective, laser-based antimicrobial treatments for Chronic Rhinosinusitis (CRS)
  • Company #1191 - Modular, 3D, real-time, stereoscopic vision and recording systems to change the surgical paradigm from 2D to 3D-HD stereoscopic vision for minimally invasive surgery (MIS)
  • Company #1190 - Next-generation infusion pump platform to bring new standards of accuracy and ease-of-use to the hospital and homecare markets
  • Company #1189 - Non-hormonal, one-size-fits-all intravaginal contraceptive ring
  • Company #1188 - Single-use high-definition (HD) surgical camera that will provide high-quality HD imaging at a fraction of the price of current market-leading HD cameras
  • Company #1187 - Endoscopic accessory devices that fill unmet needs in the field of gastrointestinal (GI) endoscopy
  • Company #1186 - Needle technology that reveals visible blood flow at the instant of vein penetration without activation or additional instruction
  • Company #1185 - Non-invasive method for detecting the presence of a right-to-left cardiac shunt (i.e., PFO) to enable medical treatment and/or closure before the occurrence of a debilitating or life-threatening stroke or heart attack
  • Company #1184 - Medical devices and procedures for optimizing fat distribution and metabolism and for tissue aspiration and processing, with targeted applications for: the bariatric market; the liposuction and body sculpting market; and fat autograft and adipocyte-derived stem cell processing and reinjection markets
  • Company #1183 - Technology for: 1-prophylactic treatment of allergic asthma and 2-infection control in surgical theatres
  • Company #1182 - Non-invasive, controlled, and sustained release back-of-the-eye therapeutics for sight-threatening diseases such as: severe uveitis, diabetic macular edema, and age-related macular degeneration (AMD)
  • Company #1181 - Technology that can regenerate nerves
  • Company #1180 - Compound that can regenerate new blood vessels and has a biodegradable stent
  • Company #1179 - Transcatheter aortic valve implantation (TAVI) system
  • Company #1178 - The first robotic system capable of offering full force-reflection to laparoscopic surgeons in any surgical practice
  • Company #1177 - An intraocular lens, customized to the patient\'s vision needs and adjustable throughout the patient\'s life, for greater quality of vision
  • Company #1176 - Minimally invasive stents to treat patients suffering from dysfunctional uterine bleeding (DUB), urinary tract obstruction, prostate enlargement (BPH), or prostate cancer
  • Company #1175 - 1-Real-time device navigation and positioning system for cardiovascular interventions and 2-Real-time angiography-based system, designed to assist in delivery of a transcatheter heart valve (THV)
  • Company #1174 - Biomimetic prosthetic vascular grafts that are transformed in the body into bioartificial arteries which resemble \"healthy\" arteries in form and function
  • Company #1173 - Novel neurovascular clot retrieval device for acute ischemic stroke intervention
  • Company #1172 - Flexible endoscopic tools for interventional gastroenterologists to perform therapeutic procedures
  • Company #1171 - Modern, sophisticated system to ensure a proper blood match is obtained and the patient gets the correct cord blood unit in a timely manner
  • Company #1170 - Implantable device to treat patients with left ventricular dilation following myocardial infarction
  • Company #1169 - Blood glucose monitoring system designed to integrate test strips, the lancing device, and lancets into one compact glucose meter
  • Company #1168 - A wound dressing constructed from a biocompatible matrix and coagulating agents
  • Company #1167 - Handheld, wireless device that can detect possible vertebral cortex perforation during pedicle preparation for screw placement
  • Company #1166 - Hand-held, battery-powered product using intense therapeutic ultrasound (ITU) technology for skin care
  • Company #1165 - Bone cement for cranial defect repair
  • Company #1164 - Vascular robotic system designed to place coronary guidewires, stents and balloon catheters during percutaneous coronary interventions, with less radiation exposure
  • Company #1163 - An integrated system featuring sensors and software to enable the monitoring of seniors in multiple care settings
  • Company #1162 - Convective WAVE (water vapor/steam energy) technology platform to treat a variety of endourology conditions beginning with BPH, and including applications to treat prostate and kidney cancer
  • Company #1161 - Controlled Deployment Technology (CDT), which uses a low-profile access sheath that may be increased to provide a wider working diameter
  • Company #1160 - A portable device that provides therapeutic hypothermia in emergency care settings
  • Company #1159 - Proprietary neurostimulation technology for nerve protection and repair
  • Company #1158 - An absorbable skin stapler for skin closure that eliminates the need for removing staples after surgery
  • Company #1157 - Esophageal cardiac monitoring device for use in surgery and critical care
  • Company #1156 - Custom hyaline cartilage system for treating articular cartilage defects by restoring normal physiological conditions in the defected area
  • Company #1155 - Quantitative and qualitative cardiac assays to assist in the diagnosis of cardiovascular diseases at the point of care
  • Company #1154 - Advanced, portable and easy-to-use noninvasive devices for the assessment of traumatic brain injury (TBI) at the point of care
  • Company #1153 - Next-generation wellness program with sophisticated physical and mental health diagnostic software
  • Company #1152 - Combination of a proprietary ELISA substrate with Raman spectroscopy to dramatically increase the performance of immunoassays for diagnostics, research, and drug discovery
  • Company #1151 - Physcient develops new surgical instruments that speed surgery, expand surgeons abilities, and improve outcomes by combining proprietary insights into the mechanics of tissues with advanced technologies from other industries. Our lead technology, the Differential Dissector replaces centuries old technology and allows a surgeon to safely dissect tissues more rapidly, displacing instruments that contribute to hundreds of thousands of severe surgical complications each year in the US.
  • Company #1150 - Non-ablative skin rejuvenation technology which produces immediate and visible aesthetic improvement together with long-term skin remodeling effects
  • Company #1149 - Implantable medical device that helps diabetic patients control their eating habits, lowering their blood glucose and body weight, by applying electrical stimulation to the stomach during meals
  • Company #1148 - Ophthalmic devices for minimally invasive treatment of corneal blindness and vision correction using proprietary corneal implants and microsurgical instrumentation
  • Company #1147 - Device that measures the presence, progression, and severity of any disease condition and the effectiveness of treatment and timing of non-acute death
  • Company #1146 - Non-obtrusive CPAP mask that uses the natural oral cavity anatomy to create the seal required for effective CPAP treatment
  • Company #1145 - rEEG(R) technology for the assessment of neurophysiological abnormalities and determination of psychiatric treatment
  • Company #1144 - Innovative sleep diagnostics and web-based home sleep apnea tests. Double digit growth each month in sleep tests in the U.S. for the last 36 months and currently expanding into Europe and the Middle East and South America
  • Company #1143 - Dedicated Diabetic Machine (DDM) insulin regulation therapy for type 2 diabetes
  • Company #1142 - Non-invasive glucose monitoring device targeting the eye
  • Company #1141 - Universal oncology, cardiology, stroke and diabetes molecular imaging agents
  • Company #1140 - Implantable hearing device that provides extraordinary acoustic performance in a completely invisible device
  • Company #1139 - Surgical sponge detection using radiofrequency identification
  • Company #1138 - Home monitoring technologies with automatic fall detection capabilities
  • Company #1137 - Implantable neuromodulation devices for epilepsy and other neurological disorders
  • Company #1136 - Unique non-invasive blood pressure and cardiac output monitor, offering a precise hemodynamic profile with real-time data posted within a minute
  • Company #1135 - Robot-assisted surgery platform that incorporates haptics and eye-tracking technology
  • Company #1134 - Advanced over-the-wire vascular access device
  • Company #1133 - Technologies that improve visualization during laparoscopic surgery, permit laparoscopic suturing, and enable simpler removal of ureteral stones
  • Company #1132 - Portable hyperthermic perfusion system for raising the core temperature of the thoracic or peritoneal cavity
  • Company #1131 - Optical guidance systems for computed tomography (CT), fluoroscopy, and magnetic resonance imaging (MRI) procedures
  • Company #1130 - Liposome-encased nanoparticles for computed tomography (CT) contrast imaging
  • Company #1129 - Cartridge-based portable hemodialysis machine
  • Company #1128 - Capillary force vaporizer technology
  • Company #1127 - Home-based diagnosis of sleep disorders
  • Company #1126 - Office-based, minimally-invasive ablation device for enlarged prostate
  • Company #1125 - Molecular breast imaging (MBI) technology
  • Company #1124 - Ultrasound systems powered by the Scan Engine, a device that may be interchanged with any of the company\'s 3 carts, promoting efficiency and cost-effectiveness
  • Company #1123 - A drug-eluting stent coated with bioabsorbable polymers
  • Company #1122 - Parts and services for new and refurbished imaging and patient monitoring technologies
  • Company #1121 - Inhalation delivery technologies
  • Company #1120 - Synthetic bone substitutes
  • Company #1119 - Organ-specific molecular imaging
  • Company #1118 - Image analysis for the diagnosis of Alzheimer\'s and other diseases
  • Company #1117 - High-speed, disposable dental drill
  • Company #1116 - Software systems for cardiology
  • Company #1115 - Spinal implant technologies for remote-controlled spine deformity and trauma correction
  • Company #1114 - Non-surgical, endoluminal bypass device for treating obesity and obesity-related metabolic disorders
  • Company #1113 - A non-invasive diagnostic medical device that replaces the current traumatic procedure used to detect pediatric VUR (urinary reflux) and prevent kidney damage in 4M children annually
  • Company #1112 - Highly differentiated aorto-ostial stent and delivery platform for both peripheral and coronary applications
  • Company #1111 - Medical records application on a simple USB flash drive for patients, providers, and insurers
  • Company #1110 - Intelligent orthopedic devices to address the growing clinical and economic cost of orthopedic implant failure and osteoporosis
  • Company #1109 - Pro-Vas is a novel less-invasive alternative to vasectomy for men seeking permanent contraception
  • Company #1108 - Minimally invasive lumbar annular repair technologies to prevent disc re-herniation and interrupt disc degeneration
  • Company #1107 - Innovative imaging that provides real time and wide field visualization of cancer margins during surgery to increase tissue conservation and comprehensive removal of cancerous areas, specifically for the treatment of breast cancer
  • Company #1106 - Device to non-invasively detect and monitor blood borne diseases in vivo, without taking blood
  • Company #1105 - Products ranging from needleless injection site connectors, to safety syringes, and biodiagnostic sampling devices
  • Company #1104 - Products for the urinary incontinence market
  • Company #1103 - New medical diagnostic system for the early detection of lung cancer
  • Company #1102 - Non-invasive ultrasound device for the treatment of glaucoma
  • Company #1101 - Technology that will impact the way surgeons perform laparoscopic surgery, making it possible for one surgeon to do what now requires two, and to reduce the number of surgical incisions for most all procedures
  • Company #1100 - Varicose vein stripping under direct vision for ablation of the diseased saphenous vein in a kit that reduces trauma, minimizes bleeding, and expects improved clinical outcomes
  • Company #1099 - Advanced biofeedback stimulator with diagnose and treatment modes
  • Company #1098 - Device for treating diseases in patients with acute renal failure (ARF) and acute inflammation induced by cardio pulmonary bypass (CPB) surgery, to produce improvement in survival rates and reduce costs
  • Company #1097 - Technology that bridges the gap between low-tech aspiration and complex electromechanical aspiration systems for use in thrombus removal, rotational vacuum assisted biopsy, tissue resection, and spinal disc decompression
  • Company #1096 - A handheld device for the as-needed treatment of allergic rhinitis
  • Company #1095 - Non-compressible hemostatic fibrin sealant for high-volume bleeding in intraoperative surgery and trauma
  • Company #1094 - Minimally invasive device for midface lift and other lift procedures
  • Company #1093 - Bionic prosthetic devices
  • Company #1092 - Diagnostics products that combine electrochemical sensing with microfluidics, enabling highly accurate, low-cost diagnostics in a handheld device; first application is HIV testing in Africa
  • Company #1091 - Auto-adjusting portable oxygen system
  • Company #1090 - Magnetically-guided enteral feeding tube
  • Company #1089 - Wireless electrocardiography
  • Company #1088 - Human fibrinogen-based tissue sealant
  • Company #1087 - Gastrointestinal endoscopy, imaging, diagnostics and infection control products
  • Company #1086 - Interventional cardiology devices for chronic total occlusions
  • Company #1085 - Dental imaging
  • Company #1084 - Type 1 diabetes medication delivery via a fully featured insulin pump with prefilled cartridges
  • Company #1083 - Innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders such as migraine, Parkinson\'s disease, schizophrenia, and bipolar disorder
  • Company #1082 - 1-Hydrogel soft tissue marker that is fully absorbable and visible under several imaging modalities and 2-Absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy
  • Company #1081 - Protein signature-based diagnostic tests for prostate, lung, and breast cancers
  • Company #1080 - Synthetic polymer for osteoarthritis therapy
  • Company #1079 - Controlled warm air delivery device for human head lice removal
  • Company #1078 - Polymolecular system for the treatment of inflammatory disease
  • Company #1077 - Critical care monitoring technologies
  • Company #1076 - Advanced feeding tube technology which can be placed using ultrathin endoscopes
  • Company #1075 - An accurate, low-cost home healthcare device for use by patients to self-measure Intraocular Pressure (IOP)
  • Company #1074 - Ultrasonic technologies and related techniques for aesthetic surgery
  • Company #1073 - Therapeutic ultrasound to treat hypertension
  • Company #1072 - Early detection of mammographically occult small breast cancers in women with dense breast tissue and/or breast implants
  • Company #1071 - RFID technology and software systems for medical device manufacturers, distributors, and hospitals
  • Company #1070 - Smart card platform that identifies and authenticates a patient to the healthcare provider and matches the patient to his or her medical record
  • Company #1069 - "Lap-Pak" is a flexible, one-piece, device contoured to enable the rapid and secure re-positioning of the bowels to expose the surgical site while eliminating the need for re-positioning during surgery
  • Company #1068 - Enhanced meter dose inhalers and spacer devices for the treatment of Asthma and COPD
  • Company #1067 - Sensor-based, video-monitored, automatic/semi-automatic laryngoscope that makes intubation easy, safe, and fast
  • Company #1066 - Diagnostics that aim to reduce blood transfusions in cancer patients and minimize platelet refractoriness
  • Company #1065 - Portable diagnostic device used to determine the presence and level of Myocardial Ischemia (MI)
  • Company #1064 - Suite of diagnostic imaging products using near-field and forced-resonance principles targeting several specialties including cardiology, oncology, orthopedics, and neurology
  • Company #1063 - Rapid endovascular vessel occlusion and blood flow interruption
  • Company #1062 - Innovative flat panel x-ray sources for new types of irradiators (blood transfusion GVHD) and stationary CT imaging systems, including breast tomosynthesis and phase contrast imaging
  • Company #1061 - Non-invasive, easy-to-use device that uses pulsed radio frequency energy (PRFE) for tissue growth, wound healing, and pain relief
  • Company #1060 - Robotic assistance device for CT-guided soft tissue interventions
  • Company #1059 - Fatigue-resistant/fiber-reinforced bone cement for orthopedic joint replacement
  • Company #1058 - Full line of products specifically dedicated to avoiding a total joint replacement and preserving the shoulder, hip, knee, or ankle joints
  • Company #1057 - Single-use, disposable silver ion delivery device to treat Osteomyelitis (OM)
  • Company #1056 - Micro-format, CMOS-based, imaging technology for minimally-invasive, disposable endoscopic medical procedures
  • Company #1055 - Fish-skin-derived tissue regeneration technology for chronic wounds and hernia repair that improves upon current human and porcine technologies through improved economics & clinical performance, reduced disease transfer risk, and absence of cultural constraints on usage
  • Company #1054 - Hand-held ultrasound tool that displays a see-through image in the medical practitioner\'s line of sight, at the patient\'s skin surface
  • Company #1053 - Minimally invasive ultrasound-guided RF ablation system to treat symptomatic uterine fibroids through a transcervical approach
  • Company #1052 - Products for minimally invasive bypass surgery
  • Company #1051 - Rapid/sensitive/cost-effective diagnostic products for detecting microbes causing hospital associated infections
  • Company #1050 - Diagnostic products for rapid infection determination at the point-of-care (POC) for professional and consumer markets
  • Company #1049 - Cancer immunotherapy device, which selectively removes specific blood-borne inhibitors of the immune system
  • Company #1048 - POC/PST device to directly detect clot formation and do it in real time
  • Company #1047 - 1-Low-cost, disposable point-of-care (POC) Pap smear replacement requiring no lab or technician; 2-Disposable, woman-controlled, cervical cap embedded with an anti-HIV drug to provide contraception and help prevent infection from HIV
  • Company #1046 - Small/wearable/all-mechanical insulin delivery device containing a 3-day supply of insulin
  • Company #1045 - The next major step in the treatment of early breast cancer: replacing lumpectomy with a percutaneous, minimally invasive outpatient procedure under local anesthesia that not only eradicates the cancer, but is not disfiguring and leaves no scar
  • Company #1044 - Autologous cell harvesting device for the treatment of burn injuries
  • Company #1043 - System that measures airway inflammation to determine asthma severity for improved treatment
  • Company #1042 - Minimally invasive, image-guided therapies to treat back pain
  • Company #1041 - Products enhancing focally-delivered radiation and drug therapies for patients with spinal metastatic disease or bone tumors
  • Company #1040 - Needle-free drug delivery for migraine attacks and cluster headache episodes
  • Company #1039 - Image-guided ultrasound for prostate cancer tissue ablation
  • Company #1038 - Obstetric position tracker and ultrasound technology
  • Company #1037 - Handheld ultrasound technology
  • Company #1036 - Continuous blood glucose measurement devices
  • Company #1035 - Radiosurgical therapy for neurovascular and inflammatory ocular conditions
  • Company #1034 - Wound closure technology
  • Company #1033 - Technology for the field of corridor surgery, including Cranial, ENT, Spinal and Otolaryngology where access to the surgical site is limited
  • Company #1032 - Surgical device for treating benign prostatic hyperplasia (BPH) and other conditions
  • Company #1031 - Radiofrequency balloon catheter technology
  • Company #1030 - Spinal plate implants as an alternative to traditional lumbar spinal fusion
  • Company #1029 - Implants for sensorineural hearing loss
  • Company #1028 - Medical textiles for hemostasis
  • Company #1027 - 1-System for use in spinal surgical procedures such as vertebroplasty, 2-System to provide immediate vascular access through the intraosseous space for the delivery of essential drugs and fluids, 3-System for aspirations, biopsies, and stem cell collections
  • Company #1026 - Pressure cycling technology (PCT) to safely, conveniently, and reproducibly control the actions of molecules in biological samples
  • Company #1025 - Low-cost technology to survey the genome in its native state, in context, and at ultra-high resolution, without the need for DNA amplification
  • Company #1019 - Temperature management technology to treat hyperthermia and hypothermia, prevent damage from stroke, and enhance cancer therapies
  • Company #1018 - Unique solutions for ophthalmic conditions such as: presbyopia, myopic progression using contact lenses, intraocular lenses and lasik, or other corneal surgeries
  • Company #1017 - Non-invasive radiofrequency (RF) energy-based system to treat vaginal stretching caused by childbirth
  • Company #1016 - High-quality, cost-efficient, single-room proton beam radiotherapy (PBRT) system as an alternative to conventional high-energy x-rays
  • Company #1015 - Controlled, targeted deep-tissue therapeutic warming system to promote pain relief, reduce joint stiffness, and enhance recovery/rehabilitation programs
  • Company #1014 - 1-Artificial larynx, 2-Ear, nose, and throat (ENT) prostheses/implants
  • Company #1013 - microRNA-based tests to diagnose various cancers and gastrointestinal diseases
  • Company #1012 - Brain training software aimed at enabling individuals to strengthen cognitive function using the concept of neuroplasticity
  • Company #1011 - Non-invasive near-infrared (NIR) laser energy for the treatment of: acute ischemic stroke, spinal cord injury, traumatic brain injury, global cerebral ischemia, spinal cord injury, Alzheimer's disease, Parkinson's disease, and sepsis
  • Company #1010 - Hydrogel materials that can be fabricated into devices, nanogels, and polymer solutions with applications in ophthalmology as well as cardiology, urology, and tissue engineering
  • Company #1009 - Advanced polymer-based biomaterials for applications in cardiology, dentistry, orthopedics, surgery, and urology
  • Company #1008 - Neurostimulation device to block residual limb pain caused by complications of amputations, as well as chronic pain after surgery, and migraine pain
  • Company #1007 - Joint, spine, and trauma implants
  • Company #1006 - "Minimally invasive" gene repair
  • Company #1005 - Implantable device for the surgical treatment of obesity without reliance on sutures, staples, or other mechanisms that puncture the stomach wall
  • Company #1004 - Microdermabrasion system with polyester/nylon bristle tips and variable vacuum levels for particle-free/crystal-free performance
  • Company #1003 - Elastic, self-expanding devices to specifically improve left ventricle relaxation and diastolic function
  • Company #1002 - Point-of-care handheld immunoassay system providing high-performance quantitative laboratory blood test results in an inexpensive, portable, and easy-to-use configuration
  • Company #1001 - Routine serum DNA blood tests for early cancer diagnosis and management
  • Company #1000 - Minimally invasive alternative to the surgical treatment of obesity
  • Company #999 - Drug-eluting balloons that allow for controlled release of different and even multiple substances, for the treatment of coronary (CAD) and peripheral artery disease (PAD)
  • Company #998 - Cancer prognostic tests for predicting specific individual patient clinical outcomes
  • Company #997 - Genomics-based in vitro diagnostic (IVD) tests developed from FFPE tissue for personalized medicine
  • Company #996 - Needleless/transdermal delivery system for insulin, analgesics, or vaccines with on/off control of dosing
  • Company #995 - MRI-compatible ultrasound applicator to deliver controlled thermal therapy to cancerous regions of the prostate gland, as well as an ablation device for treating uterine fibroids and bone metastases
  • Company #994 - Non-invasive, transdermal, continuous glucose monitoring (CGM) system utilizing a patented skin permeation platform technology that will enable both needle-free drug delivery and analyte extraction
  • Company #993 - Self-sterilizing osteoconductive polymer which resists infection and biofilm adhesion
  • Company #992 - Tissue repair platform that obviates the need for sutures, stapes, glues, or other foreign bodies and instead allows the body to repair and heal itself
  • Company #991 - Catheter-based system to treat large vessel acute ischemic strokes
  • Company #990 - Next-generation remote patient monitoring (RPM) to continuously monitor vital life-sign functions such as: heart rate, respiratory rate, body position, activity level, and skin temperature
  • Company #989 - Total artificial heart (TAH) to replace both ventricles of a failed heart, thus, restoring the circulatory system to normalcy
  • Company #988 - Antalgic-Trak(R) (A-T) is the only non-surgical spinal decompression system in the world engineered with a series of multi-axis articulating sections that provide and create spinal \"Range-Of-Motion\" (ROM) therapy
  • Company #987 - Portable DNA analyzers for on-demand, non-batched testing, with real-time polymerase chain reaction (PCR) results in 30-60 minutes
  • Company #986 - Novel biomimetic shape memory hydrogel implants for minimally invasive vessel protection following surgical treatment of degenerative conditions of the anterior spine
  • Company #985 - System designed to prevent contrast-induced nephropathy (CIN)
  • Company #984 - A novel suite of workflow tools that automate the viewing, analysis, and interpretation of x-rays for musculoskeletal disease
  • Company #983 - Technology to preserve the normal, healthy tissue of patients that today is damaged as a by-product of current treatments
  • Company #982 - Ventricular Assist Device (VAD) that can be inserted above the diaphragm
  • Company #981 - Handheld, non-invasive, real-time Central Venous Pressure (CVP) monitor for cardiology and nephrology diagnostic applications
  • Company #980 - Next-generation stent platform with: significantly thin walls for reduced restenosis, ease-of-use, superior deliverability, and improved radiopacity for accurate placement
  • Company #979 - In-line, battery-powered, disposable, lightweight, and completely portable blood and IV fluid warming device, capable of intravenous application and irrigation warming
  • Company #978 - Next-generation endovascular devices that incorporate advanced fiber optics technology into currently used products/procedures to improve patient outcomes without adding to procedure time/cost
  • Company #977 - Digital fluorescence scanners for molecular pathology research, biomarker development, and clinical molecular diagnostics (MDx) for personalized medicine
  • Company #976 - Software for efficiently coordinating the delivery of patient care outside of hospitals; it optimizes home care operations and can turn a medical practice into an ACO
  • Company #975 - Polymer technologies for drug delivery and regenerative medicine with applications in orthopedics and spine
  • Company #974 - A-FX(TM) is a minimally invasive platform technology for creating an orthopedic implant in-situ which provides superior fixation in osteoporotic bone
  • Company #973 - Non-invasive device designed to offer transcutaneous pulsed electro-magnetic field stimulation therapy for treating postoperative pain and edema in superficial soft tissue
  • Company #972 - Non-invasive reverse thermal gradient technology to treat conditions of tendons, ligaments, muscles, fasciae, and joints
  • Company #971 - Automatic screw delivery system for cranial maxillo-facial bone fasteners
  • Company #970 - Noninvasive intracranial pressure monitor, and technology for monitoring cerebrovascular autoregulation
  • Company #969 - Smallest/passive/implantable tag using RFID (radio-frequency identification) technology
  • Company #968 - Diabetic pain relief via topical dermal administration and controlled release of pure Nitric Oxide (NO)
  • Company #967 - A percutaneous, catheter based system for the temporary isolation of the liver from the systemic blood circulation and local administration of chemotherapy drugs at high concentrations, directly into the liver without systemic side effects - under optimal drug conditions
  • Company #966 - Vacuum-based clean surface nanotechnology for faster and larger osseointegration
  • Company #965 - Technology for: 1-Glaucoma diagnosis and 2-Real-time homecare monitoring of intraocular pressure (IOP)
  • Company #964 - Precision stapling devices enabling minimally invasive vascular connections, especially for Coronary Artery Bypass Graft (CABG) surgery
  • Company #963 - The technology, based on growth factor extract from reindeer bones, improves bone formation in bone healing problems
  • Company #962 - A range of injectable gels made from hyaluronic acid for applications in Aesthetic Dermatology, Ophthalmology, and Orthopaedics
  • Company #961 - Mobile air purification unit that captures and destroys airborne pathogens
  • Company #960 - Therapy delivery platform for the upper airway with applications to initially target chronic sinusitis, nasal allergies, cystic fibrosis, and CPAP users
  • Company #959 - 1-Multi-generational devices using hybrid technologies for Natural Orifice Transluminal Endoscopic Surgery (NOTES) procedures, 2-Low profile single-patient-use tissue retractor, 3-Range of 7Fr intra aortic balloon catheters with fluid-filled technology that plugs into current hardware
  • Company #955 - Percutaneous anastomosis device to improve long-term vascular access for dialysis and cancer patients
  • Company #954 - Intelligent 3DHD visualization and guidance platform for ophthalmic, cranial, and spine surgeries
  • Company #953 - Wireless/battery-less antenna on a chip (tag) for continuous tracking of blood samples
  • Company #952 - Permanently implanted electrical neural stimulators to treat balance/hearing/perceptual disorders
  • Company #951 - Real-time advanced fluid sensing with smart solutions for safe preparation and delivery of IV medications
  • Company #950 - Electrical stimulators via electrode garments for the treatment of pain related to chronic/acute soft tissue injuries
  • Company #949 - Non-invasive neuromodulation technology platform to therapeutically address several major areas of disease; the Company\'s lead indication is Parkinson\'s Disease (PD)
  • Company #948 - Surgical instrument designed to solve recurrent problems in managing sutures, tissue reattachment, and visualization during surgical procedures
  • Company #947 - Nanolayer surface technology to improve the osteoconductive/bio-resistant/anti-infective attributes of implants
  • Company #946 - Ultrasound-guided cryothermally enhanced devices used to facilitate the site-specific C(2) (Cryo-Chemo) Cancer Ablation Procedure, which delivers newly developed proprietary therapies to cancer sites while avoiding toxic side effects
  • Company #945 - The NuLens(TM) Dynacurve IOL is an implantable, flexible lens that changes it curvature in response with the movements of the eyes accommodative muscle system
  • Company #944 - Systems to diagnose neurological and sleep disorders
  • Company #943 - Technology that precisely eliminates irregularly shaped/invasive solid tumors while avoiding significant damage to surrounding healthy tissue and is non-toxic
  • Company #942 - Extracellular matrix (ECM) implant that is completely integrated, remodeled, and replaced by the patients native tissue over time
  • Company #941 - Non-surgical/injectable tissue revitalization and stabilization to address lower back pain (LBP) and the underlying problem of mechanical insufficiency
  • Company #940 - 1-System for remote home patient monitoring of glucose, blood pressure, and thermal weight, 2-Glucose meter cell phone
  • Company #939 - 1-A proprietary non-invasive ophthalmic diagnostic device designed to quickly detect elevated advanced glycosolated end products (AGEs) for very early detection of diabetes and 2-A rapid non-invasive, ophthalmic-based glucometer for painless and convenient measurement of glucose levels
  • Company #938 - Implantable replacement valve to treat incompetent deep vein valves causing degenerative pain, swelling, and non-healing ulcers associated with chronic venous insufficiency (CVI)
  • Company #937 - Advanced blood purification to reduce cytokine storm and inflammation that leads to multi-organ failure in sepsis and other critical care diseases
  • Company #936 - Next-generation anatomic pathology (AP) with improved speed, automation, and ease-of-use
  • Company #935 - Injectable biopolymer for the direct treatment of acute myocardial infarction (AMI)
  • Company #934 - Endoear(R) is the world\'s first implantable hearing device of its kind, created for the treatment of mild to moderate hearing loss
  • Company #933 - Wireless device for the treatment of stress/urge/mixed urinary incontinence (UI)
  • Company #932 - Communication device that acquires neurological signals from the brain and translates them into speech
  • Company #931 - Endoscopic ablation system for the treatment of atrial fibrillation
  • Company #930 - Next-generation vessel closure
  • Company #929 - Pneumatic compression devices targeted to the lymphedema, venous insufficiency, and sports medicine markets
  • Company #928 - Technology that enables the "packaging" of chronic therapies/biologics in an easy-to-use, disposable patch-like device
  • Company #927 - Instrumentation that provides surgeons with real-time sensing/feedback from the operative site
  • Company #926 - Lab-free salt intake monitor for hypertension/congestive heart failure (CHF) patients
  • Company #925 - Endoscopically placed dual-balloon device for the treatment of obesity
  • Company #924 - Minimally invasive radiofrequency (RF) device to treat aging skin
  • Company #923 - Real-time spectral analysis-based prostate biopsy system
  • Company #922 - Imageless total knee replacement solution which combines a robotic cutting guide with a robotic tool to measure ligament function
  • Company #921 - Catheters for dissolving/removing cerebral blood clots then delivering therapeutics to the diseased site
  • Company #920 - Targeted molecular assays for onco-diagnostics/personalized medicine
  • Company #919 - Biomarker discovery platform for detecting Type 2 diabetes, prostate cancer, and amyotrophic lateral sclerosis (ALS, aka Lou Gehrig\'s disease), among other conditions
  • Company #918 - Molecular diagnostic technologies for organ transplantation and various complex genetic disorders
  • Company #917 - Non-invasive breast cancer diagnostic test via breast fluid analysis
  • Company #916 - Non-invasive vascular disease detection that combines the advantages of MRI with the temporal resolution and ease-of-use of ultrasound
  • Company #915 - Endoscopic/removable device for the treatment of obesity that mimics the effects of gastric bypass surgery on a patient's metabolism
  • Company #914 - "Smart" cells than can determine the type of disease/injury present in the body and repair/regenerate tissue accordingly
  • Company #913 - Imaging systems for the non-invasive, in vivo detection of cancerous and pre-cancerous lesions
  • Company #912 - Microarray-based technology enabling targeted next-generation sequencing of genomic regions of interest
  • Company #911 - Minimally invasive therapy for Emphysema
  • Company #910 - Comfortable, soft, and pliable cloth mask for the treatment of obstructive sleep apnea (OSA)
  • Company #909 - Wearable neuroimaging cap for mapping brain function
  • Company #908 - Computer-controlled rehabilitation table for the management of lower back pain
  • Company #907 - 1-Bioactive/conductive polymer materials and coatings for implantable biomedical devices and 2-Next-generation all-polymer leads that may be grown in the body
  • Company #906 - Non-invasive tests to detect fetal chromosomal abnormalities
  • Company #905 - Minimally invasive spine surgery devices
  • Company #904 - Wearable sensor technology that safely and accurately measures individual sleep patterns
  • Company #903 - Vascular navigation system designed to more accurately and rapidly position venous catheters (CVC and PICC)
  • Company #902 - Minimally invasive breast tumor diagnosis and treatment
  • Company #901 - Lightweight, waterproof, medical alert pendant for seniors - to avoid the dangers of missed medications
  • Company #900 - Non-invasive DNA-based prenatal diagnostic test
  • Company #899 - Heart pump technologies
  • Company #898 - High-throughput, on-demand, portable sequencer for the detection of biomarkers for infectious and other diseases
  • Company #897 - Computer-assisted surgical devices for precise alignment in total joint replacement surgery
  • Company #896 - Diagnostic and therapeutic ophthalmic devices
  • Company #895 - Nanomaterials for angiogenesis/anti-angiogenesis/diagnostic applications
  • Company #894 - Non-invasive neurostimulation device to restore vision to patients suffering from stroke, traumatic brain injury (TBI), dry age-related macular degeneration (AMD), and glaucoma
  • Company #893 - Surgical/restorative dental implants
  • Company #892 - Molecular diagnostic/prognostic tests for cancer
  • Company #891 - Joint-unloading knee implant for pre-arthroplasty patients who lead an active lifestyle
  • Company #890 - Minimally invasive implant for treating spinal stenosis
  • Company #889 - Non-polymeric drug-eluting stent (DES)
  • Company #888 - Variety of diagnostic tests for infectious diseases, cardiology, hepatology, and various cancers
  • Company #887 - Non-woven fabric with extended shelf-life to restore/repair tissue function
  • Company #886 - Radiofrequency thermal ablation system for removing uterine fibroids
  • Company #885 - ALIVIOS Intelligent Eyewear enables people challenged with low vision to do more, including the ability to zoom in and out, improve brightness and contrast of whatever they are looking at, and even quickly store visual information for a closer look later
  • Company #884 - Diagnostic retinal imaging system for use in the primary care setting
  • Company #883 - The Unyvero(TM) System is a novel high-multiplex MDx/IVD platform for severe infectious disease (Pneumonia Application has 39 analytes: 17 pathogens, 22 antibiotic resistance markers)
  • Company #882 - Inferior vena cava (IVC) filter that includes: 1-automatic self-centering, 2-bi-directional deployment and retrieval, 3 -atraumatic design, and 4-total transluminal filtration
  • Company #881 - Compliant balloon platform technology for use in neuroradiology, cardiovascular, and peripheral vascular applications
  • Company #880 - Mechanical thrombectomy device to treat ischemic stroke
  • Company #879 - Artificial heart technologies
  • Company #878 - Cancer diagnostic test which enables the development of personalized therapeutics
  • Company #876 - Bone graft material that is: 1- synthetic, 2-non-immunogenic, 3-inclusive of all bone regenerative properties of an autograft, and 4-cost-effective
  • Company #875 - Portable/rapid cooling technologies via the nasal cavity to improve patient outcomes after cardiac arrest, stroke, or traumatic brain injury (TBI)
  • Company #874 - Tests for the diagnosis/prognosis of cardiovascular disease
  • Company #873 - Catheter-based, endoscopic solutions for the improved detection and prevention of cancer in the gastrointestinal (GI) tract
  • Company #872 - Neuromodulation for hypertension/heart failure
  • Company #871 - Helical anchor technology that allows physicians to perform minimally invasive aneurysm repair while still providing the control and potential long-term durability of an open surgical repair
  • Company #870 - Endoscopic device to treat sinusitis
  • Company #869 - Drug delivery platform that releases a cocktail of therapeutic proteins in response to a variety of local and systemic inflammatory and ischemic diseases
  • Company #868 - Aortic embolic protection device for acute and long-term use
  • Company #867 - Autologous adult stem cell technology, cultured from the nasal passageway, to repair damage resulting from spinal cord injury
  • Company #866 - 1-Minimally invasive treatment of spinal compression, 2-Minimally invasive treatment of long bone factures, 3-Neuromodulation catheter that can be introduced into the spinal canal to treat pain
  • Company #865 - Next-generation needleless drug delivery devices, including an insulin pump for the treatment of diabetes
  • Company #864 - Minimally invasive products designed to enable the surgeon to rapidly, safely, and effectively decompress the cervical spine without the need to perform a discectomy, fusion, or arthroplasty
  • Company #863 - Tissue fusion via infrared laser to replace sutures
  • Company #862 - Ultrasound system that can measure true tissue elasticity in a reproducible/quantifiable/user-independent manner
  • Company #861 - Next-generation nanostructured capacitors for: 1-implantable cardiac defibrillators (ICD) and 2-microsteerable cardiac ablation and related catheters
  • Company #860 - Minimally invasive spine implant (facet versus pedicle screw)
  • Company #859 - Spine implant that allows for post-operative adjustment of the implant size via radio control
  • Company #858 - Spine fusion implant for motion preservation/dynamic stabilization
  • Company #857 - Next-generation medical devices with anti-fouling surface modifications that reduce the risk of complications over long durations
  • Company #856 - Device for the treatment of benign prostate hypertrophy (BPH), prostatitis, erectile dysfunction (ED), lower urinary tract symptoms, and infertility
  • Company #855 - Andara technology for the treatment of acute spinal cord injury
  • Company #854 - A biodegradable, biocompatible polymer scaffold specifically designed to support tissue in-growth and regeneration in the meniscus, with additional applications for the shoulder and hip
  • Company #853 - Electrodes/neural interface products for functional neurosurgery and neurostimulation
  • Company #852 - Non-systemic/non-invasive system that delivers magnetic pulses transcranially for the treatment of depression
  • Company #851 - Implantable neuromodulation device designed to electrically alter the pain signal pathways
  • Company #850 - Next-generation implants, stem cell enabling technology, and other minimally invasive surgical instruments
  • Company #849 - Invisible hearing device
  • Company #848 - Cooling and compression therapy for the relief of pain/swelling after orthopedic/other surgery
  • Company #847 - Catheter insertion systems, designed for extended IV dwell time, to eliminate the risk of related bloodstream infections
  • Company #846 - A rapid, monthly test that uses glycated albumin to monitor gestational and type 2 diabetes more effectively
  • Company #845 - Products for surgical radiofrequency (RF) ablation, valve replacement or repair, and coronary artery bypass (CABG) grafting
  • Company #844 - Biomaterial with exceptional hardness/low friction/bio-inertness that also prevents the leaching of metallic ions into the body
  • Company #843 - Disposable and needleless patch that can be placed on the body inconspicuously for insulin delivery - an alternative to daily insulin injections
  • Company #842 - Small shunt-like device implanted into the bloodstream to modify, collect, or eliminate a broad range of Target Cells
  • Company #841 - Artificial heart made of biosynthetic tissues, with two-pumps
  • Company #840 - Miniaturized, wireless monitoring heart failure (HF)sensor proven to significantly reduce HF hospital admissions and improve quality of life
  • Company #839 - Fully implantable device for the treatment of central sleep apnea in heart failure patients
  • Company #838 - Heart valve implant
  • Company #837 - Diagnostic instrument that can detect and track age-related macular degeneration (AMD) from its beginning stages, allowing for early intervention
  • Company #836 - Nanotechnology-based liquid that absorbs energy on a near-molecular scale versus relying on the mechanical properties of solid materials
  • Company #835 - Cyanoacrylate-based products for wound care and infection prevention
  • Company #834 - Femtosecond pulse laser system for various ophthalmic applications
  • Company #833 - Technology that uses the patient\'s own blood to make either: 1-A surgical sealant to prevent/stop bleedings or 2-A gel to stimulate the healing of chronic wounds
  • Company #832 - Real-time/multi-user image communication/collaboration system that consolidates images and text records into a single point of access
  • Company #831 - Polymer-based/biodegradable/drug-eluting peripheral vascular stent for tibial and infrapopliteal arteries
  • Company #830 - Ultrasound-based diagnostic biosensor that enables blood analysis at the molecular level for the patient self-testing market
  • Company #829 - Non-invasive biomechanical diagnostic system that records/analyzes range of motion (ROM) in a full 3-D environment for musculoskeletal diagnostics/therapeutics
  • Company #828 - Full Sense(TM) Bariatric Device which is implanted and extracted via endoscopy and causes satiety leading to weight loss
  • Company #827 - Continuous glucose monitoring and drug delivery devices for use in the Intensive Care Unit (ICU)
  • Company #826 - Real-time interactive training visualization system, specifically for the task of training any designated personnel in successfully accomplishing a limited "focused assessment with sonography for trauma" (FAST) examination
  • Company #825 - Molecular diagnostic tests to: 1-Differentiate between squamous and non-squamous non-small-cell lung cancer, 2-Differentiate between mesothelioma and adenocarcinoma, 3-Identify more than 20 types of cancer
  • Company #824 - Nasal stent to treat obstructive sleep apnea
  • Company #823 - 1-Pacing/sensor-enabled device for Cardiac Resynchronization Therapy (CRT), 2-Real-time modality to quantify cardiac performance, 3-System that adds ingestible microchips to drugs
  • Company #822 - Pocket-sized, affordable, and easy-to-use resuscitation devices that can be effectively deployed by both trained professionals and laymen
  • Company #821 - Wearable health monitoring system for potential diabetes, heart disease, and sleep apnea applications
  • Company #820 - Biomarkers for the screening and diagnosis of cervical and other cancers
  • Company #819 - Implantable vagus nerve stimulation system for the treatment of tinnitus and post-stroke motor rehabilitation
  • Company #818 - Smart, accurate guiding device based on image technology for orthopedic trauma procedures such internal fixation with intramedullary (IM) nails, osteotomy, and others
  • Company #817 - Non-invasive molecular diagnostics for autism, chronic obstructive pulmonary disease (COPD), multiple sclerosis, and diseases with a genetic susceptibility
  • Company #816 - Natural polymer technology that mimics the physiological clotting cascade without reliance on blood-derived proteins - to stop severe bleeding, reinforce staple and suture lines, and repair tissues
  • Company #815 - Effective and convenient phototherapy system available for in-home treatment of scalp/small-area psoriasis and other photo-responsive skin diseases
  • Company #814 - Electroporation-delivered/DNA-based vaccines against cancers and infectious diseases
  • Company #813 - Next-generation computer-assisted laparoscopic tool composed of multiple rigid elements with intervening controllable joints
  • Company #812 - Novel, ultrasound-based POC diagnostic instrument that rapidly diagnoses blood coagulation defects based on sonorheometry
  • Company #811 - Fluorescent markers/optical sensors that provide an accurate and rapid determination of kidney function
  • Company #810 - Ready-to-market medical device for assessing - via the eye - exposure to neurotoxins, cyanide, and low level radiation. Future products include assessment of mild TBI and other health conditions, including diabetic diseases of the eye.
  • Company #809 - The SatiSphere System is a non-invasive obesity device that safely and effectively uses the body\'s natural physiology to treat obesity by regulating satiation mechanisms, slowing digestion, and discouraging excessive eating
  • Company #808 - Catheter ablation for the treatment of cardiac arrhythmias
  • Company #807 - Monitoring products/clinical services for advanced ambulatory cardiac monitoring
  • Company #806 - Technology used in: 1-Finished products designed for micro-surgical/microscopy procedures and robotics and 2-Biosensors with applications in gene expression, neuroscience, and nanotechnology
  • Company #805 - Resorbable hydrogel that 1-Seals annular tears in the intervertebral disc and 2-Provides an environment for nucleus regeneration
  • Company #804 - Non-invasive/fast/easy-to-use/reliable medical devices that test for neuro-visual disorders
  • Company #803 - High-dose drug delivery system for the minimally invasive and repeatable treatment of liver cancers, colorectal cancer, and hepatitis
  • Company #802 - Technologies that integrate bone and cartilage forming peptide and small molecule therapies with osteostimulating matrices
  • Company #801 - A non-invasive, safe cardiac diagnostic system that in a 10-minute test reliably detects existence or absence of ischemia and monitors treatment efficacy
  • Company #800 - Injectable porous scaffolds/spheres/composites with fully interconnected pores, for multiple applications
  • Company #799 - Compact, remote, wireless, real-time device for biomedical monitoring such as cardiac, neurological, sleep disorder, obstetrics, orthopedic, and other vital signs outside the hospital/clinic
  • Company #798 - Permanent implant to address mitral regurgitation directly
  • Company #797 - In vitro diagnostics technology that enables the fast and sensitive detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types including whole blood, plasma, serum, saliva, sputum and urine
  • Company #796 - Next generation of minimally invasive treatments for back pain due to disc disease.
  • Company #795 - Technology that allows surgeons to rapidly treat tissue at the surgical site/reduce blood loss
  • Company #794 - A1c diabetes testing at the point of care, with results in under 4 minutes
  • Company #793 - Next- generation/predictive blood tests to help warn of potential future health problems
  • Company #792 - Vertebral compression fracture treatment
  • Company #791 - Orthopedic imaging
  • Company #790 - 1-Artificial vascular graft with self-sealing, non-woven, synthetic fiber structure, 2-Ventral hernia mesh
  • Company #789 - 1-Prohealing coronary stent as an alternative to drug-eluting stents (DES), 2-Balloon -expandable/crush-resistant nitinol peripheral stent, 3-Nano-based transcatheter, 4-Anatomy-specific combination embolic protection and stent delivery systems, 5-Localiz
  • Company #788 - The first early-stage, noninvasive combination drug-device diagnostic test for Alzheimer\'s disease; detects beta amyloid aggregates in the lens of the eye via a laser-based eye scanning device and an ophthalmic ointment
  • Company #787 - Drug-coated balloon angioplasty technology
  • Company #786 - Behavioral remote patient monitoring system that uses wireless sensors to non-intrusively track and report on the daily patterns of seniors\' activities
  • Company #785 - System that assesses, then provides therapy to develop infant feeding skills
  • Company #784 - Painless, continuous glucose monitoring
  • Company #783 - Wireless/wearable/ultra-compact device that automatically tracks/wirelessly uploads data about a person's activities (exercise intensity levels, calories burned, sleep quality, steps, distance)
  • Company #782 - Joint reconstruction device that ideally/anatomically matches the size/shape of the facet joint
  • Company #781 - Platforms for: 1- Pedicle screw fixation (even with poor bone quality), 2-Vertebral compression fractures, 3-Simple- to-use trauma products
  • Company #780 - Implantable device for maintaining adequate blood flow to the brain in patients experiencing a buildup of excess cerebral spinal fluid (CSF) due to trauma
  • Company #779 - 1- Straightforward knotless suture anchor, 2-Instrumentation for percutaneous suture management, 3- Endotendonous repair system, 4-Shape memory staples
  • Company #778 - Coagulation analyzer to eliminate unnecessary blood transfusions
  • Company #777 - Simple, rapid, blood-based cancer tests to provide accurate and individualized clinical information on disease status/treatment selection/treatment response
  • Company #776 - Neurostimulator for cardiac contractility in Acute Decompensated Heart Failure, to improve cardiac output and increase renal flow and end organ perfusion
  • Company #775 - Endoscopically delivered devices focused on slowing gastric emptying, to treat all stages of obesity
  • Company #774 - Autonomic nervous system stimulation devices for pulmonary and headache disorders
  • Company #773 - Optimization of T cell receptors (TCRs) for use in adoptive T cell therapy - to target and destroy cancerous/infected cells
  • Company #772 - Technology for wound care and slow release drug delivery, by both transdermal and subcutaneous routes
  • Company #771 - Intraoperative wavefront aberrometer for use in intraocular lens replacement surgeries
  • Company #770 - Technology to treat atrial fibrillation that allows doctors to perform radiofrequency ablation under direct visualization
  • Company #769 - Tests to "predict" chronic diseases/conditions, such as diabetes/osteoporotic bone fracture/a major cardiac event
  • Company #768 - Disposable/miniature/minimally invasive surgical devices including reusable endoscopes for visualization, initially for use in spinal surgeries
  • Company #767 - Dental implant that can be placed into a multi-rooted molar extraction site "immediately"
  • Company #766 - Bioresorbable scaffold to regenerate the ACL
  • Company #765 - Ingestible/wireless capsule with sensor technology to measure pH, pressure and temperature from within the entire GI tract
  • Company #764 - Counter-stimulation technology to treat Restless Legs Syndrome (RLS)
  • Company #763 - Minimally invasive device to treat emphysema
  • Company #762 - Gene expression test for the diagnosis of ambiguous tumors
  • Company #761 - Non-invasive, rapid, quantitative measurement of metabolic health of the retina using a novel spectroscopic biomarker
  • Company #760 - Implantable neuromodulation device for the treatment of chronic back pain and other applications
  • Company #759 - Home-use devices for hair removal/acne/skin rejuvenation
  • Company #758 - Technology that restores natural physiologic outflow as a foundation of significant/steady/sustained glaucoma management
  • Company #757 - Minimally invasive surgery system for simpler and safer soft-tissue suturing/fastening
  • Company #756 - Effective/consistent/non-invasive neuromodulation for the treatment of urinary incontinence and future applications
  • Company #755 - 1-Needleless mesotherapy to treat cellulite, 2-Non-invasive/non-thermal treatment for skin laxity/hypertrophic scars/striae
  • Company #754 - Laparoscopic instruments that articulate/rotate/lock for single port access/"scar-less" surgery
  • Company #753 - Miniature implantable sensors to accurately/continuously pinpoint the location of tumors in real-time, during radiation therapy delivery
  • Company #752 - Minimally invasive devices to treat degenerative conditions of the lumbar spine
  • Company #751 - Convenient/improved continuous glucose monitoring system
  • Company #750 - Coating that triggers the body to generate nitric oxide (NO) at the device surface, by using naturally circulating blood substances
  • Company #749 - Real-time/in vivo/cellular-level/3-D imaging for: image-guided surgery; early cancer diagnosis without a biopsy
  • Company #748 - In vivo transdifferentiation to regenerate ischemic/diseased organs
  • Company #747 - Technology that has demonstrated its usefulness in tracking all facets of in vivo oxygen metabolism using normally installed MRI scanners
  • Company #746 - True seizure "prediction" - up to an hour before the event
  • Company #745 - Wearable mobile device to accurately measure real-time energy (calorie) expenditure/combat obesity
  • Company #744 - 1-Non-embryonic cell technology that creates cells/tissues/organs for virtually anyone needing a transplant, 2-Non-toxic cancer vaccine that uses the body's natural immune response to fight cancer, 3-Cell separation system to diagnose/monitor cancer
  • Company #743 - Custom miniaturized mechanical components/devices for a broad range of medical device applications
  • Company #742 - Wireless/disposable sleep-monitoring device
  • Company #741 - 1-Next-generation, natural fibrin sealant, 2-Human thrombin
  • Company #740 - In vivo smart sensor to help women get pregnant, automatically detecting pregnancy and any early pregnancy loss, and screening for cervical cancer and other STDs, with additional uses central to women\'s health & lifestyle
  • Company #739 - Technologies that focus on wound diagnostics, infection control, and wound therapy
  • Company #738 - Wireless/MEMS-fabricated/nano-processed/dermal/percutaneous continuous glucose monitoring device
  • Company #737 - Diagnostic instrument to measure the material properties of bone
  • Company #736 - Electronic Brachytherapy (eBx) systems based upon miniaturized x-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments
  • Company #735 - Minimally invasive method for lumbar spine decompression to treat patients with lumbar spinal stenosis (LSS), which may be performed in conventional operating rooms or interventional radiology suites with fluoroscopic imaging
  • Company #734 - Next-generation respiratory device that delivers synchronization of flow/temperature/humidity/oxygen percentage, without discomfort, via nasal cannula, for patients with chronic or acute breathing disorders
  • Company #733 - Minimally invasive system to treat emphysema and resolve prolonged air leaks following lung surgery
  • Company #732 - 3-D mesh pouches that are implanted empty, positioned, filled, then deployed to their full size for spinal/orthopedic applications
  • Company #731 - Painless photo-pulsation technology for diminishing fine lines/wrinkles/age spots on the face/neck/hands
  • Company #730 - Breast implant and breast tissue expander devices
  • Company #729 - A disposable contact lens telemetric sensor, which for the first time provides ophthalmologists with a full ambulatory 24-hour IOP profile, conveniently and during uninterrupted daily activities and sleep
  • Company #728 - Technology for the non-fusion treatment of scoliosis
  • Company #727 - Atraumatic injectable plugs for 1-Temporary occlusion of blood vessels, 2-Kidney stone removal, and 3-future applications
  • Company #726 - Percutaneously deliverable endograft to treat Abdominal Aortic Aneurysms (AAA) and Thoracic Aortic Aneurysms (TAA)
  • Company #725 - Optical Coherence Tomography (OCT) for sub-surface biological tissue imaging at much greater resolution than ultrasound/MRI/CT scanners, with an initial application of non-melanoma skin cancer
  • Company #724 - Next-generation femtosecond laser that can operate inside the eye to make cataract surgery safer/more effective
  • Company #723 - Totally implantable pumps delivering targeted medications directly to the spinal cord
  • Company #722 - Point-of-care diagnostic tests for infectious diseases capable of detecting virulence markers produced only during ACTIVE infections
  • Company #721 - Therapeutic gene delivery
  • Company #720 - 1-Vertebral augmentation system and 2-On-demand ultra-high viscosity cement injection, for spinal applications
  • Company #719 - Miniature implantable neurostimulator for treating central nervous system disorders
  • Company #718 - Simple, point-of-care blood test for the detection/monitoring of traumatic brain injury (TBI)
  • Company #717 - Resurfacing system to treat lesions/defects in the body's weight bearing, non-weight bearing, and extremity joints
  • Company #716 - Molecular imaging of apoptosis (programmed cell death) for disease detection/monitoring
  • Company #715 - Technology to close incisions made during Natural Orifice Transluminal Endoscopic Surgery (NOTES) procedures
  • Company #714 - Transitional in vivo imaging
  • Company #713 - Collapsible titanium-alloy implant for spinal fusion
  • Company #712 - Non-invasive type 2 diabetes and pre-diabetes screening with no blood draw/no fasting/no waiting for a lab result
  • Company #711 - Devices for the destruction of pathogens responsible for: heart/blood/respiratory/gastrointestinal/periodontal/otological diseases, pancreatic cancer, and toe nail fungus
  • Company #710 - Device that delivers a low-level/precisely controlled heat for the treatment of acne
  • Company #709 - Nanomaterial-based MRI coil for higher image quality/faster scan times
  • Company #708 - Handheld/at-home hair removal via laser
  • Company #707 - Enhanced diabetes insulin pump that uses a smartphone-style interface, along with accessories
  • Company #706 - Transpedicular/minimally invasive approach to vertebral body reconstruction/anterior spinal column support
  • Company #705 - Next-generation Spinal Cord Stimulation (SCS) technology to treat chronic back/lower extremity pain
  • Company #704 - Dynamic and intelligent optics for use in spectacle lenses for the correction of presbyopia
  • Company #703 - Blood screening tests for breast and ovarian cancers
  • Company #702 - Implantable/battery-less diagnostic system to allow orthopedic surgeons to monitor spinal fusion progress
  • Company #701 - Next-generation coatings/advanced drug-delivery systems for cardiovascular stents and other implantable medical devices
  • Company #700 - Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) device for acute coronary syndrome (ACS) and heart failure patients
  • Company #699 - Ultra-thin/personalized/single-use/flexible/transdermal drug delivery patch
  • Company #698 - DNA-based diagnostic tests for early identification/management of cancer/acute diseases
  • Company #697 - Device with bio-active formulae to rapidly/painlessly treat/control the wound environment
  • Company #696 - Less invasive, balloon dilation technologies to treat chronic sinusitis
  • Company #695 - Leadless/implantable pacing device for left ventricular stimulation/the treatment of heart failure
  • Company #694 - Technologies to acquire/process/visualize data from 3-D breast imaging
  • Company #693 - Mental stimulation system to help maintain mental acuity/quality of life
  • Company #692 - Implantable device to treat high blood pressure that cannot be controlled with medications/lifestyle modifications
  • Company #691 - Polymer technologies for cardiac/cranio-maxillofacial/orthopedic surgery applications
  • Company #690 - Leadless/subcutaneously implantable cardiac defibrillator (ICD)
  • Company #689 - Robotic surgical instruments for use in orthopedic procedures, and other surgical specialties including neurosurgery, spinal and otolaryngology
  • Company #688 - Synthetic peptides for tissue regeneration for the treatment of musculoskeletal/vascular/chronic wound diseases
  • Company #687 - Radiofrequency (RF) energy to reshape the cornea without incision
  • Company #686 - Atherectomy system used in the treatment of peripheral artery disease
  • Company #685 - Cells derived from bone marrow which can be used in an allogeneic/off-the-shelf setting to treat kidney/other difficult to treat diseases
  • Company #684 - Thin-walled/removable/entirely covered stents designed to match the site to be treated and the surrounding anatomy
  • Company #683 - Technologies to: 1-Treat the progression of age-related macular degeneration (AMD) and retinitis pigmentosa (RP), 2-Stop/reverse some of the vision loss from Glaucoma, 3-Prevent diabetic retinopathy, 4-Greatly enhance pars plana vitrectomy surgery
  • Company #682 - Therapeutic ultrasound platform technology for use in aesthetic procedures such as lifting skin above the eyebrow, on the neck and under the chin
  • Company #681 - Low-level laser technology for aesthetics, bone healing, neck/shoulder pain, and wound healing
  • Company #680 - Light-based aesthetic systems that are pain-free/seven times faster than existing systems
  • Company #679 - 1-Image analysis technology for virus detection/analysis, 2-Antiviral drugs
  • Company #678 - Simultaneous testing of sobriety and identy that is simple/rapid/non-invasive, requiring no bodily fluids
  • Company #677 - Technology for diagnosing breast and ovarian cancers and determining responsiveness to new therapeutics
  • Company #676 - Synthetic graft/stent technology that reduces neo-intimal hyperplasia (NIH) and occurrence/rate of restenosis
  • Company #675 - Disposable endoscopic assist device that can be used with existing equipment to significantly improve flexible endoscopy procedures
  • Company #674 - Systems using radiofrequency (RF) energy for the treatment of GERD and fecal incontinence (FI)
  • Company #673 - Sutureless anastomosis systems to reduce/eliminate cross clamping time and suturing during minimally invasive surgery (MIS)
  • Company #672 - Anti-infective compounds designed to mimic host defense proteins, but with completely synthetic/non-peptide backbones, for serious, life-threatening, acute disorders
  • Company #671 - Minimally invasive interstitial laser therapy (ILT) as an alternative to lumpectomy in breast cancer and removal of benign breast tumors (fibroadenomas)
  • Company #670 - Mitral valve repair system intended to treat mitral valve regurgitation
  • Company #669 - High-resolution dermoscopy imaging technology to identify melanoma at an earlier stage/reduce the number of unnecessary excisions
  • Company #668 - Nanotechnology surface treatments for combination medical devices that address nosocomial (in-hospital) infections and thrombus
  • Company #667 - Non-invasive, fully automated system for the accurate assessment of: cardiovascular/diabetic autonomic neuropathy, effectiveness of beta-blocker therapy, and risk stratification of sudden cardiac death
  • Company #666 - Wireless/motorized orthopedic lengthening implants for applications in deformity correction/cosmetic limb lengthening/bone fractures
  • Company #665 - 3-D scaffold that enhances the biointegration of percutaneous/fully implanted current and next-generation devices
  • Company #664 - Injectable gels for localized and controlled release of biologicals
  • Company #663 - Portable/palm-held endoscopic imaging with a mobile platform for recording/sharing/archiving images
  • Company #662 - Hand-held ultrasound device to quantify strain and stiffness of tendons/ligaments
  • Company #661 - Lightweight brace support suit that restores mobility function for paraplegics/lower limb paralysis patients
  • Company #660 - Non-invasive gene expression-based tests for the monitoring of transplant rejection/autoimmune diseases
  • Company #659 - Cobalt-chromium, balloon-expandable stent, which is used in combination with a drug-eluting stent to treat the entire spectrum of coronary artery bifurcation lesions
  • Company #658 - Non-invasive intracranial pressure monitor to diagnose/treat head injury
  • Company #657 - Temperature-controlled/multi-functional next-generation cutting/sealing product
  • Company #656 - Interspinous/interlaminar functionally dynamic stabilization device and other non-fusion scoliosis technologies
  • Company #655 - CO2 lasers through flexible/rigid endoscopes for use in minimally invasive surgery and soft tissue procedures in otolaryngology/head and neck surgery/pulmonology
  • Company #654 - Real-time/PCR-based molecular diagnostic tests for life-threatening respiratory fungal infections
  • Company #653 - Ultra-lightweight/soft/non-palpable mesh technology to treat urinary stress incontinence/pelvic organ prolapse
  • Company #652 - Medipacs first-ever, solid-state polymer pump platform is the \"end-game\" for low cost, high precision drug delivery solutions and it will spawn electronic syringe products that reformulate markets
  • Company #651 - Surgical implants and biological products for spinal surgery
  • Company #650 - In situ formed hydrogels designed/indicated for ophthalmic surgery
  • Company #649 - Light-activated glue system to stabilize shattered bone
  • Company #648 - Non-contact imaging system that provides local anatomical and oxygenation information
  • Company #647 - Affordable/good quality standard-of-care surgical devices
  • Company #646 - Low-dose-rate brachytherapy that will replace individual seeds and provide more uniform/consistent radiation delivery to patients
  • Company #645 - Recombinant adeno-associated viral (AAV)-based gene therapy as a treatment for congestive heart failure (CHF)
  • Company #644 - Aortic valve bypass graft system for use as a minimally invasive, beating heart alternative to traditional aortic valve replacement therapy
  • Company #643 - Single-use catheter device w/controller that delivers radiofrequency energy during outpatient bronchial thermoplasty for the treatment of asthma
  • Company #642 - Contact and non-contact devices to advance the standard-of-care for treating wounds and other hard/soft tissue injuries
  • Company #641 - Percutaneous soft tissue lifts for the breast/neck/other soft tissue structures
  • Company #640 - Bioresorbable polymer surgical implants designed to prevent/reduce the formation of post-operative adhesions
  • Company #639 - Implanted electronic subretinal device to restore vision to those who are blind due to retinitis pigmentosa (RP) or age-related macular degeneration (AMD)
  • Company #638 - Noninvasive tests for the risk assessment of cardiovascular disease and the detection of early-stage lung/breast/colorectal cancer
  • Company #637 - Guidewire system intended to safely/quickly cross occluded peripheral and coronary vessels
  • Company #636 - Matrix therapy based technology that treats skin ulcers/reduces amputation
  • Company #635 - Artificial muscle technology for the treatment of sphincter dysfunction and urinary incontinence (UI)
  • Company #634 - Radiotherapy-activated nanoparticle technology that selectively treats only cancer cells and avoids destruction of normal cells
  • Company #633 - Full line of precision-crafted/disposable/ultra-minimally invasive surgical instruments
  • Company #632 - Beam steering/target tracking/treatment planning solutions to the external beam radiation therapy market
  • Company #631 - Device that uses combined electric field and low-intensity, noninvasive ultrasound for the treatment of solid tumors without the need for chemotherapy
  • Company #630 - 1. Vascular staplers for open surgery of abdominal aortic aneurysms (AAAs) or aorto-biliac/femoral bypasses 2. Endovascular staplers for fixation of any current stent-grafts 3. Staplers for Critical Limb Ischemia surgery, aiming to replace Femoro-Popliteal bypasses
  • Company #629 - Stent to treat cerebral/aortic aneurysms by modulating hemodynamic flow
  • Company #628 - Biomotion sensors that enable easy/non-contact capture of high-quality physiological data - remotely/wirelessly
  • Company #627 - Flexible/single-use/sterile video-endoscopes which may be used at the patient bedside and which avoid all cross-contamination risks
  • Company #626 - Therapeutic gene delivery to treat diabetes/obesity/intestinal disorders/hemophilia/anemia
  • Company #625 - Non-invasive technique for sampling the surface layers of the skin to generate individual genetic profiles for diagnostic/prognostics, for use in skin cancer, inflammatory diseases, and aging-related conditions
  • Company #624 - Non-invasive, proprietary controlled-cooling technology designed to only kill fat cells and not harm the skin or other tissue
  • Company #623 - 3-D/single-piece/dual optic accommodating intraocular lens (IOL)
  • Company #621 - Cellular therapy to act directly at the level of the cause of autoimmune disorders, the dysregulated immune regulation
  • Company #620 - Next-generation transluminally placed endovascular grafts for the treatment of aneurysmal disease in the AAA/TAA
  • Company #619 - The first tomographic, real-time, high-resolution imaging system for pulmonary disease management. The Tomophase OCTIS(TM) is being deployed in major hospitals worldwide.
  • Company #618 - Very strong/customizable/biomimetic/easily revisable artificial disc implant, requiring no assembly in situ
  • Company #617 - Diagnostic and therapeutic catheter-based devices for prevention/treatment of heart attacks caused by soft plaque
  • Company #616 - Advanced method of photocoagulation to provide more rapid, precise, and safe treatment for a variety of retinal conditions
  • Company #615 - Next-generation personal diagnostics for hematological malignancies/autoimmune disorders
  • Company #614 - Regenerative biomaterials and bioimplants processed from human amniotic membrane, with application in the wound care, surgical, sports medicine, ophthalmic and dental markets
  • Company #613 - Sirolimus-based product as a next-generation therapeutic for the treatment/prevention of wet AMD and the treatment of diabetic macular edema
  • Company #612 - Phototherapy/ultraviolet light to inactivate the organisms that cause nail infections
  • Company #611 - Technology enabling detection and monitoring wirelessly, remotely, and with no contact to the subjects; also through clothing/barriers
  • Company #610 - Biochips to identify gene expression patterns
  • Company #609 - Automated blood analysis at point-of-care
  • Company #608 - 1-Applicator for breast brachytherapy that delivers targeted dose of radiation following lumpectomy in early-stage breast cancer; 2-Surgical guidance system that uses non-radioactive, electromagnetic wave technology to detect a reflector that is placed in the target tissue up to seven days prior to lumpectomy and excisional biopsy procedures
  • Company #607 - MRI contrast agents to monitor the position/quantity of transplanted cells non-invasively in vivo
  • Company #606 - Soft tissue ligament reconstruction in the knee and shoulder, with plans to expand focus to extremity reconstruction
  • Company #605 - Non-invasive/convenient measurement and monitoring of human hydration status, using saliva as a sample
  • Company #604 - Cryotherapy to ablate diseased tissue
  • Company #603 - Reliable/accurate/solid-state laser system for customized treatment of many vision disorders
  • Company #602 - Non-invasive/iontophoretic drug delivery system with broad applicability for treating serious ocular diseases
  • Company #601 - Electrical stimulation technology, along with single-use disposables, to restore continence control to individuals with abdominal ostomies and eliminate the need for traditional ostomy pouching systems
  • Company #600 - MRI-guided laser ablation system for targeted, minimally invasive, focal tumor therapy
  • Company #599 - Soft tissue navigation technology focused on the early diagnosis of lung cancer
  • Company #598 - Non-invasive devices for the treatment of superficial venous disease
  • Company #597 - High-quality low-cost spine implants
  • Company #596 - The CoolTools family of products, which target support/microcatheterization, local vascular drug delivery, and selective hypothermia for the treatment of ischemic brain injury (e.g., stroke, cardiac arrest, trauma)
  • Company #595 - Cardiac assist device for patients in moderate/severe long-term heart failure
  • Company #594 - Digital image acquisition, coupled with proprietary CAD decision-making algorithms, to provide an immediate/automated colposcopic evaluation
  • Company #593 - Robotic system for fabrication of nano-material based wound dressings, delivered on-demand, at the POC
  • Company #592 - Spine imaging informatics technology
  • Company #591 - Electromagnetic thermal therapy to relieve pain/improve function in patients suffering from osteoarthritis
  • Company #590 - System to inactivate pathogens in all three major blood components: platelets/plasma/red cells
  • Company #589 - Therapeutic approaches to prevent the abnormal tissue growth that inhibits recovery from surgical procedures/impairs normal wound healing
  • Company #588 - Biocompatible shape memory polymers which can be programmed to change shapes/rigidity when an initiating stimulus is applied
  • Company #587 - A fully integrated, affordable, sample-to-result platform for rapid, accurate PCR-based detection/differentiation of infectious disease
  • Company #586 - Technologies that will prevent infection for many large patient populations
  • Company #585 - Light-activated drug therapy to transform cancer into a treatable chronic disease
  • Company #584 - 1-Percutaneous venous valve, 2-Inferior vena cava filter, 3-Multi-purpose/disposable laparoscopic scissor grasper, 4-Multi-sized/multi-stiffness guidewire
  • Company #583 - Non-invasive infrared imaging system for the early detection of breast cancer
  • Company #582 - Device for the treatment of sudden cardiac arrest for both in- and out-of-hospital markets
  • Company #581 - Line of antimicrobial coatings to prevent microbial colonization/biofilm formation of endotracheal tubes/other indwelling medical devices
  • Company #580 - 3-D tracking devices for use in surgical navigation and MIS
  • Company #579 - Implantable cardiac monitor system intended for patients who had prior acute coronary syndrome events, including myocardial infarctions or unstable angina, and who remain at high risk for recurrent events
  • Company #578 - Minimally invasive/RF nerve ablation to reduce of migraine headache pain
  • Company #577 - A micro-invasive implant designed to treat patients with glaucoma, a leading cause of blindness, by creating a new drainage pathway in the eye to reduce intraocular pressure
  • Company #576 - Natural cell-based technologies to restore normal neuron function in the central nervous system
  • Company #575 - Non-invasive/urine-based diagnostic assays for specific cancer types
  • Company #574 - Fluid-controlled accommodating intraocular lens (IOL) to restore vision of youth to middle-aged/elderly individuals
  • Company #573 - Single, multi-cannula laparoscopic port and specially designed curved instrumentation
  • Company #572 - Technology that provides the precision of a scalpel and the bleeding control of traditional electrosurgery, without extensive collateral tissue damage
  • Company #571 - More viable/cost-effective method for treating intracranial aneurysms
  • Company #570 - System that enables consistent tissue contact/complete lesions during cardiac ablation surgery for the treatment of arrhythmias
  • Company #569 - Lightweight, non-invasive, powered orthoses to restore function in paralyzed or weakened arms and hands such as amyotrophic lateral sclerosis or multiple sclerosis
  • Company #568 - Cerebral protection system to prevent embolic strokes
  • Company #567 - Catheter-based drug delivery using high-frequency/low-power ultrasound
  • Company #566 - RF spectroscopy technology for real-time identification/localization of cancer cell clusters to enable complete/residual-free therapeutic excisions
  • Company #565 - Third-generation cancer-associated biomarkers using proteomics
  • Company #564 - Cardiac mapping system that is non-invasive, maps the entire heart in one beat, and provides catheter localization
  • Company #563 - Repair and regeneration technology platforms designed to mend and regrow hard tissue (such as bone) and soft tissue (such as cartilage)
  • Company #562 - Minimally invasive/flexible spinal implant technology to treat vertebral compression fractures and degenerative disc disease
  • Company #561 - Catheter-based drug delivery system designed to dissolve blood clots in a single/rapid/one-step procedure
  • Company #560 - DNA-based point-of-care diagnostics for the ultra-rapid diagnosis of a broad range of infectious diseases, including chlamydia and gonorrhea
  • Company #559 - Joint prostheses as an adjunct to laminectomy/laminotomy/neural decompression/facetectomy, in lieu of fusion
  • Company #558 - Advanced trilobal pericardial valve technologies
  • Company #557 - Protective coatings for medical instrumentation to combat bacterial biofilms
  • Company #556 - Wireless ECG monitoring
  • Company #555 - Decellularization technology to remove DNA and other cellular material from tissue, leaving intact an inert acellular matrix upon which patients' cells can repopulate, for use in applications such as wound care, heart valve replacement and knee repair The potential applications of dCELL® are diverse and address critical clinical needs such as; wound care, heart valve replacement and knee repair.
  • Company #554 - Non-invasive, wearable, watch-sized metabolism measurement system that employs the use of a low-cost proprietary disposable sensor using direct-calorimetry, to accurately measure minute-by-minute caloric expenditures
  • Company #553 - Advanced, intuitive real-time imaging for abdominal minimally invasive surgery
  • Company #552 - Technology that improves vascular access accuracy and visualization of veins and arteries as well as related vascular events such as rolled veins, bifurcations, vasospasm, and extravasation
  • Company #551 - Regenerative medicine company developing novel treatments from hair growth to cancer therapies based on the products of cells grown under simulated embryonic conditions
  • Company #550 - Next-generation cell-based/tissue-engineered products
  • Company #549 - Mesh wrap for permanent implantation around the heart to prevent/reverse the progression of heart failure
  • Company #548 - Handheld/breath-based blood glucose monitor
  • Company #547 - Cancer radiation therapy system that incorporates simultaneous magnetic resonance imaging and radiation therapy delivery
  • Company #546 - Bioactive glass-ceramic material that offers whiter and less-sensitive teeth while protecting from tooth decay
  • Company #545 - Membrane optimization, coatings technologies, and development of polymers for biomedical applications
  • Company #544 - System to process/concentrate cellular components from autologous bone marrow, including adult stem cells, at the point-of-care and in just 15 minutes
  • Company #543 - Devices to control bleeding post-hysterectomy/in other cases of pelvic area trauma
  • Company #542 - Safe, non-invasive body shaping technologies
  • Company #541 - Non-invasive/fast/accurate diagnostic kits for: fertility, hormones, infectious agents, auto-antibodies, and tumor markers
  • Company #540 - Gene therapy products for the treatment of inherited/acquired diseases, including rare eye diseases
  • Company #539 - Stent technology for the treatment of atherosclerotic disease at/near peripheral and coronary bifurcations
  • Company #538 - Neo-organs/tissues derived from the patient's own (autologous) cells
  • Company #537 - Computer-controlled pressure garments for the effective treatment of lymphedema and chronic venous insufficiency
  • Company #536 - Small/portable/disposable infusion pump kit to treat post-operative pain more effectively than narcotics
  • Company #535 - Pulsatile perfusion generator technology to greatly enhance the preservation time window and organ transplant quality
  • Company #534 - Retinal prosthesis system that utilizes electrical stimulation to partially restore sight in patients blinded by outer retinal degeneration
  • Company #533 - Device to improve drainage following heart, lung, and trauma surgery, as well as other procedures where drainage is critical
  • Company #532 - Next-generation/fully-automated/electronically-controlled/self-contained blood glucose system
  • Company #531 - Minimally invasive system for treating long-bone fractures using an intermedullary stent/cement
  • Company #530 - Non-invasive measurement of magnetic fields to diagnose functional brain disorders
  • Company #529 - Products to diagnose/treat dry and wet age-related macular degeneration (AMD) and other chronic diseases involving the alternative complement system
  • Company #528 - Wearable artificial kidney device
  • Company #527 - Multi-generational devices using hybrid technologies for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
  • Company #526 - Miniature patch that dispenses insulin
  • Company #525 - Microcatheter and imaging technologies for interventional ophthalmology
  • Company #524 - Easy, safe, and convenient injection of drugs and vaccines in a solid dosage form using the Glide SDI(R) (Solid Dose Injector)
  • Company #523 - Non-epigenetic cell reprogramming technology that enables the generation of patient-identical replacement tissue/organs on an as-needed basis
  • Company #522 - Device to percutaneously repair the mitral valve
  • Company #521 - Miniature intravascular flow augmentation device for every organ that needs temporary change of flow
  • Company #520 - Minimally invasive surgical procedure intended to reduce the incidence of stroke/thromboembolism associated with atrial fibrillation
  • Company #519 - Plaque vulnerability biomarkers to detect patients at risk for the development of stroke, myocardial infarction or claudication
  • Company #518 - A platform for minimally-invasive cardiac surgery (MICS) via single-port, subxiphoid access, and an endoscope that reaches any anatomical location, including complex paths, from one single access port
  • Company #517 - Percutaneous mitral valve replacement (PMVR) for Mitral Regurgitation (MR)
  • Company #516 - Medical devices for the osteoarthritis/rhinosinusitis markets
  • Company #515 - Miniaturized ultrasound probe that is easier-to-use/more flexible
  • Company #514 - Resonating sensor made out of piezoelectric ceramics that can be miniaturized and is suitable for use in diagnostic equipment
  • Company #513 - Bioresorbable peripheral/coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty
  • Company #512 - Less invasive therapies for the treatment of obesity
  • Company #511 - True 3-D imaging to improve evaluation/planning of radiation treatments
  • Company #510 - Next-generation spinal implants
  • Company #509 - New unilateral posterior fusion technology
  • Company #508 - Products for nuclear replacement/augmentation, vertebral compression fracture repair, and spinal fusion
  • Company #507 - Second-generation, metal-on-metal cervical/lumbar artificial discs
  • Company #506 - Artificial cervical disc designed to help patients suffering from degenerative spinal disc disease, featuring controlled range of motion in all six degrees of freedom
  • Company #505 - Next-generation of biomaterials for spinal implants
  • Company #504 - Intradiscal arthroplasty device utilizing articulating PEEK-on-PEEK material
  • Company #503 - Hydrogel matrix with applications across multiple specialties
  • Company #502 - Intelligent microgels as injectable scaffolds for intervertebral disc repair
  • Company #501 - Minimally invasive disc augmentation system to repair/rehabilitate an intervertebral disc
  • Company #500 - Implant designed to retain motion following the removal of diseased disc and/or bone material in the upper spine
  • Company #499 - Tissue repair/surgical mesh systems for soft tissue repair
  • Company #498 - Silicon nitride spinal and orthopedic implants with 3-D structured cancellous ceramic for strong capillary action
  • Company #497 - Tibial knee implant for stable fixation to the medial tibial plateau without bone cuts/cement/screws
  • Company #496 - Technologies to treat obstructive sleep apnea (OSA) and snoring
  • Company #495 - Minimally invasive spine surgery devices
  • Company #494 - Tissue engineering technologies for orthopedic/sports medicine patients
  • Company #493 - Real-time imaging/image guidance for the operating room
  • Company #492 - Embolic prevention systems/thrombus management technologies and neurovascular devices
  • Company #491 - Minimally invasive vapor technology to treat emphysema
  • Company #490 - Human-based tissue scaffolds, including a biological vascular graft to provide vascular access to end-stage renal disease patients who need hemodialysis
  • Company #489 - Simple, low-cost infusion pump that contains the IV bag within it
  • Company #488 - Non-intrusive patient monitoring systems that facilitate timely intervention for cardiac/respiratory deterioration
  • Company #487 - Bifurcated stenting
  • Company #486 - Bioabsorbable implants for accurate soft tissue fixation either to apposing soft tissue/to bone
  • Company #485 - Drug delivery vehicles that can easily be targeted to specific cell types/disease state tissues
  • Company #484 - Minimally invasive therapies for interventional neuroradiology
  • Company #483 - Autologous platelet separator technology for use in cardiac, orthopedic and vascular surgeries
  • Company #482 - Cell-based therapy targeting the treatment of acute liver failure
  • Company #481 - Customizable vibration therapy devices to stimulate bone/muscle tissue
  • Company #480 - Deep brain stimulation (DBS) guidance system
  • Company #479 - Cellular imaging technology, using the Internet to transfer real-time/secure/accurate cellular resolution images
  • Company #478 - Transcatheter aortic valve implantation (TAVI) systems for the treatment of aortic valve disease
  • Company #477 - Off-the-shelf implantable allograft tissue to support peripheral nerve repair and regeneration
  • Company #476 - Advanced detection, staging, endoscopic treatment and follow-up care for acute and chronic lung disease
  • Company #475 - Minimally invasive therapy for the treatment of chronic disc pain
  • Company #474 - A minimally invasive device for stomach-reduction surgery consisting of a stapling tool that can be passed down the throat into the stomach
  • Company #473 - Kidney stone management device and urethral dilating introducer
  • Company #472 - Ventricular elastic support therapy for heart failure
  • Company #471 - Plastic medical devices for gynecological exams and surgeries
  • Company #470 - Inferior vena cava filters for the prevention of recurrent pulmonary embolism
  • Company #469 - Neuromodulation system for both traumatic brain injury (TBI) and stroke
  • Company #468 - Minimally traumatic, bone- and cartilage-preserving knee implants and instrumentation
  • Company #467 - Radio-frequency (RF)-based tissue sealing and cutting instruments with a long jaw sealing length and high quality seal to greatly reduce procedure time and surgeon fatigue
  • Company #466 - Fast, accurate, and easy-to-use in vitro molecular diagnostic products that rapidly identify infectious pathogens
  • Company #465 - Unique spinal implant designed to promote rapid fusion
  • Company #464 - Devices for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
  • Company #463 - Transcranial magnetic stimulation system that allows direct non-invasive neurostimulation of deep brain structures, for the treatment of major depression and other disorders
  • Company #462 - Dynamic "shape memory" platform to optimize mitral/tricuspid valve repair
  • Company #461 - Molecular technologies for multi-drug resistant organism (MDRO) testing that can detect more quickly and accurately
  • Company #460 - Biomaterials-based medical devices focusing on cardiovascular, metabolic, inflammatory, and fibrotic diseases
  • Company #459 - Transdermal/wound dressing/mucosal drug delivery
  • Company #458 - A unique solution similar to ring annuloplasty/edge-to-edge repair, all in one modality, for mitral valve repair
  • Company #457 - Minimally invasive devices that improve oxygenation for patients with COPD
  • Company #456 - Hands-free internal retractor/internally-anchored laparoscope camera cleaner
  • Company #455 - Particle technologies for the treatment/prevention of chronic respiratory disorders
  • Company #454 - Minimally invasive, single-procedure approach for the repair of cartilage damage/osteoarthritis
  • Company #453 - Dural sealant technology to provide watertight closure during cranial procedures
  • Company #452 - Silk-based biomaterial platforms for tissue rejuvenation/connective tissue repair
  • Company #451 - Ankle replacement implant for patients with chronic pain/arthritis
  • Company #450 - Biomarker assays for the early detection of cancer
  • Company #449 - Diagnostics for the assessment of patient motility disorders during endoscopy
  • Company #448 - Detection products for viral/bacterial infections, genetic diseases, mutations, cancers, etc.
  • Company #447 - Video integration and equipment management system to enhance the MIS market
  • Company #446 - Multi-pixel x-ray source for enhanced system performance/new capabilities
  • Company #445 - Combination ultrasound/electrical stimulation device for skin rejuvenation
  • Company #444 - Bioprosthetic two-piece tissue valve system for minimally invasive valve replacement utilizing a transapical approach
  • Company #443 - Advanced suturing technology for minimally invasive/NOTES/bariatric/cardiac/other surgical specialties
  • Company #442 - A minimally invasive electromagnetic navigation system for early detection of lung cancer
  • Company #441 - Patient-centric data system and analysis tools for translational medicine and research
  • Company #440 - Hand-held device to monitor post-operative/trauma patients for early warning signs of sepsis or infection in the bloodstream
  • Company #439 - Spinal cage with dynamic stabilization/MIS placement (3mm access) and easily revisable
  • Company #438 - Fully modular total hip replacement systems to reduce wear/add longevity
  • Company #437 - A \"plug & play\" system for treating non-invasive, curative, and palliative cancers and precursors
  • Company #436 - Products for the early detection of lung and oral cancers
  • Company #435 - System that performs a non-invasive, 30-second test to identify the risk of heart disease
  • Company #434 - Non-molecular bacterial screening, identification, and antibiotic susceptibility testing
  • Company #433 - Optical coherence tomography for evaluation of human tissue microstructure with real-time depth visualization
  • Company #432 - Wireless electronic skin patch sensors for the real-time measurement/monitoring/diagnosis/clinical management of cardiac arrhythmias
  • Company #431 - Non-fusion spinal solutions that control segmental motion/maintain the neutral zone simultaneously
  • Company #430 - Optical cell sorters used in stem cell/cell therapy treatments for cancer, autoimmune disease, and regenerative medicine applications
  • Company #429 - BQT®, a non-invasive point-of-care diagnostic test for osteoporosis and bone fracture risk
  • Company #428 - Low-mass PFO closure system capable of repairing the defect from within the tunnel
  • Company #427 - Third-generation biodegradable annuloplasty rings
  • Company #426 - Easy-to-use, instrument-free, disposable molecular diagnostic tests
  • Company #425 - 1-Bone cement to replace PMMA-based materials, 2-A liquid hydrogel wound dressing able to cure rapidly and in situ
  • Company #424 - Monitoring system to replace the manual assessment of labor progress with real-time/continuous information
  • Company #423 - Delivery of proteins and peptide drugs without burst, with near-zero order release, and with high bioavailability
  • Company #422 - Contrast agents/molecular imaging for detection using a modified porous Silicon (mpSi™) platform
  • Company #421 - Cosmetic lasers with user-validated superiority on key attributes: efficacy and safety, particularly on hard to treat darker complexions; unique multi-purpose function and portability; and industry-low cost
  • Company #420 - Knotless Anatomic Fixation System for double row arthroscopic rotator cuff repair
  • Company #419 - Biodegradable, resorbable surgical adhesives and sealants for seroma reduction in plastic surgery, and gastrointestinal leaks following surgery
  • Company #418 - Miniature blood pump, designed to be placed superficially like a pacemaker, for the long-term treatment of chronic heart failure (CHF)
  • Company #417 - Devices that use bio-electric stimulation therapy (bio-current) to treat hard-to-heal wounds
  • Company #416 - Minimally invasive catheter-based ablation technologies to treat atrial fibrillation and other cardiac arrhythmias
  • Company #415 - Transvaginal, ultrasound image-guided HIFU device, capable of real-time guidance and monitoring of therapy
  • Company #414 - A portable breath collection apparatus (BCA) which can collect breath samples virtually anywhere, for highly sensitive laboratory analysis
  • Company #413 - Automatic tools to support image visualization, lesion detection and quantification, temporal evolution assessment, and automatic reporting in chest and abdominal CT scans
  • Company #412 - RNA-based therapeutics
  • Company #411 - Wireless seizure alarm systems for people with epilepsy
  • Company #410 - Arm training device to restore arm movement in stroke patients who have experienced arm paralysis
  • Company #409 - Ophthalmic surgery solutions
  • Company #408 - Products to diagnose the risk for heart attacks by means of assessing endothelial function
  • Company #407 - Minimally invasive medical devices for patients who are at risk for or have suffered a stroke
  • Company #406 - AOKit™-bio: an adaptive optics kit for biologists which enhances microscopic imaging
  • Company #405 - Neowater®, a water-based nanotechnology which has physical properties that mimic intracellular water
  • Company #404 - Metabolomic profiling of biomarkers for the diagnosis of early forms of dementia and neurodegenerative diseases
  • Company #403 - A portable oxygen delivery and ventilation system
  • Company #402 - Interventional bronchoscopy devices for lung diseases
  • Company #401 - Advanced endotracheal tube for intubation, fitted with advanced fiberoptic visualization technology
  • Company #400 - Modular hip stem technology and total knee replacement systems
  • Company #399 - First viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure (CHF)
  • Company #398 - Fusion and non-fusion spinal implants
  • Company #397 - A device that seals blood vessels after hemodialysis as an alternative to central venous catheters for kidney-dialysis patients
  • Company #396 - Non-invasive ultrasound body contouring
  • Company #395 - Non-invasive brain stimulation technology for brain diagnostics and therapy
  • Company #394 - Noninvasive breast cancer risk assessment device
  • Company #393 - Low cost, easy-to-use, credit-card-sized devices which will allow on-the-spot quantitative diagnosis
  • Company #392 - Telemedicine paired with state-of-the-art ophthalmologic imaging
  • Company #391 - Low-intensity collimated ultrasound designed to image and treat cardiac arrhythmias
  • Company #390 - Custom implant service, alongside a portfolio of orthopaedic implants for limb salvage and complex joint replacement, in addition to a robotic bone preparation technology
  • Company #389 - Female sterilization technology
  • Company #388 - Electromedical/electrotherapeutic equipment
  • Company #387 - Products for the minimally invasive repair of bone fractures of the humerus, clavicle and wrist, among others
  • Company #386 - Molecular diagnostic products for laboratories that are intended to enhance medical care by providing early diagnostic information rapidly
  • Company #385 - New pulmonary drug delivery system
  • Company #384 - Next-generation laser therapy
  • Company #383 - Devices for the in-office polypectomy/myomectomy market
  • Company #382 - Low-cost, fast, and accurate molecular diagnostic products
  • Company #381 - EXPANSE Vertebral Body Replacement Device for use in the thoracolumbar spine
  • Company #380 - An oncology visualization system that integrates advanced graphics processing capabilities with proprietary software algorithms to register multiple CT image sets in real-time
  • Company #379 - Minimally invasive, single-use, disposable devices that enable incisionless, transoral procedures for the treatment of upper gastrointestinal problems such as gastrointestinal reflux disease (GERD) and failed bariatric surgery
  • Company #378 - Mobile phone-based data collection for chronic disease management
  • Company #377 - Advanced gene expression and DNA quantification products and services
  • Company #376 - Optical backscatter technology to improve the way cancer is detected and diagnosed
  • Company #375 - Laser, light-based, and radiofrequency devices for aesthetic and medical applications
  • Company #374 - Diagnostic methods using microarray gene expression profiling to determine specific properties of tumors
  • Company #373 - Catheter-based devices which rapidly provide quantitative data to the physician about vessel and stent size, suitable for peripheral and cardiac applications
  • Company #372 - Advanced wheelchair technologies
  • Company #371 - Human bionic devices that can instantaneously interact with the human body to replace or restore biomechanical or physiological functions
  • Company #370 - Cell-based epicardial patch designed to promote blood vessel growth in ischemic cardiac tissue
  • Company #369 - Methods for treating human tissue based on volumetric bipolar radio frequency ablation (RFA), and surface ablation of tissue
  • Company #368 - Infusing normothermic fluids from 10mL/hour-1200mL/minute with 30-second setup through a disposable cassette
  • Company #367 - Opto-acoustic imaging technology designed to locate cancerous tumors in breast tissue, via the detection of angiogenesis
  • Company #366 - High-intensity focused ultrasound in a catheter to treat atrial fibrillation
  • Company #365 - 1-Alternative to instrument-based viscosity testing; 2-A disposable blood to plasma device for use in micro-fluidic assays; 3-A home-use test for clotting time
  • Company #364 - Portable, easy-to-use consumer device that allows for easy, safe and green disposal of used insulin syringes, lancets and pen needles by vaporizing the sharp
  • Company #363 - Catheter-based micro-infusion technologies for drug delivery in blood vessels, airways, and other applications
  • Company #362 - Device based therapy targeting ischemic brain stroke and chronic heart failure
  • Company #361 - Integrated wireless monitoring
  • Company #360 - Non-invasive robotic radiosurgery system for cardiac ablation
  • Company #358 - Ceramic components for spine, orthopaedic, and other implant needs
  • Company #357 - Target-specific recombinant human protein focused on spinal fusion surgery
  • Company #356 - Patient controlled analgesia device for pain management
  • Company #355 - Advanced polymer technology meniscus implant for treating persistent knee pain caused by deteriorating or injured knee cartilage
  • Company #354 - Dual function, automatic, handheld sinus irrigator and aspirator for OTC consumer use
  • Company #353 - Computer-integrated robotic instrumentation/navigation tools for orthopedic surgery
  • Company #352 - Next-generation disposable colonoscope incorporating diagnostic/therapeutic capabilities allowing for a potentially sedation-less treatment
  • Company #351 - Total hip replacement system that addresses resistance to wear and resistance to dislocation with ceramic and double mobility
  • Company #350 - Percutaneous mitral valve replacement system for treatment of mitral regurgitation
  • Company #349 - Non-invasive continuous glucose monitoring device, for patients with diabetes, based on a multi-sensor platform
  • Company #348 - Growth factor and biomaterial addressing the needs of spinal fusion, osteochondral defects, osteoarthritis, dental medicine, and other indications
  • Company #347 - Open-sky, cryogen-free, superconductive MRI scanner that uses a U-shaped magnet with no barriers in between the patient and the environment for orthopaedic, general purpose, and interventional applications
  • Company #346 - Minimally invasive retractors for pelvic surgery to optimize pneumoperitoneum pressure and patient position (OP5)
  • Company #345 - Handheld device which measures the amount of calories a person requires to maintain body weight
  • Company #344 - Intelligent nasal drug delivery devices for topical, systemic and nose-to-brain applications
  • Company #343 - Developing a fully implantable extra-aortic counterpulsation device designed to provide long-term, cost-effective treatment and significantly improve quality of life for heart failure patients
  • Company #342 - An absolutely non-invasive, radiation- and side-effect free electro physiological high speed cardiac diagnostic system to identify upcoming heart attacks and sudden cardiac deaths
  • Company #341 - DART is utilizing an interstitial radiation source that by nuclear decay recoil mechanism emits high-energy alpha particles widely dispersed by diffusion and by convection in the tumor mass
  • Company #340 - Producer of surgical devices including a self-attaching hernia patch, anti-clog surgical drain, and cavity implosion device
  • Company #339 - Non-surgical serum based cure, proven effective for PAD, Diabetic and Cardiovascular disorders
  • Company #338 - Portable and networked medical devices such as handheld ultrasounds
  • Company #337 - Single-use rigid endoscopes, with superior image quality, at a reduced per-use cost
  • Company #336 - Providing private and hospital-based OB/GYNs, Perinatologists, and Radiologists with integrated reporting and image management systems
  • Company #335 - Neuromodulation for treating blindness-causing diseases to which there are no cures and limited approved therapies, including: Retinitis Pigmentosa (RP), Macular Degeneration, and Stargardt\'s disease
  • Company #334 - Minimally invasive surgical technology that uses ionizing radiation to treat wet age-related macular degeneration (AMD)
  • Company #333 - An automated blood glucose monitor for the intensive care unit using near infra-red spectroscopy
  • Company #332 - Human Globin, a biopolymer to replace animal collagens in dermal fillers and create biomaterials for tissue repair
  • Company #331 - Indigo Orb, Inc is a technology leader in "Automatic Detection of Epidural Cavity"
  • Company #330 - Developing and marketing EEG systems, tools and services for Neurologists, Neurosurgeons, and Neuroscience Researchers
  • Company #329 - Orthopedic products, specifically for upper and lower extremity small bone applications
  • Company #328 - Lumbar system for dynamic stabilization without fusion, artificial discs, and minimally invasive surgery systems
  • Company #327 - Reintroducing CHYMOPAPAIN, the only proven minimally-invasive therapy for herniated discs; it allows nuclear regeneration.
  • Company #326 - Implants and allograft materials for use in minimally invasive spine surgery
  • Company #325 - Surgical adhesives that serve to augment or replace sutures and staples/tacks
  • Company #324 - Revisable cervical and lumbar total disc replacement that can be converted to fusion
  • Company #323 - Proprietary, non-fusion spinal motion preservative total disc replacement technology (ErgoFlex) that provides permanent solutions for lower back (lumbar) area disc problems. The technology is easily adaptable to the entire spine and the company\'s next target area is the neck (cervical).
  • Company #322 - Two clinically proven lumbar, motion-preservation spinal implants that offer surgeons: 1-a lumbar joint replacement that has provided superior treatment over fusion and disc replacement, for patients with degenerative lumbar joint disease and 2-a posterior dynamic stabilization system used to restabilize the spine after surgery for spinal stenosis, as an alternative to lumbar fusion
  • Company #321 - Building on an exclusive intellectual property platform for both fusion and non-fusion products
  • Company #320 - Tumor necrosis factor alpha (TNF-a) inhibitor therapy for treatment of chronic persistent radiculopathy (including sciatica) related to disc herniation.
  • Company #319 - Spinal implants, cervical, thoracolumbar, interbody, bone substitutes, motion preservation
  • Company #318 - Biocellulose technology that eliminates the risks/complications/limitations inherent in animal, human, and synthetic biomaterials
  • Company #317 - Wireless patient vital signs monitoring
  • Company #316 - Disease management system for early detection of heart failure using a noninvasive cardiovascular-sleep prognostic marker
  • Company #315 - 1-Soft tissue attachment nanotechnology, 2-Bioactive/biocompatible/osteoconductive synthetic bone filler, 3-Biodegradable fiberglass fiber & composites
  • Company #314 - Noninvasive blood glucose monitor that will measure glucose in sweat in a disposable dermal patch
  • Company #313 - Affordable thermal systems that are portable, easy-to-use, and comfortable to wear
  • Company #312 - High Intensity Focused Ultrasound for incisionless male surgical sterilization
  • Company #311 - Ambulatory infusion pumps and disposables that require no programming and use pre-filled solution containers
  • Company #310 - ViaDerm - home use transdermal drug delivery system creating microscopic passageways in the top skin layer
  • Company #309 - Tools for enabling adult stem cell based regenerative medicine
  • Company #308 - Lectin-based cell adhesion technology which enables stents that traffic cells in the bloodstream
  • Company #307 - Programmable lab-on-a-chip platform for applications ranging from drug discovery to consumer diagnostics
  • Company #306 - New core biopsy technology that has been optimized to minimize the duration of image-guided biopsy procedures while addressing the specific needs of targeted medicine - to better preserve biomarker, to maximize the ratio between biopsy sample size and needle size, to streamline and automate the processing of the biopsy samples in the pathology lab.
  • Company #305 - Diagnostic, prognostic and predictive tests for cancers affecting women, including breast and gynecologic cancers
  • Company #304 - Spinal implants utilizing elastomeric polymers for non-fusion treatment of disc degeneration
  • Company #303 - ECG software for assessing acute ischemia and cardiac safety surrogates in clinical trials
  • Company #302 - Resorbable pegylated hydrogel for surgical wound sealing/adhesion prevention/sustained and targeted drug delivery
  • Company #301 - Nanotechnology-based point-of-care diagnostic tests to enable earlier and more accurate testing in hospital and pre-hospital settings
  • Company #300 - Robot-assisted stroke therapy devices
  • Company #299 - Endothelial management - less trauma combined with new agents for improved healing in vascular interventions
  • Company #298 - Digital Pulse Analyzer - provides early detection of arterial wall stiffness and biological age of arteries
  • Company #297 - Diagnostic platform with a test for measuring unbound Bilirubin for the management of newborn jaundice
  • Company #296 - Percutaneous light activation reduces intra-abdominal fat, returning Type 2 diabetic patients towards normoglycemia
  • Company #295 - 1-Cartilage implant for the knee, 2-Injectable cell therapy for the spinal disc/nucleus, 3-Bone graft extender to treat spinal deformities
  • Company #294 - Protein free induction of endochondral ossification, no human origin, not contagious, no soft tissue ossification
  • Company #293 - 1-Instant-on/instant-off proximal occlusion funnel catheter, 2-Scoring balloon with drug delivery capability
  • Company #292 - An internal adhesive biotechnology designed for strength, biocompatibility, and ease-of-use with applications in cardiovascular surgery
  • Company #291 - Technology that prepares the spinal disc for a nucleus replacement/minimally invasive fusion device
  • Company #290 - Tissue repair devices exploiting shear force transfer and large-interface substrates for adherent new tissue formation
  • Company #289 - Advanced skin biopsy and wound healing solutions to dermatology, cosmetic, primary care, and oncology clinicians
  • Company #288 - Advanced optical systems/services that are changing the way doctors evaluate and treat the eye
  • Company #287 - Non-invasive cardiac output monitoring to assess stroke volume, contractility, cardiac output, cardiac index, and thoracic fluid content
  • Company #286 - 1-Cardiovascular-directed growth factor therapeutics; 2-Endovascular catheter-based system to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events
  • Company #285 - Endovascular platform technologies for use in treating peripheral vascular disease
  • Company #284 - A bioactive ceramic that delivers better/faster spine fusion and bone repair
  • Company #283 - Percutaneously delivered implantable system to treat mitral valve regurgitation and improve congestive heart failure
  • Company #282 - Electro-grafting coating technology for implantable biomedical applications; used for the fast healing post drug-eluting-stent (DES) implantation (avoiding late stage thrombosis)
  • Company #281 - Noninvasive medical device for the treatment and prevention of obesity using controlled hypoxia
  • Company #280 - An implantable ophthalmic device to treat vision correction associated with Age-Related Macular Degeneration (AMD)
  • Company #279 - Accommodating and multifocal phakic IOLs, CE-approved for $ billion refractive IOL market
  • Company #278 - Biocompatible polymer implant to prevent or reverse the progression of chronic heart failure and mitral valve regurgitation
  • Company #277 - Noninvasive device used in the differential diagnosis of disc or facet mediated low back pain
  • Company #276 - Surgical stapling devices for open and laparoscopic procedures developed for the growing China market
  • Company #275 - The first-and-only, fully self-contained, low-cost, and market-proven disposable iontophoretic patch - topical drug delivery platform for enhanced penetration and efficacy
  • Company #274 - IBraces - 100% customized, invisible orthodontic braces designed for efficient, effective treatment of teens and adults
  • Company #273 - Flash Ultrasound
  • Company #272 - Free-floating optical probe with multiple LD scanning and magnetic stabilization for noninvasive blood glucose monitoring
  • Company #271 - Repositionable/removable percutaneous heart valve, precision controlled delivery device, and calcified valve encapsulation system
  • Company #270 - Next-generation estrogen-based drug-eluting coronary stent and an orthopedics/sports injury pain management device
  • Company #269 - Heart pump that achieves superior flow and pressure performance, mimicking the physiological performance of the human heart, and reducing post-surgery kidney failure, mortality, and complications cost by 50%
  • Company #268 - Porcine-derived tissue devices for ligament, cartilage, bone, and soft tissue replacement and augmentation
  • Company #267 - MIS platform technologies for creating cavities in tissue and partially molding an orthopedic implant in situ
  • Company #266 - Orbital atherectomy for the treatment of coronary artery and peripheral vascular disease
  • Company #265 - Functional brain imaging centers that identify Alzheimer's, brain injury, stroke, ADHD, bipolar, depression, anxiety, OCD
  • Company #264 - A protein therapeutic biotreatment that regresses solid tumors and protects against relapses
  • Company #263 - Analyze, search, store, mine, share and unlock the power of digital tissue images
  • Company #262 - Smart devices to harness human physiology for health care, industrial safety, and law enforcement applications
  • Company #261 - Medical devices for wound management and surgical soft tissue repair
  • Company #260 - Facet fixation system that is a less-invasive/faster alternative to pedicle screw fixation
  • Company #259 - The Extremity Compartment Syndrome (ECS) System is being launched as the only FDA-cleared continuous monitoring device that assists physicians with diagnosing a limb-threatening complication
  • Company #258 - Shielded reciprocating tissue sculpturing instrument, able to navigate into neural foramen to relieve nerve compression
  • Company #257 - 1-LIFEBACK® Spine Programs for non-operative and post-operative spine patients and 2-the LTX 3000® Rehabilitation System
  • Company #256 - Stable and extractable self locking intramedullary nails and proximal femoral fixation
  • Company #255 - Emperor Mobile Spinal Disc, P.E.E.K Cages, Pedicle Screw System, and Saturn Hip Resurfacing
  • Company #254 - Rapid table-mounted retraction/surgical site access for MIS placement of hip/knee/shoulder/spine implants
  • Company #253 - Lumbar dynamic stabilization with MIS compatibility and pedicle screws
  • Company #252 - Real-time image-guidance technology with an FDA-accepted accuracy claim of +/-1mm at 1 meter
  • Company #251 - Noninvasive, ambulatory, portable, 3-D traction technology providing an effective and unique therapy for spinal disorders
  • Company #250 - Fusion technology platforms and second-generation artificial discs for the cervical and lumbar spine
  • Company #249 - A biological and mechanical solution to annular repair and spine fusion
  • Company #248 - Low-profile implants and less invasive surgical instruments to treat spinal disorders, utilizing fusion and non-fusion technologies
  • Company #247 - A CE-marked resorbable plating system for cervical fusions allowing for load sharing
  • Company #246 - Biomaterials-based product that augments or replaces the diseased nucleus pulposus of the spinal disc
  • Company #245 - Nitric oxide-based therapies to accelerate healing of tendon, bone, and other musculoskeletal tissue
  • Company #244 - Drug product for the treatment of acute spinal cord injury, cancer, macular degeneration, and glaucoma
  • Company #243 - Synthetic bone that duplicates the microstructure, composition, and performance of human bone
  • Company #242 - Implanted oscillating field stimulation device which regenerates acute and sub-acute damaged spinal cord nerve tissue
  • Company #241 - PuraMatrix injectable synthetic nanofibrous hydrogels for bone, cartilage and soft tissue regeneration, and drug delivery
  • Company #240 - Non-surgical assistive device for orientation, mobility, object identification, and spot reading by individuals who are profoundly blind. The device translates digital information from a video camera into electrical stimulation patterns on the surface of the tongue
  • Company #239 - Naturally occurring neuropeptide to treat ischemia associated with myocardial infarction, heart failure, and angina
  • Company #238 - Miniature/patient-controllable/valved catheter to improve quality of life/decrease urinary tract infections in patients suffering urinary retention
  • Company #237 - Phase-shifting technology for Contrast Ultrasound imaging
  • Company #236 - Innovative, implantable, combination drug+device products that utilize novel biomaterials. TYRX\'s first commercially available products include the AIGISRx(R) Antibacterial Envelope & Flat Sheet technologies, designed to reduce surgical-site infections associated with Cardiac Implantable Electronic Devices (CIEDs).
  • Company #235 - Laparoscopic surgical access technology device for use in abdominal surgeries that insufflates the rectum and provides continuous smoke evacuation
  • Company #234 - Theramers
  • Company #233 - Respiratory diagnostics for noninvasive assessment of airway acidification in Asthma, COPD, and GERD
  • Company #232 - A "preventative" vaccine for HIV-AIDs
  • Company #231 - Post-proteomics multiplexed MS-based diagnostics/theranostics linked to drug development and personalized medicine
  • Company #230 - Image-guided therapy for metastatic liver disease
  • Company #229 - Biomaterial that regulates resorbability and enhances bone regeneration
  • Company #228 - Drug/device products for post-operative pain and orthopedic drug delivery indications using syntinate synthetic absorbables
  • Company #227 - Ultrasonic surgical devices for neurosurgical, spinal, advanced wound care, and general surgery procedures
  • Company #226 - Multi-channel implantable microelectrodes for deep brain stimulation and recording, enabling enhanced neuromodulation therapies
  • Company #225 - Aesthetic treatment device using collimated high-energy light and laser, delivered simultaneously by fiber delivery system
  • Company #224 - A remotely controlled, wireless-powered implantable 230-channel nerve stimulator built on a 15
  • Company #223 - Real-time, noninvasive monitoring of blood loss, anemia, and other vital blood measurements
  • Company #222 - Hand-held diagnostic devices for head injury and stroke based on near infrared (NIR) technologies
  • Company #221 - Fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify lipid rich plaques in the coronary arteries
  • Company #220 - Laparoscopic surgeons maintain direct control of the laparoscope movement/placement with GMP's Laparocision
  • Company #219 - Automated, non-destructive, rapid microbial detection for quality control testing of pharmaceutical and personal care products
  • Company #218 - World\'s smallest leg compression device for the prevention of deep vein thrombosis (DVT) in surgical patients, as a safe and effective alternative to Lovenox, for a significantly reduced price
  • Company #217 - Ultraviolet light technologies for the inactivation of RNA viruses in/out of the body
  • Company #216 - Minimally invasive percutaneous neuromodulation pain therapy
  • Company #215 - The Axya Shoulder Fixation System generates ultrasonic energy for knotless suture welding in shoulder surgery
  • Company #214 - Gene-based products for the diagnosis and treatment of spinal disorders
  • Company #213 - A platform aerosol drug delivery nebulizer device for multiple- and single-use applications with disposables
  • Company #212 - Non-invasive continuous measurement of tissue oxygenation for various intraoperative and post-operative applications
  • Company #211 - Peripheral vascular stents and grafts with increased patency by improved flow dynamics, reducing stenosis and restenosis
  • Company #210 - 1-Next-generation liquid embolic for treating cerebral aneurysms and arteriovenous malformations (AVMs); 2-Two wound management products that will be out-licensed
  • Company #209 - SurfLink
  • Company #208 - A line of self-apposing bare-metal and drug-eluting coronary stents
  • Company #207 - Monitoring products based on microsensor technology allowing minimally invasive, real-time measurement of clinical chemistry parameters and therapeutic drug concentrations
  • Company #206 - Noninvasive, outpatient bariatric device for overweight/obesity
  • Company #205 - A suite of tools for automated CT Angiography (CTA) diagnostics for Coronary Artery Disease
  • Company #204 - Magnetically actuated telescopic intramedullary (IM) nail activated by an induced low power directional magnetic field
  • Company #203 - Transdermal delivery system of levodopa (L-DOPA) for the treatment of Parkinson's Disease
  • Company #202 - Immediate, active, device-less, and painless topical drug delivery, of small/macromolecules, for local/systemic indications
  • Company #201 - Endotracheal tube with video, self-locking orthopedic implants, structured TPN lipids, cell therapy for cancer, etc.
  • Company #200 - Products that digitize manual breast examination tissue elastic properties into objective computerized visual maps/reports
  • Company #199 - Technology for the manipulation of adult stem cells to repopulate chronically diseased liver tissue
  • Company #198 - Non-invasive airway clearance in ICU patients to prevent ventilator associated pneumonia
  • Company #197 - Unique add on and removable needle safety product that fits to standard glass/plastic syringes
  • Company #196 - Endoscopic device for tumor ablation via ERCP using radiofrequency energy in patients with advanced and inoperable pancreatic cancer and cholangiocarcinoma
  • Company #195 - Non-invasive screening of Peripheral Arterial Disease (PAD), combining postural/infrared blood volume testing
  • Company #194 - Tissue fixation implants, injectable bone grafting biomaterials, and tissue scaffolds with drug releasing properties
  • Company #193 - Miniature implantable, continuous blood glucose sensor for diabetics, incorporating noninvasive wireless monitoring
  • Company #192 - Coronary guidewire, to provide real-time ultrasonic measurement of coronary arteries to determine stent size and apposition without exchange of catheters
  • Company #191 - Bioabsorbable, bioactive, and drug-releasing medical device products for various fields of surgery
  • Company #190 - 1- Interventional single-use cardiac support device and drug delivery platform, 2- Implants for use in/with magnetic resonance imaging (MRI) systems
  • Company #189 - A tubular valve implanted through the mouth during an ambulatory procedure for the treatment of gastroesophageal reflux disease (GERD), although future applications for the technology include obesity and irritable bowel syndrome
  • Company #188 - Cellular implants for orthopedic, trauma, and spinal applications based on a biological form stable matrix
  • Company #187 - SmartStep
  • Company #186 - Dynamic optimization of pacing intervals according to hemodynamic sensors for CRT devices
  • Company #185 - Neuro-monitoring systems for brain protection and stroke acute care in stroke units, cardiovascular ORs, during stenting, and in the ICU
  • Company #184 - Medical devices that enable diabetes disease management and the prevention of lower extremity amputations
  • Company #183 - Customized miniature disposable stereoscopic cameras that provide 3D vision, measurements, and image fusion in real-time
  • Company #182 - Infusion catheter for treatment of tumors which are unresponsive to systemic chemotherapy by the local delivery of drugs and other agents
  • Company #181 - Non-invasive imaging tool designed to provide automated, 3-D ultrasound images of the breast
  • Company #180 - RFID hardware and software platform for test tubes/ apheresis device for blood component separation
  • Company #179 - Saliva-based consumer diagnostic systems, which enable the development of personalized therapeutics
  • Company #178 - Disposable, noninvasive, pump-less, and valve-less automatic blood pressure monitor "on-a-chip"
  • Company #177 - Noninvasive neural vision enhancement
  • Company #176 - Nanotechnologies for use in orthopedic implants, dental implants, and stents
  • Company #175 - Specialty and standard electrophysiology catheters that have superior performance, advantageous features, and are affordable
  • Company #174 - Dedicated angioplasty and stent systems for the treatment of arterial bifurcations
  • Company #172 - System to ablate cardiac tissue as a means to potentially treat atrial fibrillation
  • Company #171 - Point-of-care IVD platform that provides rapid, accurate, automated laboratory testing using low cost, disposable biochips
  • Company #170 - Interventional MRI technology for cardiovascular imaging including detection/treatment of vulnerable plaque
  • Company #169 - System analyzes a patient's susceptibility to cardiac arrest and consequent need for implantable defibrillator
  • Company #168 - Patient recovery system for cosmetic and reconstructive surgery
  • Company #167 - Microscope slide scanners and information management software that enable the digitization of pathology
  • Company #166 - SutureLock - a versatile suture-securing knot-replacement device for endoscopic wound approximation
  • Company #165 - Multi-Sensing Wireless Catheter platform attached along the GI-Uro tract detecting GERD, incontinence, and other abnormalities
  • Company #164 - Noninvasive medical device providing low-risk hypoxic treatment that induces appetite suppression and weight loss
  • Company #163 - Minimally invasive telemetric and continuous measurement of left atrial blood pressure at heart failure
  • Company #162 - Catheter-based photoreactive treatment system for endovascular intervention in coronary and peripheral atherosclerotic disease
  • Company #161 - Transcatheter mitral valve repair technology offering minimally invasive treatment option for mitral regurgitation/congestive heart failure
  • Company #160 - A platelet reactivity test to measure the effect of anti-platelet drugs, particularly aspirin and Plavix
  • Company #159 - OmniWave(R) catheter-based technology that delivers transverse ultrasonic energy to targeted thrombus in a diseased blood vessel, without damaging the surrounding vessel walls
  • Company #158 - A portable laseroptical system for noninvasive differentiation between ischemic stroke and spontaneous intracerebral hemorrhages
  • Company #157 - Alginate-based embolic material designed to fill blood vessel defects thereby displacing blood pressure effects and preventing vessel rupture
  • Company #156 - A wearable continuous ultrafiltration device that removes fluid overload in patients with Congestive Heart Failure
  • Company #155 - Minimally-invasive cardiac implantable devices for treating mitral valve regurgitation without atriotomy or cardiopulmonary bypass
  • Company #154 - Surgical and percutaneous cardiac valve repair
  • Company #153 - Annuloplasty system for treating functional mitral and tricuspid regurgitation
  • Company #152 - Pressure and flow sensing systems for vascular and other applications
  • Company #151 - Advanced ECG-heart sound analysis to enable superior diagnosis/monitoring of CHF/ACS patients
  • Company #150 - Minimally invasive interventional radiology/vascular surgery devices
  • Company #149 - PeriVasc
  • Company #148 - Perfusion monitoring for preventing septic shock, the greatest hospital mortality
  • Company #147 - A noninvasive test for endothelial dysfunction using digital (fingertip) thermal monitoring
  • Company #146 - Transcatheter aortic valve replacement system
  • Company #145 - Catheter-based therapy which increases cerebral perfusion for the treatment of ischemic stroke and vasospasm
  • Company #144 - Catheter-based devices to reconstruct the ventricle and downsize the heart volume
  • Company #143 - Non-invasive device using muscular counter pulsation (MCP) technology for the treatment of acute and chronic heart failure (CHF) in a clinical, ambulatory, or at-home setting
  • Company #142 - 1-Bio-therapeutic designed from autologous stem cells and committed to a cardiac lineage before implantation, 2-Corresponding catheter for accurate transmyocardial injection
  • Company #141 - Minimally invasive device-based technologies targeting the treatment of hemodynamic instability and perfusion
  • Company #140 - Peptide-based therapeutic to enhance stent/graft patency
  • Company #139 - Biomimetic coronary stent coating that prevents restenosis/reduces the need for extended courses of dual antiplatelet therapy
  • Company #138 - Disposables for drawing blood -- percutaneous or from a catheter -- neonates to geriatrics
  • Company #137 - Electrode sensor array, with integrated lead wires, simple, accurate and repeatable ECGs
  • Company #136 - In vivo plasmapheresis and ultrafiltration to remove excess fluid from CHF patients in clinical trials
  • Company #135 - Noninvasive therapeutic ultrasound to enhance perfusion for treatment of acute myocardial infarction
  • Company #134 - Affordable handheld metabolic monitor (indirect calorimeter) with both medical and consumer weight management applications
  • Company #133 - Unique microsphere-based technology for chronic/acute wounds
  • Company #132 - Technologies that utilize flexible cross linking and sterilization processes which stabilize and sterilize biological tissue for use in orthopedic, wound, oral/dental, spine and neurological, breast, abdominal and thoracic applications
  • Company #131 - Devices for mechanically induced bone growth, together with a \"smart device\" system for risk management
  • Company #130 - Nitric oxide releasing surface treatments for enhanced biocompatibility in medical devices
  • Company #129 - Automated implantable pump systems for managing fluid overload in patients suffering from liver disease, cancer and congestive heart failure
  • Company #128 - Minimally invasive surgical access system used in laparoscopic surgery
  • Company #127 - Long-term, miniature drug delivery implant with physician- controllable, zero-order release characteristics
  • Company #126 - 1-Single-use, patented, disposable, hemorrhoid banding system; 2-Two-tier colon cancer diagnostic screen, Fecal Occult Blood Testing (FOBT)
  • Company #125 - Minimally invasive transcatheter mitral valve replacement technologies and minimally invasive devices for the treatment of refractory angina
  • Company #124 - Unique minimally invasive implantable therapy to treat the root cause of functional mitral valve regurgitation, the dilated ventricle
  • Company #123 - Light-based therapy for eradication of ulcer-causing Helicobacter pylori
  • Company #122 - Developing a digital health, non-invasive RF sensor and AI analytics system that improves care management of patients living with: 1) respiratory distress and lung diseases and 2) congestive heart failure (CHF) in hospital, ambulatory, and home settings.
  • Company #121 - Enteric Dialysis with Kibow Biotics - a food-grade microbial Gel cap formulation towards kidney failure applications
  • Company #120 - IYIA has developed a proprietary, clinically effective device, O2Misly, for treating slow healing foot wounds, primarily diabetic foot ulcers
  • Company #119 - Genetic and personal history based testing to predict age-specific risk of breast cancer diagnosis
  • Company #118 - Controlled fluid delivery system for every medical application without batteries or power cords
  • Company #117 - Non-contact intelligent medical vigilance for the hospital
  • Company #116 - Capture and analysis of heart sounds leading to rapid and accurate diagnosis of cardiac pathologies
  • Company #115 - Blood test that screens/diagnoses cervical cancer without need of a cervical exam/pap smear
  • Company #114 - Implantable Left Ventricular Assist Device (LVAD) for heart failure
  • Company #113 - Bioabsorbable drug eluting stents and stent coatings for treatment of vulnerable plaque and coronary stenosis
  • Company #112 - Electronic pill for oral delivery of low bioavailability drugs
  • Company #111 - Microsyringe delivery of cells, genes, and drugs to the vasculature/deep tissues of the body
  • Company #110 - Percutaneous noninvasive heart valve replacement
  • Company #109 - Molecular FingerPrinting process for early-stage diagnosis of cancer, enabling point-of-care therapeutics based on gene regulation
  • Company #108 - Bioabsorbable vascular closure system that facilitates rapid hemostasis following diagnostic and interventional endovascular procedures
  • Company #107 - Totally implantable LVAD that does not interface with circulating blood
  • Company #106 - Blood test for breast cancer measuring 5 protein biomarkers using super-sensitive ELISA with 95% accuracy
  • Company #105 - Ablation technology that delivers radiofrequency energy endoscopically, to eliminate Barrett\'s esophagus and prevent esophageal cancer
  • Company #104 - A device for the left atrial appendage for stroke prevention in patients with atrial fibrillation
  • Company #103 - Noninvasive monitor to measure exhaled nitric oxide for the management of asthma
  • Company #102 - Microplate-based electronic biosensor system for label-free, real-time cell based assays
  • Company #101 - Interactive intraoperative CT scanning technology for image-guided interventions
  • Company #100 - High Intensity Focused Ultrasound for minimally invasive thermal treatment of disc herniation without disc penetration
  • Company #99 - Percutaneous systems to treat lower back pain
  • Company #98 - Least invasive approach for the delivery of lumbar fusion and motion preservation therapies
  • Company #97 - Telemeterized natural motion elastomer disc
  • Company #96 - Interspinous process implant to treat Lumbar Spinal Stenosis (LSS)
  • Company #95 - Clinical expertise, facility development, new technology, and business services including marketing and contracting
  • Company #94 - Less invasive products for the treatment of spinal deformities, without the need for braces or extensive future spinal fusion surgeries
  • Company #93 - Lumbar, thoracic, and cervical fusion devices including less invasive instrumentation; lumbar and cervical artificial discs
  • Company #92 - Lumbar spine motion preservation via dynamic stabilization utilizing a semi-rigid rod and screw system
  • Company #91 - Integrated interbody fusion devices for patients with degenerative disc disease
  • Company #90 - Compliant artificial lumbar disc with graduated modulus for restoration of normal spine biomechanics/enhanced durability
  • Company #89 - 1-Synthetic alternatives to autograft/cadaver-based bone material, 2-Surgical hemostat as an adherent matrix/impermeable barrier to blood flow, 3-Bone augmentation material for injections in osteoporotic spines to treat vertebral compression fractures
  • Company #88 - Orthopeutics, LP introduces Intrabrace a new non-surgical, injectable treatment for resisting spinal curvature in scoliosis.
  • Company #87 - Bioactive synthetic bone graft substitute that is osteostimulative, osteoconductive, antimicrobial, and hemostatic
  • Company #86 - Next-generation fusion, motion sparing, and minimally invasive spinal implant products
  • Company #85 - Minimally invasive fusion system
  • Company #84 - High velocity water jet technology for minimally invasive applications in wound care, spine surgery, interventional pain and orthopedic sports medicine
  • Company #83 - Osteogenica - bone marrow concentration system
  • Company #82 - Dascor Arthroplasty System, spinal implants technology
  • Company #81 - Medical devices and implantable living tissues used in cardiac and vascular surgical procedures
  • Company #80 - Second-generation, viscoelastic artificial lumbar and cervical disc technologies
  • Company #79 - Three-dimensional surgical visualization technologies and expanding portfolio for digital surgical environment and digital healthcare network
  • Company #78 - Real-time disposable stereotactic navigation devices for biopsy/targeted therapy compatible with CT, fluoroscopy, and MRI
  • Company #77 - Minimally invasive cancer therapy using Magnetically Energized (ME) Thermotherapy
  • Company #76 - Magneto-Optical Enantiomeric Detection (MOPED) for real-time, non-contact analysis of chiral pharmaceuticals
  • Company #75 - First noninvasive, transcutaneous sensor array that continuously monitors peripheral circulation and/or core body temperature
  • Company #74 - Disposable balloon cervical dilator for improved uterine access that decreases pain, avoids tearing and perforations
  • Company #73 - Biological therapeutics for the treatment of neurological disorders including: Alzheimer\'s disease, epilepsy, Huntington\'s disease, Parkinson\'s disease, and neuropathic pain
  • Company #72 - Complete line of disposable connectors, cannula, tubing, and accessory packs for use in cardiopulmonary bypass, extracorporeal membrane oxygenation (ECMO), and cardiac surgery
  • Company #71 - Catheter-based sealing of heart defects associated with stroke, migraine headaches, and other brain attacks
  • Company #70 - Technology for imaging peripheral nerves in regional anesthesiology, pain management, and other markets
  • Company #69 - Nanomagnetic particles enabling controlled drug delivery and elution for drug targeting and medical device applications
  • Company #68 - MRI-compatible, minimally invasive, precision-guided laser therapy for the treatment of brain tumors
  • Company #67 - Implantable blood pump with magnetic levitation technology for patients suffering from heart failure
  • Company #66 - Virtual Bone Biopsy MRI scanner add-on, allowing noninvasive imaging of bone microstructure for osteoporosis monitoring
  • Company #65 - A surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner
  • Company #64 - Nanotechnology-based cancer therapy with contactless activation of tumor-specific nano-particles, adaptable to all solid tumors
  • Company #63 - Point-of-care platform technology for assessing risk of cardiovascular disease and renal dysfunction
  • Company #62 - Continuous blood gas monitoring and cardiac output measurement for the intensive care unit
  • Company #61 - Non-blood contacting, active implantable direct cardiac compression device for the treatment of CHF
  • Company #60 - Augmented reality simulators that train surgeons in the skills required for minimally invasive surgery
  • Company #59 - Continuous, non-invasive glucose monitor for tight glycemic control at the hospital and at home
  • Company #58 - ERBLAN MIS Surgical Devices allow safe entry into virtually any actual or potential anatomical space
  • Company #57 - Technology that non-invasively measures/monitors mechanical heart function and disease utilizing a disposable brachial cuff
  • Company #56 - Nd:YAG and Ho:YAG medical lasers for the aesthetic surgery, endovenous, general surgery, and cardiovascular markets
  • Company #55 - Micro-porous ceramic wound treatment device that creates optimal conditions for normal wound healing
  • Company #54 - Direct, real-time vision through flowing blood to guide therapy inside the heart and vessels
  • Company #53 - Cath lab solution providing rapid onset of circulatory support in patients with acute heart failure
  • Company #52 - Novel bone void filler made from magnesium which provides a resorbable and biocompatible binding platform for synthetic bone grafting following trauma
  • Company #51 - AepEX auditory evoked potential depth of anesthesia monitor and aepEX-Fusion servo-controlled anesthesia delivery system
  • Company #50 - Posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion
  • Company #49 - Site-specific biological and drug delivery
  • Company #48 - HistoScanning(TM) is an innovative imaging-based modality available in the Tissue Characterization market; the only one offering accurate 3D detection and localization of cancer lesions
  • Company #47 - Non-irritating dry electrodes now enabling long-term cardiac monitoring
  • Company #46 - Non-incisional female sterilization
  • Company #45 - Biopharmaceuticals targeting osteo-renal indications, including the complications of chronic kidney disease and dialysis, bone and cartilage repair and regeneration, and general dental and oral care
  • Company #44 - Portable, compact, easy-to-use automated external defibrillators with full energy delivery and complete resuscitation solutions
  • Company #43 - Rapid, point-of-care in vitro diagnostics
  • Company #42 - Endoscopy systems allowing physicians to see very small, early-stage cancer and subtle pre-cancerous lesions
  • Company #41 - Surgical instruments employing thermal welding technology to seal and cut tissue
  • Company #40 - Minimally invasive disc replacement for chronic back pain
  • Company #39 - A smart, communicating cigarette case, online support, and daily e-mails delivering an effective stop-smoking method
  • Company #38 - A wireless personal emergency alert system that integrates with, and enhances, existing implanted medical devices
  • Company #37 - Artificial total intervertebral disc capable of normal physiological movement and weight loading
  • Company #36 - Catheters designed to diagnose, terminate, and treat cardiac arrhythmia during EP and ablation procedures
  • Company #35 - Conservative Motion Preservation technology including minimally invasive facet joint replacement
  • Company #34 - Miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness
  • Company #33 - System that prevents embolic events by removing plaque and thrombus found in diseased arteries
  • Company #32 - Bioresorbable polymer implants for use in a variety of orthopedics and spine surgical applications
  • Company #31 - Liposomal formulation of recombinant IL-2 for use as chemotherapy or cancer vaccine adjuvant
  • Company #30 - Helical stent providing enhanced abilities and flexibilities in drug delivery, scaffolding, and embolic protection
  • Company #29 - Trabectome, an FDA-cleared, minimally invasive medical device technology for the treatment of open angel glaucoma
  • Company #28 - ACDx uses novel, patented algorithms, AI and advanced functions to reduce MRI-impacting artifacts to improve image quality & patient safety monitoring, reduce exam times and deliver enhanced decision-support data.
  • Company #27 - Prevention of scarring caused by disease, medical intervention, or trauma via a beta emitting biopolymer
  • Company #26 - Noninvasive, site-specific drug delivery technology to deliver compounds to the posterior segments of the eye
  • Company #25 - Real-time, CT-guided, robotically controlled needle drivers for minimally invasive cancer therapy
  • Company #24 - Automated, continual blood glucose monitoring for critically ill patients
  • Company #23 - Molecular diagnostics based on patented, standardized, next-generation, multi-gene expression (StaRT-PCR) products and high margin services
  • Company #22 - THERMOCEPS - a handheld, wireless device that stops bleeding during surgical procedures using focused, thermal coagulation
  • Company #21 - Interventional catheter system for the mechanical recanalization of arterial chronic total occlusions quickly and reliably
  • Company #20 - Portable automated critical care neuro instruments using advanced digital signal processing technology
  • Company #19 - Monitor for autonomic nervous system displaying sympathovagal balance in real-time for diabetes/ anesthesia/cardiology applications
  • Company #18 - Branched endografts for aortic disease
  • Company #17 - Next-generation biomaterials using bioactive-ceramics technology platform
  • Company #16 - Immunodiagnostics of placental recombinant markers to screen the risk of preeclampsia, preterm delivery, and IUGR
  • Company #15 - Methods for eyebrow lifting, non-thermal loading of degradable matrices, and degradable implants
  • Company #14 - Non-invasive modality for the treatment of insulin resistance/diabetic neuropathy
  • Company #13 - Minimally invasive needle biosensor for in vivo glucose or lactate monitoring of intensive care patients
  • Company #12 - Osteobiologic products based on a proprietary small peptide technology on anorganic bone mineral
  • Company #11 - MIST Therapy using non-contact ultrasound to stimulate healthy cells allowing chronic wounds to heal
  • Company #10 - Arthroscopic surgical devices
  • Company #9 - Electronic device that closes the gap between drugs and surgery in osteoarthritis of the knee
  • Company #8 - Cell-based therapy products for the treatment of heart failure secondary to myocardial infarction
  • Company #7 - A five-carbon carbohydrate that increases cellular energy, improving cardiovascular health and tissue function
  • Company #6 - Proprietary, clinically validated technology using near infrared light therapy for regenerative medicine
  • Company #5 - Next-generation non-vascular interventional pulmonary and gastrointestinal stenting technology
  • Company #4 - A respiratory dialysis product comprising a controller, cartridge and catheter; intended to replace or supplement mechanical ventilation in intensive care unit (ICU) patients with acute hypercapnic respiratory failure
  • Company #3 - Intravascular temperature management systems and catheters for cardiac and neuro intensive care patients
  • Company #2 - Implantable devices for the endovascular treatment of hemorrhagic stroke
  • Company #1 - Ultrasound catheters for targeted thermal ablation of tumors
Contact Us

Need help finding medtech research? Let us help you!